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Chiral boronic esters are valuable synthetic intermediates widely used in a variety
of stereospecific transformations. Transition metal-catalyzed asymmetric hydroboration
(CAHB) of alkenes is among the most popular methods for their preparation.
Enantioselective hydroboration of activated alkenes (i.e., vinyl arene derivatives or
conjugated carbonyl compounds) have been extensively studied by many research
groups. We, on the other hand, are interested in enantioselective hydroboration of
unactivated alkenes utilizing coordinating functional groups (e.g., carbonyl derivatives)
to give functionalized, chiral boronic esters. While conjugate addition and C–H activation
methodologies provide efficient alternatives to CAHB for enantioselective -borylation
of carbonyl compounds, direct - and -borylations were essentially unknown prior to our
wok on CAHB. The -borylated products were used for understanding stereochemical
aspects of Suzuki–Miyaura cross-coupling reactions resulting in stereoretention and in
contrast to similar -borylated carbonyl derivatives reported in literature. Some other
selected transformations were carried out to construct a number of biologically relevant
structural motifs, such as lignan precursors, 1,4-amino alcohols, -amino acid derivatives,
5-substitued--lactone and lactam ring systems. In addition, collaborative experimental
and computational studies of the enantioselective desymmetrization via CAHB gain a
better understanding of the mechanistic pathways.
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PREFACE
The first chapter of this dissertation is an overview of the current state-of-the-art
in the enantioselective preparation of chiral boronic esters, versatile intermediates used in
many stereospecific transformations. Giving a brief discussion on alternative methods,
the introductory chapter mainly focuses on transition-metal-catalyzed asymmetric
hydroboration (CAHB) directly relevant to the work in this thesis. The chapter also
highlights current understanding of the mechanistic pathways along with experimental
results. It serves as part of the invited perspective in preparation. The subsequent chapters
highlight the innovation and significance of the methodology developed. Chapter two
describes the two publications and a manuscript in preparation, introducing the unique
direct routes to acyclic - and -borylated carbonyl compounds, for which currently exists
no alternative direct methods for their preparation. Chapter three including other two
published manuscripts is a collaborative experimental and computational studies (in
collaboration with Zhao-Di Yang and Rhitankar Pal, previous members in Zeng group,
UNL chemistry) via CAHB of symmetrical cyclic substrates. The experimental work in
chapter three also serves as an interesting approach, enantioselective desymmetrization
towards the synthesis of quaternary or tetrasubstituted carbon stereogenic centers.
Chapter four is part of published and in preparation manuscripts mentioned in chapters 2
and 3, but is separated to highlight the significance of the chemistry, mono- and bifunctionalizations of - and -borylated carbonyl derivatives obtained from CAHB as
well as to understand the stereochemical aspects of the conventional palladium-catalyzed
cross-coupling reactions. The last chapter is the combined experimental procedures for
substrates, intermediates, and products discussed in the previous chapters.
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CHAPTER ONE: INTRODUCTION
1.1 Chiral boronic esters – Useful synthetic intermediates
Chiral boronic esters are significantly useful synthetic intermediates for a growing
number of stereospecific transformations. Figure 1 illustrates some selected stereospecific
transformations of C–B bond to a wide range of other useful functionalities, including C–
O, C–N, C–E (E = electrophile; e.g., nitrogen, oxygen, and halides), C–H, and C–C bond
formations. Examples are shown in simplified theme for secondary organoboranonates,
but many of listed transformations work equally well for tertiary boronic esters.1

Figure 1. Some selected stereosepecific transfomations of C–B bonds

2

Among the examples shown in Figure 1, the stereospecific C–B to C–O bond
formation via oxidation (Figure 1, route A) is the most commonly used method, in which
the most widely used reagent is basic hydrogen peroxide developed by Brown and coworkers.2 However, many functional groups (e.g., ester) could not be tolerated under the
harsh conditions. Alternatively, when oxidizing boronic esters in the present of versatile
functional groups (e.g., ester), sodium perborate is a good choice.3
Building from the mechanism of oxidation of boronic esters by basic hydrogen
peroxide, in which the peroxide attacks the empty p-orbital on the boron to form the “ate”
complex followed by 1,2-metallate rearrangement and hydrolysis, many research groups
sought other nucleophiles en route to new carbon–hetereoatom bond formations. For
example, C–B to C–N bond formation (Figure 1, route B) has been developed by Brown,4
Matteson,5,6 Knochel,7 Morken,8 and Aggarwal.9 The mechanisms of C–O and C–N bond
formations are somewhat similar; however, since neutral nitrogen (e.g., amine containing
a good leaving group or alkyl azide) is not as good nucleophile as peroxide, the reaction
conditions typically require a base for amine deprotonation (i.e., to enhance the amine
nucleophilicity) or in case of azide nucleophile, a chlorine sources (e.g., SiCl4 or BCl3)
are used to increase the Lewis acidity of the boron (i.e., converting the boronic ester to
the corresponding dichloroborane) (Scheme 1). More than 80% of all drugs and drug
candidates contain amine functionality; hence, the transformation of C–B to C–N bond
further illustrates the importance of chiral boronic esters.

3

Scheme 1. Selected examples of C–B to C–N bond formation
The two stereospecific transformations described above (i.e., C–B to C–O and C–
N) proceed with stereoretention rationally explained by the 1,2-metallate shift pathway.
To complement the stereoconfiguration, Aggarwal proposed a nucleophilic boron “ate”
complex that could undergo invertive SE2 in the presence of an electrophile (Figure 1,
route C and Scheme 2).10 The methodology works quite well for halogenation (i.e.,
chlorination, iodination, bromination, and fluorination) as well as C–B to C–O and C–N
bond formations.

4

Scheme 2. Mechanistic comparison between retentive and invertive pathways
Chiral boronic esters are useful not only in stereospecific transformation but also
can be removed (i.e., C–B to C–H bond formation; Figure 1, route D) for late-stage
functionalization purpose. Figure 2 illustrates some biologically active molecules
prepared via protodeboronation methodology.1

5

Figure 2. Preparation of biologically active molecules via protodeboronation
methodology.
Though C–B to C–O bond formation is the most commonly used method, perhaps
for analysis purpose, the stereospecific transformation to C–C bond has recently received
extensive interest (Figure 1, routes E–L). Following initial report on one-carbon
homologation using dihalomethane (e.g., iodochloromethane) to form enantioenriched
primary alcohol after oxidation (Figure 1, route E) by Matteson11 and co-workers,
Crudden12 et. al synthesized enantioenriched carboxylic acid (Figure 1, route F) and
aldehyde (Figure 1, route G) via homologation/ oxidation using NaClO2 and NaBO3,
respectively. Later on, Aggarwal13 and Fandrick14 found that the method also works well
for tertiary boronic esters. In addition, Aggarwal group applied Matteson’s homologation
following by Pd-catalyzed 1,3-borotropic shift to achieve three-carbon homologated
primary boronic esters in essentially complete retention of configuration (Figure 1, route
H).15 Similarly, when vinyl Grignard or organolithium reagent is used in replacement of
dihalomethane followed by treatment with I2/NaOMe or I2/TBAF, either alkene13,16,17 or
alkyne18 is formed with complete stereoretention (Figure 1, routes I and J).
Besides the above C–C bond formations, Pd-catalyzed cross-coupling (e.g.,
Suzuki–Miyaura) is one of the most established methods in modern organic synthesis
(Figure 1, route K).19–21 Crudden,22,23 Molander,24 Suginome,25–27 Hall,28,29 Morken,30
Biscoe,31 and our group32,33 have recently shown interest in the stereochemical aspects of
the palladium-catalyzed cross-coupling of chiral secondary organoboron derivatives; the
reactions could undergo either retention or inversion of configuration depending on the
choice of substrates and catalysts. It is one of the main points of this thesis and will be

6

discussed in details vide infra (Chapter 4). In contrast to the conventional palladiumcatalyzed cross-coupling, main group organometallic assisted sp3–sp2 cross-couplings
developed by Aggarwal34–37 (Figure 1, route L) undergo SEAr and stereoretentive 1,2metallate shift as shown in Scheme 3.

Scheme 3. Aggarwal’s proposed mechanism of main group organometallic-assisted
stereoretentive sp2–sp3 cross-coupling.
In addition to those versatile transformations described above, boronic esters have
been applied to many syntheses of natural products and pharmaceutical compounds.38–43
For example, Hoveyda and co-workers introduced the synthesis of anti-HIV agent (–)equisetin, in which 3 steps utilizing transformations of boronic esters (Scheme 4).40
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Scheme 4. Hoveyda’s total synthesis of (–)-equisetin involving 3 steps using boronic
esters.
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1.2 Recent development in the preparation of chiral boronic esters
Since chiral boronic esters are valuable synthetic intermediates as shown in
section 1.1, an extensive assortment of asymmetric routes for their preparation have been
carried out by many research groups. Among all of the available methodologies,
transition-metal-catalyzed asymmetric hydroboration (CAHB) of alkenes is arguably the
most attractive approach mostly due to the atom-economic nature of the transformation.44
Enantioselective hydroboration of activated alkenes (i.e., vinyl arene derivatives,
conjugated alkenes, or conjugated carbonyl compounds) have been extensively studied
by many research groups and will be discussed in details vide infra in this chapter
(section 1.4). Takacs group, on the other hand, is interested in enantioselective
hydroboration of unactivated alkenes utilizing coordinating functional groups (e.g.,
carbonyl derivatives) to give functionalized, chiral boronic esters. Previous work by Dr.
Sean M. Smith45–48 (University of Nebraska, 2012) opened access to -borylated
carbonyl derivatives via carbonyl directed CAHB; work by Mr. Suman Chakrabarty49 and
Ms. Veronika Shoba50 involving phosphonate and oxime ether-directed CAHB,
respectively, produced chiral tertiary boronic esters which are only accessible by a few
alternative methods (Chapter 1.4.2). These studies demonstrated that the selectivity of
hydroboration is highly dependent not only on directing group but also on alkene
substitution patterns, the choice of catalyst systems and borane reagents. Experiments
discussed in this dissertation will amplify mentioned above discoveries with novel direct
routes to chiral secondary - and -borylated carbonyl derivatives as well as their
applications to a wide range of stereospecific transformations demonstrating the synthetic
utility of the organoboron intermediates (Chapters 2–4).
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Apart from CAHB, there are recently extensive developments for the
enantioselective preparation of chiral boronic esters (Figure 3). Most recently, the Yu
group at Scripps reported amide-directed palladium-catalyzed C–H -borylation of small
ring systems highlighting the first and only one enantioselective version using the same
methodology up to date (Figure 3A).51 Shortly before that, the Fu group reported
stereoconvergent alkyl–alkyl cross couplings of racemic -haloboronates with
organozinc reagents using Nickel catalysts (Figure 3B).52 The method allows access to
stereogenic secondary boronic esters bearing multiple chiral centers via an iterative
homologation process. Using mechanistically different method but with similar approach,
Aggarwal’s lithiation-borylation/ Matteson’s homologation also provides entry to
multiple contiguous stereocenters (Figure 3C).53 The methogology en routes to several
natural products (i.e., (+)-kalkitoxin and (+)-hydroxyphthiocernanic aid)54 and highlights
one of a few methods for the preparation of chiral tertiary boronic esters.55 Several
alternative methods for the synthesis of chiral tertiary boronic esters are independently
reported by Shibasaki56,57/ Yun58/ Hoveyda59,60 via enantioselective conjugate borylation
(Figure 3D) and Tang61 via directed CAHB (see Figure 6 for Tang’s example); Hoveyda
and co-workers also independently developed an efficient copper-catalyzed allylic
substitution with B2pin2 affording tertiary allylboronic esters (Figure 3E).62 Compared to
tertiary boronic esters, chiral primary and secondary organoboronates are thought to be
more easily accessed but are not less useful (i.e., the current applications of tertiary
boronic esters are limited to main group organometallic-assisted transformations mainly
developed by Aggarwal1 group). Consequently, many research groups have developed a
wide range of methodologies for the asymmetric preparation of the latter. For example,
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using different substitution patterns of alkenes (i.e., disubstituted alkenes as opposed to
trisubstituted alkenes as shown in Figure 3D) in conjugate borylation, Hoveyda along
with other groups reported the enantioselective synthesis of chiral secondary boronic
esters.63 Not restricted to conjugate borylation, Hoveyda and co-workers developed an
enantioselective copper-catalyzed allylic substitution with diborylmethane to generate
synthetic useful chiral primary homoallylic boronic esters and well as illustrate their
applications in synthesis (Figure 3F).64 Similarly, Niu and co-workers independently
reported the same approach using silver-assisted, iridium-catalyzed allylation.65 The
Morken group is one of the most active groups in this area (i.e., preparation of chiral
boronic esters). His group has developed a number of methods for the enantioselective
preparation of chiral secondary organoboranes including asymmetric hydrogenation of
vinyl boronates (Figure 3G)66–68 and Pt-catalyzed diboration69 followed by Pd-catalyzed
group-selective cross-couplings70 of diboranes (Figure 3H). Recently, his group found
that chiral carbohydrates also serve as efficient catalysts for enantioselective diboration
reactions.71 In addition to those, Morken and co-workers have also developed palladiumcatalyzed enantioselective conjunctive cross-coupling reactions (Figure 3I).72–74 The
groups of Yun and Miura are also very active in this area. For instance, besides conjugate
borylation as discussed above, Yun and co-workers also reported several different
examples of asymmetric reactions with vinyl boronates (Figure 3J).75 Miura group, in
addition to independent report of asymmetric reactions with vinyl boronates,76 has
developed the three-component coupling generating chiral -amino boronic esters in high
yield and enantioselectivity (Figure 3K).77 Referring to the three-component coupling, the
Toste78 and Liao79 groups independently reported enantioselective palladium-catalyzed
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1,1-arylboration (Figure 3L) and copper-catalyzed 1,2-allylboration (Figure 3M),
respectively. Referring to the formation of chiral -amino boronic esters, Liao80 and
Ellman81 groups independently introduced asymmetric borylation of imine using different
approaches; while Ellman and co-workers pioneered a copper-catalyzed borylation of
chiral N-(tert-butanesulfinyl)aldimines, Liao group reported a copper-catalyzed
borylation of prochiral N-Boc-imines using a chiral tert-butyl sulfoxide–phosphine ligand
(Figure 3N illustrated Ellman’s example). In addition to CAHB and the methodologies
discussed above, there are several other attractive approaches including enantioselective
B–H insertion (Figure 3O), independently reported by Zhou82 and Xu83 groups,
enantioselective nucleophilic addition to aldehyde (Figure 3P), separately reported by
Ito84 and Meek,85 and stereospecific Miyaura borylation (Figure 3Q) obtained by Watson
and co-workers.86,87

12

Figure 3. Selected examples of recent developments in the preparation of chiral boronic
esters
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1.3 Stoichiometric asymmetric hydroboration of alkenes
Despite the effectiveness of alternative methods for generation of chiral boronic
esters discussed in section 1.2, asymmetric hydroboration remains the most attractive
method highlighted by the discovery of H. C. Brown in 1956 resulting in the Nobel Prize
in 1979.88 The history of hydroboration is briefly shown in Figure 4.

Figure 4. Brief hydroboration history.
Five years after the initial discovery, Brown showed that the asymmetric version
could be performed using a chiral borane reagent (i.e., diisopinocampheylborane
(Ipc)2BH, Table 1).89–92 The (Ipc)2BH provides excellent enantioselectivity for cisalkenes but poor selectivity for trans- and trisubstituted alkenes. The observations could
be explained by steric hindrance; the size of trans- and trisubstituted alkenes could be too
large for the reagent.93 To solve the problem, monoisopinocampheylborane (Ipc)BH2 was
synthesized in essentially complete enantiopurity (i.e.; 100% ee).94 The borane reagent
successfully improved the selectivity for trans- and trisubstituted alkenes (results shown
in Table 1 for direct comparison see refs 95–97 for better selectivity) from moderate to
excellent selectivity.95–97 However, in contrast to the di- discussed above, the mono-
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version of the borane provided poor selectivity for cis-alkenes. These Brown’s reagents
(Ipc)2BH and (Ipc)BH2 are apparently complementary to each other giving good
selectivity for all cis-, trans-, and trisubstituted alkenes. In 1985, Masamune introduced a
C2-symmetric dimethylborolane (DMB) which also provides excellent selectivity for all
alkenes discussed above.98 Even though Masamune’s DMB seems to be more effective
compared to Brown’s reagents, the seven-step synthesis of the otherwise simple looking
borane dramatically decreases its practicality. It is worth noting that both Brown’s and
Masamune’s reagents are not effective for 1,1-disubstituted alkenes (i.e., methylidene
substrates). In 2008, Soderquist and co-workers developed bicyclic boranes labeled
[3.3.2]-Ph and [3.3.2]-TMS in Table 1.99 The Soderquist’s borane reagents provide good
selectivity for not only the three types of alkenes discussed above but also the more
challenging sub-class of alkenes, methylidene substrates in which the steric demand
between the alkene substituents is significantly different (e.g., methyl vs. tert-butyl or
phenyl vs. deuterium). The 1,1-disubstituted alkene is considered more challenge than its
other substituent patterns because it is not easy for the catalysts to recognize or
effectively differentiate between the prochiral enantiotopic faces.100
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Table 1. Stoichiometric asymmetric hydroboration using chiral borane reagents. Color
code: excellent selectivity, moderate selectivity, and poor selectivity

Though the development of asymmetric hydroboration obtained by Brown,
Masamune, and Soderquist is very much appreciated, the stoichiometric use of the chiral
sources (i.e., borane reagents) is not the most efficient method. In addition, the above
reagents are either not easy to make or quite reactive, and thus controlling the chemo- and
enantioselectivity becomes a big challenge. To overcome the problem, many research
groups have been seeking for a catalytic version using substoichiometric amount of the
chiral sources. As shown in Figure 4, after H. C. Brown’s Nobel Prize, in 1985 Mӓnnig
and Nӧth introduced the first catalytic hydroboration using catecholborane and
Wilkinson’s catalyst.101 Though the first catalytic asymmetric hydroboration was credited
to Burgess in 1988 using catecholborane (catBH) in the present of neutral rhodium-DIOP
or rhodium-BINAP,102 the products obtained were in low enantioinduction ranging from
racemic up to 69% ee. Shortly thereafter, Hayashi and coworkers introduced the first
cationic rhodium-catalyzed asymmetric hydroboration of styrenyl derivatives with (+)BINAP and catBH resulting in exclusively benzylic boronic esters with excellent
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enantioselectivity (85–96% ee).103After that, there is an extensive development in this
area which will be discussed in details in the next section 1.4.
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1.4 Transition-metal-catalyzed asymmetric hydroboration of alkenes
Compared to stoichiometric asymmetric hydroboration discussed in section 1.3,
the transition-metal-catalyzed asymmetric hydroboration received much of interest. The
developments of catalytic asymmetric hydroboration of activated substrates (e.g., vinyl
arenes) were extensively studied by many research groups and have been reviewed by
Crudden,104,105 Guiry,106 Westcott,107 and J. M. Brown.108 This section will cover materials
mostly developed after those reviews; materials were covered in those reviews will only
be mentioned when being related. In this dissertation, vinyl arenes, conjugated alkenes,
and conjugate carbonyl compounds are referred to as activated substrates. Some might
also consider substrates bearing functional groups to be activated substrates, in which the
alkene is activated by the functional group either with electronic, steric, stereoelectronic,
or coordinating effects. However, substrates that are not vinyl arenes, conjugated alkenes,
and conjugate carbonyl compounds will be considered unactivated substrates herein; they
are unactivated alkenes utilizing directing functional groups. Consequently, this section
will be divided into two main subsections: catalytic asymmetric hydroboration of vinyl
arenes and related conjugated alkenes (i.e., activated substrates) and of non-vinyl arenes
(unactivated substrates).

1.4.1 Catalytic asymmetric hydroboration of vinyl arenes and related conjugated
alkenes
1.4.1a Rhodium catalysis
Among the transition metals, rhodium has a long-standing history. For example,
the first catalytic hydroboration by Mӓnnig and Nӧth101 and the first catalytic asymmetric
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hydroboration by either Burgess102 or Hayashi103 were all carried out by rhodium metal
precursors. Figure 5 illustrates some successful examples of rhodium-catalyzed
asymmetric hydroboration of styrene (i.e., A, R1 = H. R2 = H). After Hayashi’s initial
report highlighting the effective bidentate P,P-ligand (i.e., BINAP), several groups have
found some other effective bidentate ligands including QUINAP,109 PYPHOS,110
JOSIPHOS,111 or the ferrocenylpyrazole derivative E. Though those catalyst systems
provide excellent selectivity for styrene, the substrate scope and the catalyst tunability
remain limited; for example, for a long time, 78 and 74% ee were the best results
obtained for 4-chlorostyrene B (R1 = Cl, R2 = H) and 4-trifluoromethylstyrene C (R1 =
CF3, R2 = H), respectively using QUINAP. To overcome the problem, Takacs group
showed that monodentate ligands Taddol-derived phosphite F and phospharamidite G
could tolerate the electronic effect of substrates B and C resulting in 94 and 90% ee,
respectively.112
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Figure 5. Rhodium-catalyzed hydroboration of styrene and styrenyl derivatives
To further introduce catalyst tuning, Takacs group presented a two-step
optimization strategy using hetereobimetallic catalyst systems: ligand/catalyst scaffold
and ligating group.113 There was no results obtained for styrene A but focused on the
more challenging substrates and finding the general catalyst could well tolerate the
electronic differentiation at meta position. The most general optimized catalyst system H
performed

hydroboration

of

meta-substituted

substrates

D

with

excellent

enantioselectivities (93–94% ee) using as low as 0.05% rhodium catalyst.
In the case of CAHB of vinyl arenes, the most attractive example is perhaps the
one obtained by Tang’s group due to several reasons, (i) different from other examples, it
is directed CAHB, (ii) the products are not only tertiary boronic esters but also -amino
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boronic acid derivatives, extensively used in medicinal chemistry (Figure 6).61 Using
cationic Rh(I) catalyst precursor in conjunction with a chiral phosphine ligand (R)-BIDIME, amide-directed CAHB of -arylenamides provides access to a series of chiral
tertiary -amino boronic esters in excellent enantioselectivity (up to 99% ee). One major
drawback of this transformation is that a diborane (i.e., B2pin2) is required for high
enantioselectivity; the use of pinacolborane (pinBH) generates the same product in much
lower ee with otherwise the same reaction conditions illustrating that the reaction is not
atom-economical. It is also worth noting that the NH acidic proton is important; only
trace amounts of borylated products was obtained using tertiary amide.

Figure 6. Tang’s directed rhodium-catalyzed CAHB of vinyl arenes

1.4.1b Iridium catalysis
In 2004, Crudden and co-workers used a cationic rhodium(I) precursor (i.e.,
Rh(COD)2BF4)/ JOSIPHOS (used by Togni in 1994 with catBH, Figure 5) in conjunction
with pincabolborane (pinBH) instead of catecholborane (catBH) to show the reversal in
enantioselectivity (Figure 7).114 In the same paper, Crudden also showed that with the use
of iridium catalyst, she obtained complete reversal in regioselectivity. Based upon similar
observation of CAHB of diazines introduced by Bonin and Micoun, it was proposed that
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reversal in enantioselectivy takes place due to a change in mechanism from Rh–H
insertion to Ir–B insertion (see section 1.5 for details).115

Figure 7. Reversal in regioselective CAHB of styrene using rhodium and iridium
catalysts
Recognizing the complementary regiocontrol of iridium catalyst precursor, in
2011 Mazet and co-workers applied it to geminal -substituted styrene (i.e., 1,1disubstituted alkenes) to introduce asymmetric CAHB (Figure 8).116 This was also an
important accomplishment at that time due to the hardly controlled enantioselectivity of a
barely prochiral sub-class of alkenes, methylidene substrates. In 2015, Diéguez et. al
expanded the substrate scope using slightly modified bidentate P,N ligand (Figure 8).117
The generality of both catalyst systems is only applied to substrates bearing significant
differences in steric demand of the alkene substituents; moderate to poor selectivities are
obtained for other substrates with otherwise the same reaction conditions. Iridium
catalysts are considered more effective for regio- and diastereoselectivity control
compared to rhodium catalysts in some previous findings;118–121 however, in term of
enantioselectivity, it still remains a challenging problem.
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Figure 8. Iridium-catalyzed hydroboration of 1,1-disubstituted vinyl arenes

1.4.1c Cobalt and iron catalysis
In the past decade, many research groups have focused on the base-metal catalysts
due to their low cost, high earth abundance, as well as environmentally benign nature.122–
137

Similar to iridium catalysts, iron and cobalt catalysts are found to typically produce a

complementary selectivity to rhodium catalysts for catalytic hydroboration of vinyl
arenes except for a few examples.122–124 Up to date, successful enantioselective
hydroboration using iron and cobalt catalysts are limited to geminal -substituted
styrenes (i.e., 1,1-disubstituted vinyl arenes). However, cobalt and iron catalysts seem to
dominate the area as their generality are applied to ca. 90 examples; many of which
results in good yields and excellent enantioselectivities (Figure 9).
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Figure 9. Fe- and Co-catalyzed hydroboration of 1,1-disubstituted vinyl arenes
The mechanism of Fe- and Co-catalyzed hydroboration reactions is distinct
depending on the ligand employed (i.e., oxazoline iminopyridine (OIP) versus oxazoline
aminoisopropylpyridine (OAP); see section 1.5 for mechanistic details). Interestingly,
Co-OAP- and Co(Fe)-OIP-catalyzed hydroborations were achieved with opposite
stereoconfigurations. In the case of OIP ligands, the generation of the M–H active
catalyst species, however, is slightly different; Lu’s138–140 work shows the M–H formed
by the activating reagent, NaB(R)3H, whereas, Huang’s141 studies claim the hydride
source is not necessary, and the M–H is presumably formed by the addition of pinBH. By
slightly modified the OIP along with the novel OAP ligands and the activating reagent, in
2016, Lu and coworkers showed the Co-catalyst systems efficiently catalyze
hydroboration of sterically hindered 1,1-disubstituted styrenyl derivatives (i.e., orthosubstituted substrates), which were problematic substrates in previous studies.140
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1.4.1d Copper catalysis
Though iron- and cobalt-catalysts employing OAP and OIP ligands seem to be the
best catalyst system for asymmetric hydroboration of gem-arylalkyl alkenes as illustrated
in Figure 9, the current limitation is of substrates bearing 1,1-diaryl alkenes; the
substrates are neither reactive nor selective. For instance, in the same work showing
excellent selectivity for hydroboration of gem-arylalkyl alkenes, Huang and co-workers
pointed out that the current catalyst system (i.e., cobalt with OIP ligand) is not efficient
for gem-diaryl alkenes (Figure 10A).141 Recently, Xiong group found that copper system

Figure 10. Recent advancement for asymmetric hydroboration of gem-diaryl alkenes
using copper(I) catalyst.
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could fix the problem; a series of 1,1-diaryl substituted alkene efficiently undergoes
copper(I)-catalyzed hydroboration with high yield and enantioselectivity (Figure 10B).142
The generality of the catalyst system can also be applied for gem-arylalkyl alkenes
(Figure 10C).
While iridium-, cobalt-, and iron-catalyzed hydroboration reactions are currently
limited to 1,1-disubstituted alkenes, along with rhodium, copper catalysts have been
shown to facilitate hydroboration of different classes of alkenes. The first
enantioselective copper-catalyzed hydroboration was carried out by Yun and co-workers
in 2009 for styrenes.143 With the use of Tangphos ligand, styrenes undergo coppercatalyzed hydroboration to afford benzylic boronic esters in good yield and excellent
enantioselectivity (Figure 11). Later on, the same group found that DTBM-Segphos is
more reactive for -substituted vinyl arenes;144 i.e., Tangphos is also selective but less
reactive. Both ligands afford the same regioisomers (i.e., benzylic boronic ester/ selective) in high yield and enantioselectivity (Figure 11).

Figure 11. Yun’s -selective copper(I)-catalyzed hydroboration of vinyl arenes
It is worth to note that the Yun’s hydroboration uses pinBH as the boron source
resulting in -selective hydroration of vinyl arenes. On the other hand, replacement of
pinBH by B2pin2 gives the rise to complement regioselectivity (i.e., -selective). For
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example, Cu-NHC-catalyzed hydroboration of both - and -substituted vinyl arenes
employing B2pin2 provide -borylated products (Figure 12).145,146

Figure 12. Hoveyda’s -selective Cu-NHC-catalyzed hydroboration of vinyl arenes
Different from the above examples, Tian and Lin claimed that their work on
Cu(I)-catalyzed hydroboration of dehydroamino acid methyl esters was achieved via
ester-directed asymmetric hydroboration (see section 1.5 for mechanistic details).147
Although the work is not diastereoselective (i.e., dr ~ 1:1), the two diastereoisomers can
be separated in total good yield with each high enantioselectivity (Figure 13). Another
drawback of the methodology is that 4–5 equiv of B2pin2 is necessary for high
conversion; it is not clear what result was obtained with pinBH. Systematically, it can
also be considered as a conjugate borylation process.

Figure 13. Copper(I)-catalyzed hydroboration of dehydroamino acid methyl esters
Similarly, Tortosa’s work on p-quinone methides could be considered as either
hydroboration or conjugate borylation (Figure 14).148 Different from conventional
conjugate borylation, the driving force in this case is aromatization making this process a
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unique example. In addition, this methodology highlights one of a few examples
producing highly enantioenriched diaryl substituted benzylic boronic esters.149,150

Figure 14. Copper(I)-catalyzed borylative aromatization of p-quinone methides
Though Ito’s substrate is not vinyl arene but conjugate diene (i.e., 1,3-diene), it is
considered to belong to activated substrate category.151 A series of cyclic 1,3-diene
substrates undergo Cu(I)-catalyzed hydroboration resulting in either allylic- or
homoallylicboronic esters with temperature being the most important factor of
regiocontrol (Figure 15).

Figure 15. Temperature dependence in regioselective Cu(I)-catalyzed hydroboration of
cyclic 1,3-dienes.

1.4.2 Catalytic asymmetric hydroboration of non-vinyl arenes
Thus far, catalytic asymmetric hydroboration of unactivated alkenes was achieved
only with rhodium and copper catalysts. The story of rhodium in this category started
with Gevorgyan’s on the enantioselective desymmetrization of a few examples of
cyclopropenes via Rh(I)-catalyzed asymmetric hydroboration.152 After that, besides
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Takacs’ Rh(I)-catalyzed CAHB, there are only four examples using copper up to date in
which three of them are enantioselective desymmetrizations of cyclic substrates (Figure
16A). In 2014, Tian and co-workers introduced a series of cyclopropenes substrates
bearing an aryl and a methylester group at the tetrasubstituted carbon; copper(I)catalyzed CAHB of these substrates affords solely trans-product in high yield and
enantioselectivity.153 The trans-diastereoselectivity is claimed due to the steric effect of
the methylester group as well as the weak coordination of copper to the carboxyl group.
Tortosa and co-workers also applied the copper catalyst on enantioselective
hydroboration of cyclopropenes154 via desymmetrization. Later on, the same group with
slightly modified reaction conditions was able to carry out desymmetrization of
cyclobutenes.155 Notably, both systems do not involve the coordinating functional group
indicating that the high diastereoselectivity is completely controlled by steric effect. In
2016, Xi and Hartwig reported the only example of Cu(I)-catalyzed asymmetric
hydroboration of acyclic aliphatic internal alkenes in which the regioselectivity is
controlled by the electronic effect of the directing group employed (Figure 16 B).156
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Figure 16. Cu(I)-catalyzed asymmetric hydroboration of unactivated alkenes
Takacs group has been actively involved in catalytic asymmetric hydroboration of
unactivated alkenes utilizing rhodium catalyst and coordinating functional groups since
2008. The group found that the controlling factors for regio- and enantioselectivity are
varied as a function of directing groups (e.g., carbonyl, oxime ether, phosphonate),
substitution patterns (e.g., disubtituted, trisubstituted), nature of substituents (e.g., aryl,
alkyl), ligands (e.g., phosphites, phospharamidites), and boranes (e.g., pinBH, tmdBH).
For examples, with similar system, carbonyl-directed CAHB of methylidene substrates
differs from oxime-ether in several important aspects, including (i) the borane attacks
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from opposite -face, from the top face in the case of carbonyl and from the bottom in the
case of oxime, and thus (ii) giving rise to complement regioselectivity; carbonyl-directed
CAHB affords -primary boronic esters while oxime ether-directed CAHB generates tertiary organoboranes (Figure 17). One might notice that different hydroborating agents
were used (tmdBH for carbonyl- and pinBH for oxime-directed CAHB); however, choice
of borane reagents was based only on slightly improved enantioselectivity. While the
carbonyl case highlighted the first high regio- and enantioselective CAHB of unactivated
1,1-disubstituted alkenes producing primary boronic esters, the oxime ether case is
interesting as one of a few examples for the introduction of enantioselective boron
delivery to tertiary carbon centers.

Figure 17. Effect of directing groups in CAHB of methylidene substrates leading to
complementary regio- and -facial selectivities
We have been more successful to find efficient CAHB conditions for 1,1- 1,2and 1,2,2-substituted alkenes using carbonyl directing groups, when 1,1,2-susbtitution
pattern was successfully hydroborated utilizing oxime ethers and phosphonates. (Figure
18). It is not that surprising in case of carbonyl-directed CAHB of 1,2,2-trisubstituted
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alkenes in term of high regio- and diastereoselectivity; the boron is more likely to attach
to the less substituted carbon and in the syn fashion along with hydrogen giving rise to
syn- and anti-products from (Z)-alkenes and (E)-alkenes, respectively. In the case of 1,2disubstituted alkenes, the boron prefers the carbon double bond proximal to the carbonyldirecting group illustrating the crucial role of the coordinating effect for high
regioselectivity. In addition to the example of 1,1-disubstituted alkenes shown in Figure

Figure 18. Directed Rh(I)-catalyzed asymmetric hydroboration of different alkene
substitution patterns
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17, oxime ether is also the efficient directing group for CAHB of 1,1,2-trisubstituted
alkene (Figure 18C). Interestingly, oxime ether-directed CAHB of these two classes of
alkene affords the enantiomeric products with the same sense of -facial selectivity (both
are bottom face borylation according to the structure drawn). Shortly thereafter,
phosphonate was found to be as good directing group as oxime ether for CAHB of 1,1,2
trisubstituted alkenes generating the same regio- and -facial selective borylated products
(Figure 18D). Notably, despite the difference in the effect of directing groups and alkene
substitution patterns, all of the substrates shown in Figure 18 have the same sense of facial selectivity (i.e., bottom approach as illustrated). In addition, it is fair to say that up
to this point that TADDOL-derived phosphites (labeled T in Figure 18) and BINOLderived phospharamidites (labeled B in Figure 18) demonstrated the most successful
results; while BINOL-derived phospharamidite is the best choice for 1,2-disubstituted
alkenes, TADDOL-derived phosphite is superior ligand for most of substitution patterns.
This statement was further supported with experiments described in this dissertation
(Chapter 2 and 3).
Though ligands T and B discussed above are the most successful ligands, it does
not mean that other related ligands do not provide any positive results. For example, by
slightly modified the ligand backbone from phosphite to phospharamidite while keeping
the stereoconfiguration of the TADDOL the same, amide-directed CAHB of 1,2,2disubstituted alkenes gives rise to essentially complete enantioreversal (Figure 19).47
Even though the TADDOL-phospharamidite is not as selective as its phosphite analogue,
the interesting results in hetereombination experiments might lead to new catalyst design.
The mechanistic understanding of the enantioswitching is not yet clear.
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Figure 19. Enantioswitching in Rh(I)-catalyzed asymmetric hydroboration of (Z)-1,2,2trisubstituted alkenes
In addition to the controlling factors discussed above, the nature of the borane
reagents is also important. The later studies were typically carried out using pinBH and
tmdBH based upon borane optimization studies obtained by Smith and Takacs.48 The
detailed results for one of the substrates studied (all give similar trends) are shown in
Figure 20 illustrating that the yield and enantioselectivity vary widely as a function of
borane. Importantly, both enantiopure (R)- and (S)-tmdBH gave similar results as
compared to the racemic one.
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Figure 20. Effect of borane on Weinreb amide-directed CAHB of 1,2-disubstituted
alkenes.
The above brief discussion in Rh(I)-catalyzed asymmetric hydroboration of
unactivated alkenes had been carried out by Dr. Sean M. Smith, Ms. Veronika M. Shoba,
and Mr. Suman Chakrabarty. The methodology gives rise to highly selective primary,
secondary, and tertiary boronic esters. All borylated products are -selective except for
the case of carbonyl-directed CAHB of 1,1-disubtituted alkenes (Figure 17) carried out
by Dr. Smith with my collaboration highlighting the first direct -selective borylation
which will be discussed more details in Chapter 2. Other examples in this dissertation
include synthesis of for - and -borylation of carbonyl compounds; currently no other
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alternative methods for their direct enantioselective preparations have been reported.
Besides the controlling factors mentioned above, work in this thesis will also show the
effects of alkene substituents (aryl versus alkyl) in regioselectivity as well as alkene
environment (cyclic versus acyclic) in groupselectivity.
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1.5 Mechanistic implications in transition-metal catalyzed hydroboration of alkenes
The mechanism of transition-metal-catalyzed hydroboration of alkenes is thought
to depend on the nature of the substrate, the metal precursor employed, the ligand used,
and even the nature of the borane reagents. For example, recently, Zhang and Lu
proposed that with a slight change in the nature of the ligand employed, the catalytic
pathways could be mechanistically distinct from each other resulting in reversal of
enantioselectivity (Figure 21).140 With the use of an amine ligand, which has a flexible
arm undergoes Co(0)/ Co(II) catalytic cycle (i.e., mechanistically involving oxidative
addition and reductive elimination steps, cycle I). On the other hand, when a rigid ligand
side arm, imine, is employed, the reaction undergoes cycle II without changing the
oxidation state of the metal (i.e., Co(I) cycle). The distinct proposed mechanisms are

Figure 21. Proposed reversal enantioselective catalytic pathways of cobalt-catalyzed
asymmetric hydroboration of 1,1-disubtituted vinyl arenes. Adapted with permission
from reference 140. Copyright (2016) American Chemical Soceity.
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reasonable as many findings before and after this study are either, (i) oxidative addition/
reductive elimination or (ii) maintaining the metal’s oxidation state (i.e., redox neutral)
throughout the catalytic cycle. The previous studies by the same group130–140 as well as
Zhang141 and co-workers on the same class of alkenes (i.e., methylidene substrates) using
cobalt- and iron catalysts in conjunction with similar imine ligands support proposed
catalytic cycle II.
1.5.1 Catalytic pathways without changing oxidation state of the metal precursor
The discovery of this pathway perhaps is credited to Yun and co-workers for their
Cu(I)-catalyzed hydroboration of styrenes in 2009.143 The -bond metathesis between
Cu–C and B–B is challenging to recognize and advocate.157 The same applies to Yun’s
proposal of metathesis between Cu–C(sp3) and pinBH to generate the catalytically active
Cu–H species (Figure 22, cycle A). However, DFT calculations were carried out to
support the proposed mechanism; the results demonstrated that -bond metathesis, in
fact, could take place and what is more, the addition of Cu–H to styrene is the ratelimiting step.158 In 2011, the same group found that changing ligand from Tangphos to
DTBM-Segphos with otherwise the same reaction conditions does not lead to reversal in
selectivity; however, the latter ligand was found to improve either reactivity or
enantioselectivity for the hydroboration of -substituted vinyl arenes.144 Preliminary DFT
calculations were carried out to prove the efficiency of the DTBM-Segphos ligand;
Segphos acts as a monodentate ligand due to steric hinderance around the phosphines,
which might be responsible for the decreased stabilization of the reaction–catalyst
complex. Using similar reaction conditions (i.e., CuCl and DTMB-Segphos), Hartwig
and co-workers successfully carried out asymmetric hydroboration of a series of aliphatic
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Figure 22. Effect of boranes on regioselectivity of Cu(I)-catalyzed hydroboration of
vinyl arenes.
internal alkenes.156 The transformation presumably undergoes similar mechanistic cycle
A with the aid of DFT calculations to illustrate the effect of the proximal polar group in
regio- and enantioselectivity.
In contrast to the above studies, Cu(I)-catalyzed hydroboration of vinyl arenes
employing different types of ligand and using diborane (e.g., B2pin2) undergoes catalytic
cycle B (Figure 22) resulting in complementary regioselectivity.145,146,159 For example,
similar to cycle A, starting from LCu–alkoxide, reaction with B2pin2 generates LCu–Bpin
instead of Cu–hydride.160–162 In the next step, LCu still favors the more stabilized position
(i.e., benzylic position); however, C–B migratory insertion generates the intermediate that
complement the one in cycle A (i.e., C–H migratory insertion). In addition, reactions
following cycle B require a proton additive (e.g., methanol) for the last step,
stereoretentive Cu–C protonation to afford the desired product. There are also several
examples of aliphatic terminal alkenes in which the use of the diborane is crucial for the
pathway shown in cycle B.163,164 In these studies, the steric effect of the ligands employed
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is also responsible for regioselectivity. Similarly, Cu(I)-catalyzed hydroboration of cyclic
1,3-dienes using B2pin2 by Ito151 and coworkers also proceed in similar fashion to cycle B
(Figure 22); however, the formation of allyl-copper species after Cu–B addition requires
the protonation by alcohol occurring via SE2’ pathway instead of stereoretentive Cu–C
protonation.
Different from the above pathways, Cu(I)-CAHB of -dehydroamino acid methyl
esters could be undergo either conjugate borylation or ester-directed Cu(I)-catalyzed
hydroboration (Figre 23).147 However, due to the pro-tertiary nature of the -carbon, it is
less likely for the CuL to add to this carbon for conjugate borylation to happen. Another
evidence for directed hydroboration pathway is that the product obtained is a nearly 1:1
mixture of diastereomers indicating the enantiodetermine step, LCu–C formation, is not
likely to occur. On the other hand, after several first steps (as in Figure 21, cycle B) to
generate LCu–Bpin species, copper can coordinate to the ester carbonyl directing group
following by Bpin conjugate addition to afford copper-enolate species. Finally,
protonation by alcohol gives the desired borylated product and regenerates the active
catalyst.
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Figure 23. Ester-directed Cu(I)-catalyzed hydroboration of -dehydroamino acid methyl
esters.
1.5.2 Catalytic pathways involving oxidative addition/ reductive elimination
The discovery of this pathway is credited to Kono and Ito165 for their finding in
oxidative addition of 4,4,6-trimethyl-1,3,2-dioxaborinane (tmdBH) and catecholborane
(catBH) to Wilkinson’s catalyst (Rh(PPh3)3Cl) and to Mӓnnig and Nӧth101 for their first
report on the rhodium(I)-catalyzed hydroboration of alkenes using Wilkinson’s catalyst
and catecholborane (catBH) (Figure 24).
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Figure 24. A. Discovery of oxidative addition of tmdBH and catBH to Wilkinson’s
catalyst by Kono and Ito; B. First example of Rh(I)-catalyzed hydroboration of alkenes
by Mӓnnig and Nӧth.
In the first introduction of Rh(I)-catalyzed hydroboration, Mӓnnig and Nӧth also
proposed the generally accepted mechanism which later supported by Evans and Fu
(Figure 25).118,119 First, one equivalent of PPh3 ligand is dissociated from Wilkinson’s
catalyst to generate the active catalyst Rh(I) (intermediate I). Oxidative addition of
borane HB(OR)2 to Rh(I) gives Rh(III) intermediate II. Next, alkene chelation with
dissociation of another equivalent of PPh3 ligand forms intermediate III. Migratory C=C
double insertion to Rh–H generate either branched alkyl-Rh IV-a or its linear regioisomer
alkyl-Rh IV-b. Reductive elimination of either IV-a or IV-b affords the desired
corresponding borylated product and regenerates active catalyst species I to continue the
catalytic cycle. Recently, Schomaker group proposed a similar mechanism for Nikel(0)/
Nickel(II) catalytic cycle in which the regioselectivity is controlled by the size of the
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ligand in migratory insertion step.166 While small NHC ligand affords branched alkyl-Ni
IV-a, large NHC ligand prefers linear alkyl-Ni IV-b.

Figure 25. Proposed mechanistic pathway for Rh(I)-catalyzed hydroboration
In 1992, Burgess suggested a similar mechanism to one shown in Figure 24.167
However, according to Burgess’ proposal, alkene chelation step does not require the
dissociation of the phosphine ligand to afford intermediate III as an octahedral structure
instead (i.e., associative mechanism). Several ab initio studies were also carried out; work
by Morokuma168 and co-workers supports the associative pathway, while Schleyler169
group favors the dissociative mechanism.
In another computational study, Ziegler170 found that alkene insertion to Rh–B
followed by reductive C–H formation is also possible. While hydride migration is slightly
more favorable for associative mechanism, boron migration seems to be more compatible

43

with dissociative pathway. This proposal, in principle, makes the mechanistic
understanding of Rh(I)-catalyzed hydroboration more difficult. Perhaps, there should be
an ab initio study using iridium(I) catalyst precursor, which might facilitate the
possibility of metal–boron bond migratory insertion. In fact, Rablen and Hartwig showed
that insertion into the Ir–B bond is favored by 8 kcal/ mol over the insertion into the Ir–H
bond based upon theoretical studies on bond dissociation energies.171 Experimentally,
Bonin and Micouin115 and later on Crudden114 showed the strong effect of these metal
precursors in migratory insertion step resulting in reversal of enantio- and
regioselectivity, respectively (Figure 26).

Figure 26. Effect of metal precursors on regio- and enantioselectivity
Enantioswitching was also observed to be effected by ligands employed or the
nature of the borane reagents. As a recall from section 1.4, Smith and Takacs47 showed
that relatively small changes in ligand substituents could lead to complete enantioreversal
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while the absolute stereochemistry of the ligands remains the same. The distinct
mechanism for this effect is not yet clear. Fernández172 and Crudden114 independently
reported the effect of boranes (i.e., pinBH and catBH) in conjunction with P,P-bidentate
(i.e., BINAP and JOSIPHOS) ligands led to the reversal in enantioselectivity. Crudden
claimed that unfavorable steric interactions between Bpin and PPh2 are responsible for
the change in enantioselectivity; this statement was supported by Fernández’s
computational studies (Figure 27).

Figure 27. Fernández’s calculations for most stable isomers of H-Rh-BINAP-boranestyrene complex employing catBH and pinBH
Building up from Fernández’s model of cationic rhodium complex illustrated in
Figure 27 for a one-point binding substrate (i.e., no coordinating group), this dissertation
will show the model DFT calculations for two-point binding substrates which will be
discussed in details in Chapter 3. To reduce the computing times, a proposed symmetric
ligand (caged phosphine ligand), a symmetric borane (pinBH instead of tmdBH using
experimentally), and a symmetric cyclopentene-based substrate will be used. The
combination of computational and experimental studies provides better outlook of the
mechanistic pathways. This dissertation will discuss in details the current understanding,
limitation, as well as alternative pathways which should be also considered. The
simplified proposed mechanistic cycle is illustrated in Figure 28. Though it look similar

45

to the one-point binding substrates illustrated in Figure 25, there are some significant
differences, including (i) the two-point binding mechanism require cationic rhodium as
an active catalyst species while the one-point binding substrates, in theory, can used both
neutral and cationic metal precursors, (ii) the regioselectivity is mainly controlled by the
proximity effect of the directing group rather than by the formation of stabilized benzylic
alkyl–Rh intermediate as in case of simple vinyl arenes (i.e., one-point binding
mechanism).

Figure 28. Proposed simplified mechanistic pathway for Rh(I)-catalyzed hydroboration
of two-point binding substrates
It is worth to note that in Takacs’ two-point binding systems, there is a wide range
of functional group compatibility. For instance, it is not restricted to the secondary amide
(i.e., benzyl amide) coordinating group as shown in Figure 28 (i.e., other functional
groups such as ester, oxime ether, phosphonate, and later on in this dissertation, tertiary
amide (e.g., morpholine and Weinreb amides) can also be applied) indicating the acidic
NH proton does not play the crucial rule in the reaction mechanism. On the other hand,
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Tang’s amide-directed CAHB requires a secondary amide and diborane reagent (i.e.,
B2pin2) for high conversion and enantioselectivity, respectively (recalled from Figure
6).61 Therefore, though in the two-point binding framework, Tang’s proposed mechanism
is quite different from Takacs’ as illustrated in Figure 28. The main differences include,
(i) oxidative addition of diborane to generate Rh-diborane complex, (ii) presence of an
extra step for H–B exchange after alkene chelation (Figure 29).

Figure 29. Tang’s proposed mechanism for amide-directed CAHB of -arylenamides
illustrating the crucial roles of diborane reagent and NH acidic proton.

47

1.6 Summary
Chiral boronic esters are versatile intermediates because of their widely used
stereospecific transformations to other classes of interest. Among the functionalization
methodologies, conventional Pd-catalyzed Suzuki–Miyaura cross-coupling of secondary
boronic esters has recently attracted great deal attention due to the interest of
understanding their stereochemical aspects. Herein, the configuration of the crosscoupling reaction will be discussed, rationalized and compared to the information
provided in current literature.
In addition to the applications in stereospecific transformations, organoboranes
have been recently used in total synthesis of natural products or other compounds of
interest. Consequently, many research groups have been seeking for enantioselective
methods for their preparations including stoichiometric reagents, stereoconvergent
couplings

of

enantioselective

alpha-haloboronates,
allylic

enantioselective

substitution

with

allyl-

and

diborylmethane,

arylborylation,
enantioselective

aminoborylation, enantioselective B–H bond insertion, enantioselective C–H borylation,
enantioselective conjugate borylation, enantioselective conjunctive cross-coupling,
enantioselective diboration, group selective cross-coupling of diboranes, enantioselective
nucleophilic addition to aldehydes, enantioselective homologation of organoboron via
lithiation-borylation, stereospecific catalytic Miyaura borylation, asymmetric reactions
with vinylboronates, etc.
Despite the fact that many effective methodologies having been carried out,
transition-metal-catalyzed asymmetric hydroboration has a long-standing story and is the
most attractive method due to the atom-economic nature of the transformation. The
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current literature on CAHB is still largely limited to vinyl arene substrates with a few
exceptions from Hartwig, Tortosa, and other groups. Early carbonyl-directed CAHB in
Takacs group obtained by Dr. Sean M. Smith and recently oxime ether-directed CAHB
by Ms. Veronika Shoba and phosphonate-directed CAHB by Mr. Suman Chakrabarty
made a great impact on the extension of the substrate scopes. Phosphonates and oxime
ethers are particularly interesting due to their ability to direct the boron towards the
tertiary carbon centers. Directed CAHB of -unsaturated carbonyl compounds along
with enantioselective conjugate borylation and enantioselective C–H borylation mark a
few direct routes to -borylated carbonyl derivatives. With a more challenging further
remote coordinating distance, directed CAHB of -unsaturated carbonyl compounds
opens the first direct route to stereogenic - and -borylated carbonyl derivatives (the first
direct route to non-stereogenic -borylated amides and esters carried out in collaboration
with Dr. Sean Smith in directed CAHB of germinal -unsaturated amides and esters
will also be discussed).
To gain knowledge for better understanding of mechanistic pathways of CAHB
with two-point binding substrates, collaborative experimental and computational studies
of symmetric cyclic -unsaturated amides were carried out. The computational results
suggest the catalytic cycle that is supported by the experimental results. However, some
experimental results are in good agreement with alternative pathways that has not been
theoretically considered yet.
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CHAPTER 2: ENANTIOSELECTIVE - AND -BORYLATION OF ACYLIC AND -UNSATURATED CARBONYL DERIVATIVES

2.1 Enantioselective -borylation of -unsaturated amides and esters1
The work described in this section 2.1 was in collaboration with Dr. Sean M.
Smith, a previous member of the Takacs group. I was involved in this project when first
joining the group. At that time, the optimization studies were done; using the best
performing conditions, I obtained several CAHB of substrates which were later used for
Suzuki–Miyaura cross-coupling reactions (i.e., 4b and 4h–j) as well as transformations of
the latter.
This work was already included in Dr. Smith’s thesis (University of Nebraska,
2012) as the highlight of the first highly regio- and enantioselective CAHB of unactivated
1,1-disubstituted alkenes (i.e., methylidene substrates). However, I would like to
summarize it herein as a different approach – first general direct asymmetric route to borylation of carbonyl derivatives illustrating the innovation of this work. In addition, it
is significant because the formation of the -borylated products broadens the range of
structures that can subsequently be accessed from chiral boronic ester products. While
conjugate addition2 and C–H activation3 methodologies provide efficient alternatives to
CAHB for enantioselective -borylation of carbonyl compounds (Figure 1), direct borylation is unique to CAHB.
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Figure 1. Enantioselective conjugate borylation and C–H borylation for the preparations
of chiral -borylated of carbonyl compounds.
In contrast to the CAHB of 1,2-disubstituted alkenes (e.g., 1a) previously
reported,4 CAHB of these methylidene substrates (e.g., 3a) differs in two important
aspects (Figure 2). (i) The methylidenes undergo CAHB, using 1% [Rh(nbd)2BF4/2
(R,R)-T1] and 4,4,6-trimethyl-1,3,2-dioxaborinane (tmdBH), with complementary
regioselectivity. While 1,2-disubstituted alkene 1a generates -borylated amide 2a, 1,1disubstituted alkene 3a affords -borylated amide 4a. (ii) Using the same catalyst system,
the borane (i.e., tmdBH) adds to opposite faces of the alkene; borane adds to the top face
for methylidenes (for the perspective illustrated) versus bottom face addition in the
isomeric 1,2-disubstituted alkenes.
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Figure 2. Contrasting regio- and -facial selectivity of 1,2- and 1,1-disubstituted alkenes.
Having developed an efficient catalyst system for enantioselective -borylation of
1,1-disubstituted unsaturated amide 3a, we explored the substrate scope (i.e., 3b–j) to
illustrate some of the current advances and limitations (Figure 3). Phenyl amide
substrates bearing small substituents (i.e., 3b–c, R = Me or Et) exhibits more modest
regioselectivity (5–6:1); however, CAHB proceeds in good yield and a high level of
enantioinduction (54–60%, 92–94% ee). Substrates with larger side chains including
primary alkyl (i.e., 3d–e) or secondary alkyl (i.e., 3f), and aryl (i.e., 3g) substituents
predominantly

provide

-borylated

products

4d–g

in

excellent

yield

and

enantioselectivity (regioselectivity >20:1, 70–73%, 90–94% ee). The versatile functional
group tert-butyl ester also acts as an efficient directing group; CAHBs of -unsaturated
tert-butyl esters 3h–j proceed with good yield and high enantioselectivity (62–78%, 92–
94% ee). Similar to the phenyl amide cases, tert-butyl ester substrates bearing small
substituents exhibits lower regioselectivity (i.e., 3i–j, R = Me or Et).
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Figure 3. Enantioselective -borylation of -unsaturated amides and esters
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2.2 Enantioselective -borylation of -unsaturated amides5
The work in section 2.1 introduced the first general direct asymmetric route to borylated carbonyl compounds; however, due to the substitution pattern the boronic
esters generated do not bear boron at a secondary or tertiary carbon stereocenter. To
address the latter and to consider the challenge of further distal coordination in CAHB
reactions, we sought a direct route to secondary -borylated carbonyl compounds. CAHB
of -unsaturated amide 7a undergoes highly -selective borylation in excellent yield and
with high enantioselectivity (Figure 4). It differs from the previous -unsaturated
amides1,4 (i.e., 1 and 3) in a number of important aspects. (i) - and -Borylation of
isomeric -substrates (e.g., 1b and 3d) differ in the sense of stereoinduction (i.e., facial discrimination). In contrast, -borylation of -unsaturated amide 1b and borylation of the one-carbon homologue -unsaturated amide 7a add to the same face of
the alkene. (ii) CAHB of 7a is more efficient; it is not necessary to use 2 equivalents of
borane to effect complete hydroboration. As shown in previous studies of CAHB of unsaturated carbonyl compounds, complete conversion of starting material requires an
excess (2 equiv) of borane; i.e., using only one equivalent of borane fails to consume all
starting material regardless of the amount of time and catalyst loading. The results
indicate the borane is apparently being consumed in an undesired side-reaction (e.g., the
reported rhodium- catalyzed formation of tris(pinacolato)diboron).6,7 In the present case,
CAHB of -unsaturated amides 7 requires only a slight excess of pinBH (i.e., 1.1
equiv). However, 1.5 equiv is typically used to facilitate faster conversion and/or permit
the use of lower catalyst loading; optimization studies are discussed below, vide infra.
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Figure 4. Comparing -facial discrimination in CAHB of - and -unsaturated phenyl
amides
Given the promising results obtained for CAHB of the one-carbon further remote
-unsaturated phenyl amide 7a, we wanted to focus this study on more versatile amides
(i.e., benzyl amide, Weinreb amide, and morpholine amide). It is worth noting that the
benzyl amide is not an efficient directing group for -unsaturated systems.4 An
extensive optimization study evaluating the effect of ligands, boranes, and the
ligand:metal ratio are obtained for CAHB of -unsaturated benzyl amide 7b (Table 1
and Figures 3–4). First, the effects of using various ligands and boranes are evaluated as
shown in Table 1. Though tmdBH is very efficient in both - and -borylation of -
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unsaturated carbonyl derivatives (Figure 1), it is much less reactive and selective for
hydroboration in the present study (Table 1, entries 14–26). In some cases (entries 16–
18), the conversions are good (as little as 11% starting material left over); however, there
is only trace amount of the desire -borylated product observed; the major side-products
obtained are reduced products in all cases. Catecholborane (catBH, entries 27–39) gives
good yield in many cases; however, the products obtained are nearly racemic. On the
other hand, pinacolborane (pinBH, entries 1–13) is quite effective. In conjunction with
pinBH, simple BINOL-derived phosphonamidite ligands B1–2 are among the successful
catalyst systems (entries 1–2). The effect of 3,3’-substituents of varying steric and
electronic character on BINOL-derived phosphonamidite ligands (i.e., B3–6, entries 3–6)
are also tested. Except for B6 (R = TMS, entry 6), which gives results similar to B1 and
B2, other derivatives proceed in lower yield and enantioselectivity (entries 3–5); the
major side-products using these derivatives are either reduced products or those derived
from alkene isomerization to the sterenyl derivative (i.e., vinyl arene). Simple TADDOLderived phosphonamidite TN1 and phosphite T1 give high yield and regioselectivity for
-borylation but only exhibit moderate enantioselectivity (entries 7–8). In contrast to
BINOL-derived phosphonamidite ligands, BINOL-derived phosphite L1 and BINAP L2
are not reactive (i.e., 80–84% starting 7b is recovered; entries 9–10). The oxazolinecontaining monodentate and bidentate ligands L3–5 are not selective for hydroboration
pathway (entries 11–13); although starting material was consumed in these cases, only
small amounts of hydroborated products were formed (14–24%).
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Table 1. Evaluating the effects of ligands and boranes in CAHB of 7b

B1 (pinBH)
Ligand Entry 5d 7d
B1
B2
B3
B4
B5
B6
TN1
T1
L1
L2
L3
L4
L5
a

1
2
3
4
5
6
7
8
9
10
11
12
13

0
0
0
0
0
0
0
0
80
84
0
50
0

91
95
64
52
19
90
70
85
0
0
14
17
24

%
ee
93
90
87
85
85
90
–43b
46
n.d.
n.d.
n.d.
n.d.
n.d.

B2 (tmdBH)
Entry 5d
7d
14
15
16
17
18
19
22
23
20
21
24
25
26

80
60
35
27
11
70
>90
>90
>90
>90
>90
80
75

12
15
0
5
0
10
0
0
0
0
0
11
0

%
ee
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.

B3 (catBH)
Entry 5d 7d
27
28
29
30
31
32
33
34
35
36
37
38
39

0
0

18
10
0
30
0
22
6

81
83
–
–
–
–
69
76
60
57
40
67
36

%
ee
37
30

–8b
48
n.d.
n.d.
n.d.
–16c
n.d.

CAHB conditions: 0.0528 mmol 5d, 1.0 mol% Rh(nbd)2BF4, 1.0 mol% bidentate ligand or 2.0 mol%
monodentate ligand, 2.0 equiv. borane, THF (C = 0.106 M), 40 oC, 5h; yield was reported as crude 1H
NMR yield using mesitylene as an internal standard and an average of two experiments generally
exhibiting a spread of ±2%; % ee was determined by chiral HPLC Chiralpak-IC column; n.d. = not
determined. b Enantioswithching observed when using (R)-TN1. c (S)-L4 was used.
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With the best performing borane and ligand (i.e., pinBH and B1) identified, we
next evaluate the effects of catalyst loading, amount of borane, and temperature for
CAHB/ oxidation of 7b (Figure 5). The study was carried out in six different conditions
A–F; the x-axis represents the reaction time and the y-axis stands for the yield of four
components: starting material (SM, blue), reduced product (red), the desired -hydroxy
product 9b (green), and the enantiomer excess of 9b (ee, purple). Condition A is the same
as the optimal condition obtained from Table 1 (entry 1, 0.5% Rh/2 B1, 2.0 equiv pinBH,
40 oC); brief kinetic results here show that all starting materials were consumed after 2
hours with good yield and enantioselectivity of 9b (90%, 93% ee). According to Curtin–

A

B

C

D

76

E

F

Figure 5. Temperature and amount of catalyst and borane effects on CAHB of unsaturated amide 7b
Hammett principle, lower the reaction temperature would lead to higher ee; however,
condition B run at room temperature with otherwise the same reaction conditions as A
affords the same results at the slower rate (6h for complete conversion). Notably and as
highlighted above, condition C with slight excess of borane (i.e., 1.1 equiv pinBH) is also
effective; however, it is still slower (3h for complete converstion) than A even with
higher catalyst loading (1.0% Rh/2 B1) affording the same final results. Similar
conditions to C, but increasing the amount of borane to 1.5 (D) and 2.0 (E) equiv push
the reactions to completion in 1 and 0.5 hours, respectively. Condition F run at room
temperature once again does not help to enhance the ee; the reaction maybe too fast for
the Curtin–Hammett principle to be applied. Several conclusions from the optimization
studies are shown in Figure 3; these include, (i) the catalyst loading can go as low as
0.5% without loss of yield or prolonged reaction time, (ii) increasing temperature from
room temperature to 40 oC provides not only faster rate but also retain high selectivity,
and (iii) as discussed above (Figure 2), in contrast to the CAHB of -systems only a
slight excess of borane is required (as low as 1.1 equiv) for complete consumption of
starting material. In addition, the graphs indicate that the reduced product forms at the
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beginning of the reaction and reaching its maximum yield (i.e., 10%) before the
borylation reaction is complete. The competing hydrogenation pathway is currently under
investigation by Veronika Shoba, a current Ph.D. candidate in the Takacs lab.8
It is worth noting that the cationic rhodium catalyst precursor used above (i.e.,
Rh(nbd)2BF4) is essential for the two-point binding substrates (i.e., alkenes utilizing the
directing group). Neutral rhodium (e.g., [Rh(COD)Cl]2) is indeed ineffective resulting in
no reaction. It is because the counterion (e.g., BF4–) of the cationic rhodium is ready to
dissociate giving open binding sites for not only the alkene but also the directing group to
bind to the metal. In addition, the 1:2 Rh:Ligand ratio (i.e., [Rh(nbd)2BF4/2 B1)
employed is suggested by early work in the Takacs group.9 Can we use 1:1 Rh:Ligand
(e.g., [Rh(nbd)2BF4/ B1) as the missing coordination can be replace by the coordinating
solvent (i.e., THF)? To probe the question, several metal:ligand ratios were carried out
for CAHB of 7b (Figure 4). The color codes and labels are similar to Figure 5 with x-axis
now represents the ligand:rhodium ratios ranking from 1:1.1–1:2 Rh(nbd)2BF4:B1. All
conditions are the same as depicted in the Scheme of Figure 6 with different reaction
times (0.5–2 hours). Interestingly, with 1.1:1 ligand:metal ratio, the conversion is even
faster than the suggested one; only approximate 2% of starting material left over after 0.5
hour, while the case of 2:1 ratio provides only slightly more than half conversion (i.e.,
57%). After 2 hours, the reaction goes to completion in all cases. While the 1:1
ligand:rhodium catalyst is decidedly faster, the final yield of borylated product using the
2:1 ligand:metal ratio is higher (90% versus 84%) due to lower amounts of the reduced
product formed. In addition, with more ligand, the level of enantioselectivity is also
slightly higher (86% ee versus 93% ee). The results indicate that 1:1 ligand:metal ratio is
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sufficient to form an active catalyst; however, having excess ligand reduces the unwanted
side reaction and enhances the enantioselectivity. The results obtained using a 1.8:1
ligand:metal ratio are as good as 2:1; however, we settled on using the 2:1 ratio in further
investigations as well as for publication purposes.

Figure 6. Ligand:metal ratio studies on CAHB of -unsaturated amide 7b suggest that
1:1 ligand:metal ratio is sufficient to form an active catalyst; however, having excess
ligand reduces the unwanted side reaction and enhances the enantioselectivity.
To further explore the generality of the optimized catalyst system, CAHB of a
series of -unsaturated amides 7b–m varying in their amide and the vinyl substituents
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were converted to their -borylated intermediates and oxidized to their -hydoxy amides
9b–m (Figure 7). As expected from previous CAHB of -unsaturated amides,4 the E/Zalkene geometry of the 1,2-disubstituted alkene moiety only slightly effect affects the
results; e.g., comparable results are obtained for CAHB of (E)- and (Z)-7b (78%, 94:6
er). Along with the secondary amides (i.e., N-phenyl and N-benzyl) discussed above, the
more labile tertiary amides (i.e., Weinreb and morpholine) 7c and 7d are also well
tolerated under the reaction conditions resulting in high yield and enantioselectivity (68–
81%, 89–92% ee). Among the amide series, secondary amides give the highest selectivity (>20:1), and thus N-benzyl amide was chosen for further exploring the
substrate scope. N-benzyl amide substrates 7e–g bearing heteroaromatic ring systems also
undergo CAHB/oxidation effectively yielding 9e–g (59–72%, 84–88% ee). Not only nalkyl but also certain branched alkyl substituents (i.e., 7h–j) are well tolerated under the
standard reaction conditions. In particular, substrate 7j bearing a pre-installed chiral
center and two double bond moieties undergoes CAHB selectively on the proximal
double bond with respect to the amide directing group with essentially complete catalyst
controlled; CAHB/ oxidation with (R)-B2 affords (4S,7S)-7j and with (S)-B2 affords
(4R,7S)-7j in similar yield and diastereoselectivity. Oxygen- containing compounds (i.e.,
silyl ether and chiral acetal) 7k–m are also good substrates. Chiral acetal 7l again
undergoes catalyst controlled -borylation with high diastereoselectivity.
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Figure 7. Substrate scope for CAHB of -unsaturated amides.
a

Unless otherwise noted all reaction use 0.5% [Rh(nbd)2BF4/2 B1], 1.5 equiv. pinBH, THF, 40 oC (12 h)
followed by oxidation using H2O2/aq. NaOH. Unless otherwise noted, the isolated yield is that of the major
regioisomer and reflects the average of three experiments generally exhibiting a spread of 2%;
regioselectivity is determined from the crude 1H NMR of 9. Enantiomer ratios (er) are determined by chiral
HPLC analysis; diastereomer ratios (dr) are determined for the purified mixture of diastereomers by
integrating major and minor 13C NMR resonances. b 2.0% [Rh(nbd)2BF4/2 B1]. c Oxidation conditions:
NaBO3/H2O. d 1.0% [Rh(nbd)2BF4/2 B1]. e 1.0% [Rh(nbd)2BF4/2 B2].
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Despite the generality of the catalyst system to the broad range of substrates
shown in Figure 7, there are still some limitations found in the current study (Figure 8).
For example, substrate 7m, which is similar to substrate 7l in bearing chiral acetal
moiety, but one which is in closer proximity to the site of hydroboration, shows a strong
matched/mismatched effect. While the matched case using (R)-B1 affords (R,S)-7m
(70%, 92:8 dr) as shown in Figure 5, the catalyst employing (S)-B1 gives rise to a
complex mixture of regioisomers 10. A substrate in which vinyl substituent is small (e.g.,
7n, R = Me) exhibits only modest regioselectivity (3:1) even though CAHB proceeds in
good yield and high enantioselectivity (61%, 90% ee). Recall that ester functionality is
found to be good directing group in -borylation of germinal -unsaturated carbonyl
derivatives (section 2.1). However, attempted -borylation of -unsaturated ester 11
yields only trace amounts of borylated product; in this example, there is evidence for
alkene isomerization.10
In spite of successful CAHB of -unsaturated amides, our attempts to carry out
CAHB for a one carbon homologue -unsaturated amide 12 was less efficient and less
regioselective under the standard conditions. In individual reactions, CAHB of 12
required 2% catalyst loading for complete consumption of starting material (56%, 1.5:1
regioselectivity), whereas 0.5% is sufficient in the case of 7b. However, the direct
competition of 12 and 7b for limiting pinBH (1:1:1 proportions of each) affords only a
modest excess of recovered 12 (74% recovered) relative to recovered 7b (61%
recovered). The results suggest that 7b is consumed only slightly faster than 12 by active
catalyst. A relatively slow conversion of rhodium precatalyst to active catalyst by 12 in
the absence of 7b could account of the conflicting observations.
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Figure 8. Current limitations of CAHB of -unsaturated amides.
a

Standard conditions as shown in Figure 5. b 1.0% [Rh(nbd)2BF4/2 B1]. c er is determined by 19F NMR of
the corresponding Mosher ester. d 2.0% [Rh(nbd)2BF4/2 (R)-B1].

In order to prove the absolute configuration of the -borylation products derived
from -unsaturated amides, -borylated Weinreb amide 7c was treated with H2O2/aq.
NaOH to afford the enantiomer of the known chiral 5-substituted--lactone (R)-13
(Figure 9).11 The opposite sign of optical rotation showed that CAHB products have the
(S)-configuration. To further confirm the assignment, (S)-13 and 9d were converted to
9b, both products exhibiting the same order of elution by chiral HPLC.
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Figure 9. Proof of absolute configuration of alcohols 9b–d via comparing optical rotation
with known lactone (R)-13.
In addition to the chemical correlation and comparison of optical rotation depicted
in Figure 9, Mosher’s ester analysis provides additional evidence for the absolute
configuration. Figure 10 illustrates the 1H NMR regions of NH and methyl groups of
Mosher’s ester 14, prepared from 7n (obtained from CAHB of 7n with (R)-B1) and (S)Mosher acid, respectively). From the figures, the major NH is more downfield, whereas,
the major methyl group is more upfield. According to Feng Shao’s12 protocol for
determination of absolute configuration using Mosher’s ester analysis, the NH is on the
same side of the methoxy group and the methyl group is on the opposite side of the
methoxy group resulting in S,S-configuration of 14. The method might not be reliable for
determining absolute configuration of 9n by itself since both NH and methyl groups are
quite far away from the Mosher ester chiral center. However, the result is consistent with
correlation to the known lactone (R)-13 as described above.
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Figure 10. Additional evidence for the absolute configuration of (S)-9n via 1H NMR
analysis of Mosher’s ester (S,S)-14.
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2.3 Enantioselective -borylation of -unsaturated carbonyl derivatives
In contrast to the results described above, -unsaturated amides bearing aryl
substituents (i.e., vinyl arene substrates) behave much differently. Eor example, substrate
15a (R = Ph) (Figure 11) gives predominantly opposite regioisomer (i.e., -selective
borylation) to generate chiral benzylic boronic esters and the corresponding benzylic
alcohols (16a) after oxidation. In addition, the borane adds to the opposite face of the
alkene, that is, to the top face of the alkene (as illustrated in Figure 11) as opposed to the
previous study of 7.

Figure 11. Effect of vinyl substituents on regioselectivity and -facial selectivity of
CAHB of -unsaturated amides.
Benzylic boronic esters are attractive building blocks for complex biologically
active natural products and pharmaceuticals,13 and consequently have been the focus of a
variety of synthetic methods. Besides conventional methods such as asymmetric
hydroboration of vinyl arenes,14–19 enantioselective allylic borylation,20 enantioselective
conjugate borylation,21 and asymmetric hydrogenation of vinyl boronates,22 there has
been significant interest in developing new enantioselective methods for their
preparations. Scheme 1 shows several recent methodologies. Hall,23 Yun,24 and Morken25
independently reported group selective cross-coupling of diborane. While Hall’s and
Yun’s work exploit stereoretentive Pd-catalyzed cross-coupling of chiral diboranes,
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Morken’s approach uses enantiotopic group-selective cross-coupling using a chiral
palladium catalyst. Watson constructed the targeted derivatives via stereospecific
Miyaura borylation of a chiral ammonium salt precursor.26 Toste and co-workers
developed a new strategy for a three component coupling using alpha-olefins,

Scheme 1. Recent methodologies for the preparations of chiral benzylic boronic esters.
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aryldiazonium salts, and bis(pinacolato)diboron; the enantioselective is controlled by a
cooperative chiral anion phase transfer catalyst and a palladium catalyst.27 Though the
CAHB of vinyl arenes has long been known,14–19 high levels of enantioselectivity are
often limited to simple sterene (i.e., vinyl arene) derivatives. This work introduced
similar approach resulting in bifunctional chiral benzylic boronic esters bearing multichiral centers in some cases (vide infra).
Synthesizing the appropriate substrate(s) is always a potential challenge for every
project. For example, benzyl amide substrates bearing alkyl (e.g., 7b) and aryl (e.g., 15a)
are prepared in overall good yield by the six-step synthetic routes depicted in Figure 12.
However, several of the steps are overnight reactions and the time-consuming route
reduces its practicality.

Figure 12. Six-step synthetic routes for -unsaturated amides
We sought a shorter synthetic strategy and found that Claisen-Johnson
rearrangement methodology worked well for the alkyl-substituted substrates such as 7b
(Figure 13). However, when the same method was applied for aryl-substituted substrates
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(e.g., 15a), the benzylic alcohol intermediate, formed upon addition of the vinyl
Grignard, suffered from competing pathways; a low yield of the desired -unsaturated
ethyl ester 17 was obtained after the Claisen-Johnson rearrangement. Though the ethyl
ester intermediate was reported as to be formed in good yield by this route,28 we always
see a nearly 1:1 mixture with allylic alcohol 18 obtained via the competitive pathway
proposed in Figure 11. In our hands, similar results were found for other benzylic
aldehyde derivatives.

Figure 13. Preparation of -unsaturated amides via Claisen-Johnson rearrangement and
the potential problem with benzylic alcohol derivatives
Several other routes, including ones involving Heck reaction and Claisen-Ireland
rearrangements, were explored.29 Ultimately, we found that Julia olefination29 worked
best in our hands. The modified Julia reagent (Figure 14) was easily prepared and used as
the common intermediate to afford the desired -unsaturated amides 15 in just two extra
steps.
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Figure 14. Preparation of aryl/ heteroaryl substituted -unsaturated amides 15 via Juliatyped olefination.
As mentioned above, CAHB of 15a (at the time unexpectedly) affords the
benzylic alcohol 16a after oxidation. Does the strong electronic effect of the vinyl arene
moiety simply override the directing group effect? We tested the several potential
directing-groups to probe this question (Figure 15). Non-coordinating functional group
silyl ether 15b and weak coordinating functional group ester 15c undergo CAHB
standard conditions in high regioselectivity (>20:1) and yield (75–77%) suggesting that
the potential directing group plays no role. However, the level of enantioselectivity is
reduced, ranging from 85:15 to 90:10 er. N–Benzyl amide 15a, another secondary amide
15d (i.e., N-phenyl) and tertiary amide 15e (i.e., morpholine) are all good substrates; the
latter two afford -borylated products 19d (76%, 94:6 er) and 19e (78%, 95.5:4.5 er),
respectively. While the ratios change only mostly in terms of the percentages of the
minor enantiomer formed, those changes are energetically significant when expressed as
the difference in free energy between competing diastereotopic transition states.30

90

In addition to probing the effect of varying the directing group, we asked whether
the one carbon homologue 15f (i.e., the substrate in which the alkene is further remote to
the amide directing group) behaved in the same manner under the standard conditions.
Substrate 15f once again predominate the benzylic selective affording -borylated
product 19f in high yield (78%), regioselectivity (>20:1) with somewhat lower
enantioselectivity (90.5:9.5 er). The results suggest that the electronic effect of the aryl
substituent is stronger that the directing group effect in determining regioselectivity,
however, the coordination to the directing group still may play an important role in the
mechanism to explain the higher enantioselectivity that is observed for stronger
coordinating functional groups (i.e., amides versus ester and OTIPS; amide versus
-amide).

Figure 15. Directing group and coordinating distance effects on -borylation of unsaturated carbonyl derivatives
To probe why the N-aryl phosphoramidite ligands are efficient ligands for CAHB
under the conditions employed, we carried out a brief survey of BINOL-derived
phosphoramidites B1–2 and B7–9 for substrate 15a (Table 2). The results indicate that
the N-aryl moiety is needed for good conversion (entries 1–4, B1, 2, and 7). It is also
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worth noting that a 1:1 Rh:L ratio (entry 2) is also efficient using B1. However, the level
of enantioselectivity is little lower (94:6 vs. 95:5 er), and the yield drops from 89% to
81% reflecting the formation of more reduced product. Thus, we propose that the 1:1
Rh:L is essential to form the active catalyst, but additional ligand slows other competing
pathways and enhances the enantioselectivity. Ligands B1–2 with one N–phenyl
substituent are among the best ligands found thus far. These afford the desired product
16a in high yield and enantioselectivity (87–89%, 95:5 er). Ligand B7 with an N,N–
diphenyl substituent also afford 16a in good yield (87%) and regioselectivity (>20:1) but
with a lower er in this case (85:15). For a few other substrates, B7 proves more optimal
(vide infra). Ligands B8, which lacks an N-aryl substituent, and B9, which bear in
indoline substituent, are not as effective resulting; we find lower conversion (50–80%),
lower mode selectivity and lower regioselectivity (<4:1) (entries 5 and 6).
Table 2. Brief survey of ligand effect on CAHB of 15aa

entry
1
2b
3
4
5
6

ligand
conv (%) rr
yield (%)
B1
100
>20:1 89
B1
100
>20:1 81
B2
100
>20:1 87
B7
100
>20:1 87
B8
50
3.5:1 18
B9
80
3:1
28
a
Standard conditions. b 1:1 Rh:L was used.

er
95:5
94:6
95:5
85:15
–
–

The studies described above lead us to conclude that (i) regioselectivity is largely
controlled by the aryl electronic effect, (ii) enantioselectivity is enhanced by the directing
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group coordination effect, (iii) 1:1 Rh:L ratio is essential for the formation of the active
catalyst, and (iv) the N-aryl scaffold is crucial for high reactivity and selectivity. Based
on these conclusions, we propose as a working model the catalytic cycle illustrated in
Figure 16. First, the Rh(I)-catalyst used in our CAHB is proposed to undergo concerted
metalation/deprotonation (CMD) with the N-aryl of BINOL-derived phosphoramidite to
generate the active catalyst species A and release HBF4 to begin the catalytic cycle.
Notably, N-aryl BINOL-derived phospharamidite acts like a bidentate though it is
designed for a monodentate ligand. After alkene 15a chelation to form intermediate B,

Figure 16. Proposed catalytic cycle for CAHB of 15a using N-aryl ligand scaffold
involving Rh(I)-catalyzed concerted-metalation-deprotonation
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oxidative addition of pinacolborane (pinBH) affords Rh(III) octahedral species C. Since
the regioselectivity is controlled by the aryl alkene substituent, migratory insertion of
Rh–H would generate intermediate D following by reductive elimination to form the
desired borylated product 19a and regenerate the active catalyst A.
It should be addressed that rhodium(I) has been used in many C–H activation
reactions; however, all of them are suggested to undergo oxidative addition to form
Rh(III)–H intermediate or coordination facilitated by deprotonation with an adjacent
basic nitrogen.31 There is no precedent in literature on concerted metalation/
deprotonation (CMD) for Rh(I); the proposed mechanism, which needs further study to
be confirmed, could lead to another thoughtful and innovative project. Alternatively,
Rh(III), the well-known metal precursor used in CMD,31 can be generated in the presence
of pinBH prior to CMD step (Figure 17).
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Figure 17. Proposed catalytic cycle for CAHB of 15a using N-aryl ligand scaffold
involving Rh(III)-catalyzed concerted-metalation-deprotonation
To further probe the generality of the reaction, a series of -unsaturated benzyl
amides 15g–t was prepared and evaluated in CAHB using ligands B1–2 and B7 (Figure
18). Although with N,N-diphenyl ligand B7 gives lower ee for substrate 15a, it gives the
highest levels of enantioselectivity for several substrates. For example, substrate 15g,
which bears a 4-CF3-Ph substituent, undergoes CAHB with B7 to afford -borylated
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product 19g in high yield and enantioselectivity (78%, 95:5 er); B1 and B2 give
comparable yields but only 91:9 and 90:10 er, respectively. Other substrates bearing
different electron withdrawing groups at para position (i.e., 15h–i) also well tolerated
under standard conditions affording 19h–i in high yield and enantioselectivity (75–77%,
95:5 er). In particular, 19i bearing a 4-chlorophenyl substituent, could in principle be
used in subsequence cross-coupling if desired. Substrates with alkoxy substituents at
meta- and para-positions of the aryl ring (e.g., 15j–k) also undergo efficient CAHB (72–
79%, 96:4–97:3 er). However, when the methoxy group is appended to the ortho-position
(e.g., 15l), only moderate enantioselectivity (85.5:14.5 er) was obtained; nonetheless
CAHB proceeds in good yield (82%) and high regioselectivity (>20:1). Substrate 15m,
another ortho-substituted aryl derivative is a good substrate affording 19m in good yield
and enantioselectivity (84%, 93:7 er). A series of heteroaromatic substituted substrates
15n–q also undergo CAHB efficiently, although sluggishly; three equivalent of borane
are needed for complete conversion in 12 hours (69–73%, 92:8–97:3 er).
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Figure 18. Substrate scope for CAHB of aryl/ heteroaryl substituted -unsaturated
amides.
Unless otherwise noted all reaction use 0.5% [Rh(nbd)2BF4/2 B], 1.5 equiv. pinBH, THF, 40 oC (12 h).
Unless otherwise noted, the isolated yield is that of the major regioisomer and reflects the average of three
experiments generally exhibiting a spread of 2%; regioselectivity is determined from the crude 1H NMR of
19 and is greater than 20:1 unless otherwise noted. Enantiomer ratios (er) are determined by 19F NMR of
the corresponding Mosher’s ester. a B7 was used. b B1 was used. c B2 was used. d 3.0 equiv pinBH was
used.

We examined several variations of chiral substrates in the vinyl arene series
(Figure 19). Substrate 20a bearing a chiral N-phenethyl amide undergoes CAHB with
largely catalyst control; CAHB/ oxidation with (R)-B1 affords 21a in comparable yield
(82%) and enantioselectivity (94.5:5.5 dr) with the parent substrate 15a; (S)-B1 generates
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the diastereomer dia-21a in similar yield but with a somewhat diminished diastereomer
ratio (80%, 91:9 dr). Benzyl amide substrate with chiral -methylated center also
undergoes catalyst controlled -borylation yielding two diastereomers 21b and dia-21b in
the same results (79%, 91:9–92:8 dr). We found it interesting that Evans’ chiral auxiliarycontaining 20c is also good substrate, albeit exhibiting a stronger matched/mismatched
effect. While (R)-B1 generates dia-21c with high yield and dr (79%, 92:8 dr), the
mismatched ligand (S)-B1 gives 21c in much lower selectivity (51%, 80:20 dr). The
origin of the matched/mismatched response is not yet clear; it could be predominantly
influenced by either the chiral auxiliary or the relatively sterically demanding -phenyl
substituent. CAHB of 20d and 20e will be obtained shortly to address the issue. In
addition, substrates bearing chiral centers at both - and -positions are also worth
exploring. These proposed substrates could be made via Evans’ chiral auxiliary enolate
alkylation32/aldolation.33
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Figure 19. CAHB of pre-installed -chiral center aryl substituted -unsaturated amides.
Unless otherwise noted all reaction use [Rh(nbd)2BF4/2 B1], 1.5 equiv. pinBH, THF, 40 oC (12 h)
followed by oxidation using H2O2/aq) NaOH (NaBO3 for 20c). Unless otherwise noted, the isolated yield is
that of the major regioisomer and reflects the average of two experiments generally exhibiting a spread of
2%; regioselectivity is determined from the crude 1H NMR of 21 and is greater than 20:1 unless otherwise
noted. Diastereomer ratios (dr) are determined for the purified mixture of diastereomers by integrating
major and minor 1H or 13C NMR resonances. a 0.5% [Rh(nbd)2BF4/2 B1]. b 1.0% [Rh(nbd)2BF4/2 B1].

The absolute configuration of -borylation of -unsaturated amides was
obtained via 1H NMR analysis of Mosher’s ester 22e; the latter is synthesized from the
morpholine amide substrate 15e via CAHB/ oxidation and DCC condensation with (S)Mosher acid (Figure 20). The secondary benzylic Mosher’s ester (e.g., 22e) is deemed a

99

trustworthy source for determining absolute configurations. According to Feng Shao’s12
and co-workers, the major benzylic methyne proton is more downfield, it is on the same
side of the methoxy group and on the opposite side of the phenyl group resulting in R,Sconfiguration of 22e and thus R-configuration of 16e.

Figure 20. Determination of absolute configuration of CAHB of 15e via 1H NMR
analysis of Mosher’s ester 22e
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2.4 Concluding remarks
In summary, CAHBs of - and -unsaturated carbonyl derivatives provide a
novel direct route to acyclic - and -borylated carbonyl compounds highlighting the
innovation of the dissertation. In particular, the methodology has opened a door to the
more challenging substrates with further coordinating distance as compared to the
previous studies. In addition, the electronic effect of the aryl substituents has proven to be
overridden the carbonyl coordinating effect; however, the choice of a suitable directing
group is still crucial to achieve high level of enantioinduction. The significances of these
versatile intermediates will be emphasized via mono- and bifunctionalizations in Chapter
four.
Not only the well-defined directing group, but also a suitable catalyst system as
well as a choice of borane reagent are highly responsible for the current success. While
tmdBH is better than pinBH for -substrates, it is essentially not reactive and selectivity
for -systems; pinBH, on the other hand, are quite effective for the longer coordinating
distance. Moreover, ligands also have crucial role in order to obtain high
enantioselectivity; TADDOL-derived phosphite (i.e., T1) is the best choice for 1,1disubstituted

alkenes

(i.e.,

methylidene

substrates),

whereas

BINOL-derived

phospharamidites (i.e., B1, B2, and B7) give best performance for 1,2-disubstituted
alkenes. Interestingly, in this study, we also find that N-aryl moiety of the B ligand family
is required for good conversion perhaps due to the possibility for concerted metalation/
deprotonation.
In some cases of pre-installed chiral substrates, the system is found to be
essentially catalyst controlled in most cases to achieve both diastereomers in good yield
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and high diastereoselectivity. In addition, substrate bearing two different alkene
environments undergoes completely group-selective in which only the alkene proximal to
the directing group gets hydroborated. Though not being mentioned in this thesis, CAHB
of other sub-classes of alkenes (i.e., 1,2,2- and 1,1,2-trisubstituted alkenes) should be of
interest to the scientific community.
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CHAPTER 3: ENANTIOSELECTIVE -BORYLATION OF CYCLIC UNSATURATED AMIDES: DESYMMETRIZATION TO QUATERNARY
STEREOCENTERS AND MAPPING OUT THE CATALYTIC CYCLE WITH THE
AID OF COMPUTATIONAL STUDIES

3.1 Some selected desymmetrization methodologies
Enantioselective desymmetrization of prochiral or meso compounds has recently
attracted much interest for the synthesis of enantioenriched molecules.1 The majority of
this methodology is categorized as shown in Figure 1, including nucleophilic ringopening of cyclic substrates,2 desymmetrization of meso difunctional compounds,3
oxidative desymmetrization,4 inter- and intramolecular C–C bond formation,5 and
reductive desymmetrization.1

Figure 1. Selected desymmetrization methodologies
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In addition to the above methods, enantioselective desymmetrization is recently
highlighted as the most powerful approach to constructing quaternary or tetrasubstituted
carbon stereogenic centers, existing widely in natural products, drugs, and bioactive
molecules.6
Despite the rapid growth of interest, there is only a few catalytic enantioselective
desymmetrization obtained via asymmetric hydroboration toward the synthesis of
molecules bearing quaternary carbon stereogenic centers (Figure 2). Previous reports are
based upon the enantioselective hydroboration of cyclopropene derivatives. In 2003,
Gevorgyan introduced the directed Rh(I)-catalyzed hydroboration of a few cyclopropanederived substrates. High yield and enantioselectivity with complete cis-diastereoselection
is attributed to carbonyl-directed CAHB.7 With similar substrates, Tian and co-workers
on the other hand reported the exclusive formation of trans-products using a chiral
copper(I) catalyst.8 The formation of the latter was explained by the steric hindrance of
the methyl ester group overriding the weak coordination of copper to the carboxyl group.
Similarly, Tortosa’s system does not involve the coordinating functional group indicating
that the high diastereoselectivity is completely controlled by steric effect of the larger
group (i.e.; RL).9
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Figure 2. Current literature reports on enantioselective desymmetrization via CAHB
toward the synthesis of molecules bearing quaternary carbon stereogenic centers product
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3.2 Enantioselective desymmetrization to all-carbon quaternary stereocenters via borylation of cyclic -unsaturated amides10
Inspired by the approach, we examined the homologous symmetric cyclic
cyclopentene-derived substrate 23. Three reasons were important in selecting this
structural motif: (i) we would like to achieve -borylation using the more challenging
substrates (i.e., longer coordinating distance), symmetric cyclic -unsaturated amides
23, to complement -borylation of cyclopropene-based substrates reported in literature
(Figure 2), (ii) a series of non--hydrogen substrates (i.e., 23a) should generate quaternary carbon stereogenic centers after enantioselective desymmetrization via
CAHB, and (iii) the symmetric substrate is, in principle, a good choice for computational
studies (Figure 3) described later in this chapter.

Figure 3. CAHB of symmetric cyclic -unsaturated amide 23a, a model substrate for
computational studies. Copyright (2014) ACS AuthorChoice (ref. 30).
In contrast to the related acyclic -unsaturated amides discussed in Chapter 2,
tmdBH, rather than pinBH, illustrates the best selectivity for the cyclic substrate 23a. It
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affords (1R,3S)-26a in 80% yield and 94% ee after CAHB/ oxidation; pinBH generates
(1R,3S)-26a in much lower yield (45%) and enantioinduction (80% ee). In spite of
pinBH’s poor performance in practice, asymmetric structures render the computational
study more time-consuming. Therefore, pinBH along with the caged-phosphite ligand
B10 are used as model compounds in density functional theory (DFT) calculations to
reduce the computing time. The computational details will be discussed in later section
3.4.
CAHB of the parent substrate 23a was screened with pinBH and tmdBH using a
broad collection of simple, chiral TADDOL- and BINOL-derived ligands initial
optimization studies. The results are summarized in Table 1.
Table 1. Optimization studies of enantioselective desymmetrization via CAHB of 23a

A. Enantioselective desymmetrization via CAHB of 23a with tmdBH.
Entry

Ligand

1
2
3

B1
B2
T1a

Abs.
Config.
(cis-26a)
(1R,3S)
(1R,3S)
(1R,3S)

% ee
(cis-26a)

% Yield
(cis-26a)

% Yield
(trans-26a)

% Yield
(27a)

% Yield
(28a)

94
94
83

80
80
70

1
1
1

2
1
3

14
12
25
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4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21

T2a
T3a
T4a
T1b
T2b
T3b
T4b
T1c
T2c
T3c
T4c
T1d
T2d
T3d
T4d
T1e
T3e
T4e

(1R,3S)
(1R,3S)
(1R,3S)
(1R,3S)
(1R,3S)
(1R,3S)
(1R,3S)
(1R,3S)
(1R,3S)
(1S,3R)
(1R,3S)
(1R,3S)
(1R,3S)
(1R,3S)
(1R,3S)
(1R,3S)
(1S,3R)
(1R,3S)

88
87
92
26
35
23
30
11
10
40
49
20
1
2
11
11
45
50

60
59
65
35
47
45
37
9
29
22
30
2
2
5
9
5
8
9

2
2
1
2
3
2
3
3
1
1
2
2
2
3
3
2
2
3

4
4
3
4
5
5
4
5
5
4
6
4
16
17
19
4
7
7

27
32
25
55
41
45
52
81
60
68
60
81
71
69
65
71
74
70

B. Enantioselective desymmetrization via CAHB of 23a with pinBH.
Entry

Ligand

22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42

B1
B2
T1a
T2a
T3a
T4a
T1b
T2b
T3b
T4b
T1c
T2c
T3c
T4c
T1d
T2d
T3d
T4d
T1e
T3e
T4e

Abs.
Config.
(cis-26a)
(1R,3S)
(1R,3S)
(1R,3S)
(1R,3S)
(1R,3S)
(1R,3S)
(1S,3R)
(1S,3R)
(1S,3R)
(1S,3R)
(1S,3R)
(1S,3R)
(1S,3R)
(1R,3S)
(1S,3R)
(1S,3R)
(1S,3R)
(1S,3R)
(1R,3S)
(1S,3R)
(1R,3S)

% ee
(cis-26a)

% Yield
(cis-26a)

% Yield
(trans-26a)

% Yield
(27a)

% Yield
(28a)

80
81
70
60
55
68
60
75
65
60
6
60
78
15
10
13
50
10
5
70
2

45
52
59
66
60
62
62
64
66
62
25
75
77
63
11
48
46
23
27
55
40

3
3
8
8
10
9
4
6
5
4
4
5
7
4
19
8
5
34
5
8
17

7
8
13
7
7
8
14
11
12
15
22
8
6
15
10
18
25
8
22
12
15

25
28
17
16
20
18
17
16
14
16
47
15
14
16
51
20
20
22
31
19
25

The results shown in Table 1 lead to several important conclusions, including (i)
(BINOL)-derived phosphoramidites (i.e., B1–2) in conjunction with tmdBH gives the
best catalyst/borance combination for this substrate (i.e., entries 1–2), (ii) tmdBH in
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combination with certain ligands are much favorable for hydrogenation pathway giving
reduced product 28a in up to 81% yield (e.g., entries 11–21), (iii) with pinBH, changing
from a TADDOL-derived phenyl phosphite (i.e., X = OPh, entries 24–27) to a TADDOLderived phosphoramidite (i.e., X = NR1R2, entries 28–33 and 35–40) usually leads to
enantioswitching with a few exceptions (entries 34, 41 and 42). To illustrate the latter
aspect, see the graph in Figure 4. The blue data is obtained from experiments with
tmdBH, the red data correspond to pinBH; negative numbers indicate predominantly the
(1S,3R) absolute configuration while the positive numbers for percent ee are for
predominantly the (1R,3S) absolute configuration. Most of the TADDOL-derived
phosphoramidite ligands (i.e., T1b–T4e) in conjunction with pinBH give negative ee
while using BINOL-derived phosphoramidites B1/B2 and TADDOL-derived phosphite
T1–5a give positive values.

Figure 4. Brief ligand and borane survey for CAHB of 23a reveals moderate levels of
enantioswitching. Adapted with permission from reference 10. Copyright (2015)
American Chemical Soceity.

113

The observed enantioreversal is in qualitative agreement with the previous report
from the Takacs group of a high level of enantioswitching in CAHB of a series of acyclic
-unsaturated amides.11 In principle, both enantiomeric products can be obtained via
asymmetric catalysis by preparing both enantiomers of the catalyst. However, many
chiral sources are available predominately in one absolute configuration; the other
enantiomer might only be accessed by complicated synthetic routes or kinetic resolution
of the racemic mixture. Therefore, uncovering additional strategies by which both
enantiomers can be obtained from a single chiral source of interest in the community. 12
The work described above again demonstrates an ability to use modest changes in ligand
substituents, while preserving the absolute configuration, to effect enantioswitching.
Though this interesting feature is difficult to predict and rationalize and further catalyst
designs are required to reach high level of enantioselectivity in this case, it is in
consistent with the previous study.11 Thus, the effect might be generalized as “TADDOLderived phosphites and TADDOL-derived phosphoramidites in conjunction with pinBH
can potentially provide enantioreversal in carbonyl-directed CAHB, at least for
rhodium(I) catalyst system; modification of the ligand backbones might be needed to
enhance the enantioselectivity.”
It is expected that the level of asymmetric induction obtained with a chiral
catalyst should be dependent on the enantiomeric purity of the catalyst. Often a linear
relationship is observed when a single chiral ligand is present in a chiral metal catalyst;
that is, the product enantioselectivity is directly proportional to the enantiomeric excess
of the chiral ligand employed in the reaction. However, many reports in literature have
shown to deviate from this expectation resulting in a so-called nonlinear effect.13 It is
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now widely used as a mechanistic tool and most commonly to suggest multiple ligands
are present in the active catalyst.14 In the same report of enantioswitching discussed
above, Smith and Takacs also report a negative nonlinear effect ((–)-NLE) and positive
nonlinear effect ((+)-NLE) for TADDOL-derived phosphites and TADDOL-derived
phosphoramidites, respectively.11 The results suggest that the heterochiral combination
(i.e., LRLSRh+) is more reactive for phosphite ligands (i.e., (–)-NLE), whereas it is more
stable and less reactive than the homochiral (i.e., LRLRRh+ or LSLSRh+) species in the
case of phospharamidites (i.e., (+)-NLE). In either case, it is suggested that two ligands
are bound to the rhodium in the active catalyst species.12,13 However, earlier in this
dissertation (i.e., Chapters 2.2 and 2.3), we have shown that 1:1 Rh:L ratio is effective for
the CAHB of acyclic -unsaturated amide derivatives. In order to have better
understanding of mechanistic implications, we therefore carried out a NLE study of the
cyclic substrate. The two best ligands in term of enantioreversal (i.e., T1a and T3c) are
chosen for this investigation (Figure 5). The blue data represent the change in
enantiomeric excess of T1a, and the red data points are obtained varying T3a. The y-axis
illustrates the enantiomeric excess of CAHB/ oxidation product 26a, in which negative
numbers correspond to formation of the (1S,3R)-diastereomer, while the positive numbers
are for formation of the (1R,3S)-diastereomer. Viewing from left-to-right of the x-axis is
the variation from pure (S,S)- to (R,R)-ligands. We were surprised to find that in contrast
to the results obtained by Smith and Takacs, this work shows that both TADDOL-derived
phosphite T1a and phosphoramidite T3c ligands afford an essentially linear relationship
in the case of 1:2 Rh:Ligand ratio. The results could indicate that only chiral 1:2
Rh:Ligand catalysts (i.e., LRLRRh+ or LSLSRh+) are most likely involved in CAHB of the
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cyclic -unsaturated amide 23; the heterochiral combination (i.e., LRLSRh+) is ether not
formed or is unreactive.13,15 The result is also consistent with a 1:1 Rh:Ligand complex
being the active catalyst.

Figure 5. 1:2 Rh:Ligand ratio reveals linear relationship between the enantiomeric excess
of ligand T1a (blue) and T3c (red) and that of the product 26a.
From the results obtained for the case of 1:2 Rh:L ratio (Figure 5), we expected
similar trends should be observed for 1:1 Rh:L ratio. Indeed, a linear relationship was
obtained, although the percent enantiomeric excess of product obtained using
enantiomerically pure ligand was lower using the 1:1 Rh:L combination (Figure 6). In
agreement with CAHB of acyclic -unsaturated carbonyl compounds discussed in
Chapter 2, we now hypothesize that a 1:1 Rh:L complex might be the active chiral
catalyst. The presence of excess chiral ligand enhances the enantioselectivity, perhaps by
pushing an equilibrium towards complete complex formation. Another possibility is that
the two complexes (i.e., 1:2 Rh:L and 1:1 Rh:L) might generate two different active
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catalysts. The computational studies discussed in the next sections will focus on +RhL2
complex based upon the results built at the early stage; however, the pathway involving
+

RhL should now also be considered.

Figure 6. 1:1 Rh:Ligand ratio reveals linear relationship between the enantiomeric excess
of ligand T1a (blue) and T3c (red) and that of the product 26a.
With the optimized conditions employing tmdBH and ligand B2 from our brief
ligand and borane survey, a series of -substituted cyclopentene-based substrates 23a–l is
subjected to CAHB afford secondary -borylated amides 26a–l bearing stereogenic
quaternary -carbon centers (Figure 7). Along with the parent -hydrogen phenyl amide
substrate 23a, other phenyl amides with -substituted quaternary carbon including alkyl
(i.e., 23b, R = Me), aryl (i.e., 23c, R = Ph), and trifluoromethyl l (i.e., 23b, R = CF3)
efficiently undergo CAHB affording the cis isomer in high yield (65–78%) and
enantioselectivity (96:4–97:3 er). Corresponding benzyl amides 23e–h are also good
substrates giving comparable diastereoselectivity and yield, albeit with somewhat slightly
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lower enantioselectivity (92:8–96:4 er). Substrates 23i and 23j, each contain two different
alkenes, but undergo CAHB selectively with the endocyclic double bond leaving the
other untouched; 26i and 26j are formed in good yield (75–80%) and high
enantioselectivity (97:3–99:1 er). The observed products could be explained by the
preferred orientation of the carbonyl oxygen which leads to greater reactivity for the

Figure 7. Enantioselective desymmetrization towards stereogenic quaternary carbon
centers via CAHB of 23
a

Unless otherwise noted all reaction use 1.0% [Rh(nbd)2BF4/2 B2], 2.0 equiv. tmdBH, THF, 40 oC (12 h)
followed by oxidation using H2O2/aq. NaOH. Unless otherwise noted, the isolated yield is that of the major
diastereomer (cis) and reflects the average of two experiments generally exhibiting a spread of 2%.
Enantiomer ratios (er) are determined by chiral HPLC analysis; diastereomer ratios (dr) are determined
for the purified mixture of diastereomers by integrating major and minor 1H NMR resonances. b 2.0%
[Rh(nbd)2BF4/2 B2].
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endocyclic double bond and highlights unusual group selectivity in the CAHB. In
contrast, chiral substrates 23k and 23l exhibit somewhat lower stereoselectivity and
exhibit a matched/mismatched diastereomer effect with enantiomeric catalysts.
Nonetheless, CAHB proceeds with high cis/trans-diastereoselectivity (i.e., solely cis
product is obtained) and high yield (74–76%). In addition, these chiral substrates will be
used to conﬁrm structural assignments for both CAHB and product functionalization
(vide infra).
CAHB of diene 23j, which bears two similarly substituted alkenes with the same
coordinating distance (i.e.,  with respect to the carbonyl moiety), selects for the
endocyclic alkene as depicted in Figure 7. This observation is consistent with tmdBH
being an ineffective borane reagent for the related acyclic -unsaturated substrates
discussed in Chapter 2. Consequently, we would like to understand a little more on the
selectivity of this substrate; Table 2 summarizes the results of some selected CAHB
conditions.
Table 2. Brief survey on CAHB of diene substrate 23j reveals that tmdBH is crucial for
high group- and enantioselectivity.
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Conditions

A
B
C
D
E
F

Isomerized
+ Reduced
+ SMa
Yield

Reduced
27j

Reduced
28j

Alcohol 26jb

Alcohol 29jb

Alcohol
30jc

Othersd

Yield

Yield

Yield

er

Yield

er

Yield

Yield

0
20
78
trace
trace
trace

15
–
–
–
0
–

0
–
–
–
18
–

80
73
18
27
0
10

99:1
99:1
98:2
94:6
–
–

trace
trace
0
11
65
10

–
–
–
–
88:12
–

0
0
0
17
0
19

0
0
0
30
0
45

General CAHB conditions: x mol% [Rh(nbd)2BF4/2 B2], y equiv borane, N2 or H2, THF, 40 oC, 18h
Condition A: 2 mol% cat., 2 equiv tmdBH, N2
Condition B: 1 mol% cat., 2 equiv tmdBH, N2
Condition C: 1 mol% cat., 2 equiv tmdBH, H2
Condition D: 1 mol% cat., 2 equiv pinBH, N2
Condition E: 1 mol% cat., 2 equiv pinBH, H2
Condition F: 1 mol% cat., 4 equiv pinBH, N2
a
In case the reaction did not go to completion, the mixture of isomerized alkenes (-endocyclic alkenes
obtained via -hydride elimination), reduced products, and starting material could not be separated via
column chromatography
b
In case of little selectivity, alcohol 26j and alcohol 28j could not be separated via column
chromatography
c
Alcohol 30j was reported after subtracting the yield of pinacol diol (a side product of oxidation of
pinacolato boronic esters) using 1H NMR mole ratio (the mixture might be separated, but not with
conditions used to separate all other possible products)
d
Other spots indicate other alcohols as they are more polar than alcohols 26j and 28j; their identifications
are not yet determined

Condition A are the optimized conditions; CAHB of diene 23j requires 2%
catalyst loading for complete conversion. In addition to major alcohol 26j obtained in
high yield and selectivity (80%, 99:1 er), monoreduced product 27j is also isolated in
significant amount (15%) suggesting that under the standard condition, the competing
hydrogenation pathway is also selective for the endocyclic alkene. Reducing the catalyst
loading to 1% leads to an incomplete conversion but similar selectivity (condition B).
Building on the contemporaneous results obtained by V. Shoba, the reaction was carried
out under a hydrogen atmosphere; however, unexpectedly, the reactivity was low and a
complex mixture of products obtained (condition C). Borane tmdBH is indeed crucial for
high group- and enantioselectivity; several conditions using pinBH were carried out
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(conditions D–F) but the results obtained were rather complicated mixtures. Some
insights gleaned from reactions using pinBH include (i) pinBH is more reactive than
tmdBH (all conditions using pinBH went to completion) and (ii) pinBH is more selective
for hydroboration mode of cyclopentene ring. Under condition D (N2 atmosphere) only a
trace amount of reduced product was isolated; even under condition E (H2 atmosphere),
alcohol 30j was the major product (65%) albeit with modest enantioselectivity (88:12).
As mentioned above, the chiral amide substrate 23k proved useful for structural
studies. Although CAHB proceeds with only modest diastereoselectivity (88:12 dr), the
major diastereomer could be further functionalized to confirm the stereochemical course
of CAHB (Scheme 1). Our first attempts to grow crystal of -hydroxy 26k were
unsuccessful. We turned to the corresponding trifluoroborate salt as a potentially more
suitable candidate for x-ray crystallographic analysis. The isolated boronic ester 24k was
converted to 31k by the method developed in Molander group.16 Crystals suitable for xray analysis were grown by vapor diffusion method initially with minimum amount of
3:1 diethylether:methanol. The crystal structure of 31k was determined by Dr. Victor Day
(University of Kansas). The structure clearly establishes the stereochemistry of the boronbearing carbon stereocenter relative to the pre-existing amide side chain stereocenter thus
establishing the absolute stereochemical course of the CAHB. To further confirm the
assignment for achiral amide substrates such as 23c, -hydroxy amide 26c was
transamidated to 26k via boric acid-catalyzed reaction resulting in formation of the same
major diastereomer as that obtained from 23k.
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Scheme 1. Determination of absolute configuration of CAHB of cyclic -unsaturated
amides via x-ray crystallographic analysis of -trifluoroborato amide 31k. Adapted with
permission from reference 10. Copyright (2015) American Chemical Soceity.
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3.3 Deuterium-labeling studies
Deuterium-labeling studies for CAHB have been carried out by several groups to
probe the mechanism of the reaction, in particular the degree of reversibility of certain
steps in proposed mechanisms.17–19 The absence of deuterium scrambling often suggests
that the migratory insertion of Rh–H(D) into C=C double bond is irreversible. The level
of deuterium scrambling is found to vary as a function of the substrate and borane
employed in the reaction. Previous D-labeling studies in the Takacs’ group obtained by
Dr. Sean M. Smith (University of Nebraska, 2012) on Rh(I)-catalyzed CAHB of a series
of -unsaturated amides suggested some important aspects, including (i) the
stereospecific syn-addition of borane to alkenes, (ii) the absence of deuterium scrambling
or isomerization indicating the migratory insertion of Rh–H(D) to C=C double bond is
irreversible, and (iii) the mechanism involves a one-step oxidative addition of borane to
the rhodium as supported by the lack of scrambling in a double-labeling experiment.
For comparison to the previous studies in the group as well as to support
computational studies discussed later in this chapter, several sets of deuterium-labeling
reactions were carried out. First the -phenyl substituted substrate 23c was chosen to
study the extent of deuterium incorporation into the major product after CAHB/oxidation,
cis-hydroxy amide 26c. CAHB of 23c was carried out under similar conditions using
several different borane sources (Figure 8); inset 8A illustrates the reference reaction
using tmdBH. Using either deuterated borane reagent, tmdBD or pinBD, the major
product is 26c with high deuterium incorporation at one position (i.e., the -carbon). The
1

H NMR spectra of 26c as well as the deuterated versions are shown in Figure 9. The
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spectra show little evidence for reversible C–H formation except based on the formation
of 28c with tmdBD.

Figure 8. Deuterium-labeling studies for CAHB of 23c show little evidence for
reversible C–H formation
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A. 1H NMR spectrum of 26c using tmdBH (no deuterium incorporation)

B. 1H NMR spectrum of 26c using
tmdBD
(74% deuterium incorporation at carbon)

C. 1H NMR spectrum of 26c using
pinBD (88% deuterium incorporation at
-carbon)

Figure 9. 1H NMR spectra illustrating the deuterium incorporation into -hydroxy
product 26c
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Hydrogenation is a major competing pathway in most reported transition-metalcatalyzed hydroborations20–27 and is also observed in this study. For example, as
illustrated in Figure 8, up to 25% of the reduced product is formed under the optimal
conditions for CAHB of 23c; certain ligands (e.g., T1d) afford the hydrogenation product
28a in up to 81% yield (Table 1). In effort to better understand the mechanism of the
hydrogenated pathway, some selected deuterium-labeling studies under the conditions
shown in Figure 8 were carried out (Table 3 and Figure 10). By adding a hydrogen source
(e.g., methanol, water), Ms. Veronika Shoba was subsequently able to turn the undesired
products into useful compounds.28
Table 3. CAHB of -phenyl 23c under H2 with different tmdBH loading: the role of
borane is important for the reaction to proceed

Equiv
of Starting
Isomerized
Reduced 28c
tmdBH
material
0
37
59
0
0.5
5
39
44
1.0
0
0
66
1.5
0
0
62
2.0
0
0
42
Conditions: 1% [Rh(nbd)2BF4/2 (R)-B2], THF, 40 oC, 20h

Alcohol 26c
0
7
30
35
45

Table 3 shows the results obtained by varying the amount of borane (i.e., tmdBH)
in reactions set up under a hydrogen atmosphere (i.e., hydrogen balloon). The results
indicate that the presence of borane is required for the reaction to proceed; without the
borane, only significant amounts of recovered starting material and the corresponding
isomerized alkene are obtained as an inseparable mixture (mole ratio determined by 1H
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NMR). Increasing the amount of borane employed leads to more alcohol product 26c (up
to 45% with 2 equiv tmdBH) via hydroboration pathway. To be consistent with the
conditions throughout the studies, we chose 2.0 equiv of tmdBH for further investigation
on D-labeling (Figure 10).

Figure 10. Deuterium-labeling studies for CAHB of 23c using tmdBH under D2.
In agreement with the results in Table 3, CAHB of 23c employing tmdBH under a
deuterium atmosphere afford nearly 1:1 ratio of hydroboration:hydrogenation products
(i.e., 26c:28c). In addition, there is no deuterium incorporated to 26c, whereas 100% D is
labeled at -carbon of reduced product 28c. The conclusion is based on 1H NMR analysis;
the 1H NMR spectra of 28c as well as the deuterated versions using different conditions
are shown in Figure 11.
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A. 1H NMR spectrum of 28c using tmdBH (no deuterium incorporation)
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B. 1H NMR spectrum of 28c using
tmdBD under nitrogen
(39% deuterium incorporation at carbon, 48% deuterium incorporation at
-carbon)

C. 1H NMR spectrum of 28c using
pinBD under nitrogen
(no deuterium incorporation at -carbon,
77% deuterium incorporation at carbon)

D. 1H NMR spectrum of 28c using tmdBH under D2 gas (no deuterium incorporation at
-carbon, 100% deuterium incorporation at -carbon)

Figure 11. 1H NMR spectra illustrating the deuterium incorporation of -hydroxy product
28c
Based upon the preliminary results of D-incorporation as well as the crucial role
of borane, the proposed simplified mechanistic pathways for the formation of reduced
product 28c under different conditions are illustrated in Figure 12. After alkene chelation
to form the common intermediate A, under D2/H2 atmosphere in theory could potentially
undergoes oxidative addition of D2/H2 to generate intermediate B (path I) to afford the dideuterated product, but this is not observed. Therefore, path I is eliminated from the
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possible pathways. Some precedents in literature on -bond metathesis suggest that the
reaction employed tmdBH under D2 could potentially undergo competitive D2-sigma
bond metathesis leading to 100%-mono-D incorporated reduced product 28c (path II).29
Similarly, path III using pinBD under hydrogen is proposed to proceed with H2-sigma
bond metathesis to produce an enantiomer of mono-D incorporated reduced product 28c
obtained via path II.

Figure 12. Potential hydrogenation pathways.
In addition to the potential hydrogen pathways depicted in Figure 12, the
observation of 1:1 reduced:alcohol (i.e., 26c:28c) could be explained by competing
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reductive elimination (to the right) versus D2-sigma bond metathesis (to the left) as
illustrated in Figure 13. These two pathways perhaps undergo with overall the same
energies leading to the nearly 1:1 mixture of the mode selectivity products (i.e.,
hydrogenation versus hydroboration).

Figure 13. Proposed formation of 1:1 mixture 26c:28c via equal energies of reductive
elimination versus potential D2-sigma bond metathesis
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3.4 Computational studies – Mechanistic insights into directed CAHB30
Chapter 1.5 has introduced some current literature on experimental and
computational investigations into the mechanism of CAHB mainly focusing on one point
binding substrates (e.g., vinyl arenes).31–34 Building from those work as well as some
preliminary calculations obtained by Dr. Sean M. Smith (University of Nebraska, 2012)
in collaboration with Dr. Rhitankar Pal (UNL Chemistry alumni), this section
summarizes density functional theory (DFT) calculations on a model compound and
catalyst illustrating some current understanding of the mechanistic pathways for CAHB
of a two point binding substrate (i.e., an otherwise unactivated alkene whose reaction is
promoted by a nearby carbonyl directing group). Though it was later suggested by
experimental work that a 1:1 rhodium:ligand complex forms the active catalyst (Chapters
2.2, 2.3, and 3.2), the calculations discussed below focus on a model catalyst complex
employing 1:2 rhodium:ligand, which at the time was consistent with the experimental
results obtained in the Takacs group.11,35–37 The 1:1 rhodium:ligand model, however,
should explored in future studies. It should also be noted that the symmetric cyclic alkene
(i.e., 23a) used for DFT calculations differs from other acyclic substrates that the
enantiodetermining step reflects re/si site selectivity rather that -facial discrimination.
In Dr. Sean M. Smith’s dissertation (University of Nebraska, 2012), models of
diastereomeric complexes A and B were evaluated to see whether the observed
enantiomeric product could be predicted (Figure 14). Interestingly, complex B which is
calculated to be 3.8 kcal/mol lower in energy than A, however, it leads to the minor
enantiomer (1S,3R)-26a. Those results indicated that the partitioning between the
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diastereomeric reaction pathways could not be directly determined from the relative
stabilities of complexes A and B.

Figure 14. Preliminary studies by Dr. Smith found that the higher relative energy
complex A correlates to a major product observed.
To address the problem, DFT calculations in this dissertation consider the
differentiation between migratory insertion into the Rh–H bond (pathway I) and into the
Rh–B (pathway II) bond (Figure 15). Unless otherwise noted, the computation work
described herein was done in collaboration with Dr. Zhao-Di Yang (UNL Chemistry
alumni), Dr. Rhitankar Pal (UNL Chemistry alumni), Prof. Liberty S. W. Pelter (Purdue
University Calumet Chemistry), and Prof. Xiao C. Zeng (UNL Chemistry); Dr. Yang is
most responsible for the published computational results presented below. DFT
calculations for the model reaction are carried out using B3LYP method implemented in
the Gaussian 09 package;38 gradient optimizations were done with LANL2DZ for Rh
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atom and 6-31+G** for all non-metal atoms. In addition, the sum of the free energies of
all reactants (i.e.,[Rh(B10)2S2]+ + substrate 23a + pinBH, where S = solvent = THF) is set
to zero.

Figure 15. Proposed mechanistic pathways to isomeric products (1R*,3S*)- and
(1S*,3R*)-26a are differentiated via migratory insertion into Rh–H versus Rh–B bonds.
Adapted with permission from reference 30. Copyright (2014) American Chemical
Soceity; ACS AuthorChoice.
Figure 15 shows the proposed competing pathways for the model reaction. The
model reaction uses and achiral ligand and therefore the sense of asymmetric induction is
not under investigation here, just the potential competing pathways. After alkene
chelation of 23a to cationic rhodium(I) complex generates the initial Intermediate
(Im0), pinBH can be added either parallel or perpendicular to form Im1 or Im4,
respectively. Im1 is aligned to undergo migratory insertion into Rh–H bond to afford
Im2. Reductive elimination via Im3 affords major isomer (1R*,3S*)-26a and regenerate
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the active catalyst, Im4 proceeds with similar pathways with differentiation in migratory
insertion into Rh–B bond to form Im5, Im6, and finally the minor isomer (1S*,3R*)-26a.
As a recall, (1R*,3S*) and (1S*,3R*) are for denoting the relative but not the absolute
configuration as the ligand B10 employed in this computational study is achiral.39 The
energy profiles of these two pathways (i.e., pathways I and II) are depicted in Figure 16.

Figure 16. Comparison of the potential energy profiles for pathway I and II.
Although pathway I undergoes with overall lower energies to afford the major borylated product (1R*,3S*)-26a, the transition state of reductive elimination step (i.e.,
TS3) with potentially high energy (i.e., 26.5 kcal/mol) make it difficult for the pinB
group to migrate directly to -carbon. The high energy profile of TS3 is proposed due to
the agostic interaction between Rh–HCIn order to enhance the reductive elimination
step, we proposed other two possible pathways in which pathway I-1 with the addition of
THF and pathway I-2 involving an unusual amide bond rotation both having ability to
break the high energy barrier Rh–HC agostic interaction (Figure 17).
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Figure 17. Proposed other mechanistic pathways to major -borylated product (1R*,3S*)26a. Adapted with permission from reference 30. Copyright (2014) American Chemical
Soceity; ACS AuthorChoice.
As illustrated in Figure 17, starting from Im2, pathway I-1 with the reintroduction
of THF to form a stable hexacoordinate octahedral complex Im7 (TS7 energy is only
7.82 kcal/mol from Im2) which then can undergo reductive elimination to produce
(1R*,3S*)-26a via Im8. Another alternative pathway I-2 shows that the Rh-coordinated
carbonyl group of the amide functionality in Im2 rotates approximately 78 degree from
an equatorial to an axial position to afford Im9 (TS9 energy is approximately the same
(7.74 kcal/mol) as THF addition in pathway I-1). In addition, the long Rh–H distances in
the two proposed alternative pathways I-1 and I-2 (3.092 and 3.057Å, respectively, as
compared to 1.944 Å in Im2) indicate that Rh–HC agostic interaction has been broken.
The energy profiles for these alternative pathways are shown in Figure 18.
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Figure 18. Comparison of the potential energy profiles for pathway I, I-1 and I-2.
The overall energy diagrams of possible pathways leading to (1R*,3S*)-26a
suggest that pathway II-2 with unusual amide bond rotation is the most favorable
pathway. However, the amide rotation also opens accessibility to -hydride elimination
accounting for the competing formation of -borylated product 27 observed
experimentally in some cases (Figure 19). According to DFT data, III-2 starting from
Im9 is an overall lower energy pathway as compared to III-1 beginning from Im2 for the
formation of Im14 and Im12, respectively; these two intermediates can potentially afford
the isomerized alkene of 23a; DFT calculations for the beyond stages have not been
obtained.
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Figure 19. Proposed pathways III-1 and III-2 for the formation of isomerized alkene
leading to minor regioisomer -borylated product 27 and the comparison of the potential
energy profiles. Adapted with permission from reference 30. Copyright (2014) American
Chemical Soceity; ACS AuthorChoice.
It is worth noting that the highest energy barrier of pathway III-2 (i.e., TS14 =
17.30 kcal/mol), the major pathway leading to the formation of isomerized alkene then
potentially the minor regioisomer -borylated product 27, is even ca. 2.5 kcal/mol lower
than the highest energy barrier of the most favorable pathway I-2 (i.e., TS10 = 19.84
kcal/mol). The preliminary results suggest that the calculation beyond Im14 must be
obtained for the definite answer since CAHB of the isomerized alkene can also
potentially give -borylated 26 as the major product. Initial experimental results revealed
that CAHB of isomerized 23b still afford -borylated 26b as the major product with
somewhat lower enantioselectivity (Figure 20).
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Figure 20. CAHB of 23b versus isomerized 23b: both alkenes undergo CAHB leading to
the major -borylated product. CAHB/ oxidation conditions as shown in Figure 7.
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3.5 Concluding remarks
In complementary to literature reports on CAHB of cyclopropenes, the
experimental work in this Chapter described the only enantioselective desymmetrization
via CAHB of cyclopentene-based substrates. The method allows the accessibility to a
series of secondary -boronic esters or alcohols (after oxidation) in conjunction with the
stereogenic -quaternary carbon centers bearing alkyl-, aryl-, or trifuloromethyl side
chains in the same molecule. Substrates bearing two alkene moieties undergo essentially
selective CAHB for endocyclic alkenes. Though the chiral substrate with chiral center on
N-amide side chain only provides modest stereoselectivity, its CAHB also proceeds with
high diastereoselectivity (i.e., solely cis product) and yield; further transformation to the
corresponding trifluoborate salt is used to determine the reaction configuration via x-ray
crystallographic analysis.
Preliminary results of deuterium-labeling studies suggest Rh–H(D) migratory
insertion into either C=C alkene starting material or isomerized alkene is irreversible.
Some simplified mechanistic pathways of the major competitive hydrogenation mode
selectivity are also proposed based upon deuterium-labeling data.
Though experimental results (i.e., essentially linear relationship) suggest that the
model 1:1 rhodium:ligand should also be theoretically considered, DFT calculations
applied 1:2 rhodium:ligand based upon early studies in the group. The computational
work supports the essential role of a directing group in the two-point binding motif
leading to the solely cis product and in agreement with experimental studies. Migratory
insertion of the coordinated alkene into the Rh–H to generate the major isomer borylated (1R*,3S*)-26a is more favorable than Rh–B bond suggesting the re/si site
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selectivity is responsible for enantioselective desymmetrization when chiral ligand is
experimentally applied. Among the potential pathways leading to (1R*,3S*)-26a, I-2
involving unusual amide bond rotation is found to be the most favorable pathway with
reductive elimination is the rate-determining step. Additionally, I-2 can potentially
undergo -hydride elimination to generate the isomerized alkene which can subsequently
afford the minor regioisomer -borylated product 27; however, DFT calculations beyond
this stage have not been obtained yet.
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CHAPTER 4: APPLICATIONS OF CHIRAL BORONIC ESTERS IN
STEREOSPECIFIC TRANSFORMATIONS AND UNDERSTANDING THE
STEREOCHEMICAL ASPECTS IN COORDINATION-DIRECTED PALLADIUMCATALYZED CROSS-COUPLING REACTIONS

4.1 Stereorententive transformations of chiral boronic esters
One of the main reasons for the growth in the development of enantioselective
preparation of organoboranes over the last couple decades is their subsequent use in
stereospecific transformations.1 The utility of the chiral boronic esters obtained via
CAHB described in Chapters 2 and 3 will be highlighted herein in that context. The
stereochemical course of the chemical reactions shown in this section is retention of
configuration (i.e., stereoretention) via stereoretentive 1,2-metallate shift (see Chapter 1
for a representative mechanism). In addition, with the directing group in the same
molecule, it will open opportunities for functionalized organoboranes. While the
development of efficient methods for the CAHB of unactivated alkenes is a popular and
worthwhile goal, CAHB of functionalized substrates directly afford functionalized
organoboranes which are often the ultimate goal.
With respect to the synthetic utility of functionalized organoboranes, the Takacs
group converted oxime ether- and phosphonate-containing chiral boronic esters to several
targets of interest by utilizing both the directing group functionality as well as the C–B
bond in subsequent reactions (Figure 1).2,3 In case of oxime ether (Figure 1A),2 treatment
of 32 with lithiated ethyl vinyl ether followed by hydrolysis generates keto oxime 33. The
oxime ether is then treated with acid to yield 4,4,5-trisubstituted isoxazoline 34 via
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cyclization. The methodology developed by Shoba and Takacs introduces the first
example of a chiral 4,4,5-trisubstituted isoxazoline; the structure complements the known
5,5-disubstituted isoxazolines found in many biologically active natural products.4
Recently, Chakrabarty and Takacs introduced a formal total synthesis of the natural
product (S)-(+)-bakuchiol methyl ether 38 via manipulation of the phosphonatecontaining boronic ester 35 (Figure 1B).3 The work highlights the synthetic usefulness of
not only boronic ester moiety but also the phosphonate functionality which is used for
olefination.

Figure 1. Bi-functionalizations of oxime ether- and phosphonate containing chiral
boronic esters
Conditions: (a) (i) LiC(OEt)=CH2, –78 °C, THF, (ii) I2, (iii) NaOMe, MeOH; (b) HCl/H2O/MeOH
(1:1:1), 40 °C; (c) (i) CH2=CHMgBr, THF, -78oC, (ii) I2, MeOH, –78 oC, (iii) NaOMe, MeOH, (iv)
Na2S2O3 (aq.); (d) TBAF, H2O; (e) DMSO, Py.SO3, Hünig's base; (f) (CH3)2CH=PPh3; (g) Lawesson's
Reagent, Toluene Reflux; (h) nBuLi, 4-methoxy-benzaldehyde.

Among the stereospecific transformations of C–B bond, the stereoretentive C–B
to C–O oxidation is the most common and, given the relative ease of characterizing
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alcohols, has until recently been the standard way to analyze the products of CAHB.
Oxidations of boronic esters bearing no or relatively robust functional groups (e.g.,
phenyl amides, benzyl amides) are usually carried out under rather harsh oxidation
conditions, such as basic aqueous hydrogen peroxide (aq. H2O2/NaOH).5 However, with
compounds containing more labile functional groups (e.g., esters), milder conditions
employing sodium perborate should be used to keep the other functionality intact.6 For
example, treatment -borylated esters with aq. H2O2 affords the labile -hydroxyester
which spontaneously lactonizes to generate the -lactone. This was used in collaboration
with Dr. Sean M. Smith as shown in Figure 2.7 CAHBs of -benzyl substituted 39a and
39b under standard conditions (see Chapter 2.1 for more details) afford -borylated tert-

Figure 2. Bi-functionalizations of tert-butylester containing chiral boronic esters.
Reproduced from Ref. 7 with permission from The Royal Society of Chemistry.
CAHB Conditions: a 1% [Rh(nbd)2BF4/2 (R,R)-T1], 2 equiv tmdBH, THF, 40 oC.
(S,S)-T1], 2 equiv tmdBH, THF, 40 oC.

b

1% [Rh(nbd)2BF4/2
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butylester 40a and 40b; in situ treatment with aq. H2O2 affords -benzyl substituted lactones 41a and 41b in high yield (75–79%) and enantioselectivity (96:4–97.5:2.5 er).
These -benzyl substituted -lactones have been used in syntheses of the lignan natural
products (–)-enterolactone and (+)-arctigenin via diastereoselective alkylation.8
-Borylated boronic ester bearing Weinreb amide functionality also undergoes
CAHB/ oxidation to produce a -lactone in the same manner. Recently, we reported the
formation of the known 5-substituted -lactone 139 by oxidation of -borylated Weinreb
amide 8c to determine the absolute configuration of -unsaturated amide 7 produced by
CAHB (Figure 3A; also see Chapter 2.2).10a In the same report, we highlight some useful
stereospecific transformations of boronic esters 8b–d many of which utilize both the C–B
bond and the amide functionality (Figure 3). Compound 8d underwent BCl3-assisted
amination with benzyl azide under conditions reported by Knochel11 to form the -amino
acid derivative 43d (Figure 3B). Using the same amination conditions with phenyl azide
afforded the corresponding N-phenyl -amino acid en route to the 5-substituted--lactam
44 after acid catalyzed cyclization (Figure 3C).

Aggarwal12 has developed several

methods using main group organometallic reagents to effect stereoretentive C–B to C–C
bond construction. Two of these were successfully applied to generate 45d and 46b
(Figure 3D and 3E). Benzyl amide derivative 8b was efficiently converted to 1,4aminoalcohol 47b after oxidation of the C–B bond followed by amide reduction with
LAH.
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Figure 3. Stereospecific transformations of organoboranes 8b–d. Reproduced from Ref.
10a with permission from The Royal Society of Chemistry.
Conditions: (a) NaOH/H2O2; (b) BCl3, BnN3; (c) BCl3, PhN3; (d) 6M HCl; (e) (i) n-BuLi, thiophene, (ii)
NBS; (f) (i) vinylMgBr, (ii) I2/ NaOMe; (g) LiAlH4 (LAH).
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4.2 Stereochemical aspects in coordination-directed palladium-catalyzed crosscoupling reactions.
Palladium-catalyzed cross-coupling (e.g., Suzuki–Miyaura) is one of the most
widely used methods in modern pharmaceutical synthesis.13–15 For Pd-catalyzed crosscoupling reactions of sp3 boronic acid derivatives, trifluoroborate salts have found
increasingly wide use due to the facts that: (i) compared to boronic acids and esters,
trifluoroborate salts, monomeric in nature, are stable to air and aerobic moisture, (ii) with
a tetrahedral geometry, due to the four groups bound to the boron center and
exceptionally strong B–F bond, they are not Lewis acidic, and (iii) as salts, most
trifluoroborate salts are free-flowing crystalline solids making them being easy to
handle.16,17 Despite the rapid growth in their use, organotrifluoroborate salts are not the
active transmetalating species;18,19 slow hydrolysis to the corresponding boronic acid is a
key transformation in the raction.20 Though the mechanism suggests that the hydrolysis to
boronic acid is crucial for the reactivity of organotrifluoroborate salts, boronic acids
themselves are less frequently used in sp3 boron cross-coupling because it is typically a
mixture of monomeric and trimeric boronic acid in nature; the latter makes an accurate
assessment of stoichiometry challenging.17 On the other hand, boronic esters are less
reactive as well as less atom economical than boronic acids. In addition, the hydrolysis of
boronic esters (e.g., pinacolboronates) to the boronic acids active species is rather
complicated due to the high tendency of the liberated diol to regenerate the pinacol
boronic esters; removing the pinacol is an example of driving the equilibrium in the
forward direction.16 Therefore, sp3 boron cross-coupling is less likely to involve the use
of boronic esters except for a few examples using activated benzylic organoboranes.21–24
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Using Molander’s conditions without modification,25 primary -borylated boronic
esters 4b and 4h–j, obtained via CAHB of geminal -unsaturated amides and esters 3b
and 3h–j (see Chapter 2.1), were converted to the corresponding trifluoroborate salts 48b
and 48h–j (Figure 4) and successfully subjected to Pd-catalyzed cross-coupling with
several representative aryl- and heteroaryl halides employing Molander’s protocol.26 The
-trifluoborato amides (i.e., 48b) and esters (i.e., 48h–j) are both well tolerated under the
standard conditions affording cross-coupled products 49 in high yield (51–98%). Not
only aryl halides but also hetereoaryl halides are good coupling partners; in particular,
49jd is the precursor to a chiral antispasmodic compound previously only reported as the
racemate,27 an example that highlights the utility of CAHB. In addition, the first
successful cross-coupling of -borylated carbonyl derivatives, no examples of the latter
have previously been reported, complements the examples using -borylated carbonyl
compounds.23,24,28,29
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Figure 4. Palladium-catalyzed cross-coupling of primary -borylated amides and esters.
The stereochemical aspects of the palladium-catalyzed cross-coupling of chiral
secondary organoboron derivatives have recently attracted a great deal attention. Though
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the above work on cross-coupling of primary -borylated carbonyl derivatives represents
the first examples using -borylated derivatives, boron is not directly attached at the
stereogenic center and thus does not address the key stereochemical issue of croscoupling. However, we have introduced the first direct route to chiral secondary borylated amides (see Chapter 3.2);10b Pd-catalyzed cross-coupling of the latter will
addresses the question of the stereochemical course of cross-coupling: is it
stereochemical retention or inversion?10 Though first characterized in 1960,30 the
improved method for organotrifluoroborate salts to prevent the extensive etching of
glassware was not introduced until 2012 by Lloyd-Jones and co-workers.31 By applying
this non-etching conditions (Figure 5B) to our chiral secondary -borylated amide 24k
(see Chapter 3.2),10b we found that the yield of trifluoroborate salt 50k obtained are much
higher (e.g., 96% versus 72% of 31k (see Chapter 3.2)) than the method depicted in
Figure 5A. The same method was also applied to other related -borylated amides 24 (see
Chapter 3.2) affording 50c, 50g, and 50h in good yield (80–83%).
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Figure 5. Preparation of organotrifluoroborate salts
Having developed an efficient method for the -borylation of cyclic unsaturated amides as well as their conversions to the corresponding trifluoroborate salts,
Suzuki–Miyaura cross-coupling of the latter was examined (Figure 6).10b Our first
attempt with the potassium trifluoroborate salt of chiral phenethyl amide 31k was
successful; 31k was cross-coupled with several representative aryl and heteroaryl halides
affording 51ka–f in high yield (66–92%). To the best of our knowledge, this is the first
time the Buchwald cataCXium® A Pd G3 (52) was used in literature, even before it
becomes commercially available.32 The cesium trifluoroborate salt of chiral phenethyl
amide 51k performs as good as the potassium salt 31k; it gives 51ka–f in similar good
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yield (66–86%) and was chosen for further investigation mostly due to higher yields in
forming the salt. Benzyl amide trifluoroborate salts bearing -phenyl and -CF3
quaternary carbon centers are also well tolerated under the standard conditions yielding
51ga and 51ha, respectively (63–69%). The spectral data of these two cross-coupled
products indicate that the cross-coupling is proceeds with high diastereoselectivity (e.g.,
the
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F of 51ha shows no more than 6% abundance in integrating a minor peak for

another diastereomer). At first (vide infra), it seemed that the N-benzyl amide moiety
seems to be crucial for the reactivity; phenyl amide trifluoroborate salt 50c only produces
51ca in 20% due to the low conversion of less than 35%; 85% of the corresponding
alcohol (yield based on excess trifluoroborate) was obtained after Oxone oxidation.

Figure 6. Palladium-catalyzed cross-coupling of cyclic -organotrifluoroborate salta
a

Isolated yields based on limiting aryl halide, an average (±2%) of two runs. b CsOH (5 equiv) replaces
Cs2CO3. c Cross-coupling proceeds with high diastereoselectivity (ca. 94:6 dr). d Less than 35% conversion
(85% of the corresponding alcohol (yield based on excess trifluoroborate) after Oxone oxidation was
obtained)
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It is clear why the N-benzyl amide moiety should be a necessary element for
cross-coupling. One might argue that the carbonyl of the phenyl amide is less Lewis basic
and thus might not coordinate to the metal as well as does the carbonyl of the benzyl
amide (Figure 7A). Another possibility, originally proposed by Molander33 in his studies,
is intramolecular hemilabile -complexation of palladium by a suitably disposed benzyl
substituent. In his studies, such a substituent was found to be a key element for enhancing
the rate of transmetallation as well as facilitating cross-coupling with stereoretention
(Figure 7B).

Figure 7. Proposed pathways for efficient cross-coupling illustrating the necessary
feature of N-benzyl amide moiety.
To further probe the apparent unreactivity of the phenyl amide, a direct
competition reaction with equal amount of the more reactive chiral phenethyl amide 50k
and the less reactive phenyl amide 50c for a limiting amount of 1-bromonaphthalene 53
was carried out. Surprisingly, a nearly 1:1 mixture of cross-coupled products 51k (42%)

157

and 51c (48%) is obtained and similar amount of the corresponding alcohols 26c (61%)
and 26k (60%) were recovered after oxidation with Oxone (Figure 8). The surprising
results observed raise doubt about the explanation in Figure 7 and suggest that 50c is
consumed as fast as 50k by active catalyst. A relatively slow conversion of palladium
precatalyst to active catalyst by 50c in the absence of 50k could account of the
conflicting observations.

Figure 8. Unexpected influence of the amide substituent in Pd-catalyzed cross-coupling.
Adapted with permission from reference 10b. Copyright (2015) American Chemical
Soceity.
To prove the structural assignment of Suzuki–Miyaura cross-coupled products, a
pyridine-based product 51ke was converted to the corresponding tetrafluoroborate salt
59; x-ray analysis of the resulting crystal confirms the structure as (1R,3S)-59
establishing that the palladium-catalyzed cross-coupling proceeds with stereoretention
(Figure 9).

158

Figure 9. X-ray analysis of 59 establishes Pd-catalyzed cross-coupling proceeds with
stereoretention. Adapted with permission from reference 10b. Copyright (2015)
American Chemical Soceity.
The above work should be of interest to a broad range of synthetic chemists,
especially those with interests in organoboron chemistry, cross‑coupling chemistry,
and/or asymmetric catalysis. It is significant because it complements the previously
reported -borylated carbonyl derivatives (i.e., 60–62), as well as simple substrates
lacking functionality needed for coordination to boron during the course of
transmetallation such as 63, which proceed with stereoinversion as previously reported by
Molander,26 Suginome,23,24 Hall,28,29 and Biscoe,34 respectively. Our work shows that borylated amides 50 undergo Suzuki–Miyaura cross-coupling with stereoretention
(Figure 10). It should be noted that Suginome35 and Morken36 also reported
stereoretentive Suzuki–Miyaura cross-couplings, however, those substrates (i.e., 64 and
65) feature a physically closer distance relationship between boron and the donor
substituent. It is proposed that a boracycle- or hydroxyl-directed, inner-sphere, retentive
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transmetallation accounts for overall cross-coupling with stereoretention. When the
hydroxyl is one-carbon further removed in 66 compared to 64 or 65, but at a similar
distance to 50, the compound fails to cross-coupled under the conditions employed for
65.

Figure 10. Coordination-directed stereocontrol in Pd-catalyzed cross-coupling.
Reproduced from Ref. 10a with permission from The Royal Society of Chemistry.
Our first attempts to cross-couple the acyclic -trifluoroborato benzyl amide 67b
(converted from the corresponding boronic ester 8b using conditions described in Figure
5B) with 4-chloro- and 4-bromoanisole was unsuccessful (Table 1). Broader screening of
-trifluoroborato benzyl amide 67b along with the corresponding morpholino amide 67d
using different palladium sources, halides, bases, ligands, solvents reveals that the tertiary
amide is much more successful in the cross-coupling; the reasons are not clear, but Hall
has also reported similar observations with explanation.29 Using the best conditions (i.e.,
entry 7), cross-coupling of 67d (94.5:5.5 er) affords 68d (52%) with essentially complete
retention (94:6 er). None of the desired cross-coupled product 68b was obtained under
any of the conditions investigated.
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Table 1. Optimization studies for Suzuki–Miyaura cross-couplings of 67b and 67d.

Entry
1
2
3
4
5
6
7
8a
9
10
11
12
13
14b
15c
16c

Pd source
Pd(OAc)2
Pd2(dba)3
Pd2(dba)3
Pd2(dba)3
XPhos Pd G3
52
52
52
52
52
52
52
52
52
52
52

Ligand
Base
XPhos
K2CO3
XPhos
K2CO3
P(tBu)3.HBF4 K2CO3
cataCXium® A K2CO3
–
K2CO3
–
K2CO3
–
K2CO3
cataCXium® A K2CO3
–
Cs2CO3
–
K3PO4
–
CsOH
–
K2CO3
–
Cs2CO3
–
K2CO3
–
K2CO3
–
Cs2CO3

Y
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Br
Br
Cl
Cl
Cl

68b (%)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

68d (%)
0
38
10
15
21
49
52
45
50
47
0
45
42
48
0
0

General conditions: 7.5 mol% Pd-precatalyst or 10 mol% Pd(OAc)2 or 5 mol% Pd2(dba)3; 20 mol%
ligand; isolated yield. a Additional 7.5 mol% cataCXium® A. b Toluene:H2O = 0.25:0.25 mL. c Bpin is
used instead of BF3Cs.

To assign the structure of the Suzuki–Miyaura cross-coupling, -trifluoroborato
morpholino amide (S)-67d (94.5:5.5 er, see Chapter 2.2 for the determination of absolute
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configuration) was cross-coupled with 4-chlorobenzene to afford (S)-69d in good yield
and high stereoselectivity (Figure 11). Chiral HPLC analysis of (S)-69d was compared
with authentic (R)-69d prepared via enolate allylation using the Evans chiral auxiliary via
the following sequence: (i) in situ half reduction to aldehyde followed by WadsworthHorner-Emmons olefination, (ii) Pd/C hydrogenation, and (iii) amidation with
morpholine.

Figure 11. Determination of absolute configuration of cross-coupled products via Pdcatalyzed cross-coupling of acyclic -trifluoroborato amides. Reproduced from Ref. 10a
with permission from The Royal Society of Chemistry.
Our first attempts at Pd-catalyzed cross-coupling of benzylic -borylated amides
72 using the above developed method was unsuccessful (Figure 12). The major product
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observed is reduced product 73 presumably via protodeboronation pathway.37 Further
investigations using different palladium sources and ligands are still in progress.

Figure 12. Unexpected protoboronation pathway for Suzuki–Miyaura cross-couplings of
benzylic -borylated amides 72.
Crudden and co-workers reported conditions for the cross-coupling conditions of
benzylic boronic esters utilizing silver(I) oxide to facilitate the transmetallation step.21,22
Using Crudden’s conditions with benzylic -borylated amides 19e gave some 74e (25%,
condition A, Table 2), however, the reaction proceeds with low conversion (59%) and the
yield of reduced product 73e via protodeborylation is high (27%). Changing the solvent
from toluene to THF, the reaction affords higher conversion increasing the yield of the
cross-coupled product (40%, condition B). The base does have an important role for the
cross-coupling mode selectivity; using cesium carbonate drastically increases the
amounts of reduced 73e (74–78%, conditions C and D) with no desired products
observed. Finally, palladium sources and ligands illustrate the most important factors;
conditions E–F improve the yield of cross-coupled product 74e as high as 81%.
Interestingly, simple triphenylphosphine ligand has been the best for the study; other
triaryl- and trialkylphosphine ligands (e.g., P(tBu)3) are under investigations.
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Table 2. Optimization studies for Suzuki–Miyaura cross-couplings of 19e.

Conditions
A
B
C
D
E
F
G

Unreacted
(%)a
41
21
12
15
10
trace
trace

19e 73e (%)a
27
33
78
74
10
15
10

15e (%)a

74e (%)a

trace
trace
trace
trace
7
15
7

25
40
trace
trace
65
62
81

Condition A: 0.12 mmol 19e (1.2 equiv), 0.1 mmol 4-iodotoluene (1.0 equiv), 8.1 mol% cataCXium® A Pd
G3, 1.6 equiv Ag2O, 1.6 equiv K2CO3, Toluene, 100 oC, 20h.
Condition B: 0.12 mmol 19e (1.2 equiv), 0.1 mmol 4-iodotoluene (1.0 equiv), 8.1 mol% cataCXium® A Pd
G3, 1.6 equiv Ag2O, 1.6 equiv K2CO3, THF, 70 oC, 20h.
Condition C: 0.12 mmol 19e (1.2 equiv), 0.1 mmol 4-iodotoluene (1.0 equiv), 8.1 mol% cataCXium® A Pd
G3, 1.6 equiv Ag2O, 1.6 equiv Cs2CO3, THF, 70 oC, 20h.
Condition D: 0.12 mmol 19e (1.2 equiv), 0.1 mmol 4-iodotoluene (1.0 equiv), 8.1 mol% cataCXium® A Pd
G3, 1.6 equiv Ag2O, 1.6 equiv Cs2CO3, Toluene, 100 oC, 20h.
Condition E: 0.12 mmol 19e (1.2 equiv), 0.1 mmol 4-iodotoluene (1.0 equiv), 8.1 mol% Pd2(dba)3, 10 mol%
PPh3, 1.6 equiv Ag2O, THF, 65 oC, 20h.
Condition F: 0.12 mmol 19e (1.2 equiv), 0.1 mmol 4-iodotoluene (1.0 equiv), 8 mol% Pd(PPh3)4, 1.6 equiv
Ag2O, 1.6 equiv K2CO3, Et2O, 65 oC, 20h.
Condition G: 0.12 mmol 19e (1.2 equiv), 0.1 mmol 4-iodotoluene (1.0 equiv), 8 mol% Pd(PPh3)4, 32 mol%
PPh3, 1.6 equiv Ag2O, 1.6 equiv K2CO3, Et2O, 65 oC, 20h.
a

Yield reported as crude 1H NMR yield
Using the best performing conditions for cross-coupling of 19e (i.e., condition G,

Table 2), several other reactions have been carried out (Figure 13). Interestingly, in
contrast to the acyclic -trifluoroborato amides discussed above, conditions developed by
Crudden group are also effective for the benzyl amides. Cross-coupling of -borylated
benzyl amide 15a with several representative aryl iodides afford 74a–77a in good yield
(68–79%). The level of enantiospecificity and the stereoretentive/stereoinvertive course
of the Suzuki cross-coupling have not yet been determined.
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Figure 13. Palladium-catalyzed cross-coupling of benzylic - borylated benzyl amide
15a.
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4.3 Concluding remarks
In contrast to similar -borylated carbonyl derivatives reported in literature, both
cyclic and acyclic -trifluoroborato amides undergo Suzuki–Miyaura cross-coupling with
clean stereoretention. Initial results for cross-couplings of benzylic-borylated amides
are

quite

promising;

however,

the

level

of

enantiospecificity

and

the

stereoretentive/stereoinvertive course of the Suzuki cross-coupling have not yet been
determined. Other stereospecific transformations of C–B bond are used to highlight the
versatility of the bifunctional intermediates generated by -borylation, including
conversion to lignan precursors, chiral -aminoacid derivatives, 1,4-amino alcohols, substituted--lactones, and -lactam ring systems. Our results should be of interest to a
broad range of chemists, especially those with interests in asymmetric catalysis,
cross‑coupling chemistry, asymmetric synthesis and organoboron chemistry.
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CHAPTER 5: EXPERIMENTALS
5.1 Experimental details
General procedures
Reactions were carried out in a dry nitrogen atmosphere. Tetrahydrofuran (THF)
was freshly distilled under sodium metal and benzophenone. HPLC solvents were filtered
through Millipore filter paper. 4,4,5,5-tetramethyl-1,3,2-dioxaborolane (pinBH) was
distilled immediately before use. All synthesized compounds were purified with flash
chromatography using EMD Silica Gel 60 Geduran®, distilled via short path distillation,
or triturated. Thin Layer Chromatography analyses were performed on Analtech Silica
Gel HLF (0.25 mm) precoated analytical plates and visualized with use of handheld short
wavelength UV light, Iodine stain (I2 and EMD Silica Gel 60 Geduran®) and Vanillin
stain (Ethanol, H2SO4, and vanillin). HPLC analyses were performed with use of an ISCO
model 2360 HPLC and Chiral Technologies, Inc. chiral HPLC columns (Chiralcel-OJ-H,
column: 250 x 4.6 mm; Chiralcel-AD, column: 250 x 4.6 mm; Chiralcel-OD, column:
250 x 4.6 mm; Chiralpak-IC, column: 250 x 4.6 mm; (S,S)-WHELK-O 1, column: 250 x
4.6 mm) and monitored with UV-VIS detector (Shimadzu SPD-10AVP/10AVP, λ = 210
nm). Data were recorded and analyzed with ChromPerfect chromatography software
(version 5.1.0). NMR spectra were recorded on 400 MHz and 300 MHz Bruker Advance
NMR spectrometers using residue CHCl3 (δ 7.27 ppm) or CDCl3 (δ 77.0 ppm) for
reference unless otherwise specified. Peaks are expressed as m (unresolved multiplet), q
(quartet), t (triplet), d (doublet) or s (singlet). IR spectra were recorded using an Avatar
360 FT-IR. Optical rotations were measured as solutions, 1.0 g/100 mL in chloroform or
methanol unless indicated otherwise, and recorded using an Autopol III automatic
polarimeter. HRMS analyses were performed by the Nebraska Center for Mass
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Spectrometry. Experimental procedures and characterization of compounds (i.e.,3a–j,
4a–j, 39a–41b, 4b, 4h–j, 48b, 48h–j and 49) in collaboration with Dr. Sean M. Smith
were already described in his dissertation (University of Nebraska, 2012) and will not be
shown herein. We thank Dr. Nathan C. Thacker for the preparation of deuterated boranes
(University of Nebraska, 2014). We thank co-workers, especially Ms. Veronika M. Shoba
for the share of catalysts used in optimization studies.
X-Ray Crystallographic Studies for [K][C20H22BF3NO], 31k
A colorless single-domain crystal of [K][C20H22BF3NO], was suspended with
Paratone N oil on a MiTeGen MicroMount and mounted on a goniometer head in a cold
nitrogen stream at 100K for a single-crystal x-ray structure determination.
Monochromatic x-rays were provided by a Bruker Diffraction System equipped with
Helios multilayer optics, an APEX II CCD detector and a Bruker MicroSTAR
microfocus rotating anode x-ray source operating at 45kV and 60mA. Intensity data were
collected with the Bruker program SMART and diffracted intensities were measured with
the Bruker program SAINT. The space group and crystallographic data are summarized
in Table 1. The Bruker software package SHELXTL was used to solve the structure
using “direct methods” techniques.

All stages of weighted full-matrix least-squares

refinement were conducted using Fo2 data with the SHELXTL Version 2010.3-0 software
package.
The final structural model incorporated anisotropic thermal parameters for all
non-hydrogen atoms and isotropic thermal parameters for all hydrogen atoms.

All

hydrogen atoms were located from a difference Fourier and included in the structural
model as independent isotropic atoms whose parameters were allowed to vary in least-
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squares refinement cycles. The absolute structure was determined experimentally using
anomalous dispersion of the x-rays. The Flack absolute structure parameter refined to a
final value of 0.034(7). The asymmetric unit consists of a single [K][C20H22BF3NO]
formula unit. All thermal vibration ellipsoids are drawn at the 50% probability level.
Table 1. Crystal data and structure refinement for [C20H22ONBF3][K], 31k
Identification code

q72d

Empirical formula

C20 H22 B F3 K N O

Formula weight

399.30

Temperature

100(2) K

Wavelength

1.54178 Å

Crystal system

Orthorhombic

Space group

P2(1)2(1)2(1)

Unit cell dimensions

a = 6.3906(3) Å

= 90°.

b = 7.7434(3) Å

= 90°.

c = 38.9797(17) Å

 = 90°.

Volume

1928.91(14) Å3

Z

4

Density (calculated)

1.375 Mg/m3
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Absorption coefficient

2.742 mm-1

F(000)

832

Crystal size

0.11 x 0.04 x 0.03 mm3

Theta range for data collection

2.27 to 69.89°.

Index ranges

-7<=h<=7, -9<=k<=8, -46<=l<=37

Reflections collected

17786

Independent reflections

3401 [R(int) = 0.0300]

Completeness to theta = 66.00°

98.2 %

Absorption correction

Multi-scan

Max. and min. transmission

1.000 and 0.843

Refinement method

Full-matrix least-squares on F2

Data / restraints / parameters

3401 / 0 / 333

Goodness-of-fit on F2

1.044

Final R indices [I>2sigma(I)]

R1 = 0.0240, wR2 = 0.0592

R indices (all data)

R1 = 0.0252, wR2 = 0.0596

Absolute structure parameter

0.034(7)

Extinction coefficient

0.00069(12)
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Largest diff. peak and hole

0.197 and -0.214 e.Å-3

X-Ray Crystallographic Studies for [C26H29N2O2][BF4]
Using procedures described for [K][C20H22BF3NO] 31k, the crystal data and
structure refinement for for [C26H29N2O2][BF4], 59 are shown in Table 2.
Table 2. Crystal data and structure refinement for [C26H29N2O2][BF4], 59.
Identification code

q43e

Empirical formula

C26 H29 B F4 N2 O2

Formula weight

488.32

Temperature

100(2) K

Wavelength

1.54178 Å

Crystal system

Orthorhombic

Space group

P 21 21 21

Unit cell dimensions

a = 8.4470(4) Å

= 90°.

b = 16.3195(8) Å

= 90°.

c = 17.2927(8) Å

 = 90°.

Volume

2383.8(2) Å3

Z

4

Density (calculated)

1.361 Mg/m3

Absorption coefficient

0.897 mm-1
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F(000)

1024

Crystal size

0.170 x 0.090 x 0.080 mm3

Theta range for data collection

3.724 to 69.959°.

Index ranges

-8<=h<=10, -19<=k<=18, -19<=l<=20

Reflections collected

20098

Independent reflections

4313 [R(int) = 0.0241]

Completeness to theta = 66.000°

100.0 %

Absorption correction

Multi-scan

Max. and min. transmission

1.000 and 0.924

Refinement method

Full-matrix least-squares on F2

Data / restraints / parameters

4313 / 0 / 432

Goodness-of-fit on F2

1.051

Final R indices [I>2sigma(I)]

R1 = 0.0410, wR2 = 0.1083

R indices (all data)

R1 = 0.0412, wR2 = 0.1085

Absolute structure parameter

0.16(6)

Extinction coefficient

n/a

Largest diff. peak and hole

0.461 and -0.406 e.Å-3
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5.2 Preparation of substrates and intermediates
General procedure for the preparation of (E)--unsaturated amides via
trimethylaluminum mediated amide bond formation (GP1)

Prepration of (E)-7-phenyl-4-heptenecarboxylic acid phenyl amide ((E)-7a).
To a solution of aniline (2 equiv, 10 mmol, 0.91 mL) in DCM (20 mL) was slowly added
trimethylaluminum (1.62 equiv, 2.0 M in hexanes, 8.1 mmol, 4.05 mL) at room
temperature. The resulting mixture was stirred at room temp for 30 mins, and the
corresponding ethyl ester ((E)-7-phenyl-4-heptenecarboxylic acid ethyl ester (E)-11, 5
mmol, 1.16g) was added dropwise. The resultant mixture was heated overnight at 35 oC.
After cooling to room temperature, the reaction mixture was quenched with HCl (1M)
and extracted with DCM (3 x 20 mL). The combined organic extracts were dried (anhyd.
Na2SO4) and concentrated under reduced pressure. Flash chromatography on silica gel
(80:20-60:40 hexanes:ethyl acetate) affords the title compound (992 mg, 71%) as a white
solid: m.p. 106.0–107.0 oC; TLC analysis Rf 0.65 (60:40 hexanes:ethyl acetate); 1H NMR
(400 MHz, CDCl3) δ 7.54 (2H, d, J = 7.8 Hz, m,m’), 7.48 (1H, br s, NH), 7.25–7.40 (4H,
m, b,b’,n,n’), 7.15–7.25 (3H, m, c,c’,a), 7.13 (1H, t, J = 7.4 Hz, o), 5.40–5.70 (2H, m,
g,h), 2.70 (2H, t, J = 7.4 Hz, e), 2.25–2.50 (6H, m, f,i,j); 13C NMR (100 MHz, CDCl3) δ
171.03 (k), 142.00 (d), 138.06 (l), 131.30 (h), 129.10 (g), 129.05 (n,n’), 128.61 (b,b’),
128.40 (o), 125.92 (c,c’), 124.36 (a), 120.07 (m,m’), 37.65 (e), 36.01 (j), 34.44 (f), 28.60
(i); IR (neat) 3305 (N-H stretch), 3265, 2193, 1664 (C=O stretch), 1603, 1546, 1439, 972,

177

757, 693 cm-1; HRMS (ESI) calcd. for C19H21NNaO (M+Na): 302.1521, found 302.1531
m/z.

(E)-7-phenyl-4-heptenecarboxylic acid benzyl amide ((E)-7b). Following GP1
with benzyl amine (2 equiv, 10 mmol, 1.1 mL) affords, after flash chromatography on
silica gel (80:20-60:40 hexanes:ethyl acetate), the title compound (1.15 g, 78%) as a
white solid: m.p. 65.5–66.5 oC; TLC analysis Rf 0.4 (60:40 hexanes:ethyl acetate); 1H
NMR (400 MHz, CDCl3) δ 7.15–7.40 (10H, m, a,b,b’,c,c’,n,n’,o,o’,p), 5.89 (1H, br s,
NH), 5.40–5.60 (2H, m, g,h), 4.44 (2H, d, J = 5.7 Hz, l), 2.67 (2H, t, J = 7.3 Hz, e), 2.20–
2.40 (6H, m, f,i,j);

13

C NMR (100 MHz, CDCl3) δ 172.45 (k), 142.04 (d), 138.55 (m),

131.03 (h), 129.23 (g), 128.80 (b,b’), 128.61 (o,o’), 128.38 (c,c’), 127.93 (n,n’), 127.60
(p), 125.89 (a), 43.66 (l), 36.71 (j), 35.96 (e), 34.40 (f), 28.73 (i); IR (neat) 3285 (N-H
stretch), 3028, 2915, 1635 (C=O stretch), 1537 (N-H bend), 1452, 1220, 965, 740, 694
cm-1; HRMS (ESI) calcd. for C20H23NNaO (M+Na): 316.1677, found 316.1681 m/z.

(Z)-7-phenyl-4-heptenecarboxylic acid benzyl amide ((Z)-7b). Following GP1
with (Z)-11 (5 mmol, 1.16g), benzyl amine (2 equiv, 10 mmol, 1.1 mL) affords, after
flash chromatography on silica gel (80:20-60:40 hexanes:ethyl acetate), the title
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compound (1.08 g, 73%) as a light yellow oil; TLC analysis Rf 0.4 (60:40 hexanes:ethyl
acetate); 1H NMR (400 MHz, CDCl3) δ 7.15–7.40 (10H, m, a,b,b’,c,c’,n,n’,o,o’,p), 6.03
(1H, br s, NH), 5.45–5.55 (1H, m, h), 5.35–5.45 (1H, m, g), 4.41 (2H, d, J = 5.7 Hz, l),
2.69 (2H, t, J = 7.8 Hz, e), 2.41 (2H, q, J = 7.4 Hz, f), 2.33 (2H, q, J = 7.4 Hz, i), 2.08
(2H, t, J = 8.6 Hz, j); 13C NMR (100 MHz, CDCl3) δ 172.53 (k), 142.10 (d), 138.55 (m),
130.29 (h), 128.81 (b,b’), 128.78 (o,o’), 128.41 (g,c,c’), 127.92 (n,n’), 127.57 (p), 125.92
(a), 43.65 (l), 36.53 (j), 35.91 (e), 29.29 (f), 23.61 (i); IR (neat) 3285 (N-H stretch), 3026,
2922, 1642 (C=O stretch), 1543 (N-H bend), 1495, 1453, 728, 695 cm-1; HRMS (ESI)
calcd. for C20H23NNaO (M+Na): 316.1677, found 316.1681 m/z.

(E)-7-phenyl-4-heptenecarboxylic acid Weinreb amide (7c). Following GP1
with N-methoxy-N-methylamine hydrochloride (5 equiv, 25 mmol, 2.4 g) and
trimethylaluminum (5 equiv, 2.0 M in hexanes, 25 mmol, 12.5 mL) affords, after flash
chromatography on silica gel (80:20-60:40 hexanes:ethyl acetate), the title compound
(780 mg, 63%) as a yellow oil; TLC analysis Rf 0.5 (60:40 hexanes:ethyl acetate); 1H
NMR (400 MHz, CDCl3) δ 7.25–7.35 (2H, m, b,b’), 7.15–7.25 (3H, m, a,c,c’), 5.45–5.65
(2H, m, g,h), 3.69 (3H, s, m), 3.20 (3H, s, l), 2.69 (2H, t, J = 7.4 Hz, e), 2.49 (2H, m, j),
2.20–2.40 (4H, m, f,i); 13C NMR (100 MHz, CDCl3) δ 174.14 (k), 142.16 (d), 130.50 (h),
129.63 (g), 128.59 (b,b’), 128.35 (c,c’), 125.84 (a), 61.33 (m), 36.10 (e), 34.50 (f), 32.30
(l), 32.01 (j), 27.65 (i) ; IR (neat) 2934 (C-H sp3 stretch), 1661 (C=O stretch), 1452,
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1413, 1383 (C-N stretch), 969, 698 cm-1; HRMS (ESI) calcd. for C15H21NNaO2 (M+Na):
270.1470, found 270.1469 m/z.

(E)-7-phenyl-4-heptenecarboxylic acid morpholino amide (7d). Following
GP1 with morpholine (2 equiv, 10 mmol, 0.87 mL) affords, after flash chromatography
on silica gel (70:30-50:50 hexanes:ethyl acetate), the title compound (1.03 g, 75%) as a
yellow oil; TLC analysis Rf 0.4 (40:60 hexanes:ethyl acetate); 1H NMR (400 MHz,
CDCl3) δ 7.25–7.35 (2H, m, b,b’), 7.15–7.25 (3H, m, a,c,c’), 5.40–5.60 (2H, m, g,h),
3.55–3.70 (6H, m, l,l’,m,m’), 3.35–3.50 (2H, m, l,l’), 2.68 (2H, t, J = 7.5 Hz, e), 2.20–
2.40 (6H, m, f,i,j);

13

C NMR (100 MHz, CDCl3) δ 171.23 (k), 142.05 (d), 131.68 (h),

129.47 (g), 128.59 (b,b’), 128.36 (c,c’), 125.87 (a), 67.05 and 66.76 (m,m’), 46.08 and
42.01 (l,l’), 36.04 (e), 34.46 (f), 33.13 (j), 28.28 (i); IR (neat) 2914 (C-H sp3 stretch),
2852, 1642 (C=O stretch), 1428, 1113, 968, 699 cm-1; HRMS (ESI) calcd. for
C17H23NNaO2 (M+Na): 296.1626, found 296.1628 m/z.

(E)-7-(furan-2-yl)-4-heptenecarboxylic acid benzyl amide (7e).1 Following
GP1 with the corresponding ethyl ester ((E)-7-(furan-2-yl)-4-heptenecarboxylic acid
ethyl ester, 5 mmol, 1.1 g) and benzyl amine (2 equiv, 10 mmol, 1.1 mL) affords, after
1

The substrate should be used immediately after preparation or stored inside a glovebox to maintain its
original quality

180

flash chromatography on silica gel (80:20-60:40 hexanes:ethyl acetate), the title
compound (596 mg, 42%) as a white solid: m.p. 60.5–61.5 oC; TLC analysis Rf 0.35
(60:40 hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.25–7.40 (6H, m,
a,b,b’,c,c’,p), 6.28 (1H, dd, J = 3.0 Hz, 1.9 Hz, o), 5.98 (1H, dd, J = 3.1 Hz, 0.6 Hz, n),
5.90 (1H, br s, NH), 5.40–5.60 (2H, m, i,j), 4.44 (2H, d, J = 5.7 Hz, e), 2.67 (2H, t, J =
7.4 Hz, l), 2.20–2.40 (6H, m, g,h,k);

13

C NMR (100 MHz, CDCl3) δ 172.40 (f), 155.78

(m), 140.89 (p), 138.51 (d), 130.53 (i), 129.50 (j), 128.80 (b,b’), 127.92 (c,c’), 127.60 (a),
110.17 (o), 105.03 (n), 43.66 (e), 36.64 (g), 31.02 (k), 28.68 (h), 28.07 (l); IR (neat) 3293
(N-H stretch), 2916, 1632 (C=O stretch), 1538 (N-H bend), 1506, 1453, 729, 695 cm-1;
HRMS (ESI) calcd. for C18H21NNaO2 (M+Na): 306.1470, found 306.1477 m/z.

(E)-7-(thiophen-2-yl)-4-heptenecarboxylic acid benzyl amide (7f).2 Following
GP1 with the corresponding ethyl ester ((E)-7-(thiophen-2-yl)-4-heptenecarboxylic acid
ethyl ester, 5 mmol, 1.19g) and benzyl amine (2 equiv, 10 mmol, 1.1 mL) affords, after
flash chromatography on silica gel (80:20-60:40 hexanes:ethyl acetate), the title
compound (945 mg, 63%) as a white solid: m.p. 62.0–63.0 oC; TLC analysis Rf 0.35
(60:40 hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.30–7.40 (2H, m, b,b’),
7.25–7.30 (3H, m, a, c,c’), 7.12 (1H, dd, J = 5.2 Hz, 0.8 Hz, p), 6.93 (1H, dd, J = 4.9 Hz,
3.5 Hz, o), 6.79 (1H, d, J = 2.6 Hz, n), 6.20 (1H, br s, NH), 5.40–5.60 (2H, m, i,j), 4.42
(2H, d, J = 5.7 Hz, e), 2.87 (2H, t, J = 7.4 Hz, l), 2.30–2.40 (4H, m, h,k), 2.26 (2H, t, J =

2

The substrate should be used immediately after preparation or stored inside a glovebox to maintain its
original quality

181

7.1 Hz, g); 13C NMR (100 MHz, CDCl3) δ 172.55 (f), 144.86 (m), 138.62 (d), 130.32 (i),
129.85 (j), 128.78 (b,b’), 127.89 (c,c’), 127.56 (a), 126.81 (o), 124.34 (p), 123.10 (n),
43.61 (e), 36.56 (g), 34.65 (k), 30.00 (h), 28.75 (l); IR (neat) 3291 (N-H stretch), 3030,
2915, 1629 (C=O stretch), 1531 (N-H bend), 1453, 968, 746, 693 cm-1; HRMS (ESI)
calcd. for C18H21NNaOS (M+Na): 322.1242, found 322.1243 m/z.

(E)-7-(2,5-dimethyl-1H-pyrrol-1-yl)-4-heptenecarboxylic acid benzyl amide
(7g).3 Following GP1 with the corresponding ethyl ester ((E)-7-(2,5-dimethyl-1H-pyrrol1-yl)-4-heptenecarboxylic acid ethyl ester, 5 mmol, 1.25g) and benzyl amine (2 equiv, 10
mmol, 1.1 mL) affords, after flash chromatography on silica gel (80:20-60:40
hexanes:ethyl acetate), the title compound (840 mg, 54%) as a colorless oil; TLC analysis
Rf 0.5 (40:60 hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.35–7.40 (2H, m,
b,b’), 7.25–7.35 (3H, m, a,c,c’), 5.99 (1H, br s, NH), 5.77 (2H, s, o,o’), 5.40–5.50 (2H, m,
i,j), 4.44 (2H, d, J = 5.8 Hz, e), 3.76 (2H, t, J = 7.4 Hz, l), 2.35–2.45 (2H, m, h), 2.25–
2.35 (2H, m, k), 2.25 (2H, t, J = 7.0 Hz, g, overlapping with n,n’), 2.23 (6H, s, n,n’); 13C
NMR (100 MHz, CDCl3) δ 172.35 (f), 138.63 (d), 131.62 (i), 128.79 (b,b’,m,m’), 127.92
(c,c’), 127.58 (a), 127.40 (j), 105.12 (o,o’), 43.63 (e), 43.48 (l), 36.51 (g), 34.18 (k),
28.80 (h), 12.73 (n,n’); IR (neat) 3283 (N-H stretch), 2914, 1643 (C=O stretch), 1539 (NH bend), 1453, 1407, 970, 743, 697 cm-1; HRMS (ESI) calcd. for C20H26N2NaO (M+Na):
333.1943, found 333.1950 m/z.
3
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(E)-6-methyl-4-heptenecarboxylic acid benzyl amide (7h). Following GP1
with the corresponding ethyl ester ((E)-6-methyl-4-heptenecarboxylic acid ethyl ester, 5
mmol, 0.85 g) and benzyl amine (2 equiv, 10 mmol, 1.1 mL) affords, after flash
chromatography on silica gel (80:20-60:40 hexanes:ethyl acetate), the title compound
(751 mg, 65%) as a white solid: m.p. 45.0–45.5 oC; TLC analysis Rf 0.4 (60:40
hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.15–7.40 (5H, m, a,b,b’,c,c’), 6.08
(1H, br s, NH), 5.30–5.50 (2H, m, i,j), 4.42 (2H, d, J = 5.7 Hz, e), 2.15–2.40 (5H, m,
g,h,k), 0.95 (6H, d, J = 6.7 Hz, l,l’);

13

C NMR (100 MHz, CDCl3) δ 172.61 (f), 139.20

(d), 138.55 (j), 128.76 (b,b’), 127.88 (c,c’), 127.53 (i), 125.35 (a), 43.61 (e), 36.73 (g),
31.04 (k), 28.69 (h), 22.60 (l,l’); IR (neat) 3292 (N-H stretch), 2959, 2928, 2870, 1633
(C=O stretch), 1534 (N-H bend), 1454, 1407, 968, 746, 694 cm-1; HRMS (ESI) calcd. for
C15H21NNaO (M+Na): 254.1521, found 254.1526 m/z.

(E)-7-methyl-4-octenecarboxylic acid benzyl amide (7i). Following GP1 with
the corresponding ethyl ester ((E)-7-methyl-4-octenecarboxylic acid ethyl ester, 5 mmol,
0.92 g) and benzyl amine (2 equiv, 10 mmol, 1.1 mL) affords, after flash chromatography
on silica gel (80:20-60:40 hexanes:ethyl acetate), the title compound (873 mg, 71%) as a
white semi-solid; TLC analysis Rf 0.4 (60:40 hexanes:ethyl acetate); 1H NMR (400 MHz,
CDCl3) δ 7.30–7.40 (2H, m, b,b’), 7.20–7.30 (3H, m, a,c,c’), 6.09 (1H, br s, NH), 5.35–
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5.55 (2H, m, i,j), 4.42 (2H, d, J = 5.6 Hz, e), 2.30–2.40 (2H, m, h), 2.25–2.30 (2H, m, g)
1.87 (2H, t, J = 6.6 Hz, k), 1.50–1.65 (1H, m, l), 0.87 (6H, d, J = 6.6 Hz, m,m’) ;

13

C

NMR (100 MHz, CDCl3) δ 172.57 (f), 138.55 (d), 130.78 (i), 129.52 (j), 128.76 (b,b’),
127.89 (c,c’), 127.53 (a), 43.63 (e), 42.00 (k), 36.75 (g), 28.79 (h), 28.45 (l), 22.37
(m,m’); IR (neat) 3286 (N-H stretch), 2953, 2923, 2868, 1642 (C=O stretch), 1544 (N-H
bend), 1454, 967, 696 cm-1; HRMS (ESI) calcd. for C16H23NNaO (M+Na): 268.1677,
found 268.1689 m/z.

(S,E)-7,11-dimethyl-4,10-dodecadienecarboxylic acid benzyl amide (7j).
Following GP1 with the corresponding ethyl ester ((S,E)-7,11-dimethyl-4,10dodecadienecarboxylic acid ethyl ester, 5 mmol, 1.26 g) and benzyl amine (2 equiv, 10
mmol, 1.1 mL) affords, after flash chromatography on silica gel (80:20-60:40
hexanes:ethyl acetate), the title compound (1.14 g, 73%) as a colorless oil; TLC analysis
Rf 0.4 (60:40 hexanes:ethyl acetate); [α]D20 = +6.2o (c 2.0, CHCl3); 1H NMR (400 MHz,
CDCl3) δ 7.30–7.35 (2H, m, b,b’), 7.25–7.30 (3H, m, a,c,c’), 6.22 (1H, br s, NH), 5.35–
5.50 (2H, m, i,j), 5.11 (1H, tt, J = 7.2 Hz, 1.3 Hz, p), 4.40 (2H, d, J = 5.8 Hz, e), 2.30–
2.40 (2H, m, h), 2.25–2.30 (2H, m, g), 1.90–2.05 (3H, m, k,o), 1.75–1.85 (1H, m, k), 1.70
(3H, s, r), 1.62 (3H, s, s),1.40–1.50 (1H, m, l), 1.25–1.40 (1H, m, n), 1.10–1.20 (1H, m,
n), 0.86 (3H, d, J = 6.6 Hz, m);

C NMR (100 MHz, CDCl3) δ 172.62 (f), 138.58 (d),
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131.17 (q), 130.47 (i), 129.69 (j), 128.73 (b,b’), 127.86 (c,c’), 127.49 (a), 124.98 (p),
43.60 (e), 40.05 (k), 36.77 (n), 36.71 (g), 32.77 (l), 28.83 (h), 25.85 (r), 25.70 (o), 19.46
(m), 17.77 (s); IR (neat) 3277 (N-H stretch), 2959, 2911, 1643 (C=O stretch), 1545 (N-H
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bend), 1453, 968, 696 cm-1; HRMS (ESI) calcd. for C21H31NNaO (M+Na): 336.2303,
found 336.2316 m/z.

(E)-7-((triisopropylsilyl)oxy)-4-heptenecarboxylic acid benzyl amide (7k).
Following GP1 with the corresponding ethyl ester ((E)-7-((triisopropylsilyl)oxy)-4heptenecarboxylic acid ethyl ester, 5 mmol, 1.64 g) and benzyl amine (2 equiv, 10 mmol,
1.1 mL) affords, after flash chromatography on silica gel (80:20-60:40 hexanes:ethyl
acetate), the title compound (1.46 g, 75%) as a colorless oil; TLC analysis R f 0.5 (60:40
hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.20–7.40 (5H, m, a,b,b’,c,c’), 6.14
(1H, br s, NH), 5.40–5.55 (2H, m, i,j), 4.41 (2H, d, J = 5.7 Hz, e), 3.67 (2H, t, J = 6.8 Hz,
l), 2.20–2.40 (6H, m, g,h,k), 1.00–1.15 (21H, m, m,m’,m’’,n,n’,n’’);

13

C NMR (100

MHz, CDCl3) δ 172.55 (f), 138.55 (d), 130.49 (i), 128.75 (b,b’), 128.29 (j), 127.84 (c,c’),
127.51 (a), 63.44 (l), 43.61 (e), 36.52 (k), 36.50 (g), 28.85 (h), 18.14 (n,n’,n’’), 12.11
(m,m’,m’’); IR (neat) 3283 (N-H stretch), 2942, 2864, 1644 (C=O stretch), 1545 (N-H
bend), 1455, 1100, 881, 679 cm-1; HRMS (ESI) calcd. for C23H39NNaO2Si (M+Na):
412.2648, found 412.2652 m/z.

(S,E)-6-(2,2-dimethyl-1,3-dioxolan-4-yl)-4-hexenecarboxylic

acid

benzyl

amide (7l). Following GP1 with the corresponding ethyl ester ((S,E)-6-(2,2-dimethyl1,3-dioxolan-4-yl)-4-hexenecarboxylic acid ethyl ester, 5 mmol, 1.2 g) and benzyl amine
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(2 equiv, 10 mmol, 1.1 mL) affords, after flash chromatography on silica gel (60:4030:70 hexanes:ethyl acetate), the title compound (1.05 g, 69%) as a white semi-solid;
TLC analysis Rf 0.25 (60:40 hexanes:ethyl acetate); [α]D20 = +19.2o (c 2.0, CHCl3); 1H
NMR (400 MHz, CDCl3) δ 7.30–7.35 (2H, m, b,b’), 7.20–7.30 (3H, m, a,c,c’), 6.11 (1H,
br s, NH), 5.40–5.60 (2H, m, i,j), 4.40 (2H, d, J = 5.7 Hz, e), 4.00–4.10 (1H, m, l), 3.97
(1H, dd, J = 8.0 Hz, 6.0 Hz, m), 3.52 (1H, dd, J = 7.9 Hz, 7.0 Hz, m), 2.30–2.40 (3H, m,
h,k), 2.25–2.30 (2H, m, g), 2.15–2.25 (1H, m, k), 1.40 (3H, s, o), 1.33 (3H, s, o’);

13

C

NMR (100 MHz, CDCl3) δ 172.32 (f), 138.53 (d), 131.82 (i), 128.76 (b,b’), 127.86 (c,c’),
127.54 (a), 126.52 (j), 109.00 (n), 75.53 (l), 68.92 (m), 43.60 (e), 36.92 (k), 36.37 (g),
28.70 (h), 27.01 and 25.74 (o,o’); IR (neat) 3291 (N-H stretch), 2984, 2933, 1643 (C=O
stretch), 1541 (N-H bend), 1454, 1369, 1213, 1154, 1058, 969, 697 cm-1; HRMS (ESI)
calcd. for C18H25NNaO3 (M+Na): 236.1732, found 326.1739 m/z.

(S,E)-5-(2,2-dimethyl-1,3-dioxolan-4-yl)-4-pentenecarboxylic

acid

benzyl

amide (7m). Following GP1 with the corresponding ethyl ester ((S,E)-5-(2,2-dimethyl1,3-dioxolan-4-yl)-4-pentenecarboxylic acid ethyl ester, 5 mmol, 1.14 g) and benzyl
amine (2 equiv, 10 mmol, 1.1 mL) affords, after flash chromatography on silica gel
(60:40-30:70 hexanes:ethyl acetate), the title compound (913 mg, 63%) as a colorless oil;
TLC analysis Rf 0.25 (60:40 hexanes:ethyl acetate); [α]D20 = +25.1o (c 2.0, CHCl3); 1H
NMR (400 MHz, CDCl3) δ 7.30–7.35 (2H, m, b,b’), 7.25–7.30 (3H, m, a,c,c’), 6.02 (1H,
br s, NH), 5.79 (1H, td, J = 15.3 Hz, 6.5 Hz, i), 5.49 (1H, dd, J = 15.4 Hz, 7.7 Hz, j),
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4.35–4.50 (1H, m, k), 4.41 (2H, d, J = 5.7 Hz, e), 4.03 (1H, dd, J = 8.1 Hz, 6.1 Hz, l),
3.52 (1H, dd, J = 8.0 Hz, 8.0 Hz, l), 2.35–2.45 (2H, m, h), 2.25–2.35 (2H, m, g), 1.41
(3H, s, n), 1.38 (3H, s, n’); 13C NMR (100 MHz, CDCl3) δ 171.96 (f), 138.41 (d), 133.72
(i), 128.80 (b,b’), 128.77 (j), 127.91 (c,c’), 127.62 (a), 109.25 (m), 69.48 (k), 43.68 (e),
35.84 (g), 28.23 (h), 26.83 and 26.01 (n,n’); IR (neat) 3294 (N-H stretch), 2985, 2933,
2872, 1644 (C=O stretch), 1541 (N-H bend), 1454, 1369, 1244, 1213, 1155, 1057, 1028,
967, 859, 732, 697 cm-1; HRMS (ESI) calcd. for C17H23NNaO3 (M+Na): 312.1576, found
312.1581 m/z.

(E)-4-hexenecarboxylic acid benzyl amide (7n). Following GP1 with the
corresponding ethyl ester ((E)-4-hexenecarboxylic acid ethyl ester (5 mmol, 712 mg) and
benzyl amine (2 equiv, 10 mmol, 1.1 mL) affords, after flash chromatography on silica
gel (80:20-60:40 hexanes:ethyl acetate), the title compound (691 mg, 68%) as a white
solid: m.p 58.5–59.5 oC; TLC analysis Rf 0.4 (60:40 hexanes:ethyl acetate); 1H NMR
(400 MHz, CDCl3) δ 7.30–7.35 (2H, m, b,b’), 7.20–7.30 (3H, m, a,c,c’), 6.20 (1H, br s,
NH), 5.25–5.55 (2H, m, i,j), 2.30–2.35 (2H, m, h), 2.20–2.30 (2H, m, g), 1.64 (3H, d, J =
5.8 Hz, k);

13

C NMR (100 MHz, CDCl3) δ 172.64 (f), 138.59 (d), 129.64 (i), 128.74

(b,b’), 127.85 (c,c’), 127.49 (a), 126.43 (j), 43.58 (e), 36.60 (g), 28.75 (h), 18.00 (k); IR
(neat) 3289 (N-H stretch), 2918, 1633 (C=O stretch), 1548 (N-H bend), 1493, 1452,
1234, 964, 747, 697 cm-1; HRMS (ESI) calcd. for C13H17NNaO (M+Na): 226.1208,
found 226.1208 m/z.
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(E)-5-phenyl-4-pentenecarboxylic acid benzyl amide (15a). Following GP1
with the corresponding ethyl ester ((E)- 5-phenyl-4-pentenecarboxylic acid ethyl ester (5
mmol, 1.02 g)) and benzyl amine (2 equiv, 10 mmol, 1.1 mL) affords, after flash
chromatography on silica gel (80:20-60:40 hexanes:ethyl acetate), the title compound
(1.05 g, 79%) as a white solid; TLC analysis Rf 0.4 (60:40 hexanes:ethyl acetate); 1H
NMR (400 MHz, CDCl3) δ 7.20–7.40 (10H, m, a,b,b’,c,c’,l,l’,m,m’,n), 6.46 (1H, d, J =
15.8 Hz, j), 6.22 (1H, dt, J = 15.8 and 6.9 Hz, i), 6.07 (1H, br s, NH), 4.45 (2H, d, J = 5.7
Hz, e), 2.55–2.65 (2H, m, h), 2.39 (2H, t, J = 7.4 Hz, g); 13C NMR (100 MHz, CDCl3) δ
172.10 (f), 138.40 (d), 137.42 (k), 131.30 (j), 128.81 (b,b’), 128.75 (i), 128.64 (l,l’),
127.90 (m,m’), 127.59 (n), 127.30 (a), 126.20 (c,c’), 43.72 (e), 36.51 (g), 29.13 (h).

(E)-5-phenyl-4-pentenecarboxylic acid phenyl amide (15d). Following GP1
with the corresponding ethyl ester ester ((E)- 5-phenyl-4-pentenecarboxylic acid ethyl
ester (5 mmol, 1.02 g)) and aniline (2 equiv, 10 mmol, 0.91 mL) affords, after flash
chromatography on silica gel (80:20-60:40 hexanes:ethyl acetate), the title compound
(892 mg, 71%) as a white solid; TLC analysis Rf 0.65 (60:40 hexanes:ethyl acetate); 1H
NMR (400 MHz, CDCl3) δ 7.53 (2H, d, J = 7.8 Hz, k,k’), 7.30–40 (7H, m,
b,b’,c,c’,l,l’,NH), 7.24 (1H, t, J = 7.0 Hz, a), 7.13 (1H, t, J = 7.3 Hz, m), 6.51 (1H, d, J =
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15.8 Hz, e), 6.25 (1H, dt, J = 15.8 and 6.7 Hz, f), 2.67 (2H, q, J = 7.1 Hz, g), 2.55 (2H, t,
J = 7.4 Hz, h); 13C NMR (100 MHz, CDCl3) δ 170.81 (i), 137.94 (j), 137.36 (d), 131.47
(e), 129.13 (l,l’), 128.67 (b,b’), 128.63 (m), 127.37 (f), 126.21 (c,c’), 124.44 (a), 120.04
(k,k’), 37.43 (h), 28.94 (g).

(E)-5-phenyl-4-pentenecarboxylic acid morpholine amide (15e). Following
GP1 the corresponding ethyl ester ester ((E)- 5-phenyl-4-pentenecarboxylic acid ethyl
ester (5 mmol, 1.02 g)) and morpholine (2 equiv, 10 mmol, 0.87 mL) affords, after flash
chromatography on silica gel (70:30-50:50 hexanes:ethyl acetate), the title compound
(957 mg, 78%) as a yellow oil; TLC analysis Rf 0.4 (40:60 hexanes:ethyl acetate); 1H
NMR (400 MHz, CDCl3) δ 7.34 (2H, d, J = 7..2 Hz, c,c’), 7.29 (2H, t, J = 7.3 Hz, b,b’),
7.20 (1H, t, J = 7.1 Hz, a), 6.44 (1H, d, J = 15.9 Hz, e), 6.26 (1H, dt, J = 15.9 and 6.8 Hz,
f), 3.60–3.70 (6H, m, j,j’,k,k’), 3.45–3.50 (2H, m, j,j’), 2.57 (2H, q, J = 6.8 Hz, h), 2.47
(2H, t, J = 7.5 Hz, g); 13C NMR (100 MHz, CDCl3) δ 170.91 (i), 137.50 (d), 130.94 (e),
129.24 (f), 128.64 (b,b’), 127.24 (a), 126.13 (c,c’), 67.02 and 66.72 (k,k’), 46.06 and
42.06 (j,j’), 32.86 (g), 28.67 (h).

(E)-5-(4-trifluoromethyl)phenyl-4-pentenecarboxylic
(15g).

Following

GP1

with

the

corresponding

ethyl

acid

benzyl

ester

((E)-

amide
5-(4-
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trifluoromethyl)phenyl-4-pentenecarboxylic acid ethyl ester (5 mmol, 1.36 g) and benzyl
amine (2 equiv, 10 mmol, 1.1 mL) affords, after flash chromatography on silica gel
(80:20-60:40 hexanes:ethyl acetate), the title compound (1.18 g, 71%) as a white solid;
TLC analysis Rf 0.4 (60:40 hexanes:ethyl acetate); 19F NMR (376 MHz, CDCl3) δ –62.44
(CF3); 1H NMR (400 MHz, CDCl3) δ 7.56 (2H, d, J = 8.2 Hz, l,l’), 7.41 (2H, d, J = 8.2
Hz, m,m’), 7.25–7.35 (5H, m, a,b,b’,c,c’), 6.49 (1H, d, J = 15.8 Hz, j), 6.34 (1H, dt, J =
15.8 and 6.8 Hz, i), 5.81 (1H, br s, NH), 4.48 (2H, d, J = 5.7 Hz, e), 2.64 (2H, q, J = 7.1
Hz, h), 2.42 (2H, t, J = 7.3 Hz, g); 13C NMR (100 MHz, CDCl3) δ 171.75 (f), 140.90 (k),
138.32 (d), 131.62 (aryl), 130.08 (aryl), 128.83 (aryl), 127.92 (aryl), 127.68 (aryl),
126.31 (aryl), 125.57 (q, J = 4,1 Hz, aryl), 43.76 (e), 36.17 (g), 29.04 (h).

(E)-5-(4-fluoro)phenyl-4-pentenecarboxylic acid benzyl amide (15h). Following GP1
with the corresponding ethyl ester ((E)- 5-(4-fluoro)phenyl-4-pentenecarboxylic acid
ethyl ester (5 mmol, 1.11 g) and benzyl amine (2 equiv, 10 mmol, 1.1 mL) affords, after
flash chromatography on silica gel (80:20-60:40 hexanes:ethyl acetate), the title
compound (1.06 g, 75%) as a white solid; TLC analysis Rf 0.4 (60:40 hexanes:ethyl
acetate); 19F NMR (376 MHz, CDCl3) δ –115.10 to –115.25 (m, F); 1H NMR (400 MHz,
CDCl3) δ 7.20–7.30 (7H, m, a,b,b’,c,c’,l,l’), 6.99 (2H, t, J = 8.7 Hz, m,m’), 6.41 (1H, d, J
= 15.8 Hz, j), 6.13 (1H, dt, J = 15.8 and 6.9 Hz, i), 5.99 (1H, br s, NH), 4.45 (2H, d, J =
5.7 Hz, e), 2.58 (2H, q, J = 7.2 Hz, h), 2.39 (2H, t, J = 7.4 Hz, g); 13C NMR (100 MHz,
CDCl3) δ 172.08 (f), 163.40 and 160.96 (n), 138.40 (d), 133.61 and 133.58 (k), 130.10
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(j), 128.80 (b,b’), 128.50 and 128.48 (i), 127.88 (l,l’), 127.68 (a), 127.60 (c,c’), 115.59
and 115.37 (m,m’), 43.70 (e), 36.43 (g), 29.05 (h).

(E)-5-(4-chloro)phenyl-4-pentenecarboxylic

acid

benzyl

amide

(15i).

Following GP1 with the corresponding ethyl ester ((E)- 5-(4-chloro)phenyl-4pentenecarboxylic acid ethyl ester (5 mmol, 1.19 g) and benzyl amine (2 equiv, 10 mmol,
1.1 mL) affords, after flash chromatography on silica gel (80:20-60:40 hexanes:ethyl
acetate), the title compound (1.17 g, 77%) as a white solid; TLC analysis Rf 0.4 (60:40
hexanes:ethyl acetate);

1

H NMR (400 MHz, CDCl3) δ 7.20–7.30 (9H, m,

a,b,b’,c,c’,l,l’,m,m’), 6.39 (1H, d, J = 15.8 Hz, j), 6.19 (1H, dt, J = 15.8 and 6.9 Hz, i),
6.00 (1H, br s, NH), 4.45 (2H, d, J = 5.7 Hz, e), 2.59 (2H, q, J = 7.0 Hz, h), 2.39 (2H, t, J
= 7.4 Hz, g); 13C NMR (100 MHz, CDCl3) δ 172.00 (f), 138.39 (n), 135.93 (d), 132.83
(k), 130.07 (j), 129.52 (i), 128.81 (l,l’), 128.75 (b,b’), 127.89 (m,m’), 127.62 (a), 127.40
(c,c’), 43.71 (e), 36.30 (g), 29.06 (h).

(E)-5-(4-methoxy)phenyl-4-pentenecarboxylic

acid

benzyl

amide

(15j).

Following GP1 with the corresponding ethyl ester ((E)- 5-(4-methoxy)phenyl-4pentenecarboxylic acid ethyl ester (5 mmol, 1.17 g) and benzyl amine (2 equiv, 10 mmol,
1.1 mL) affords, after flash chromatography on silica gel (80:20-60:40 hexanes:ethyl
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acetate), the title compound (1.11 g, 75%) as a white solid; TLC analysis Rf 0.4 (60:40
hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.20–7.30 (7H, m, a,b,b’,c,c’,l,l’),
6.85 (2H, d, J = 8.7 Hz ,m,m’), 6.39 (1H, d, J = 15.8 Hz, j), 6.07 (1H, dt, J = 15.8 and 6.9
Hz, i), 4.44 (2H, d, J = 5.8 Hz, e), 3.82 (3H, s, o), 2.57 (2H, q, J = 7.3 Hz, h), 2.38 (2H, t,
J = 7.4 Hz, g); 13C NMR (100 MHz, CDCl3) δ 172.30 (f), 159.01 (n), 138.47 (d), 130.64
(j), 130.28 (k), 128.78 (l,l’), 127.87 (b,b’), 127.53 (a), 127.32 (c,c’), 126.57 (i), 114.06
(m,m’), 55.42 (o), 43.66 (e), 36.62 (g), 29.16 (h).

(E)-5-(3-methoxy)phenyl-4-pentenecarboxylic acid benzyl amide (15k).
Following GP1 with the corresponding ethyl ester ((E)- 5-(3-methoxy)phenyl-4pentenecarboxylic acid ethyl ester (5 mmol, 1.17 g) and benzyl amine (2 equiv, 10 mmol,
1.1 mL) affords, after flash chromatography on silica gel (80:20-60:40 hexanes:ethyl
acetate), the title compound (1.07 g, 72%) as a white solid; TLC analysis Rf 0.4 (60:40
hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.20–7.30 (6H, m, a,b,b’,c,c’,m),
6.93 (1H, d, J = 7.6 Hz ,l), 6.88 (1H, d, J = 2.1 Hz, p), 6.80 (1H, dd, J = 8.2 and 2.5 Hz,
n), 6.43 (1H, d, J = 15.8 Hz, j), 6.22 (1H, dt, J = 15.8 and 6.9 Hz, i), 5.95 (1H, br s), 4.45
(2H, d, J = 5.7 Hz, e), 3.82 (3H, s, q), 2.60 (2H, q, J = 7.5 Hz, h), 2.39 (2H, t, J = 7.5 Hz,
g); 13C NMR (100 MHz, CDCl3) δ 172.12 (f), 159.92 (o), 138.90 (k), 138.38 (d), 131.19
(j), 129.61 (i), 129.12 (m), 128.81 (b,b’), 127.89 (c,c’), 127.59 (a), 118.87 (l), 112.94 (n),
111.59 (p), 55.33 (q), 43.72 (e), 36.43 (g), 29.08 (h).
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(E)-5-(2-methoxy)phenyl-4-pentenecarboxylic

acid

benzyl

amide

(15l).

Following GP1 with the corresponding ethyl ester ((E)- 5-(2-methoxy)phenyl-4pentenecarboxylic acid ethyl ester (5 mmol, 1.17 g) and benzyl amine (2 equiv, 10 mmol,
1.1 mL) affords, after flash chromatography on silica gel (80:20-60:40 hexanes:ethyl
acetate), the title compound (1.05 g, 71%) as a white solid; TLC analysis Rf 0.4 (60:40
hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.39 (1H, dd, J = 7.8 and 1.6 Hz,
n), 7.20–7.30 (6H, m, a,b,b’,c,c’,l), 6.93 (1H, t, J = 7.4 Hz , m), 6.88 (1H, d, J = 8.2 Hz,
o), 6.80 (1H, d, J = 16.0 Hz, j), 6.23 (1H, dt, J = 16.0 and 6.9 Hz, i), 6.04 (1H, br s), 4.45
(2H, d, J = 5.8 Hz, e), 3.83 (3H, s, q), 2.61 (2H, q, J = 7.3 Hz, h), 2.40 (2H, t, J = 7.6 Hz,
g); 13C NMR (100 MHz, CDCl3) δ 172.35 (f), 156.50 (p), 138.49 (d), 129.48 (j), 128.77
(b,b’), 128.33 (l), 127.88 (c,c’), 127.52 (a), 126.68 (n), 126.49 (k), 125.90 (i), 120.77 (m),
110.92 (o), 55.53 (q), 43.68 (e), 36.62 (g), 29.61 (h).

(E)-5-(2-methyl)phenyl-4-pentenecarboxylic

acid

benzyl

amide

(15m).

Following GP1 with the corresponding ethyl ester ((E)- 5-(2-methyl)phenyl-4pentenecarboxylic acid ethyl ester (5 mmol, 1.09 g) and benzyl amine (2 equiv, 10 mmol,
1.1 mL) affords, after flash chromatography on silica gel (80:20-60:40 hexanes:ethyl
acetate), the title compound (992 mg, 71%) as a white solid; TLC analysis Rf 0.4 (60:40
hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.35–7.45 (1H, m, aryl), 7.25–7.35
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(5H, m, aryl), 7.10–7.20 (3H, m, aryl), 6.67 (1H, d, J = 15.6 Hz, j), 6.10 (1H, dt, J = 15.6
and 6.9 Hz, i), 5.97 (1H, br s), 4.47 (2H, d, J = 5.7 Hz, e), 2.63 (2H, q, J = 7.3 Hz, h),
2.42 (2H, t, J = 7.5 Hz, g), 2.33 (3H,s q); 13C NMR (100 MHz, CDCl3) δ 172.15 (f),
138.41 (aryl), 136.54 (aryl), 135.19 (aryl), 130.34 (aryl), 130.09 (i), 129.14 (j), 128.82
(aryl), 127.91 (aryl), 127.61 (aryl), 127.25 (aryl), 126.16 (aryl), 125.61 (aryl), 43.72 (e),
36.67 (g), 29.47 (h), 19.93 (q).

(E)-5-(2-furanyl)-4-pentenecarboxylic acid benzyl amide (15n). Following
GP1 with the corresponding ethyl ester ((E)- 5-(2-furanyl)phenyl-4-pentenecarboxylic
acid ethyl ester (5 mmol, 970 mg) and benzyl amine (2 equiv, 10 mmol, 1.1 mL) affords,
after flash chromatography on silica gel (80:20-60:40 hexanes:ethyl acetate), the title
compound (830 mg, 65%) as a light yellow solid; 1H NMR (400 MHz, CDCl3) δ 7.20–
7.35 (6H, m, a,b,b’,c,c’,n), 6.37 (1H, dd, J = 3.2 and 1.9 Hz, l), 6.28 (1H, d, J = 15.9 Hz,
j), 6.10–6.20 (2H, m, i and m, overlapped), 5.95 (1H, br s), 4.45 (2H, d, J = 5.7 Hz, e),
2.57 (2H, q, J = 7.2 Hz, h), 2.37 (2H, t, J = 7.5 Hz, g); 13C NMR (100 MHz, CDCl3) δ
172.03 (f), 152.89 (k), 141.62 (n), 138.36 (d), 128.78 (b,b’), 127.87 (c,c’), 127.64 (i),
127.57 (a), 119.92 (j), 111.28 (m), 106.90 (l), 43.71 (e), 36.37 (g), 28.90 (h).
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(E)-5-(2-thiophenyl)-4-pentenecarboxylic acid benzyl amide (15o). Following
GP1

with

the

corresponding

ethyl

ester

((E)-

5-(2-thiophenyl)phenyl-4-

pentenecarboxylic acid ethyl ester (5 mmol, 1.05 g) and benzyl amine (2 equiv, 10 mmol,
1.1 mL) affords, after flash chromatography on silica gel (80:20-60:40 hexanes:ethyl
acetate), the title compound (936 mg, 69%) as a white solid; 1H NMR (400 MHz, CDCl3)
δ 7.25–7.35 (5H, m, a,b,b’,c,c’), 7.13 (1H, d, J = 5.0 Hz, n), 6.96 (1H, dd, J = 5.0 and 4.0
Hz, l), 6.89 (1H, d. J = 3.3 Hz, m), 6.58 (1H, d, J = 15.7 Hz, j), 6.06 (1H, dt, J = 15.7 and
7.0 Hz, i), 5.91 (1H, br s), 4.46 (2H, d, J = 5.7 Hz, e), 2.57 (2H, q, J = 7.2 Hz, h), 2.38
(2H, t, J = 7.3 Hz, g); 13C NMR (100 MHz, CDCl3) δ 171.98 (f), 142.57 (k), 138.33 (d),
128.81 (b,b’), 128.56 (i), 127.87 (c,c’), 127.59 (a) , 127.39 (l), 124.98 (m), 124.60 (j).
123.67 (n), 43.73 (e), 36.36 (g), 28.92 (h).

(E)-5-(3-furanyl) -4-pentenecarboxylic acid benzyl amide (15p). Following
GP1 with the corresponding ethyl ester ((E)- 5-(3-furanyl)phenyl-4-pentenecarboxylic
acid ethyl ester (5 mmol, 970 mg) and benzyl amine (2 equiv, 10 mmol, 1.1 mL) affords,
after flash chromatography on silica gel (80:20-60:40 hexanes:ethyl acetate), the title
compound (870 mg, 68%) as a light yellow solid; 1H NMR (400 MHz, CDCl3) δ 7.20–
7.40 (7H, m, a,b,b’,c,c’,l,m), 6.49 (1H, d, J = 0 Hz, n), 6.30 (1H, d, J = 15.8 Hz, j), 5.94
(1H, dt, J = 15.8 and 6.9 Hz, i), 5.89 (1H, br s), 4.46 (2H, d, J = 5.7 Hz, e), 2.55 (2H, q, J
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= 7.4 Hz, h), 2.37 (2H, t, J = 7.4 Hz, g);

13

C NMR (100 MHz, CDCl3) δ 172.10 (f),

143.50 (m), 139.90 (l), 138.40 (d), 128.81 (b,b’), 128.33 (i), 127.89 (c,c’), 127.61 (a),
124.21 (k), 120.94 (j), 107.60 (n), 43.70 (e), 36.49 (g), 28.97 (h).

(E)-5-(3-thiophenyl)-4-pentenecarboxylic acid benzyl amide (15q). Following
GP1

with

the

corresponding

ethyl

ester

((E)-

5-(3-thiophenyl)phenyl-4-

pentenecarboxylic acid ethyl ester (5 mmol, 1.05 g) and benzyl amine (2 equiv, 10 mmol,
1.1 mL) affords, after flash chromatography on silica gel (80:20-60:40 hexanes:ethyl
acetate), the title compound (963 mg, 79%) as a white solid; 1H NMR (400 MHz, CDCl3)
δ 7.20–7.35 (6H, m, a,b,b’,c,c’,l,), 7.17 (1H, dd, J = 5.0 and 0 Hz, m), 7.07 (1H, dd, J =
2.2 and 0 Hz, n), 6.46 (1H, d, J = 15.8 Hz, j), 6.07 (1H, dt, J = 15.8 and 6.9 Hz, i), 5.94
(1H, br s), 4.46 (2H, d, J = 5.7 Hz, e), 2.57 (2H, q, J = 7.3 Hz, h), 2.38 (2H, t, J = 7.4 Hz,
g);

13

C NMR (100 MHz, CDCl3) δ 172.11 (f), 140.03 (k), 138.40 (d), 128.80 (b,b’),

128.65 (i), 127.89 (c,c’), 127.60 (a), 126.01 (l), 125.60 (j), 125.03 (m), 121.23 (n), 43.70
(e), 36.49 (g), 29.01 (h).

(R,E)-5-phenyl-4-pentenecarboxylic

acid

1-phenylethyl

amide

(20a).

Following GP1 with the corresponding ethyl ester ((E)- 5-phenyl-4-pentenecarboxylic
acid ethyl ester (5 mmol, 1.02 g) and (R)-(+)--methylbenzylamine (2 equiv, 10 mmol,
1.3 mL) affords, after flash chromatography on silica gel (80:20-60:40 hexanes:ethyl
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acetate), the title compound (1.06 g, 76%) as a white solid; TLC analysis R f 0.4 (60:40
hexanes:ethyl acetate);

1

H NMR (400 MHz, CDCl3) δ 7.20–7.40 (10H, m,

a,b,b’,c,c’,l,l’,m,m’,n), 6.45 (1H, d, J = 15.8 Hz, j), 6.21 (1H, dt, J = 15.8 and 6.9 Hz, i),
5.94 (1H, d, J = 7.4 Hz, NH), 5.15–5.20 (1H, m, e), 2.58 (2H, q, J = 6.9 Hz, h), 2.30–2.40
(2H, m, g), 1.50 (3H, d, J = 6.9 Hz, o); 13C NMR (100 MHz, CDCl3) δ 171.33 (f), 143.32
(k), 137.44 (d), 131.25 (j), 128.82 (i), 128.77 (b,b’), 128. 128.64 (l,l’), 127.42 (n), 127.29
(a), 126.30 (m,m’), 126.19 (c,c’), 43.77 (e), 36.57 (g), 29.16 (h), 21.86 (o).
Preparation sequence of -unsaturated benzyl amide 12

To a cooled (0 oC) solution of (E)-6-phenylhex-3-enoic acid5 79 (13.3 mmol, 2.53
g) in THF (50 mL) was added lithium aluminum hydride (LAH, 1.05 equiv, 14.0 mmol,
530 mg). The resulting mixture was warmed to room temperature and stirred overnight.
The reaction mixture was quenched with 5N KOH (1 mL) and water (0.5 mL). Following
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by 30-min stir, the resultant mixture was filtered through a pad of celite and wash with
ethyl acetate (2 x 5 mL). The filtrate was dried (anhyd. Na2SO4) and concentrated under
reduced pressure to give the crude yellow oil S3 in quantitative yield which was used in
the next step without further purification.
To a cooled (0 oC) solution of (E)-6-phenylhex-3-en-1-ol 80 (13.1 mmol, 2.31 g)
in diethyl ether (20 mL) was added PBr3 (0.5 equiv, 6.6 mmol, 0.62 mL) dropwise. The
resultant mixture was slowly warmed to room temperature and stirred overnight. The
reaction mixture was quenched with brine solution (20 mL). The organic layer was
separated and the aqueous layer was washed with ethyl acetate (2 x 20 mL). The
combined organic extracts were concentrated under reduced pressure, passed through a
short pad of silica gel eluting with 20% ethyl acetate:hexanes (50 mL), and concentrated
again under reduced pressure to afford the crude yellow oil 80 in 92% yield which was
used in the next step without further purification.
A neat mixture of (E)-(6-bromohex-3-en-1-yl)benzene 81 (6 mmol, 1.43 g),
dimethyl malonate (6 mmol, 1.0 equiv, 0.69 mL), K2CO3 (6.6 mmol, 1.1 equiv, 910 mg)
and TBAI (1.8 mmol, 0.3 equiv, 665 mg) was stirred vigorously at 60 oC for 24 hrs. The
resultant mixture was cooled down to room temperature, diluted with ethyl acetate,
filtered, washed with ethyl acetate (3 x 5 mL), and concentrated under reduced pressure
to give the crude yellow oil 81 in 81% yield which was used in the next step without
further purification.
To a solution of dimethyl (E)-2-(6-phenylhex-3-en-1-yl)malonate 82 (2.2 mmol,
635 mg) in EtOH:water (5 mL, 4:1) was added KOH (7.2 mmol, 3.2 equiv, 405 mg). The
resultant mixture was heated to 45 oC. After a 16h stir, the mixture was cooled to room
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temperature, concentrated under reduced pressure and poured into a solution of diethyl
ether:hexanes (5 mL, 1:4) and water (5 mL). The resulting mixture was acidified with
conc. H2SO4 (0.4 mL) and adjusted to pH = 1 by dilute HCl (3M). After extraction with
EtOAc (3 x 10 mL), the organic layers were combined, dried (anhyd. Na2SO4) and
concentrated under reduced pressure to give the crude off-white solid 82 in 96% yield
which was used in the next step without further purification.
To a solution of (E)-2-(6-phenylhex-3-en-1-yl)malonic acid 83 (2.1 mmol, 550
mg) in THF (5 mL) was added CDI (2.3 mmol, 1.1 equiv, 372 mg) portion wise under
positive nitrogen.6 The resulting mixture was stirred at room temp for 2h, then benzyl
amine (3.2 mmol, 1.5 equiv, 0.35 mL) was added in one portion. The resultant mixture
was refluxed for 3h, cooled to room temp, and concentrated under reduced pressure. The
obtained residue was then dissolved in 10 mL EtOAc and washed with a 10 mL aqueous
solution of citric acid monohydrate (2.1 mmol, 1 equiv, 441 mg) and a saturated sodium
bicarbonate (10 mL). The organic extract was dried (anhyd. Na2SO4) and concentrated
under reduced pressure. Flash chromatography on silica gel (80:20-60:40 hexanes:ethyl
acetate) affords the title compound 12 (473 mg, 73%) as a white solid: m.p. 67.0–68.0 oC;
TLC analysis Rf 0.4 (60:40 hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.25–
7.40 (7H, m, b,b’,o,o’,p,p’,q), 7.15–7.25 (3H, m, a,c,c’), 5.68 (1H, br s, NH), 5.30–5.50
(2H, m, g,h), 4.44 (2H, d, J = 5.7 Hz, m), 2.69 (2H, t, J = 7.4 Hz, e), 2.34 (2H, q, J = 6.6
Hz, f), 2.11 (2H, t, J = 7.4 Hz, k), 2.04 (2H, q, J = 6.6 Hz, i), 1.65–1.80 (2H, m, j); 13C
NMR (100 MHz, CDCl3) δ 172.92 (l), 142.08 (d), 138.54 (n), 130.66 (g), 130.17 (h),
128.83 (b,b’), 128.64 (p,p’), 128.37 (c,c’), 128.00 (o,o’), 127.64 (q), 125.84 (a), 43.70
(m), 36.95 (e), 35.80 (k), 34.19 (f), 31.95 (i), 25.37 (j); IR (neat) 3290 (N-H stretch),
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2924, 2848, 1629 (C=O stretch), 1550 (N-H bend), 1494, 1452, 726, 693 cm-1; HRMS
(ESI) calcd. for C21H25NNaO (M+Na): 330.1834, found 330.1833 m/z.
General procedure for the preparation of (E)--unsaturated ethyl esters via
Claisen-Johnson rearrangement (GP2)7

(E)-7-phenyl-4-heptenecarboxylic acid ethyl ester ((E)-11).7 A mixture of 5phenylpent-1-en-3-ol (61.6 mmol, 10.1 g), triethyl orthoacetate (93.3 mmol, 1.5 equiv,
17.1 mL), and n-propanoic acid (6.6 mmol, 0.11 equiv, 0.5 mL) was heated with DeanStark apparatus at 160 oC for 5h. After cooling to room temperature, the reaction mixture
was quenched with satd. NaHCO3 (10 mL), then dilute with DCM (100 mL) and HCl
(1M, 100 mL). After a 2h stir, the organic layer was separated, and the aqueous layer was
washed with DCM (2 x 50 mL). The organic layers were combined, dried (anhyd.
Na2SO4) and concentrated under reduced pressure affords, after flash chromatography on
silica gel (95:5 hexanes:ethyl acetate), the title compound (11.9 g, 83%) as a yellow
liquid; TLC analysis Rf 0.4 (90:10 hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ
7.30–7.35 (2H, m, b,b’), 7.30–7.35 (3H, m, a,c,c’), 5.45–5.60 (2H, m, g,h), 4.18 (2H, q, J
= 7.1 Hz,, l), 2.72 (2H, t, J = 7.3 Hz, e), 2.30–2.40 (6H, m, f,i,j), 1.30 (3H, t, J = 7.1 Hz,
m); 13C NMR (100 MHz, CDCl3) δ 173.27 (k), 142.07 (d), 130.85 (h), 128.96 (g), 128.59
(b,b’), 128.39 (c,c’), 125.90 (a), 60.35 (l), 36.09 (e), 34.49 (j), 34.44 (f), 28.04 (i), 14.42
(m); IR (neat) 2980, 2925, 1732 (C=O stretch), 1453, 1371, 1247, 1175, 1032, 968, 745,
698 cm-1; HRMS (ESI) calcd. for C15H20NaO2 (M+Na): 255.1361, found 255.1364 m/z.
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The above ester (E)-11 was isolated via column chromatography for screening
purpose. All other (E)-esters were pass through a short pad of silica gel eluting with 10%
EtOAc:hexanes, concentrated under reduced pressure, and used without further
purification. Note: the reaction was typically done under air. For furan-, thiophene-, and
pyrrole-containing compounds, it should be done under nitrogen to prevent partial
decomposition of the products.

Preparation of (Z)-7-phenyl-4-heptenecarboxylic acid ethyl ester ((Z)-11) via Wittig
reaction

The Wittig reagent 84 was prepared from 4-bromobutyricacid ethyl ester and
triphenylphosphine as previously reported in literature.8 To a cooled (0 oC) solution of 84
(11 mmol, 5 g) in THF (40 mL) was added NaHMDS (1.1 equiv, 1M, 12 mmol, 12 mL)
dropwise. The resultant mixture was stirred at 0 oC in 30 mins. After cooling down to -78
o

C, 3-phenylpropanal (1.1 equiv, 12 mmol, 1.6 mL) was added dropwise. The resultant

mixture was slowly warmed to room temp and stirred overnight. The reaction was
quenched with satd. ammonium chloride (20 mL) and extracted with EtOAc (3 x 30 mL).
The organic layers were combined, washed with brine, dried (anhyd. Na2SO4) and
concentrated under reduced pressure. The obtained residue was dilute with minimum
amount of DCM, passed through a short pad of silica gel eluting with 10%
EtOAc:hexanes, concentrated under reduced pressure to give a crude (Z)-11 as a yellow
liquid (1.3 g, 51%), which was used in the next step without further purification.
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General procedure for the preparation of allylic alcohol with aldehyde and vinyl
magnesium bromide (GP3)7

To a cooled (-78 oC) solution of vinyl magnesium bromide (140 mmol, 1.2 equiv,
1M, 140 mL) was added 3-phenylpropanal (120 mmol, 16 mL) dropwise. The resultant
mixture was slowly warmed to room temp and stirred for a total of 3h. After quenching
with satd. ammonium chloride, it was continued stirring for 15 more mins. The pH was
adjusted to 3-4 using dilute HCl (1M). After extraction with EtOAc (3 x 100 mL), the
organic layers were combined, washed with brine, dried (anhyd. Na2SO4) and
concentrated under reduced pressure to give the crude yellow liquid (18.2 g, 93%) which
was used in the next step without further purification.
The above procedure was applied for all allylic alcohols, except for the two
dioxolane-containing compounds.
Preparations of dioxolane-containing allylic alcohols

1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)but-3-en-2-ol (86). The preparation of
(4S)-(2,2-dimethyl-[1,3]-dipxolan-4-yl) acetic acid methyl ester 85 from (L)-malic acid
was previously reported in literature.9 To the solution of ester 85 (20 mmol, 3.5 g) in
DCM (80 mL) was slowly added DIBAL-H (1M, 1.2 equiv, 24 mmol, 24 mL) at -78 oC.
The resulting mixture was stirred at -78 oC for 30 mins, then vinyl magnesium bromide
(1M, 1.5 equiv, 30 mmol, 30 mL) was slowly added at the same temperature. The
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resultant mixture was stirred at -78 oC for 30 mins and allowed to warm to room
temperature and stirred for another 1.5h. The reaction mixture was carefully quenched
with NaOH (1M, 15 mL). After filtering through a pad of celite, a filtrate was washed
with water and brine. The organic layer was dried (anhyd. Na2SO4) and carefully
concentrated under reduced pressure to give the crude yellow liquid (3.06 g, 89%) which
was used in the next step without further purification.

1-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)prop-2-en-1-ol (88). The preparation of
(1S,2S)-1,2-bis((R)-2,2-dimethyl-1,3-dioxolan-4-yl)ethane-1,2-diol 87 from (D)-mannitol
was previously reported in literature.10 To a solution of 87 (21.7 mmol, 5.7 g) in DCM
(65 mL) was added satd. NaHCO3 (2.6 mL). While the resulting mixture is vigorously
stirred, NaIO4 (2 equiv, 43.4 mmol, 9.3 g) was added portion wise. After stirring at room
temp for 4h, the suspension was filtered through a pad of celite, flushed with nitrogen,
and used in the next step without further purification.
To the above solution, vinyl magnesium bromide (2.4 equiv with respect to 87,
1M, 52 mmol, 52 mL) was added slowly at -78 oC. The resultant mixture was stirred at 78 oC for 30 mins and allowed to warm to room temperature and stirred for another 1.5h.
The reaction mixture was carefully quenched with NaOH (1M, 35 mL). After filtering
through a pad of celite, a filtrate was washed with water and brine. The organic layer was
dried (anhyd. Na2SO4) and carefully concentrated under reduced pressure to give the
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crude yellow liquid 88 (4.46 g, 65%) which was used in the next step without further
purification.

Preparations of aldehydes 89–91 and 93

89,11 90,12 and 9113 were prepared as described in literature.
3-(2,5-dimethyl-1H-pyrrol-1-yl)propanal

(93).

The

solution

of

3-

aminopropanol (59.7 mmol, 4.56 mL), 2,5-hexanedione (59.7 mmol, 7.0 mL), and ptoluenesulfonic acid monohydrate (0.05 equiv, 3 mmol, 570 mg) in toluene (50 mL) was
reflux with Dean-Stark apparatus overnight. The resultant mixture was cooled to room
temp and washed with water. The organic layer was separated and the aqueous layer was
extracted with DCM (3 x 20 mL). The organic layers were combined, dried (anhyd.
Na2SO4) and concentrated under reduced pressure to give crude 92 as a brown liquid in
(9.1 g, quantitative) which was used in the next step without further purification.
To a cooled (0 oC) solution of crude 92 (13.7 mmol, 2.1 g) in DCM (40 mL) was
added DMSO (6 equiv, 82.1 mmol, 5.8 mL), Et(iPr)2N (3 equiv, 41 mmol, 7.1 mL) and
sulfur trioxide pyridine complex (2 equiv, 27.4, 4.35 g) sequentially. The resultant
mixture was stirred at 0 oC for 1h before quenching with brine (20 mL). The aqueous

204

layer was washed with Et2O (3 x 20 mL), and the combined organic layers were dried
(anhyd. Na2SO4) and concentrated under reduced pressure to give crude 93 as a brown
liquid (1.61 g, 78%) which was used in the next step without further purification.
General procedure for the preparation of aryl/ heteroaryl substituted unsaturated esters via Julia-typed olefination (GP4)14

To a solution of 1-phenyl-1H-tetrazole-5-thiol (10.0 g, 56.1 mmol, 1 equiv) and
K2CO3 (15.5 g, 112.3 mmol, 2.0 equiv) in acetone (300 mL) was added ethyl 4bromobutyrate (8.8 mL, 61.7 mmol, 1.1 equiv) under nitrogen atmosphere. The resulting
mixture was stirred at room temperature overnight then filtered through a pad of celite
and concentrated under reduced pressure to afford light yellow oil crude 94 (16.5 g,
quantitative) used in the next step without further purification.
Inside a nitrogen glove bag, to a solution of 94 (16.4 g, 56 mmol, 1 equiv) in
DCM (200 mL) was added m-CPBA (48.4 g, 278 mmol, 5 equiv) and NaHCO3 (11.7 g,
140 mmol, 2.5 equiv. After an overnight stir, the resulting mixture was filtered, washed
with EtOAc, and concentrated under reduced pressure. The residue was then dissolved in
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the minimum amount of DCM and pushing through a plug of silica gel eluting with 1:1
EtOAc:hexanes to afford the Julia-typed intermediate 95 as light yellow solid (17.3 g,
95%). Crude 95 is used as a common intermediate for Julia olefination.
Representative Julia olefination15 example:

(E)- 5-phenyl-4-pentenecarboxylic acid ethyl ester (R = Ph, 15c). To a solution
of Julia reagent 95 (1.6 g, 4.93 mmol, 1 equiv) in THF (25 mL) was added NaHMDS
(2M, 2.7 mL, 5.43 mmol, 1.1 equiv) at –78 oC. The resulting mixture was stirred at the
same temperature for 30 mins then benzaldehyde (0.75 mL, 7.4 mmol, 1.5 equiv) was
added dropwise. The resultant mixture was slowly warmed to room temperature and stir
overnight after quenching with water and EtOAc. The organic layer was separated and
the aqueous layer was extract with EtOAc (10 mL x 2). The combined organic layers
were dried (anhyr. Na2SO4) and concentrated under reduced pressure affords, after flash
chromatography on silica gel (95:5 hexanes:ethyl acetate), the title compound (1.09 g,
72%) as a yellow liquid; TLC analysis Rf 0.7 (90:10 hexanes:ethyl acetate); 1H NMR
(400 MHz, CDCl3) δ 7.30–7.40 (4H, m, b,b’,c,c’), 7.24 (1H, t, J = 7.0 Hz, a), 6.48 (1H,
d, J = 15.8 Hz, e), 6.25 (1H, dt, J = 15.8 and 6.3 Hz, f), 4.19 (2H, q, J = 7.1 Hz, j), 2.50–
2.60 (4H, m, g,h), 1.30 (3H, t, J = 7.1 Hz, k); 13C NMR (100 MHz, CDCl3) δ 173.08 (i),
137.54 (d), 131.09 (f), 128.63 (b,b’,e), 127.26 (a), 126.19 (c,c’), 60.51 (j), 34.20 (h),
28.45 (g), 14.41 k).
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Ester 15c was isolated for screening purpose. All other esters prepared via this
method were pass through a short pad of silica gel eluting with 10% EtOAc:hexanes,
concentrated under reduced pressure, and used without further purification.

Preparation of OTIPS substrate 15b

(E)-triisopropyl((5-phenylpent-4-en-1-yl)oxy)silane (15b). To a cooled (0 oC)
solution of (E)- 5-phenyl-4-pentenecarboxylic acid ethyl ester 15c (3.3 mmol, 679 mg, 1
equiv) in THF (15 mL) was added lithium aluminum hydride (LAH, 1.05 equiv, 3.5
mmol, 133 mg). The resulting mixture was warmed to room temperature and stirred
overnight. The reaction mixture was quenched with 5N KOH (0.3 mL) and water (0.15
mL). Following by 30-min stir, the resultant mixture was filtered through a pad of celite
and wash with ethyl acetate (2 x 5 mL). The filtrate was dried (anhyd. Na2SO4) and
concentrated under reduced pressure to give the crude yellow oil 96 in quantitative yield
(535 mg) which was used in the next step without further purification.
To the solution of alcohol 96 (520 mg, 3.2 mmol, 1 equiv) and imidazole (435
mg, 6.4 mmol, 2 equiv) in DCM (10 mL) was added dropwise triisopropylsilyl chloride
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(645 mg, 3.36 mmol, 1.05 equiv) at room temperature. The resultant mixture was stirred
overnight then concentrated under reduced pressure affords, after flash chromatography
on silica gel (95:5 hexanes:ethyl acetate), the title compound (814 mg, 80%) as a
colorless liquid; TLC analysis Rf 0.7 (90:10 hexanes:ethyl acetate); 1H NMR (400 MHz,
CDCl3) δ 7.41 (2H, d, J = 7.2 Hz, c,c’), 7.36 (2H, t, J = 7.4 Hz, b,b’), 7.26 (1H, t, J = 7.0
Hz, a), 6.49 (1H, d, J = 15.8 Hz, e), 6.32 (1H, dt, J = 15.8 and 6.8 Hz, f), 3.83 (2H, d, J =
6.4 Hz, i), 2.35–2.45 (2H, m, g), 1.75–1.85 (2H, m, h), 1.15–1.20 (21H, m,
j,j’,j’’,k,k’,k’’); 13C NMR (100 MHz, CDCl3) δ 138.06 (d), 130.78 (f), 130.21 (e), 128.61
(b,b’), 126.94 (a), 126.08 (c,c’), 62.88 (i), 32.81 (h), 29.54 (g), 18.22 (k,k’,k’’), 12.21
(j,j’,j’’).

Preparation of -unsaturated benzyl amide substrate 15f involving general
procedure for the preparation of unsaturated amides via acid chloride intermediates
(GP5)
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(E)- 6-phenyl-5-hexanecarboxylic acid benzyl amide (15f). To a solution of 4(carboxybutyl)triphenylphosphonium bromide16 (2.0 g, 4.5 mmol, 1 equiv) in THF (10
mL) was added LiHMDS (1.8 mL, 9..5 mmol, 2.1 equiv) over 10 mins at room
temperature. After 15 min, benzaldehyde (0.5 mL, 4.5 mmol) was added dropwise at
room temperature. After 15 min, water (15 mL) and ether (15 mL) were added. The
organic phase was rinsed with water (10 mL). The combined aqueous solution was
washed with EtOAc (15 mL), acidified (10% HCl), and extracted with EtOAc (2 x 15
mL). The combined organic extracts were dried and concentrated under reduced pressure
to afford crude 97 (771 mg, 90%).
(GP5) To a cooled solution (0 oC) of the crude carboxylic acid 97 (750 mg, 3.94
mmol) in dichloromethane (20 mL) was added dropwise oxalyl chloride (1.35 mL, 4.0
equiv, 15.7 mmol) followed by 3 drops of DMF. The resultant mixture was slowly
warmed to room temperature and stir for the total of 1.5 h. The reaction mixture was then
concentrated. The resulting acid chloride was redissolved in dichloromethane (20 mL)
and cooled to 0 oC. The resultant mixture was then added dropwise aniline (0.55 mL, 1.5
equiv, 5.85 mmol) followed by dropwise addition of triethylamine (1.1 mL, 2.0 equiv, 7.8
mmol). The reaction mixture was slowly warm to room temp and stir for the total of 1.5
h. Whereupon it was diluted, it was washed twice with HCl (3M), once with satd.
NaHCO3 solution, and once with brine. The organic extracts were dried (Na2SO4) and
concentrated under reduced pressure affords, after flash chromatography on silica gel
(80:20-60:40 hexanes:ethyl acetate), the mixture of 7:1 E/Z 15f as a yellow solid; TLC
analysis Rf 0.4 (60:40 hexanes:ethyl acetate). The mixture of 7:1 E/Z 15f was then diluted
with a minimum amount of EtOAc following by addition of hexanes (9:1
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hexanes:EtOAc). After 2 hours, the resultant mixture was filtered to afford the title
compound (672 mg, 61%) as a white solid; 1H NMR (400 MHz, CDCl3) δ 7.25–7.40 (9H,
m, a,b,b’,c,c’,m,m’,n,n’), 7.22 (1H, t, J = 6.7 Hz, o), 6.39 (1H, d, J = 15.8 Hz, e), 6.20
(1H, dt, J = 15.8 and 6.9 Hz, f), 5.74 (1H, br s, NH), 4.46 (2H, d, J = 5.7 Hz, k), 2.25–
2.35 (4H, m, g, i), 1.85–1.95 (2H, m, h);

13

C NMR (100 MHz, CDCl3) δ 172.65 (j),

138.45 (l), 137.62 (d), 130.93 (e), 129.80 (f), 128.86 (n,n’), 128.63 (b,b’), 128.00 (c,c’),
128.67 (o), 127.14 (a), 126.08 (m,m’), 43.77 (k), 36.01 (i), 32.52 (g), 25.24 (h).

General procedure for Evans’ chiral auxiliary alkylation (GP6)17

To a cooled (–78 oC) solution of (S)-4-benzyl-3-(2-phenylacetyl)oxazolidin-2-one
(4.4 mmol, 1.3 g) in THF (15 mL) was added NaHMDS (1.1 equiv, 2M, 4.84 mmol, 2.4
mL) dropwise. The resultant mixture was stirred at -78 oC for 1h, and cinnamyl bromide
(2 equiv, 8.8 mmol, 1.73 g) was added dropwise. The resulting mixture was slowly
warmed to room temp and stirred for another 5h before quenching with water. The crude
reaction was extracted with EtOAc (3 x 30 mL). The organic extracts were combined,
dried (anhyd. Na2SO4), and concentrated under reduced pressure. Flash chromatography
on silica gel (75:25 hexanes:ethyl acetate) affords the tile compound S20 (1.43 g, 79%) as
a white solid: 143.5–144.5 ºC; TLC analysis Rf = 0.4 (70:30 hexanes:ethyl acetate);
[α]D20 = +121o (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.49 (2H, d, J = 7.3 Hz),
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7.25–7.45 (10H, m), 7.15–7.25 (3H, m), 6.54 (1H, d, J = 15.8 Hz), 6.20–6.30 (1H, m),
5.33 (1H, dd, J = 9.0 and 6.2 Hz), 4.60–4.70 (1H, m), 4.00–4.20 (2H, m), 3.32 (1H, dd, J
= 13.4 and 3.1 Hz), 3.05–3.20 (1H, m), 2.70–2.80 (2H, m); 13C NMR (100 MHz, CDCl3)
δ 173.64, 153.11, 138.36, 137.42, 135.34, 132.76, 129.54, 129.05, 128.84, 128.77,
128.65, 127.67, 127.44, 127.38, 127.01, 126.26, 65.88, 55.80, 48.87, 38.02, 37.96; IR
(neat) 3029, 1762 (C=O stretch), 1691 (C=O stretch), 1494, 1392, 1369, 1349, 1243,
1224, 1210, 1185, 1109, 1053, 984, 969, 743, 716, 700, 690 cm-1; HRMS (ESI) calcd. for
C27H25NNaO3 (M+Na): 434.1732, found 434.1738 m/z.
Preparation of pre-installed -chiral center aryl substituted -unsaturated amide
20b

To cooled (0 oC) a solution of 20e (prepared via GP6 with (S)-4-benzyl-3propionyloxazolidin-2-one, 665 mg, 1.9 mmol) in THF (30 mL) and water (10 mL) was
added LiOH (150 mg, 3.8 mmol) and hydrogen peroxide (30%, 1.4 mL). The resulting
mixture was stirred at the same temperature for 2h before quenching with aqueous
Na2SO3 (1.5M, 13 mL). The resultant mixture was then acidified with dilute HCl (1M) to
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pH=1. Following by extraction with DCM (20 mL x 3), the combined organic layers
dried (anhyd. Na2SO4), and concentrated under reduced pressure to afford crude acid 98
in quantitative yield used in the next step without further purification.
Following GP5 for the preparation of unsaturated amides via acid chloride
intermediates, crude acid 98 (1.9 mmol) affords, after flash chromatography on silica gel
(80:20-60:40 hexanes:ethyl acetate), the title compound (814 mg, 80%) as a white solide;
TLC analysis Rf 0.4 (60:40 hexanes:ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 7.20–
7.35 (10H, m, a,b,b’,c,c’,l,l’,m,m’,n), 6.44 (1H, d, J = 15.8 Hz, j), 6.21 (1H, dt, J = 15.8
and 7.3 Hz, i), 5.91 (1H, br s, NH), 4.55 (1H, dd, J = 14.7 and 8.2 Hz, e), 4.37( 1H, dd, J
= 14.7 and 8.2 Hz, e) 2.50–2.70 (1H, m, h), 2.30–2.50 (2H, m, g,h), 1.25 (3H, d, J = 6.4
Hz, o);

C NMR (75 MHz, CDCl3) δ 175.49 (f), 138.41 (d), 137.33 (k), 132.17 (j),
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128.68 (b,b’), 128.53 (l,l’), 127.75 (m,m’), 127.49 (i), 127.41 (a) 127.21 (n), 126.13
(c,c’), 43.44 (e), 41.92 (g), 37.74 (h), 17.68 (o).

Preparation sequence of 3-cyclopentenecarboxylic acid.18.

Preparation of 3-cyclopentene-1,1-dicarboxylic acid dimethyl ester (99).1 To a cooled
(0 oC) solution of dimethylmalonate (6.6 g, 50.0 mmol) in dry N,N-dimethylformamide
(DMF, 75 mL) was added LiH (1.0 g, 126 mmol) under nitrogen atmosphere. The
reaction was stirred at this temperature for 2 h, then cis-1,4-dichloro-2-butene (6.94 g,
55.5 mmol) was added dropwise, and the resultant mixture was slowly warm to room
temperature. After 72 h, the mixture was diluted with 20% diethyl ether in hexanes (100
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mL) and poured into cold water (100 mL). The organic layer was washed with brine (3 x
50 mL). The organic layer was dried (Na2SO4) and concentrated under reduced pressure
to afford the title compound (8.06 g, 87%) as a white solid: mp 169.5–171.0 oC; 1H NMR
(300 MHz, CDCl3) δ 5.59 (2H, s, e,e’), 3.72 (6H, s, a,a’), 3.01 (4H, s, d,d’); 13C NMR (75
MHz, CDCl3) δ 172.60 (b,b’), 127.76 (e,e’), 58.74 (c), 52.77 (a,a’), 40.90 (d,d’); IR
(neat) 2983, 2897, 1720 (C=O stretch), 1430, 1258 (C-O-C antisymmetrical stretch), 752,
694 (O-C-O bend) cm-1.

Preparation of 3-cyclopentenecarboxylic acid (100).18 To the stirring solution of 3cyclopentene-1,1-dicarboxylic acid dimethyl ester (5.01g, 27.2 mmol) in 4:1
ethanol:water (55 mL) was added KOH (5.02g, 89.1 mmol). The reaction was stirred at
45 oC for 14h. The reaction mixture was then concentrated under reduced pressure and
poured into a solution of 1:4 ether:hexanes (20 mL) and water (30 mL). The mixture was
acidified with concentrated sulfuric acid (ca. 4.5 mL) until pH = 1 and then extracted
with ethyl acetate (3 x 30 mL). The combined organic layers were dried (Na2SO4) and
concentrated under reduced pressure to afford a crude white solid. The solid was heated
at 180 oC for 1 h and then cooled to room temperature. Flash chromatography on silica
gel (90:10 hexanes:ethyl acetate) affords the title compound (2.21 g, 73%, 2 steps) as a
yellow oil: TLC analysis Rf 0.35 (70:30 hexanes:ethyl acetate); 1H NMR (300 MHz,
CDCl3) δ 10.99 (1H, br s, OH), 5.68 (2H, s, d,d’), 3.25–31.0 (1H, m, b), 2.75–2.65 (4H,
m, c,c’); 13C NMR (75 MHz, CDCl3) δ 182.88 (a), 128.91 (d,d’), 41.40 (b), 36.20 (c,c’);
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IR (neat) 3265 (O-H stretch), 3064, 2929, 1695 (C=O stretch), 1614 (C=C stretch), 1422,
931, 678 cm-1. HRMS (FAB) calcd. for C6H9O2 (M+H): 113.0603, found 113.1603 m/z.

General procedure for α-alkylation of carboxylic acid via dianion intermediate
(GP7).

Preparation of 1-methyl-3-cyclopentenecarboxylic acid (101). To a cooled (–78 oC)
solution of diisopropylamine (8.15 mL, 58.0 mmol) in THF (200 mL) was slowly added
n-butyllithium (20.5 mL, 2.5 M solution in hexanes, 51.3 mmol). The resultant mixture
was stirred at that temperature for 1 h followed by a 1 h-stir at room temperature. The
reaction mixture was then cooled to –20

C – – 40oC and a solution of 3-

o

cyclopentenecarboxylic acid 100 (2.54 g, 22.6 mmol) in THF (15 mL) was slowly added
over 1 h. The resultant mixture was slowly rised to room temperature and stir for the total
of 12 h. After that, the mixture was cooled to –20 oC – – 40oC and methyl iodide (2.15
mL, 34.3 mmol) was added dropwise. The resultant mixture was slowly rised to room
temperature and stir for the total of 18 h. The mixture was quenched with dilute HCl
(3M) and extracted with ethyl acetate (3 x 25 mL). The combined organic layers were
dried (Na2SO4) and concentrated under reduced pressure. Flash chromatography on silica
gel (80:20 hexanes:ethyl acetate) affords the title compound (2.45 g, 87%) as a dark oil:
TLC analysis Rf 0.40 (70:30 hexanes:ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 12.06
(1H, br s, OH), 5.63 (2H, s, d,d’), 2.97 (2H, d, J = 14.4 Hz, c,c’), 2.27 (2H, d, J = 14.7
Hz, c,c’), 1.35 (3H, s, e); 13C NMR (75 MHz, CDCl3) δ 185.41 (a), 128.22 (d,d’), 47.71
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(b), 44.53 (c,c’), 25.71 (e); IR (neat) 3195 (O-H stretch), 3064, 2970, 2917, 1695 (C=O
stretch), 1467, 1405, 1287, 944, 670 cm-1. HRMS (EI) calcd. for C7H10O2: 126.0681,
found 126.0676 m/z.

(E)-1-(5-phenylpent-2-en-1-yl)cyclopent-3-ene-1-carboxylic acid (102). Following
GP7 with diisopropylamine (4.5 mL, 32.0 mmol in 100 mL THF), n-butyllithium (11.3
mL, 2.5 M solution in hexanes, 28.3 mmol), 3-cyclopentenecarboxylic acid 100 (1.4 g,
12.5 mmol in 10 mL THF), and allylic bromide 106 (prepared vide infra) affords, after
flash chromatography on silica gel (90:10 hexanes:ethyl acetate), the title compound
(2.95 g, 92 %) as a yellow oil: TLC analysis Rf 0.50 (70:30 hexanes:ethyl acetate); 1H
NMR (300 MHz, CDCl3) δ 12.05 (1H, br s, OH), 7.40–7.20 (5H, j, k,k’,l,l’,m), 5.63 (2H,
s, d,d’), 5.60–5.40 (2H, m, f,g), 2.92 (2H, d, J = 14.7 Hz, c,c’), 2.75–2.65 (2H, m, c,c’),
2.50–2.30 (6H, m, e,h,i);

13

C NMR (75 MHz, CDCl3) δ 184.34 (a), 141.92 (j), 133.56

(d,d’), 128.49 (g), 128.35 (l,l’), 128.31 (k,k’), 126.02 (m), 125.80 (f), 51.99 (b), 41.93 (e),
41.84 (c,c’), 36.00 (i), 34.41 (h); IR (neat) 2918 (O-H stretch), 1694 (C=O stretch), 1277,
1226 (C-O stretch), 967, 951 (O-H bend), 697, 670 cm-1. HRMS (ESI) calcd. for
C17H19Na2O2 (M-H+2Na): 301.1180, found 301.1190 m/z.

1-(2-methylallyl)cyclopent-3-ene-1-carboxylic acid (103). Following GP7 with
diisopropylamine (4.5 mL, 32.0 mmol) in 100 mL THF, n-butyllithium (11.3 mL, 2.5 M
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solution in hexanes, 28.3 mmol), 3-cyclopentenecarboxylic acid 100 (1.4 g, 12.5 mmol in
10 mL THF), and 3-bromo-2-methylpropene (1.9 mL, 18.8 mmol) affords, after flash
chromatography on silica gel (90:10 hexanes:ethyl acetate), the title compound (1.85 g,
89 %) as a yellow oil: TLC analysis Rf 0.55 (70:30 hexanes:ethyl acetate); 1H NMR (400
MHz, CDCl3) δ 12.02 (1H, br s, OH), 5.63 (2H, s, d,d’), 4.84 (1H, s, g), 4.70 (1H, s, g),
2.96 (2H, d, J = 14.4 Hz, c,c’), 2.52 (2H, s, e), 2.44 (2H, d, J = 14.8 Hz, c,c’), 1.73 (3H, s,
h); 13C NMR (100 MHz, CDCl3) δ 184.59 (a), 142.39 (f), 128.36 (d,d’), 113.60 (g), 51.66
(a), 46.57 (e), 42.49 (c,c’), 23.21 (h); IR (neat) 2911 (O-H stretch), 1694 (C=O stretch),
1229 (C-O stretch), 951 (O-H bend), 893, 693, 663 cm-1. HRMS (ESI) calcd. for
C10H13Na2O2 (M-H+2Na): 211.0711, found 211.0719 m/z.

Preparation sequence of (E)-(5-bromopent-3-en-1-yl)benzene (106).

Preparation of ethyl (E)-5-phenylpent-2-enoate (104).19 To a suspension of LiCl (2.21
g, 1.4 equiv, 52.0 mmol) in MeCN (50 mL) were added DBU (6.7 mL, 1.2 equiv, 45.0
mmol) and triethyl phosphonoacetate (9.7 mL, 1.3 equiv, 48.5 mmol). The resulting
mixture was stirred at rt for 15 mins. After cooling to 0 oC, 3-phenylpropionaldehyde (4.9
mL, 37.2 mmol) was added slowly in 5 mins. The resultant mixture was slowly warmed
to rt for the total of 1 h and quenched by saturated ammonium chloride. The resultant
mixture was extract with ethyl acetate (3 x 50 mL). The combined organic extracts were
dried (anhyd. Na2SO4) and concentrated under reduced pressure. Flash chromatography
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on silica gel (95:5 hexanes:ethyl acetate) affords the title compound (6.9 g, 91%) as a
colorless liquid: TLC analysis Rf 0.50 (90:10 hexanes:ethyl acetate); 1H NMR (300 MHz,
CDCl3) δ 7.35–7.30 (2H, m, b,b’), 7.30–7.15 (3H, m, a,c,c’), 7.05 (1H, dt, J = 15.7 and
6.8 Hz, g), 5.89 (1H, dt, J = 15.7 and 1.5 Hz, h), 4.22 (2H, q, J = 15.7 Hz, j), 2.81 (2H, t,
J = 7.3 Hz, e), 2.60–2.50 (2H, m, f) 1.32 (3H, t, J = 7.1 Hz, k);

13

C NMR (75 MHz,

CDCl3) δ 166.56 (i), 148.04 (g), 140.83 (d), 128.51 (b,b’), 128.35 (c,c’), 126.19 (a),
121.90 (h), 60.20 (j), 34.38 (e), 33.91 (f), 14.30 (k).

Preparation of (E)-5-phenylpent-2-en-1-ol (105).20 To a solution of ester 104 (6.8 g,
33.3 mmol) in dichloromethane was added DIBAL-H (67 mL, 2.0 equiv, 67 mmol, 1M in
hexane) slowly at -78 oC. The resultant mixture was stirred at -78 oC and carefully
quenched with saturated aq. potassium sodium tartrate. The layers were separated and the
aqueous layer was washed with dichloromethane (2 x75 mL). The combined organic
extracts were dried (anhyd. Na2SO4) and concentrated under reduced pressure to afford
the title compound (5.0 g, 93%) as a colorless liquid: 1H NMR (300 MHz, CDCl3) δ
7.40–7.30 (2H, m, b,b’), 7.30–7.20 (3H, m, a,c,c’), 5.90–5.60 (2H, m, g,h), 4.11 (2H, d, J
= 4.9 Hz, i), 2.78 (2H, t, J = 7.3 Hz, e), 2.50–2.40 (2H, m, f), 2.40–2.25 (1H, br s, OH);
C NMR (75 MHz, CDCl3) δ 141.79 (d), 132.04 (h), 129.71 (g), 128.49 (b,b’), 128.40

13

(c,c’), 125.94 (a), 63.49 (i), 35.61 (e), 34.04 (f).
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Preparation of (E)-(5-bromopent-3-en-1-yl)benzene (106).20 To a cooled (0 oC)
solution of allylic alcohol 105 (5.0 g, 30.8 mmol) in Et2O (50 mL) was added
phosphorous tribromide (1.45 mL, 0.5 equiv, 15.4 mmol). The resultant mixture was
stirred at 0 oC for 30 mins and quenched by saturated brine solution. The layers were
separated and the aqueous layer was washed with Et2O (2 x 30 mL). The combined
organic extracts were dried (anhyd. Na2SO4) and concentrated under reduced pressure.
The residue was passed through a short pad of silica and concentrated under reduced
pressure to afford the title compound (6.6 g, 95%) as yellow liquid: 1H NMR (300 MHz,
CDCl3) δ 7.40–7.30 (2H, m, b,b’), 7.30–7.20 (3H, m, a,c,c’), 5.90–5.70 (2H, m, g,h), 3.98
(2H, d, J = 6.8 Hz, i), 2.75 (2H, t, J = 7.3 Hz, e), 2.50–2.40 (2H, m, f);

13

C NMR (75

MHz, CDCl3) δ 141.36 (d), 135.49 (h), 128.45 (b,b’), 128.41 (c,c’), 127.01 (g’), 126.01
(a), 35.24 (i), 33.82 (e), 33.34 (f).

Preparation of methyl 1-phenyl-3-cyclopentenecarboxylate (107).21

To a cooled (0 oC) solution of methyl phenylacetate (6.0 g, 39.6 mmol) in THF (80 mL)
and N,N’-dimethylpropyleneurea (20 mL) was carefully added NaH (1.9 g, 79.7 mmol)
and the mixture was stirred at 50 oC. After 2 h, the resultant mixture was allowed to cool
to room temperature, and cis-1,4-dichloro-2-butene (5.2 mL, 47.3 mmol) was added
dropwise. The resultant mixture was then stirred at 50 oC for 3 h. After cooling to room
temperature, the mixture was quenched with saturated ammonium chloride and extracted
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with ethyl acetate (2 x 25 mL). The combined organic layers were dried (Na2SO4) and
concentrated under reduced pressure. Flash chromatography on silica gel (97:3
hexanes:ethyl acetate) affords the title compound (3.51 g, 44%) as a yellow oil: TLC
analysis Rf 0.80 (70:30 hexanes:ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 7.45–7.20
(5H, m, g,g’,h,h’,i), 5.82 (2H, s, c,c’), 3.68 (3H, s, e), 3.48 (2H, d, J = 14.6, b,b’), 2.82
(2H, d, J = 14.8, b,b’);

13

C NMR (75 MHz, CDCl3) δ 176.58 (d), 143.78 (f), 129.18

(g,g’), 128.44 (c,c’), 126.79 (h,h’), 126.58 (i), 58.42 (e), 52.49 (a), 42.88 (b,b’).
Preparation sequence of benzyl 1-(trifluoromethyl)cyclopent-3-enecarboxylate
(110).22

Preparation of allyl ethyl carbonate. To a cooled (0 oC) solution of allylic alcohol (13.6
mL, 0.2 mol) and DMAP (0.6 g, 5 mmol) in dichloromethane (300 mL) was slowly
added pyridine (32 mL, 2 equiv, 0.4 mol). Ethyl chloroformate (19.1 mL, 1 equiv, 0.2
mol) was added dropwise to the above mixture. The resultant mixture was slowly
warmed to room temperature and stirred overnight. The reaction mixture was washed
with water (3 x 100 mL). The organic extracts were dried (anhyd. Na2SO4) and
concentrated under reduced pressure. Flash chromatography on silica gel (95:5
hexanes:ethyl acetate) affords the title (24.3 g, 93%) as a colorless liquid; TLC analysis
Rf 0.55 (90:10 hexanes:ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 6.05–5.80 (1H, m,
b), 5.29 (1H, dd, J = 31.5 Hz, 17.1 Hz, a), 4.61 (2H, d, J = 5.7 Hz, c), 4.19 (2H, q, J = 7.1
Hz, e), 1.30 (3H, t, J = 7.1 Hz, f); 13C NMR (75 MHz, CDCl3) δ 154.94 (d), 131.67 (b),
118.65 (a), 68.19 (c), 63.96 (e), 14.20 (f).
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Preparation of benzyl 3,3,3-trifluoropropanoate (108).22 Using the general procedure
of DCC-mediated condensation with 3,3,3-trifluoropropanoic acid (3.0 g, 23.4 mmol),
DMAP (72.0 mg, 0.025 equiv, 0.59 mmol), DCC (4.8 g, 1 equiv, 23.4 mmol), and benzyl
alcohol (4.85 mL, 2 equiv, 46.8 mmol) affords, after flash chromatography on silica gel
(90:10 hexanes:ethyl acetate), the title compound (4.9 g, 96%) as a colorless liquid: TLC
analysis Rf 0.55 (80:20 hexanes:ethyl acetate); 19F NMR (376 MHz, CDCl3) δ -63.43 (t, J
= 9.6 Hz, CF3); 1H NMR (400 MHz, CDCl3) δ 7.50–7.35 (5H, m, e,e’,f,f’,g), 5.26 (2H, s,
c), 3.26 (2H, q, J = 14.6, a);

13

C NMR (100 MHz, CDCl3) δ 163.00 (q, J = 4.1 Hz, b),

134.91 (d), 128.71 (f), 128.66 (e), 128.37 (g), 123.43 (q, J = 274.4 Hz, CF3), 67.50 (c),
39.59 (q, J = 30.9 Hz, a).

Preparation of benzyl 2-allyl-2-(trifluoromethyl)pent-4-enoate (109).22 To a refluxed
solution

of

Pd(OAc)2

(203

mg,

0.04

equiv,

0.87

mmol)

and

1,2-

bis(diphenylphosphanyl)ethane (dppe; 1.07 g, 0.12 equiv, 2.6 mmol) in THF (50 mL)
was added a solution of benzyl 3,3,3-trifluoropropanoate 108 (4.85 g, 22.2 mmol) and
allyl ethyl carbonate (8.9 mL, 66.7 mmol, 3.0 equiv) in THF (250 mL) via cannula. After
16 h of reflux, the resultant mixture was cooled to rt and concentrated under reduced
pressure. Flash chromatography on silica gel (95:5 hexanes:ethyl acetate) affords the title
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compound (6.1 g, 92%) as a colorless oil: TLC analysis Rf 0.85 (70:30 hexanes:ethyl
acetate); 19F NMR (376 MHz, CDCl3) δ -68.05 (s, CF3); 1H NMR (400 MHz, CDCl3) δ
7.45–7.35 (5H, m, e,e’,f,f’,g), 5.85–5.70 (2H, m, i,i’), 5.24 (2H, s, c), 5.20–5.10 (4H, m,
j,j’), 2.70–2.60 (4H, m, h,h’);

C NMR (100 MHz, CDCl3) δ 168.40 (b), 135.11 (d),

13

131.50 (i,i’), 128.61 (f,f’), 128.46 (g), 128.23 (e,e’), 125.91 (q, J = 283.24 Hz, CF3),
119.69 (j,j’), 67.49 (c), 55.94 (q, J = 23.14 Hz, a), 36.19 (h,h’).

Preparation of benzyl 1-(trifluoromethyl)cyclopent-3-enecarboxylate (110).22 A
solution of diallyl benzyl ester 37 (599 mg, 2.0 mmol) and Grubbs’ I catalyst (8.3 mg,
0.01 mmol, 0.005 equiv) in dichloromethane (20 mL) was stirred at rt for 5 h. The
resultant mixture was then concentrated under reduced pressure. Flash chromatography
on silica gel (90:10 hexanes:ethyl acetate) affords the title compound (535 mg, 99%) as a
colorless oil: TLC analysis Rf 0.75 (80:20 hexanes:ethyl acetate);

19

F NMR (376 MHz,

CDCl3) δ -72.73 (s, CF3); 1H NMR (400 MHz, CDCl3) δ 7.45–7.35 (5H, m, e,e’,f,f’,g),
5.67 (2H, s, i,i’), 5.27 (2H, s, c), 3.11 (2H, d, J = 15.2, h,h’), 2.92 (2H, d, J = 15.8, h,h’);
C NMR (100 MHz, CDCl3) δ 170.12 (b), 135.29 (d), 128.63 (i,i’), 128.40 (f,f’), 127.89

13

(g), 127.67 (e,e’), 126.67 (q, J = 279.0 Hz, CF3), 67.66 (c), 57.14 (q, J = 25.7 Hz, a),
38.87 (h,h’).
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General procedure for the preparation of γ,δ-unsaturated carboxylic acids via
hydrolysis of esters (GP8).
To a carboxylate ester was added a solution of KOH 1 M in ethanol (5 equiv), and
the reaction was heated at reflux for 2 h. The reaction mixture was cooled to rt and
partially concentrated under reduced pressure. The residue was added water and extracted
twice with dichloromethane. The aqueous layer was acidified until pH = 1 with HCl (3M)
and extracted twice with dichloromethane. The combined organic extracts were dried
(Na2SO4) and concentrated under reduced pressure to afford a corresponding carboxylic
acid which was used in the next step without further purification.

General procedure for the preparation of γ,δ-unsaturated phenyl amides via EDCImediated condensation (GP9).

Preparation of 3-cyclopentenecarboxylic acid phenyl amide (23a). To a cooled (0 °C)
degassed solution of 3-cyclopentenecarboxylic acid 100 (562 mg, 5.0 mmol) in N,Ndimethylformamide (DMF, 40 mL) was slowly added aniline (0.46 mL, 5.0 mmol). The
resulting solution was stirred (0.5 h, 0 oC) and then N-(3-dimethylaminopropyl)-N’ethylcarbodiimide

hydrochloride

(EDCI,

1.06

g,

5.5

mmol)

and

4-

(dimethylamino)pyridine (DMAP, 612 mg, 5.0 mmol) were added. The resulting mixture
was allowed to slowly warm to room temperature and stirred overnight. The reaction
mixture was quenched by the addition of satd. aq. sodium bicarbonate (50 mL) and
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extracted with ethyl acetate (2 x 50 mL). The combined organic extracts were washed
with HCl (3M, 2 x 30 mL) and dried (anhyd. Na2SO4) and concentrated under reduced
pressure. Flash chromatography on silica gel (85:15 hexanes:ethyl acetate) affords the
title (815 mg, 87%) as a white solid: mp 83.0–84.5 oC; TLC analysis Rf 0.5 (75:25
hexanes:ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 7.97 (1H, br s, NH), 7.56 (2H, d, J
= 7.8 Hz, f,f’), 7.30 (2H, t, J = 7.6 Hz, g,g’), 7.10 (1H, t, J = 7.4 Hz, h), 5.71 (2H, s, c,c’),
3.25–3.05 (1H, m, a), 2.85–2.55 (4H, m, b,b’); 13C NMR (75 MHz, CDCl3) δ 174.80 (d),
138.23 (e), 129.19 (c,c’), 128.90 (g,g’), 124.13 (h), 120.10 (f,f’), 44.28 (a), 37.15 (b,b’);
IR (neat) 3288 (N-H stretch), 3253, 3142, 1655 (C=O stretch), 1544 (N-H bend), 1439,
1310, 750 cm-1. HRMS (FAB) calcd. for C12H14NO (M+H): 188.0997, found 188.1081
m/z.

1-methyl-3-cyclopentenecarboxylic acid phenyl amide (23b). Following the general
procedure, 3-cyclopentene-1-methylcarboxylic acid 101 (632 mg, 5.0 mmol) affords,
after flash chromatography on silica gel (85:15 hexanes:ethyl acetate), the title compound
(854 mg, 85%) as a white solid: mp 91.0–93.5 ºC; TLC analysis Rf 0.5 (75:25
hexanes:ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 7.52 (2H, d, J = 8.0 Hz, f,f’), 7.48
(1H, br s, NH), 7.30 (2H, t, J = 7.7 Hz, g,g’), 7.09 (1H, t, J = 7.4 Hz, h), 5.73 (2H, s,
c,c’), 2.97 (2H, d, J = 14.5 Hz, b,b’), 2.36 (2H, d, J = 14.5 Hz, b,b’), 1.42 (3H, s, i); 13C
NMR (75 MHz, CDCl3) δ 176.73 (d), 138.21 (e), 129.13 (c,c’), 128.92 (g,g’), 124.13 (h),
120.09 (f,f’), 48.96 (a), 45.10 (b,b’), 26.14 (i); IR (neat) 3657 (N-H stretch), 2974, 2897,
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1679 (C=O stretch), 1593 (C=C stretch), 1520 (N-H bend), 1438, 1303, 727 cm-1. HRMS
(FAB) calcd. for C13H16NO (M+H): 202.1232, found 202.1228 m/z.

General procedure for the preparation of γ,δ-unsaturated phenyl amides via DCCmediated condensation (GP9).

Preparation of 1-(trifluoromethyl)-3-cyclopentenecarboxylic acid phenyl amide (5d).
Using the general procedure for the preparation of γ,δ-unsaturated carboxylic acids via
hydrolysis of esters with benzyl ester 110 (501 mg, 1.85 mmol) affords the crude
carboxylic acid (327 mg) as yellow oil used in the next step without further purification.
To a solution of the crude γ,δ-unsaturated carboxylic acid (327 mg, 1.82 mmol) in
dichloromethane (6 mL) was added DMAP (5.6 mg, 0.025 equiv, 0.046 mmol) and
aniline (0.33 mL, 2 equiv, 3.64 mmol). The resultant mixture was stirred at 0 oC for 15
mins and DCC (374 mg, 1 equiv, 1.82 mmol) was added. The reaction mixture was
slowly warm to rt and stir for 5 h. After filtration, the filtrate was washed twice with HCl
(3M) and once with satd. NaHCO3. The organic extracts were dried (Na2SO4) and
concentrated under reduced pressure. Flash chromatography on silica gel (90:10
hexanes:ethyl acetate) affords, the title compound (321 mg, 68%, 2 steps) as a white
solid: mp 69.5–72.5 ºC; TLC analysis Rf 0.60 (70:30 hexanes:ethyl acetate);

19

F NMR

(376 MHz, CDCl3) δ -71.86 (s, CF3); 1H NMR (400 MHz, CDCl3) δ 7.52 (2H, d, J = 7.7
Hz, f,f’), 7.60–7.45 (1H, m, NH), 7.36 (2H, t, J = 7.6 Hz, g,g’), 7.17 (1H, t, J = 7.4 Hz,
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h), 5.74 (2H, s, c,c’), 3.21 (2H, d, J = 15.5 Hz, b,b’), 2.97 (2H, d, J = 15.3 Hz, b,b’); 13C
NMR (100 MHz, CDCl3) δ 167.06 (d), 137.32 (e), 129.07 (c,c’), 128.05 (g,g’), 127.24 (q,
J = 278.7 Hz, i), 124.98 (h), 120.43 (f,f’), 58.11 (q, J = 24.7, a), 38.89 (q, J = 2.0 Hz,
b,b’); IR (neat) 3309 (N-H stretch), 2924, 2867, 1667 (C=O stretch), 1599 (C=C stretch),
1535 (N-H bend), 1476, 1301, 1263, 1148, 753, 739, 662 (C-F stretch) cm-1. HRMS
(ESI) calcd. for C13H12F3NaNO (M+Na): 278.0769, found 278.0766 m/z.

Preparation of γ,δ-unsaturated amides via acid chloride intermediates via GP5.

Preparation of 1-phenyl-3-cyclopentenecarboxylic acid phenyl amide (23c). Using
the general procedure for the preparation of γ,δ-unsaturated carboxylic acids via
hydrolysis of esters (GP8) with methyl ester 107 (1.66 g, 8.2 mmol) affords the crude
carboxylic acid (1.47 g) as yellow solid used in the next step without further purification.
Follwing GP5 the above crude acid affords, after flash chromatography on silica
gel (90:10 hexanes:ethyl acetate) affords, the title compound (1.55 g, 72%, 3 steps) as a
white solid: mp 90.5–92.5 ºC; TLC analysis Rf 0.6 (70:30 hexanes:ethyl acetate); 1H
NMR (300 MHz, CDCl3) δ 7.50–7.20 (9H, m, f,f’,g,g’,h,j,j’k,k’), 7.08 (1H, t, J = 7.4 Hz,
l), 5.81 (2H, s, c,c’), 3.43 (2H, d, J = 14.6, b,b’), 2.92 (2H, d, J = 14.6, b,b’); 13C NMR
(75 MHz, CDCl3) δ 174.49 (d), 144.53 (e), 138.12 (i), 129.03 (j,j’), 128.90 (c,c’), 128.73
(k,k’), 127.28 (g,g’), 126.75 (h), 124.12 (l), 119.62 (f,f’), 59.24 (a), 43.89 (b,b’); IR (neat)
3286 (N-H stretch), 3056, 2846, 2917, 1648 (C=O stretch), 1595 (C=C stretch), 1518 (N-
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H bend), 1497, 1436, 1312, 1239, 753, 742, 732, 688, 655 cm-1. HRMS (ESI) calcd. for
C18H17NaNO (M+Na): 286.1208, found 286.1197 m/z.

1-phenyl-3-cyclopentenecarboxylic acid benzyl amide (23g). Following GP5 with
benzylamine (1.28 mL, 1.5 equiv, 11.7 mmol) affords, after flash chromatography on
silica gel (90:10 hexanes:ethyl acetate), the title compound (1.48 g, 65%, 3 steps) as a
white solid: mp 68.0–70.5 ºC; TLC analysis Rf 0.50 (70:30 hexanes:ethyl acetate); 1H
NMR (400 MHz, CDCl3) δ 7.40–7.30 (4H, m, g,g’,k,k’), 7.35–7.25 (4H, m, i,l,l’,m), 7.13
(2H, d, J = 6.4 Hz, h,h’), 5.79 (2H, s c,c’), 5.69 (1H, br s, NH), 4.41 (2H, d, J = 5.8 Hz,
e), 3.37 (2H, dd, J = 14.3 Hz, b,b’), 2.85 (2H, d, J = 14.4 Hz, b,b’); 13C NMR (100 MHz,
CDCl3) δ 176.35 (d), 144.97 (f), 138.57 (j), 128.81 (c,c’), 128.75 (k,k’), 128.59 (l,l’),
127.37 (h,h’), 127.28 (m), 126.95 (g,g’), 126.74 (i), 58.44 (a), 43.83 (e), 43.80 (b,b’); IR
(neat) 3393, 3351 (N-H stretch), 3057, 3029, 1637 (C=O stretch), 1518 (N-H bend),
1497, 1446, 1027, 1005, 718 cm-1. HRMS (ESI) calcd. for C19H19NaNO (M+Na):
300.1364, found 300.1364 m/z.

3-cyclopentenecarboxylic acid benzyl amide (23e). Following GP5 with carboxylic
acid 100 (562 mg, 5.0 mmol), oxalyl chloride (1.72 mL, 4.0 equiv, 20 mmol), triethyl
amine (1.4 mL, 2.0 equiv, 10.0 mmol), and benzylamine (0.82 mL, 1.5 equiv, 7.5 mmol)
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affords, after flash chromatography on silica gel (85–70:15–30 hexanes:ethyl acetate), the
title compound (684 mg, 68%, 2 steps) as a white solid: mp 103.5–105.5 ºC; TLC
analysis Rf 0.35 (70:30 hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.40–7.30
(2H, m, h,h’), 7.35–7.25 (2H, m, g,g’,i), 5.94 (1H, br s, NH), 5.70 (2H, s, c,c’), 4.46 (2H,
d, J = 5.7 Hz, e), 3.05–2.95 (1H, m, a), 2.75–2.60 (4H, m, b,b’);

13

C NMR (100 MHz,

CDCl3) δ 175.82 (d), 138.55 (f), 129.26 (c,c’), 128.71 (h,h’), 127.75 (g,g’), 127.46 (i),
43.62 (e), 43.51 (a), 37.02 (b,b’); IR (neat) 3271 (N-H stretch), 3054, 2898, 2837, 1635
(C=O stretch), 1551 (C=C stretch), 1497 (N-H bend), 1454, 1449, 1389, 1033, 746, 693
cm-1. HRMS (ESI) calcd. for C13H15NaNO (M+Na): 224.1051, found 224.1059 m/z.

1-methyl-3-cyclopentenecarboxylic acid benzyl amide (23f). Following GP5 with
carboxylic acid 101 (632 mg, 5.0 mmol), oxalyl chloride (1.72 mL, 4.0 equiv, 20 mmol),
triethyl amine (1.4 mL, 2.0 equiv, 10.0 mmol), and benzylamine (0.82 mL, 1.5 equiv, 7.5
mmol) affords, after flash chromatography on silica gel (85–70:15–30 hexanes:ethyl
acetate), the title compound (667 mg, 62%, 2 steps) as a white solid: mp 72.5–74.5 ºC;
TLC analysis Rf 0.40 (70:30 hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.40–
7.30 (2H, m, h,h’), 7.35–7.25 (2H, m, g,g’,i), 5.91 (1H, br s, NH), 5.68 (2H, s, c,c’), 4.48
(2H, d, J = 5.7 Hz, e), 2.89 (2H, d, J = 14.4 Hz, b,b’), 2.29 (2H, d, J = 14.7 Hz, b,b’),
1.35 (3H, s, j);

C NMR (100 MHz, CDCl3) δ 178.27 (d), 138.70 (f), 128.89 (c,c’),

13

128.72 (h,h’), 127.64 (g,g’), 127.43 (i), 48.17 (a), 45.12 (b,b’), 43.69 (e), 26.33 (j); IR
(neat) 3369 (N-H stretch), 3305, 2916, 1637 (C=O stretch), 1528 (N-H bend), 1414,
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1289, 1235, 948, 714 cm-1. HRMS (ESI) calcd. for C14H17NaNO (M+Na): 238.1208,
found 238.1218 m/z.

1-(trifluoromethyl)-3-cyclopentenecarboxylic acid benzyl amide (23h). Following
GP5 with carboxylic ester 110 (1.36 g, 5.0 mmol), oxalyl chloride (1.72 mL, 4.0 equiv,
20 mmol), triethyl amine (1.4 mL, 2.0 equiv, 10.0 mmol), and benzylamine (0.82 mL, 1.5
equiv, 7.5 mmol) affords, after flash chromatography on silica gel (90:10 hexanes:ethyl
acetate), the title compound (702 mg, 52%, 3 steps) as a white solid: mp 77.5–78.5 ºC;
TLC analysis Rf 0.5 (70:30 hexanes:ethyl acetate); 19F NMR (282 MHz, CDCl3) δ -72.11
(s, CF3); 1H NMR (300 MHz, CDCl3) δ 7.45–7.20 (5H, m, g,g’,h,h’,i), 6.21 (1H, br s,
NH), 5.68 (2H, s, c,c’), 4.51 (2H, d, J = 5.6 Hz, e), 3.12 (2H, d, J = 15.6 Hz, b,b’), 2.88
(2H, d, J = 15.4 Hz, b,b’); 13C NMR (75 MHz, CDCl3) δ 169.04 (d), 137.72 (f), 128.82
(c,c’), 127.90 (h,h’), 127.67 (i), 127.53 (g,g’), 127.33 (q, J = 278.7, j), 57.28 (q, J = 24.6,
a), 44.20 (e), 38.91 (b,b’); IR (neat) 3338 (N-H stretch), 3030, 2922, 1660 (C=O stretch),
1533 (C=C stretch), 1496 (N-H bend), 1419, 1302, 1127 (C-N stretch), 954, 712, 697,
655 cm-1. HRMS (ESI) calcd. for C14H14F3NaNO (M+Na): 292.0925, found 292.0923
m/z.
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(R)-1-phenyl-N-(1-phenylethyl)cyclopent-3-ene-1-carboxamide (23k). Following GP5
with (R)-(+)-α-methylbenzylamine (1.5 mL, 1.5 equiv, 11.7 mmol) affords, after flash
chromatography on silica gel (90:10 hexanes:ethyl acetate), the title compound (1.67 g,
70%, 3 steps) as a white solid: mp 73.5–75.5 ºC; TLC analysis Rf 0.6 (70:30
hexanes:ethyl acetate);

1

H NMR (300 MHz, CDCl3) δ 7.45–7.20 (8H, m,

h,h’,i,k,k’,l,l’,m), 7.14 (2H, t, J = 6.7 Hz, g,g’), 5.76 (2H, s c,c’), 5.44 (1H, br s, NH),
5.20–5.05 (1H, m, e), 3.32 (2H, dd, J = 16.6 and 10.5 Hz, b,b’), 2.81 (2H, dd, J = 15.9
and 14.8 Hz, b,b’), 1.38 (3H, d, J = 6.9 Hz, n); 13C NMR (75 MHz, CDCl3) δ 175.46 (d),
145.11 (j), 143.35 (f), 128.76 and 128.66 (c,c’), 128.69 (k,k’), 128.52 (l,l’), 127.12 (h,h’),
126.89 (m), 126.64 (i), 125.90 (g,g’), 58.25 (a), 48.93 (e), 43.87 and 43.79 (b,b’), 21.60
(n); IR (neat) 3290 (N-H stretch), 3053, 1644 (C=O stretch), 1623 (C=C stretch), 1526
(N-H bend), 1493, 1444, 741, 695, 662 cm-1. HRMS (ESI) calcd. for C20H21NaNO
(M+Na): 314.1521, found 314.1510 m/z.

(E)-1-(5-phenyl-2-pentenyl)-3-cyclopentenecarboxylic acid phenyl amide (23j).
Following GP5 with carboxylic acid 102 (1.40 g, 5.46 mmol), oxalyl chloride (1.88 mL,
4.0 equiv, 21.8 mmol), triethyl amine (1.53 mL, 2.0 equiv, 10.9 mmol), and aniline (0.77
mL, 1.5 equiv, 8.2 mmol) affords, after flash chromatography on silica gel (90:10
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hexanes:ethyl acetate), the title compound (1.36 g, 75%, 2 steps) as a light yellow solid:
mp 82.5–83.0 ºC; TLC analysis Rf 0.7 (70:30 hexanes:ethyl acetate); 1H NMR (400 MHz,
CDCl3) δ 7.51 (2H, dd, J = 8.7 and 1.2 Hz, f,f’), 7.40–7.25 (4H, m, g,g’,p,p’), 7.27 (1H,
br s, NH), 7.25–7.15 (3H, m, o,o’,q), 7.14 (1H, t, J = 7.4 Hz, h), 5.73 (2H, s, c,c’), 5.65–
5.45 (2H, m, j,k), 2.85 (2H, d, J = 14.4 Hz, b,b’), 2.70 (2H, t, J = 7.3 Hz, m), 2.50–2.40
(4H, m, b,b’,i), 2.40–2.35 (2H, m, l); 13C NMR (100 MHz, CDCl3) δ 175.54 (d), 141.85
(n), 138.15 (e), 133.74 (k), 129.13 (c,c’), 128.97 (g,g’), 128.51 (p,p’), 128.31 (o,o’),
126.44 (j), 125.82 (q), 124.15 (h), 120.03 (f), 53.00 (a), 42.38 (i), 42.16 (b,b’), 35.87 (m),
34.40 (l); IR (neat) 3329 (N-H stretch), 3060, 2916, 2844, 1659 (C=O stretch), 1598
(C=C stretch), 1529 (N-H bend), 1497, 1436, 1309, 1233, 976, 951, 755, 692, 677 cm-1.
HRMS (ESI) calcd. for C23H25NaNO (M+Na): 354.1834, found 354.1833 m/z.

1-(2-methylallyl)-3-cyclopentenecarboxylic acid phenyl amide (23i). Following GP5
with carboxylic acid 103 (454 mg, 2.73 mmol), oxalyl chloride (0.94 mL, 4.0 equiv, 10.9
mmol), triethyl amine (0.77 mL, 2.0 equiv, 5.45 mmol), and aniline (0.39 mL, 1.5 equiv,
4.1 mmol) affords, after flash chromatography on silica gel (90:10 hexanes:ethyl acetate),
the title compound (468 mg, 71%, 2 steps) as an off-white solid: mp 109.0–110.0 ºC;
TLC analysis Rf 0.7 (70:30 hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.51
(2H, d, J = 7.6 Hz, f,f’), 7.40–7.30 (3H, m, g,g’,NH), 7.12 (1H, t, J = 7.4 Hz, h), 5.74
(2H, s, c,c’), 4.92 (1H, s, k), 4.75 (1H, s, k), 2.95 (2H, d, J = 14.5 Hz, b,b’), 2.60–2.50
(4H, m, b,b’,i), 1.76 (3H, s, l);

13

C NMR (100 MHz, CDCl3) δ 175.37 (d), 142.51 (j),
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138.12 (e), 129.01 (c,c’), 128.97 (g,g’), 124.17 (h), 120.01 (f,f’), 114.21 (k), 52.90 (a),
46.78 (i), 42.99 (b,b’), 23.84 (l); IR (neat) 3240 (N-H stretch), 3066, 2925, 1646 (C=O
stretch), 1597 (C=C stretch), 1531 (N-H bend), 1485, 1438, 951, 749, 729, 690, 661 cm-1.
HRMS (ESI) calcd. for C16H19NaNO (M+Na): 264.1364, found 264.1357 m/z.
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5.3 Procedures for directed catalytic asymmetric hydroboration (CAHB) with or
without oxidation
General procedure for CAHB of unsaturated carbonyl derivatives without
subsequent oxidation. (GP10)
Note: 8b and 8d were obtained in a gram scale without loss in selectivity.

(S)-7-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)heptanecarboxylic acid
benzyl amide (8b). To a yellow solution of 0.5 mol% [Rh(nbd)2BF4/ 2(R)-B1] (i.e.,
Rh(nbd)2BF4 (1.0 mg, 2.64 µmol) and (R)-(BINOL)PN(Me)Ph B1 (2.23 mg, 5.28 µmol))
in THF (2.0 mL) was added -unsaturated amide 7b (1.08 g, 3.7 mmol) as a solution in
THF (2.0 mL). To the resulting solution was added dropwise a solution of 4,4,5,5tetramethyl-1,3,2-dioxaborolane (pinBH, 102 mg, 0.8 mmol, 1.5 equiv) in THF (1.0 mL).
The mixture was then stirred at 40 oC for 12h. Afterwards, the reaction was concentrated
under reduced pressure and purified via flash chromatography on silica gel (90:10-40:60
hexanes:ethyl acetate) to afford the title compound (1.26 g, 81%) as a yellow oil: TLC
analysis Rf 0.3 (60:40 hexanes:ethyl acetate); [α]D20 = +2.4o (c 2.0, CHCl3);

11

B NMR

(128 MHz, CDCl3) δ 34.51; 1H NMR (400 MHz, CDCl3) δ 7.30–7.40 (2H, m, q,q’),
7.25–7.30 (5H, m, b,b’,c,c’,r), 7.15–7.25 (3H, m, a,p,p’), 6.00 (1H, br s, NH), 4.44 (2H,
d, J = 5.8 Hz, n), 2.61 (2H, t, J = 7.6 Hz, e), 2.15–2.30 (2H, m, l), 1.70–1.85 (2H, m, k),
1.60–1.70 (2H, m, f), 1.50–1.60 (1H, m, g), 1.40–1.50 (1H, m, g), 1.23 (12H, s,
j,j’,j’’,j’’’), 1.00–1.10 (1H, m, h); 13C NMR (100 MHz, CDCl3) δ 173.19 (m), 142.82 (d),
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138.60 (o), 128.78 (q,q’), 128.51 (b,b’), 128.34 (c,c’), 128.00 (p,p’), 127.55 (r), 125.69
(a), 83.25 (i,i’), 43.72 (n), 36.50 (l), 36.26 (e), 30.98 (f), 30.94 (g), 27.49 (k), 24.95
(j,j’,j’’,j’’’); IR (neat) 3285 (N-H stretch), 2976, 2926, 2856, 1644 (C=O stretch), 1541
(N-H bend), 1454, 1379 (C-N stretch), 1315, 1141, 747, 697 cm-1; HRMS (ESI) calcd.
for C26H36BNNaO3 (M+Na): 444.2686, found 444.2701 m/z.

(S)-7-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)heptanecarboxylic acid
Weinreb amide (8c). Following GP10 with 2 mol% [Rh(nbd)2BF4/ 2(R)-B1] and 7c
(130 mg, 0.528 mmol) affords, after flash chromatography on silica gel (90:10-50:50
hexanes:ethyl acetate), the title compound (136 mg, 69%) as a yellow oil: TLC analysis
Rf 0.4 (60:40 hexanes:ethyl acetate); [α]D20 = +5.1o (c 2.0, CHCl3); 11B NMR (128 MHz,
CDCl3) δ 33.87; 1H NMR (400 MHz, CDCl3) δ 7.25–7.30 (2H, m, b,b’), 7.15–7.25 (3H,
m, a,c,c’), 3.67 (3H, s, o), 3.18 (3H, s, n), 2.62 (2H, d, J = 7.6 Hz, e), 2.30–2.60 (2H, m,
l), 1.40–1.80 (6H, m, f,g,k), 1.26 (12H, s, j,j’,j’’,j’’’), 1.00–1.15 (1H, m, h);

13

C NMR

(100 MHz, CDCl3) δ 174.93 (m), 142.89 (d), 128.50 (b,b’), 128.31 (c,c’), 125.63 (a),
83.09 (i,i’), 61.29 (o), 36.30 (e), 32.28 (n), 31.71 (l), 31.01 (f), 31.00 (g), 26.30 (k), 24.97
and 24.93 (j,j’,j’’,j’’’); IR (neat) 2976, 2930, 2857, 1663 (C=O stretch), 1380 (C-N
stretch), 1314, 1142, 699 cm-1; HRMS (ESI) calcd. for C21H34BNNaO4 (M+Na):
398.2479, found 398.2496 m/z.
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(S)-7-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)heptanecarboxylic acid
morpholino amide (8d). Following GP10 with 2 mol% [Rh(nbd)2BF4/ 2(R)-B1] and 7d
(1.01 g, 3.7 mmol) affords, after flash chromatography on silica gel (90:10-40:60
hexanes:ethyl acetate), the title compound (1.22 g, 82%) as a yellow oil: TLC analysis Rf
0.4 (40:60 hexanes:ethyl acetate); [α]D20 = +0.3o (c 2.0, CHCl3);

11

B NMR (128 MHz,

CDCl3) δ 34.34; 1H NMR (400 MHz, CDCl3) δ 7.25–7.35 (2H, m, b,b’), 7.10–7.25 (3H,
m, a,c,c’), 3.55–3.70 (6H, m, n,n’,o,o’), 3.40–3.50 (2H, m, n,n’), 2.61 (2H, d, J = 7.2 Hz,
e), 2.25–2.40 (2H, m, l), 1.40–1.80 (6H, m, f,g,k), 1.24 (12H, s, j,j’,j’’,j’’’), 1.00–1.10
(1H, m, h); 13C NMR (100 MHz, CDCl3) δ 172.11 (m), 144.78 (d), 128.49 (b,b’), 128.32
(c,c’), 125.67 (a), 83.17 (i,i’), 67.06 and 66.86 (o,o’), 46.19 and 41.95 (n.n’), 36.25 (e),
33.08 (l), 30.92 (f), 30.89 (g), 26.99 (k), 25.00 and 24.94 (j,j’,j’’,j’’’); IR (neat) 2974,
2924, 2854, 1644 (C=O stretch), 1425, 1380 (C-N stretch), 1142, 1114, 699 cm-1; HRMS
(ESI) calcd. for C23H36BNNaO4 (M+Na): 424.2635, found 424.2648 m/z.

(R)-5-phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentanecarboxylic acid
benzyl amide (19a). Following GP10 with 15a (140 mg, 0.528 mmol) affords, after flash
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chromatography on silica gel (95:5–90:10 DCM:ethyl acetate), the title compound (187
mg, 90%) as a yellow oil: TLC analysis Rf 0.4 (40:60 hexanes:ethyl acetate);
Enantiomeric excess was checked by converting to the corresponding Mosher’s ester 22a
(general procedure vide infra); crude 19F NMR (375 MHz, CDCl3) shows δ –71.36 (major
95%) and –71.61 (minor 5%); 1H NMR (400 MHz, CDCl3) δ 7.10–7.40 (10H, m,
a,b,b’,c,c’,n,n’,o,o’,p), 5.76 (1H, br s, NH), 4.44 (2H, d, J = 5.6 Hz, e), 2.32 (1H, t, J =
7.3 Hz, j), 2.23 (2H, t, J = 7.4 Hz, g), 1.80–1.95 (1H, m, h), 1.60–1.75 (3H, m, h,i), 1.20
(12H, d, J = 8.0 Hz, l,l’) ; 13C NMR (100 MHz, CDCl3) δ 172.76 (f), 142.94 (m), 138.55
(d), 128.79 (b,b’), 128.48 (n,n’,o,o’), 127.93 (c,c’), 127.56 (a), 125.43 (p), 83.52 (k,k’),
43.64 (e), 36.81 (g), 32.25 (h), 25.44 (i), 24.73 and 24.70 (l,l’).

(R)-2-(5-((3-isopropyl-2,4-dimethylpentan-3-yl)oxy)-1-phenylpentyl)-4,4,5,5tetramethyl-1,3,2-dioxaborolane (19b). Following GP10 with 15b (168 mg, 0.528
mmol) affords, after flash chromatography on silica gel (95:5 hexanes:ethyl acetate), the
title compound (170 mg, 75%) as a colorless oil: TLC analysis Rf 0.7 (80:20
hexanes:ethyl acetate); Chiral HPLC analysis (Chiralcel-OD, 99:1 hexanes:isopropanol,
flowrate = 1.0 mL/min) showed peaks at 35 minutes (10.0% (S)) and 42 minutes (90.0%
(R)); 1H NMR (400 MHz, CDCl3) δ 7.20–7.30 (4H, m, b,b’,c,c’), 7.10–7.20 (1H, m, a),
3.67 (2H, t, J = 6.6 Hz, l), 2.34 (1H, t, J = 7.9 Hz, e), 1.85–2.00 (1H, m, h), 1.65–1.75
(1H, m, h), 1.50–1.65 (2H, m, g), 1.30–1.45 (2H, m, f), 1.23 (12H, d, J = 7.4 Hz, n,n’),
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1.05–1.10 (21H, m, k,k’,k’’,l,l’);

13

C NMR (100 MHz, CDCl3) δ 143.51 (d), 128.49

(b,b’), 128.34 (c,c’), 125.20 (a), 83.33 (m,m’), 63.57 (l), 33.24 (g), 32.70 (h), 25.77 (f),
24.74 and 24.71 (n,n’), 18.17 (l,l’), 12.14 (k,k’,k’’).

(R)-5-phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentanecarboxylic ethyl
ester (19c). Following GP10 with 15c (108 mg, 0.528 mmol) affords, after flash
chromatography on silica gel (95:5 hexanes:ethyl acetate), the title compound (135 mg,
77%) as a yellow oil: TLC analysis Rf 0.7 (80:20 hexanes:ethyl acetate); Enantiomeric
excess was checked by converting to the corresponding Mosher’s ester 22c (general
procedure vide infra); crude

19

F NMR (375 MHz, CDCl3) shows δ –71.37 (major 85%)

and –71.56 (minor 15%); 1H NMR (400 MHz, CDCl3) δ 7.25–7.30 (2H, m, b,b’), 7.15–
7.25 (2H, m, c,c’), 7.10–7.15 (1H, m, a), 4.12 (2H, q, J = 7.1 Hz, j), 2.20–2.40 (3H, m,
e,h), 1.85–1.95 (1H, m, g), 1.65–1.75 (1H, m, g), 1.55–1.65 (2H, m, f), 1.25 (3H, t, J =
7.2 Hz, k), 1.22 (12H, d, J = 8.5 Hz, m,m’); 13C NMR (100 MHz, CDCl3) δ 173.74 (i),
142.94 (d), 128.46 (b,b’), 128.43 (c,c’), 125.37 (a), 83.45 (l,l’), 60.23 (j), 34.48 (g), 32.10
(h), 24.74 and 24.69 (f,m,m’), 14.34 (k).
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(R)-5-phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentanecarboxylic
phenyl amide (19d). Following GP10 with 15d (133 mg, 0.528 mmol) affords, after
flash chromatography on silica gel (95:5–90:10 DCM:ethyl acetate), the title compound
(152 mg, 76%) as a yellow oil: TLC analysis Rf 0.6 (50:50 hexanes:ethyl acetate);
Enantiomeric excess was checked by converting to the corresponding Mosher’s ester 22d
(general procedure vide infra); crude 19F NMR (375 MHz, CDCl3) shows δ –71.39 (major
94%) and –71.64 (minor 6%); 1H NMR (400 MHz, CDCl3) δ 7.51 (2H, d, J = 7.8 Hz,
k,k’), 7.20–7.35 (6H, m, b,b’c,c’,l,l’), 7.16 (1H, t, J = 7.1 Hz, a), 7.10 (1H, t, J = 7.1 Hz,
m), 2.30–2.40 (3H, e,h), 1.85–2.00 (1H, m, g), 1.65–1.80 (3H, m, f,g), 1.22 (12H, d, J =
9.2 Hz, o,o’);

13

C NMR (100 MHz, CDCl3) δ 171.31 (i), 142.90 (d), 138.11 (j), 129.04

(l,l’), 128.52 (b,b’,c,c’), 125.49 (a), 124.23 (m), 120.00 (k,k’), 83.58 (n,n’), 37.79 (g),
32.14 (h), 25.36 (f), 24.76 and 24.73 (o,o’).

(R)-5-phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentanecarboxylic
phenyl amide (19d). Following GP10 with (R)-B2 and 15d (130 mg, 0.528 mmol)
affords, after flash chromatography on silica gel (95:5–90:10 DCM:ethyl acetate), the
title compound (154 mg, 78%) as a yellow oil: TLC analysis Rf 0.4 (40:60 hexanes:ethyl
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acetate); Enantiomeric excess was checked by converting to the corresponding Mosher’s
ester 22e (general procedure vide infra); crude

19

F NMR (375 MHz, CDCl3) shows δ –

71.22 (major 95.5%) and –71.61 (minor 4.5%); 1H NMR (400 MHz, CDCl3) δ 7.15–7.25
(4H, m, b,b’,c,c’), 7.12 (1H, t, J = 7.0 Hz, a), 3.55–3.65 (6H, m, j,j’,k,k’), 3.30–3.35 (2H,
m, j,j’), 2.20–2.35 (3H, m, e,h), 1.85–1.95 (1H, m, g), 1.65–1.75 (1H, m, g), 1.55–1.65
(2H, m, f), 1.19 (12H, d, J = 8.2 Hz, m,m’); 13C NMR (100 MHz, CDCl3) δ 171.76 (i),
142.90 (d), 128.48 (b,b’), 128.43 (c,c’), 125.39 (a), 83.46 (l,l’), 67.00 and 67.71 (k,k’),
46.10 and 41.91 (j, j’), 33.32 (g), 32.22 (h), 24.86 (f), 24.74 and 24.71 (m,m’).

(R)-6-phenyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexanecarboxylic
benzyl amide (19f). Following GP10 with 15f (148 mg, 0.528 mmol) affords, after flash
chromatography on silica gel (95:5–90:10 DCM:ethyl acetate), the title compound (168
mg, 78%) as a yellow oil: TLC analysis Rf 0.4 (40:60 hexanes:ethyl acetate); Chiral
HPLC analysis (Chiralpak-IC, 60:40 hexanes:isopropanol, flowrate = 1.0 mL/min)
showed peaks at 47 minutes (90.5% (R)) and 56 minutes (9.5% (S)); 1H NMR (400 MHz,
CDCl3) δ 7.15–7.40 (9H, m, b,b’,c,c’,o,o’,p,p’,q), 7.14 (1H, t, J = 7.1 Hz, a), 5.72 (1H, br
s, NH), 4.42 (2H, d, J = 5.7 Hz, k), 2.30 (1H, t J = 7.8 Hz, e), 2.18 (2H, t, J = 7.2 Hz, i),
1.80–1.90 (1H, m, h), 1.60–1.80 (3H, m, f,h), 1.25–1.40 (2H, m, g), 1.21 (12H, d, J = 8.6
Hz, m,m’);

13

C NMR (100 MHz, CDCl3) δ 172.97 (j), 143.25 (n), 138.54 (d), 128.81
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(b,b’), 128.48 (p,p’), 128.44 (c,c’), 127.92 (q), 125.30 (a), 83.41 (l,l’), 43.66 (k), 36.79
(i), 32.24 (h), 28.97 (g), 25.87 (f), 24.75 and 24.69 (m,m’).

(R)-5-(4-trifluoromethyl)phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)
pentanecarboxylic acid benzyl amide (19g). Following GP10 with (R)-B7 and 15g (176
mg, 0.528 mmol) affords, after flash chromatography on silica gel (95:5–90:10
DCM:ethyl acetate), the title compound (190 mg, 78%) as a yellow oil: TLC analysis Rf
0.4 (40:60 hexanes:ethyl acetate); Enantiomeric excess was checked by converting to the
corresponding Mosher’s ester 22g (general procedure vide infra); crude

19

F NMR (375

MHz, CDCl3) shows δ –71.28 (major 95%) and –71.46 (minor 5%); 19F NMR (375 MHz,
CDCl3) δ –62.17; 1H NMR (400 MHz, CDCl3) δ 7.51 (2H, d, J = 8.1 Hz, o,o’), 7.25–7.35
(7H, m, a,b,b’,c’c’,n,n’), 5.87 (1H, br s, NH), 4.43 (2H, d, J = 5.5 Hz, e), 2.40 (1H, t, J =
7.2 Hz, j), 2.22 (2H, t, J = 7.4 Hz, g), 1.80–2.00 (1H, m, h), 1.60–1.80 (3H, m, h,i), 1.21
(12H, d, J = 5.9 Hz, l,l’); 13C NMR (100 MHz, CDCl3) δ 172.62 (f), 147.35 (m), 138.49
(d), 128.80 (aryl), 128.67 (aryl), 127.92 (aryl), 127.60 (aryl), 125.37 (q, J = 3.7 Hz, aryl),
83.79 (k,k’), 43.67 (e), 36.63 (g), 31.93 (h), 25.33 (i), 24.71 and 24.69 (l,l’).
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(R)-5-(4-fluoro)phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2yl)pentanecarboxylic acid benzyl amide (19h). Following GP10 with 15h (150 mg,
0.528 mmol) affords, after flash chromatography on silica gel (95:5–90:10 DCM:ethyl
acetate), the title compound (167 mg, 77%) as a yellow oil: TLC analysis Rf 0.4 (40:60
hexanes:ethyl acetate); Enantiomeric excess was checked by converting to the
corresponding Mosher’s ester 22h (general procedure vide infra); crude

19

F NMR (375

MHz, CDCl3) shows δ –71.25 (major 95%) and –71.51 (minor 5%); 19F NMR (375 MHz,
CDCl3) δ –118.4 to –118.6 (m, F); 1H NMR (400 MHz, CDCl3) δ 7.25–7.40 (5H, m,
aryl), 7.14 (2H, dd, J = 8.6 and 5.5 Hz, aryl), 6.94 (2H, J = 8.8 Hz, aryl), 4.44 (2H, d, J =
5.9 Hz, e), 2.30 (1H, t, J = 7.3 Hz, j), 2.22 (2H, t, J = 7.4 Hz, g), 1.80–1.90 (1H, m, h),
1.60–1.75 (3H, m, f,h), 1.21 (12H, d, J = 6.8 Hz, l,l’) ;

13

C NMR (100 MHz, CDCl3) δ

172.69 (f), 162.31 and 159.89 (p), 138.54 (d), 129.74 (aryl), 129.66 (aryl), 128.79 (aryl),
127.83 (aryl), 127.59 (aryl), 115.29 and 115.08 (o,o’), 83.59 (k,k’), 43.65 (e), 36.73 (g),
32.35 (h), 25.33 (i), 24.72 and 24.69 (l,l’).

(R)-5-(4-chloro)phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2yl)pentanecarboxylic acid benzyl amide (19i). Following GP10 with (R)-B2 and 15i
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(158 mg, 0.528 mmol) affords, after flash chromatography on silica gel (95:5–90:10
DCM:ethyl acetate), the title compound (169 mg, 75%) as a yellow oil: TLC analysis Rf
0.4 (40:60 hexanes:ethyl acetate); Enantiomeric excess was checked by converting to the
corresponding Mosher’s ester 22i (general procedure vide infra); crude

19

F NMR (375

MHz, CDCl3) shows δ –71.35 (major 95%) and –71.57 (minor 5%); 1H NMR (400 MHz,
CDCl3) δ 7.25–7.35 (5H, m, a,b,b’,o,o’,p), 7.22 (2H, d, J = 8.4 Hz, c,c’), 7.13 (2H, J =
8.4 Hz, n,n’), 4.42 (2H, d, J = 5.7 Hz, e), 2.29 (1H, t, J = 7.3 Hz, j), 2.20 (2H, t, J = 7.4
Hz, g), 1.80–1.90 (1H, m, h), 1.50–1.70 (3H, m, f,h), 1.21 (12H, d, J = 6.2 Hz, l,l’) ; 13C
NMR (100 MHz, CDCl3) δ 172.68 (f), 141.50 (m), 138.55 (d), 131.09 (p). 129.78 (n,n’),
128.79 (b,b’), 128.56 (o,o’), 127.92 (c,c’), 127.57 (a), 83.66 (k,k’), 43.63 (e), 36.67 (g),
32.10 (h), 25.55 (i), 24.73 and 24.70 (l,l’).

(R)-5-(4-methoxy)phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2yl)pentanecarboxylic acid benzyl amide (19j). Following GP10 with (R)-B2 and 15j
(156 mg, 0.528 mmol) affords, after flash chromatography on silica gel (95:5–90:10
DCM:ethyl acetate), the title compound (177 mg, 79%) as a yellow oil: TLC analysis Rf
0.4 (40:60 hexanes:ethyl acetate); Enantiomeric excess was checked by converting to the
corresponding Mosher’s ester 22j (general procedure vide infra); crude

19

F NMR (375

MHz, CDCl3) shows δ –71.40 (major 96%) and –71.68 (minor 4%); 1H NMR (400 MHz,
CDCl3) δ 7.20–7.35 (5H, m, a,b,b’,c,c’), 7.10 (2H, d, J = 8.6 Hz, n,n’), 6.80 (2H, d, J =

241

8.6 Hz, o,o’), 5.94 (1H, br s, NH)), 4.41 (2H, d, J = 5.7 Hz, e), 3.77 (3H, s, s), 2.15–2.30
(3H, m, g,j), 1.80–1.90 (1H, m, h), 1.55–1.70 (3H, m, h,i), 1.20 (12H, d, J = 7.6 Hz, l,l’);
C NMR (100 MHz, CDCl3) δ 172.92 (f), 157.51 (q), 138.59 (d), 134.90 (m), 129.34

13

(n,n’), 128.75 (b,b’), 127.90 (c,c,’), 127.51 (a), 113.94 (o,o’), 83.46 (k,k’), 55.28 (s),
43.59 (e), 36.76 (g), 32.49 (h), 25.39 (i), 24.73 and 24.71 (l,l’).

(R)-5-(3-methoxy)phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2yl)pentanecarboxylic acid benzyl amide (19k). Following GP10 with 15k (156 mg,
0.528 mmol) affords, after flash chromatography on silica gel (95:5–90:10 DCM:ethyl
acetate), the title compound (161 mg, 72%) as a yellow oil: TLC analysis Rf 0.4 (40:60
hexanes:ethyl acetate); Chiral HPLC analysis (Chiralcel-AD, 60:40 hexanes:isopropanol,
flowrate = 1.0 mL/min) showed peaks at 15 minutes (97.0% (R)) and 19 minutes (3.0%
(S)); 1H NMR (400 MHz, CDCl3) δ 7.20–7.40 (5H, m, aryl), 7.17 (1H, t, J = 7.7 Hz,
aryl), 6.75–6.85 (2H, m, aryl), 6.71 (1H, d, J = 7.8 Hz, aryl), 5.86 (1H, br s, NH)), 4.43
(2H, d, J = 5.5 Hz, e), 3.79 (3H, s, s), 2.15–2.35 (3H, m, g,j), 1.80–1.95 (1H, m, h), 1.55–
1.80 (3H, m, h,i), 1.21 (12H, d, J = 7.4 Hz, l,l’); 13C NMR (100 MHz, CDCl3) δ 172.81
(f), 159.72 (q), 144.61 (m), 138.85 (d), 129.35 (o), 128.77 (b,b’), 127.90 (c,c,’), 127.53
(a), 120.99 (n), 114.14 (p), 110.90 (r), 83.53 (k,k’), 55.18 (s), 43.62 (e), 36.79 (g), 32.26
(h), 25.46 (i), 24.73 (l,l’).
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(R)-5-(2-methoxy)phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2yl)pentanecarboxylic acid benzyl amide (19l). Following GP10 with 15l (156 mg,
0.528 mmol) affords, after flash chromatography on silica gel (95:5–90:10 DCM:ethyl
acetate), the title compound (183 mg, 82%) as a yellow oil: TLC analysis Rf 0.4 (40:60
hexanes:ethyl acetate); Chiral HPLC analysis (Chiralcel-AD, 60:40 hexanes:isopropanol,
flowrate = 1.0 mL/min) showed peaks at 17 minutes (85.5% (R)) and 23 minutes (14.5%
(S)); 1H NMR (400 MHz, CDCl3) δ 7.30–7.35 (2H, m, b,b’), 7.25–7.30 (3H, m, a,c,c’),
7.10–7.20 (2H, m, q,r), 6.88 (1H, t, J = 7.0 Hz, p), 6.82 (1H, d, J = 8.3 Hz, o), 5.95 (1H,
br s, NH), 4.42 (2H, dd, J = 5.5 and 1.8 Hz, e), 3.77 (3H, s, s), 2.43 (1H, t, J = 6.9 Hz, j),
2.22 (2H, td, J = 8.1 and 2.8 Hz, g), 1.80–1.95 (1H, m, h), 1.55–1.75 (3H, m, h,i), 1.23
(12H, d, J = 8.9 Hz, l,l’); 13C NMR (100 MHz, CDCl3) δ 173.14 (f), 157.04 (n), 138.68
(d), 131.87 (m), 130.12 (r), 128.74 (b,b’), 127.87 (c,c,’), 127.47 (a), 126.64 (q), 120.74
(p), 110.20 (o), 83.23 (k,k’), 55.15 (s), 43.56 (e), 36.84 (g), 30.54 (h), 25.47 (i), 24.90 and
24.77 (l,l’).

(R)-5-(2-methyl)phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2yl)pentanecarboxylic acid benzyl amide (19m). Following GP10 with 15m (148 mg,
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0.528 mmol) affords, after flash chromatography on silica gel (95:5–90:10 DCM:ethyl
acetate), the title compound (181 mg, 84%) as a yellow oil: TLC analysis Rf 0.4 (40:60
hexanes:ethyl acetate); Chiral HPLC analysis (Chiralpak-IC, 60:40 hexanes:isopropanol,
flowrate = 1.4 mL/min) showed peaks at 15 minutes (93.0% (R)) and 17 minutes (7.0%
(S)); 1H NMR (400 MHz, CDCl3) δ 7.30–7.35 (2H, m, b,b’), 7.25–7.30 (3H, m, c,c’,o),
7.19 (1H, d, J = 7.5 Hz, a), 7.10–7.15 (2H, m, q,r), 7.00–7.10 (1H, m, p), 5.92 (1H, br s,
NH), 4.43 (2H, d, J = 5.9 Hz, e), 2.54 (1H, t, J = 7.0 Hz, j), 2.34 (3H, s, s), 2.23 (2H, t, J
= 6.8 Hz, g), 1.85–2.00 (1H, m, h), 1.60–1.80 (3H, m, h,i), 1.21 (12H, d, J = 8.6 Hz, l,l’);
C NMR (100 MHz, CDCl3) δ 172.84 (f), 141.44 (m), 138.61 (d), 136.08 (n), 130.35 (o),

13

128.77 (b,b’), 127.91 (c,c,’), 127.86 (r), 127.53 (a), 126.07 (p), 125.25 (q), 83.44 (k,k’),
43.61 (e), 36.90 (g), 31.86 (h), 25.64 (i), 24.80 and 24.70 (l,l’), 20.30 (s).

(R)-5-(2-furanyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentanecarboxylic
acid benzyl amide (19n). Following GP10 with 1 mol% [Rh/2 (R)-B7], 3 equiv pinBH
and 15n (135 mg, 0.528 mmol) affords, after flash chromatography on silica gel (95:5–
90:10 DCM:ethyl acetate), the title compound (140 mg, 69%) as a yellow oil: TLC
analysis Rf 0.4 (40:60 hexanes:ethyl acetate); Enantiomeric excess was checked by
converting to the corresponding Mosher’s ester 22n (general procedure vide infra); crude
19

F NMR (375 MHz, CDCl3) shows δ –71.59 (major 97%) and –72.00 (minor 3%); 1H

NMR (400 MHz, CDCl3) δ 7.30–7.40 (2H, m, b,b’), 7.25–7.30 (4H, m, a,c,c’,p), 6.27
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(1H, t, J = 2.5 Hz, o), 6.03 (1H, d, J = 2.9 Hz, n), 5.84 (1H, br s, NH), 4.45 (2H, d, J =
5.6 Hz, e), 2.49 (1H, t, J = 7.1 Hz, j), 2.23 (2H, t, J = 7.4 Hz, g), 1.75–1.85 (2H, m, h),
1.65–1.75 (2H, m, i), 1.25 (12H, d, J = 2.8 Hz, l,l’);

13

C NMR (100 MHz, CDCl3) δ

172.74 (f), 156.37 (m), 140.86 (p), 138.54 (d), 128.78 (b,b’), 127.91 (c,c,’), 127.55 (a),
110.29 (o), 105.10 (n), 83.83 (k,k’), 43.85 (e), 36.65 (g), 29.81 (h), 25.20 (i), 24.80 and
24.73 (l,l’).

(R)-5-(2-thiophenyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2yl)pentanecarboxylic acid benzyl amide (19o). Following GP10 with 1 mol% [Rh/2
(R)-B2], 3 equiv pinBH and 15o (143 mg, 0.528 mmol) affords, after flash
chromatography on silica gel (95:5–90:10 DCM:ethyl acetate), the title compound (152
mg, 72%) as a yellow oil: TLC analysis Rf 0.4 (40:60 hexanes:ethyl acetate);
Enantiomeric excess was checked by converting to the corresponding Mosher’s ester 22o
(general procedure vide infra); crude 19F NMR (375 MHz, CDCl3) shows δ –71.32 (major
92%) and –71.74 (minor 8%); 1H NMR (400 MHz, CDCl3) δ 7.30–7.40 (2H, m, b,b’),
7.25–7.30 (3H, m, a,c,c’), 7.09 (1H, dd, J = 5.1 and 0.9 Hz, p), 6.91 (1H, dd, J = 5.1 and
3.4 Hz, o), 6.81 (1H, d, J = 3.4 Hz, n), 5.82 (1H, br s, NH), 4.44 (2H, d, J = 5.7 Hz, e),
2.66 (1H, t, J = 7.1 Hz, j), 2.24 (2H, t, J = 7.3 Hz, g), 1.85–1.95 (1H, m, h), 1.65–1.80
(3H, m, h,i), 1.24 (12H, d, J = 4.3 Hz, l,l’);

C NMR (100 MHz, CDCl3) δ 172.66 (f),

13
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145.87 (m), 138.53 (d), 128.80 (b,b’), 127.92 (c,c,’), 127.57 (a), 126.88 (o), 124.09 (n),
122.78 (p), 83.84 (k,k’), 43.66 (e), 36.67 (g), 33.28 (h), 25.18 (i), 24.74 and 24.73 (l,l’).

(R)-5-(3-furanyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentanecarboxylic
acid benzyl amide (19p). Following GP10 with 1 mol% [Rh/2 (R)-B2], 3 equiv pinBH
and 15p (135 mg, 0.528 mmol) affords, after flash chromatography on silica gel (95:5–
90:10 DCM:ethyl acetate), the title compound (146 mg, 72%) as a yellow oil: TLC
analysis Rf 0.4 (40:60 hexanes:ethyl acetate); Enantiomeric excess was checked by
converting to the corresponding Mosher’s ester 22p (general procedure vide infra); crude
19

F NMR (375 MHz, CDCl3) shows δ –71.59 (major 92%) and –72.00 (minor 8%); 1H

NMR (400 MHz, CDCl3) δ 7.20–7.40 (7H, m, a,b,b’,c,c’,o,p), 6.28 (1H, s, n), 5.90 (1H,
br s, NH), 4.43 (2H, d, J = 5.6 Hz, e), 2.15–2.30 (3H, m, g,j), 1.60–1.80 (2H, m, h,i), 1.23
(12H, d, J = 0.0 Hz, l,l’); 13C NMR (100 MHz, CDCl3) δ 172.90 (f), 142.62 (o), 138.89
(p), 138.55 (d), 128.77 (b,b’), 127.89 (c,c,’), 127.54 (a), 125.20 (m), 111.13 (n), 83.59
(k,k’), 43.62 (e), 36.69 (g), 31.32 (h), 25.26 (i), 24.79 and 24.74 (l,l’).

246

(R)-5-(2-thiophenyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2yl)pentanecarboxylic acid benzyl amide (19o). Following GP10 with 1 mol% [Rh/2
(R)-B2], 3 equiv pinBH and 15o (143 mg, 0.528 mmol) affords, after flash
chromatography on silica gel (95:5–90:10 DCM:ethyl acetate), the title compound (154
mg, 73%) as a yellow oil: TLC analysis Rf 0.4 (40:60 hexanes:ethyl acetate);
Enantiomeric excess was checked by converting to the corresponding Mosher’s ester 22o
(general procedure vide infra); crude 19F NMR (375 MHz, CDCl3) shows δ –71.34 (major
94%) and –71.60 (minor 6%); 1H NMR (400 MHz, CDCl3) δ 7.30–7.35 (2H, m, b,b’),
7.25–7.30 (3H, m, a,c,c’), 7.22 (1H, dd, J = 4.8 and 3.0 Hz, o), 6.90–7.00 (2H, m, n,p),
5.91 (1H, br s, NH), 4.43 (2H, d, J = 5.7 Hz, e), 2.48 (1H, t, J = 7.1 Hz, j), 2.22 (2H, t, J
= 7.4 Hz, g), 1.80–1.90 (1H, m, h), 1.60–1.80 (3H, m, h,i), 1.21 (12H, d, J = 4.2 Hz, l,l’);
C NMR (100 MHz, CDCl3) δ 172.82 (f), 142.67 (m), 138.57 (d), 128.78 (b,b’), 128.30

13

(n), 127.92 (c,c,’), 127.55 (a), 125.07 (o), 119.70 (p), 83.58 (k,k’), 43.63 (e), 36.72 (g),
31.88 (h), 25.40 (i), 24.77 and 24.72 (l,l’).
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(1R,3S)-1-phenyl-3-(4,4,6-trimethyl-1,3,2-dioxaborinan-2-yl)-1cyclopentanecarboxylic acid phenyl amide (26c). Following GP10 with 1 mol% [Rh/2
(R)-B2], 2 equiv tmdBH and

23c (139.2 mg, 0.528 mmol) affords, after flash

chromatography on silica gel (90:10 hexanes:ethyl acetate), the title compound (151 mg,
73%) as a light yellow solid: mp 112.5–114.0 ºC; TLC analysis Rf 0.75 (70:30
hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.46 (1H, d, J = 7.4 Hz, l,l’), 7.45–
7.35 (4H, m, h,h’,m,m’), 7.35–7.20 (2H, m, i,i’,j), 7.05 (1H, t, J = 7.4 Hz, n), 6.92 (1H, d,
J = 18.6 Hz, NH), 4.25–4.10 (2H, m, q), 2.60–2.45 (2H, m, b,e), 2.40–2.25 (2H, m, b),
2.20–2.10 (2H, m, e), 1.95–1.80 (3H, m, c), 1.76 (1H, dd, J = 13.9 and 3.0 Hz, p), 1.46
(1H, dd, J = 12.5 and 12.5 Hz, p), 1.40–1.30 (1H, m, d), 1.27 (6H, d, J = 3.9 Hz, r,r’),
1.24 (3H, dd, J = 6.2 and 4.1 Hz, s); 13C NMR (100 MHz, CDCl3) δ 174.95 and 174.91
(f), 143.63 and 143.57 (k), 138.33 and 138.30 (g), 128.84 (i,i’), 128.79 (m,m’), 127.04
(j), 127.03 (l,l’), 123.87 and 123.85 (n), 119.60 and 119.55 (h,h’), 70.52 and 70.50 (o),
64.69 and 64.62 (q), 61.03 and 61.02 (a), 45.93 and 45.89 (p), 39.40 and 39.31 (b), 37.67
(e), 31.27 and 31.24 (r,r’), 28.10 and 28.07 (d), 26.60 and 26.53 (c), 23.20 and 23.18 (s);
IR (neat) 3408 (N-H stretch), 2971, 1677 (C=O stretch), 1596 (N-H bend), 1519, 1493,
1436, 1303 (C-O stretch), 1208 (C-N stretch), 1163, 700, 690 cm-1.
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(1R,3S)-1-phenyl-3-(4,4,6-trimethyl-1,3,2-dioxaborinan-2-yl)-1cyclopentanecarboxylic acid benzyl amide (26g). Following GP10 with 1 mol% [Rh/2
(R)-B2], 2 equiv tmdBH and 23g (146.5 mg, 0.528 mmol) affords, after flash
chromatography on silica gel (90:10 hexanes:ethyl acetate), the title compound (154.2
mg, 72%) as a yellow oil: TLC analysis Rf 0.6 (70:30 hexanes:ethyl acetate); 1H NMR
(400 MHz, CDCl3) δ 7.45–7.35 (2H, m, m,m’), 7.35–7.30 (2H, m, i,i’), 7.30–7.20 (2H,
m, j,n,n’,o), 7.15–7.05 (2H, m, h,h’), 5.70 (1H, d, J = 31.3 Hz, NH), 4.50–4.30 (2H, m,
k), 4.20–3.95 (1H, m, r), 2.55–2.40 (2H, m, b,e), 2.30–2.10 (2H, m, b,e), 1.85–1.70 (3H,
m, c,q), 1.44 (1H, dd, J = 13.8 and 11.7 Hz, q), 1.26 (6H, s, s,s’), 1.23 (3H, dd, J = 6.2
and 6.2 Hz, t), 1.35–1.15 (1H, m, d); 13C NMR (100 MHz, CDCl3) δ 176.77 and 176.71
(f), 144.13 and 144.04 (l), 138.83 and 138.82 (g), 128.54 (i,i’), 128.51 (n,n’), 127.31 and
127.25 (h,h’), 127.13 and 127.12 (m,m’), 127.07 and 127.06 (j), 126.70 and 126.68 (o),
70.50 and 70.47 (p), 64.64 and 64.59 (r), 60.18 and 60.15 (a), 45.92 and 45.87 (q), 43.57
and 43.52 (k), 39.17 and 39.03 (b), 37.65 and 37.61 (e), 31.26 and 31.24 (s,s’), 28.09 and
28.05 (d), 26.54 and 26.52 (c), 23.21 and 23.20 (t); IR (neat) 3339 (N-H stretch), 2970,
1645 (C=O stretch), 1600 (N-H bend), 1512 (C=C stretch, aromatic), 1300 (C-O stretch),
1207, 724, 696 cm-1.
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(1R,3S)-1-phenyl-N-((R)-1-phenylethyl)-3-(4,4,6-trimethyl-1,3,2dioxaborinan-2-yl)cyclopentane-1-carboxamide (26k). Following GP10 with 2 mol%
[Rh/2 (R)-B2], 2 equiv tmdBH and 26k (154 mg, 0.528 mmol) affords, after flash
chromatography on silica gel (90:10 hexanes:ethyl acetate), the title compound (173.1
mg, 78%) as a yellow oil: TLC analysis Rf 0.7 (70:30 hexanes:ethyl acetate); 1H NMR
(300 MHz, CDCl3) δ 7.40–7.20 (8H, m, f,g,h,h’,i,i’,j,m,m’,n,n’), 7.15–7.05 (2H, m, j,o),
5.47 (1H, dd, J = 11.2 and 1.9 Hz, NH), 5.15–5.00 (1H, m, k), 4.20–4.00 (1H, m, s),
2.50–2.30 (2H, m, b,e), 2.30–2.05 (2H, m, b,e), 1.85–1.70 (3H, m, c,r), 1.50–1.40 (1H, m,
r), 1.34 (3H, dd, J = 6.8 and 4.0 Hz, p), 1.25 (6H, s, t,t’), 1.23 (3H, d, J = 6.2 Hz, u),
1.30–1.20 (1H, m, d);

C NMR (75 MHz, CDCl3) δ 175.96 and 175.89 (f), 144.22 and

13

144.05 (l), 143.58 and 143.57 (g), 128.51 and 128.48 (i,i’), 128.42 (n,n’), 127.04 and
127.02 (h,h’), 126.95 (m,m’), 126.68 and 126.64 (j), 125.90 and 125.86 (o), 70.40 (q),
64.58 and 64.54 (s), 60.10 and 60.06 (a), 48.55 (k), 45.92 and 45.88 (r), 39.33 and 39.04
(b), 37.60 and 37.49 (e), 31.26 and 31.23 (t,t’), 28.07 and 28.03 (d), 26.55 (c), 23.23 and
23.19 (u), 21.75 and 21.69 (p); IR (neat) 3345 (N-H stretch), 2970, 2932, 1649 (C=O
stretch), 1600 (N-H bend), 1493 (C=C stretch, aromatic), 1446, 1300 (C-O stretch), 1207,
765, 697 cm-1.
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General procedure for CAHB-oxidation sequence with NaBO3/ H2O (GP11).

(S)-4-hydroxy-7-phenyl-heptanecarboxylic

acid

Weinreb

amide

(9c).

Following GP10 with 2 mol% [Rh/2 (R)-B1] and 7c (130 mg, 0.528 mmol) without
purification, the obtained residue was taken up in THF (1.5 mL and water (1.5 mL).
NaBO3-tetrahydrate (231 mg, 1.5 mmol) was added to the resultant mixture. After a 5h
vigorous stir, the reaction was dilute with water (3 mL) and EtOAc (5 mL). The organic
layer was separated and the aqueous layer was extract with EtOAc (2 x 3 mL). The
combined organic layers were dried (anhyd. Na2SO4) and concentrated under reduced
pressure affords, after flash chromatography on silica gel (80:20-20:80 hexanes:ethyl
acetate), the title compound (95 mg, 68%) as a colorless oil; TLC analysis R f 0.5 (0:100
hexanes:ethyl acetate); [α]D20 = –12.5o (c 2.0, CHCl3); er of 9c was determined by using
harsh oxidation (NaOH/H2O2) instead of NaBO3-tetrahydrate to form lactone 13 followed
by Al(Me)3-assisted transamidation with benzyl amine to generate 9b (GP1): Chiral
HPLC analysis (Chiralpak-IC, 60:40 hexanes:isopropanol, flow rate = 1.3 mL/min)
showed peaks at 26 minutes (4.0% (R)) and 30 minutes (96.0% (S)); 1H NMR (400 MHz,
CDCl3) δ 7.25–7.30 (2H, m, b,b’), 7.15–7.25 (3H, m, a,c,c’), 3.70 (3H, s, m), 3.60–3.70
(1H, m, h, overlapping with m), 3.20 (3H, s, l), 2.74 (1H, br s, OH), 2.66 (2H, t, J = 7.6
Hz, e), 2.50–2.70 (2H, m, j, overlapping with e), 1.80–1.90 (2H, m, f,i), 1.65–1.75 (2H,
m, f,i), 1.45–1.65 (2H, m, g);

13

C NMR (100 MHz, CDCl3) δ 175.19 (k), 142.55 (d),
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128.54 (b,b’), 128.38 (c,c’), 125.78 (a), 71.45 (h), 61.35 (m), 37.36 (g), 35.99 (e), 32.37
(l), 31.74 (i), 28.63 (j), 27.62 (f); IR (neat) 3430 (O-H stretch), 2933, 2858, 1639 (C=O
stretch), 1452, 1416, 1386, 1177, 994, 748, 699 cm-1; HRMS (ESI) calcd. for
C15H23NNaO3 (M+Na): 288.1576, found 288.1583 m/z.

(S)-4-hydroxy-7-phenyl-heptanecarboxylic acid morpholino amide (9d).
Following GP11 with 9d (144 mg, 0.528 mmol) affords, after flash chromatography on
silica

gel

(80:20-70:30

hexanes:ethyl

acetate,

then

switch

to

50:50-20:80

hexanes:acetone), the title compound (125 mg, 81%) as a colorless oil; TLC analysis R f
0.7 (20:80 hexanes:acetone); [α]D20 = –5.1o (c 2.0, CHCl3); er of 7c was determined by
boric acid-catalyzed transamidation with benzyl amine to form the corresponding benzyl
amide 9b:11 Chiral HPLC analysis (Chiralpak-IC, 60:40 hexanes:isopropanol, flow rate =
1.3 mL/min) showed peaks at 28 minutes (5.5 0% (R)) and 31 minutes (94.5% (S); 1H
NMR (400 MHz, CDCl3) δ 7.25–7.30 (2H, m, b,b’), 7.15–7.20 (3H, m, a,c,c’), 3.55–3.70
(7H, m, h,l,l’,m,m’), 3.40–3.50 (2H, m, l,l’), 2.64 (2H, t, J = 7.6 Hz, e), 2.46 (2H, t, J =
7.0 Hz, j), 1.75–1.90 (2H, m, f,i), 1.60–1.75 (2H, m, f,i), 1.45–1.60 (2H, m, g); 13C NMR
(100 MHz, CDCl3) δ 172.44 (k), 142.50 (d), 128.53 (b,b’), 128.39 (c,c’), 125.83 (a),
71.28 (h), 66.95 and 66.68 (m,m’), 46.11 and 42.14 (l,l’), 37.44 (g), 35.97 (e), 32.11 (i),
29.75 (j), 27.62 (f); IR (neat) 3418 (O-H stretch), 2919, 2855, 1622 (C=O stretch), 1432,
1271, 1232, 1114, 1068, 1031, 748, 699 cm-1; HRMS (ESI) calcd. for C17H25NNaO3
(M+Na): 314.1732, found 314.1743 m/z.
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(S)-4-benzyl-3-((2S,5R)-5-hydroxy-2,5-diphenylpentanoyl)oxazolidin-2-one

(21c).

Following GP11 with 1 mol% [Rh/2 (R)-B1] and 20c (109 mg, 0.264 mmol) affords,
after flash chromatography on silica gel (90:10 hexanes:ethyl acetate), the title compound
(58 mg, 51%) as a white solid; TLC analysis Rf 0.6 (70:30 hexanes:ethyl acetate);

1

H

NMR (400 MHz, CDCl3) δ 7.20–7.40 (15H, m, aryl), 5.09 (1H, t, J = 7.3 Hz, f), 4.74
(0.16H, t, J = 6.5 Hz, q), 4.70 (0.83H, t, J = 6.1 Hz, q), 4.55–4.65 (1H, m, j), 4.11 (1H,
dd, J = 9.0 and 2.2 Hz, g), 4.04 (1H, dd, J = 7.9 and 0 Hz, g), 3.38 (1H, dd, J = 13.3 and
3.2 Hz, e), 2.79 (1H, dd, J = 13.2 and 9.8 Hz, e), 2.30–2.40 (0.8H, m, o), 2.15–2.25
(0.2H, m, o), 1.95–2.05 (0.2H, m, o), 1.65–1.90 (2.8H, m, o,p);

13

C NMR (100 MHz,

CDCl3) δ 174.06 (i), 153.09 (h), 144.46, 138.52, 135.46, 129.55, 129.09, 128.80, 128.76,
128.65, 127.77, 127.56, 127.47, 126.03, 74.49 (q), 65.96 (g), 55.96 (f), 48.56 (j), 38.17
(e), 36. 80 (p), 30.51 (o).

(S)-4-benzyl-3-((2S,5S)-5-hydroxy-2,5-diphenylpentanoyl)oxazolidin-2-one (dia-21c).
Following GP11 with 1 mol% [Rh/2 (S)-B1] and 20c (109 mg, 0.264 mmol) affords,
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after flash chromatography on silica gel (90:10 hexanes:ethyl acetate), the title compound
(89 mg, 79%) as a white solid; TLC analysis Rf 0.6 (70:30 hexanes:ethyl acetate);

1

H

NMR (400 MHz, CDCl3) δ 7.20–7.40 (15H, m, aryl), 5.09 (1H, t, J = 7.6 Hz, f), 4.74
(0.92H, t, J = 6.5 Hz, q), 4.70 (0.08H, t, J = 6.3 Hz, q), 4.55–4.65 (1H, m, j), 4.12 (1H,
dd, J = 9.1 and 2.4 Hz, g), 4.05 (1H, dd, J = 7.8 and 0 Hz, g), 3.37 (1H, dd, J = 13.3 and
3.2 Hz, e), 2.79 (1H, dd, J = 13.3 and 9.8 Hz, e), 2.30–2.40 (0.08H, m, o), 2.15–2.25
(0.92H, m, o), 2.00–2.05 (0.92H, m, o), 1.65–1.90 (2.08H, m, o,p);

13

C NMR (100 MHz,

CDCl3) δ 174.07 (i), 153.14 (h), 144.51, 138.40, 135.43, 129.55, 129.09, 128.84, 128.78,
128.62, 127.70, 127.59, 127.48, 125.96, 73.96 (q), 66.03 (g), 55.95 (f), 48.43 (j), 38.16
(e), 36. 80773 (p), 30.33 (o).
General procedure for CAHB-oxidation sequence with H2O2 (GP12).

(S)-4-hydroxy-7-phenyl-heptanecarboxylic acid phenyl amide (9a). Following
GP10 with 7a (148 mg, 0.528 mmol) without purification, the resultant mixture was
diluted with THF (10 mL) followed by addition of methanol (8 mL), sodium hydroxide
(6 mL of a 3.0 M soln.), and the slow addition of H2O2 (1.0 mL of a 30% solution). The
resulting mixture stirred (2 h) and then extracted with dichloromethane (3 x 15 mL). The
combined organic extracts were dried (anhyd. Na2SO4) and concentrated under reduced
pressure. Flash chromatography on silica gel (90:10-40:60 hexanes:ethyl acetate) affords
the title compound (124 mg, 79%) as a white solid: m.p. 119.5–120.5 ºC; TLC analysis Rf
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0.3 (40:60 hexanes:ethyl acetate); [α]D20 = +7.5o (c 1.0, MeOH); Chiral HPLC analysis
(Chiralpak-IB, 70:30 hexanes:isopropanol, flow rate = 1.4 mL/min) showed peaks at 41
minutes (3.0% (R)) and 44 minutes (97.0% (S); 1H NMR (400 MHz, CDCl3) δ 7.70 (1H,
br s, NH), 7.51 (2H, d, J = 7.7 Hz, c,c’), 7.25–7.35 (4H, m, b,b’,m,m’), 7.15–7.25 (3H,
m, b,b’,n,n’,o), 7.12 (1H, t, J = 7.3 Hz, a), 3.60–3.80 (1H, m, h), 2.65 (2H, t, J = 7.8 Hz,
k), 2.45–2.60 (3H, m, f, OH), 1.90–2.00 (1H, m, g), 1.70–1.85 (3H, m, g,j), 1.50–1.60
(2H, m, i);

C NMR (100 MHz, CDCl3) δ 172.03 (e), 142.34 (l), 137.98 (d), 129.11

13

(b,b’), 128.53 (n,n’), 128.44 (m,m’), 125.90 (o), 124.43 (a), 120.02 (c,c’), 71.46 (h),
37.41 (i), 35.91 (k), 34.32 (f), 32.48 (g), 27.55 (j); IR (neat) 3670 (N-H stretch, O-H
stretch), 3279, 3247, 2950, 2911, 1659 (C=O stretch), 1600 (N-H bend), 1543, 1496,
1412 (C-N stretch), 754, 689 cm-1; HRMS (ESI) calcd. for C19H23NNaO2 (M+Na):
320.1626, found 320.1631 m/z.

(S)-4-hydroxy-7-phenyl-4-heptanecarboxylic

acid

benzyl

amide

(9b).

Following GP12 with (E)-7b (155 mg, 0.528 mmol) affords, after flash chromatography
on silica gel (80:20-20:80 hexanes:ethyl acetate), the title compound (131 mg, 80%) as a
white solid: m.p. 88.5–89.5 ºC; TLC analysis Rf 0.4 (0:100 hexanes:ethyl acetate); [α]D20
= –7.9o (c 1.0, CHCl3); Chiral HPLC analysis (Chiralpak-IC, 60:40 hexanes:isopropanol,
flow rate = 1.3 mL/min) showed peaks at 28 minutes (3.5% (R)) and 32 minutes (96.5%
(S); 1H NMR (400 MHz, CDCl3) δ 7.10–7.40 (10H, a,b,b’,c,c’,n,n’,o,o’,p), 6.28 (1H, br s,
NH), 4.40 (2H, d, J = 5.7 Hz, e), 3.55–3.70 (1H, m, i), 3.19 (1H, d, J = 4.2 Hz, OH), 2.64
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(2H, t, J = 7.6 Hz, l), 2.36 (2H, td, J = 7.3 and 2.8 Hz, g), 1.70–1.90 (2H, m, h,k), 1.60–
1.70 (2H, m, h,k), 1.40–1.60 (2H, m, j);

13

C NMR (100 MHz, CDCl3) δ 173.76 (f),

142.48 (m), 138.30 (d), 128.82 (b,b’), 128.54 (o,o’), 128.42 (n,n’), 127.89 (c,c’), 127.64
(a), 125.85 (p), 71.29 (i), 43.79 (e), 37.31 (j), 35.95 (l), 33.23 (g), 32.72 (h), 27.61 (k); IR
(neat) 3306 (N-H stretch, O-H stretch), 3025, 2937, 2919, 2867, 1637 (C=O stretch),
1546 (N-H bend), 1495, 1442, 1234, 724, 694 cm-1; HRMS (ESI) calcd. for
C20H25NNaO2 (M+Na): 334.1783, found 334.1781 m/z.
Following GP12 with (Z)-7b (155 mg, 0.528 mmol) affords, after flash
chromatography on silica gel (80:20-20:80 hexanes:ethyl acetate), the title compound
(128 mg, 78%) as a white solid: m.p. 88.0–99.5 ºC; TLC analysis Rf 0.4 (0:100
hexanes:ethyl acetate); [α]D20 = –7.8o (c 1.0, CHCl3); Chiral HPLC analysis (ChiralpakIC, 60:40 hexanes:isopropanol, flow rate = 1.3 mL/min) showed peaks at 27 minutes
(6.0% (R)) and 31 minutes (94.0% (S); spectroscopic data matched with (S)-9b obtained
from (E)-7b as shown above.

(S)-7-(furan-2-yl)-4-hydroxyheptanecarboxylic acid benzyl amide (7e).4
Following GP12 with 1.0 mol% [Rh(nbd)2BF4/ 2(R)-B1] and 7e (150 mg, 0.528 mmol)
affords, after flash chromatography on silica gel (80:20-20:80 hexanes:ethyl acetate), the
title compound (113 mg, 71%) as a light yellow solid: m.p. 72.5–74.0 ºC; TLC analysis

4

A pseudo-racemate was prepared for HPLC analysis by combining crude reactions mixtures obtained by
CAHB using (R)- and (S)-B1 then oxidizing and isolating the resulting alcohol
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Rf 0.35 (0:100 hexanes:ethyl acetate); [α]D20 = –6.1o (c 2.0, CHCl3); Chiral HPLC
analysis (Chiralpak-IB, 60:40 hexanes:isopropanol, flowrate = 1.4 mL/min) showed
peaks at 18 minutes (94.0% (S)) and 47 minutes (6.0% (R)); 1H NMR (400 MHz, CDCl3)
δ 7.20–7.40 (6H, a,b,b’,c,c’,p), 6.29 (1H, dd, J = 2.9 and 2.0 Hz, o), 6.26 (1H, br s, NH,
overlapping with o), 6.00 (1H, d, J = 3.0 Hz, n), 4.42 (2H, d, J = 5.7 Hz, e), 3.55–3.70
(1H, m, i), 2.85–3.45 (1H, br s, OH), 2.65 (2H, t, J = 7.4 Hz, l), 2.38 (2H, td, J = 7.2 and
3.4 Hz, g), 1.75–1.90 (2H, m, h,k), 1.60–1.75 (2H, m, h,k), 1.40–1.60 (2H, m, j);

13

C

NMR (100 MHz, CDCl3) δ 173.72 (f), 156.17 (m), 140.86 (p), 138.28 (d), 128.83 (b,b’),
127.90 (c,c’), 127.65 (a), 110.20 (o), 104.97 (n), 71.16 (i), 43.80 (e), 43.79 (e), 37.16 (j),
33.25 (g), 32.70 (h), 27.98 (l), 24.33 (k); IR (neat) 3288 (N-H stretch, O-H stretch), 2919,
1632 (C=O stretch), 1534, 1453, 1090, 1006, 723, 695 cm-1; HRMS (ESI) calcd. for
C18H23NNaO3 (M+Na): 324.1576, found 324.1573 m/z.

(S)-4-hydroxy-7-(thiophen-2-yl)-heptanecarboxylic acid benzyl amide (9f).5
Following GP12 with 1.0 mol% [Rh(nbd)2BF4/ 2(R)-B1] and 7f (158 mg, 0.528 mmol)
affords, after flash chromatography on silica gel (80:20-20:80 hexanes:ethyl acetate), the
title compound (121 mg, 72%) as a white solid: m.p. 73.5–74.5 ºC; TLC analysis Rf 0.35
(0:100 hexanes:ethyl acetate); [α]D20 = –4.7o (c 1.5, CHCl3); Chiral HPLC analysis
(Chiralpak-IB, 60:40 hexanes:isopropanol, flowrate = 1.4 mL/min) showed peaks at 28
minutes (94.0% (S)) and 109 minutes (6.0% (R)); 1H NMR (400 MHz, CDCl3) δ 7.35–
5

A pseudo-racemate was prepared for HPLC analysis by combining crude reactions mixtures obtained by
CAHB using (R)- and (S)-B1 then oxidizing and isolating the resulting alcohol
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7.40 (2H, b,b’), 7.25–7.35 (3H, a,c,c’), 7.12 (1H, dd, J = 5.1 and 1.0 Hz, p), 6.93 (1H, dd,
J = 5.0 and 3.4 Hz, o), 6.80 (1H, dd, J = 3.3 and 0.8 Hz, n), 6.16 (1H, br s, NH), 4.43
(2H, d, J = 5.7 Hz, e), 3.60–3.70 (1H, m, i), 2.86 (2H, t, J = 7.5 Hz, l), 2.39 (2H, td, J =
7.2 and 3.8 Hz, g), 1.80–1.90 (2H, m, h,k), 1.65–1.80 (2H, m, h,k), 1.45–1.60 (2H, m, j);
C NMR (100 MHz, CDCl3) δ 173.67 (f), 145.36 (m), 138.26 (d), 128.85 (b,b’), 127.92

13

(c,c’), 127.68 (a), 126.82 (o), 124.27 (n), 123.02 (p), 71.20 (i), 43.84 (e), 37.11 (j), 33.27
(g), 32.68 (h), 29.94 (l), 27.97 (k); IR (neat) 3291 (N-H stretch, O-H stretch), 2917, 2849,
1630 (C=O stretch), 1534, 1453, 691 cm-1; HRMS (ESI) calcd. for C18H23NNaO2S
(M+Na): 340.1347, found 340.1354 m/z.

(S)-7-(2,5-dimethyl-1H-pyrrol-1-yl)-4-hydroxyheptanecarboxylic acid benzyl
amide (9g).6 Following GP12 with 1.0 mol% [Rh(nbd)2BF4/ 2(R)-B1] and 7g (164 mg,
0.528 mmol) affords, after flash chromatography on silica gel (80:20-20:80 hexanes:ethyl
acetate), the title compound (102 mg, 59%) as a yellow oil; TLC analysis Rf 0.4 (0:100
hexanes:ethyl acetate); [α]D20 = –7.1o (c 1.8, CHCl3); Chiral HPLC analysis (ChiralpakIC, 60:40 hexanes:isopropanol, flowrate = 1.4 mL/min) showed peaks at 42 minutes
(8.0% (R)) and 54 minutes (92.0% (S)); 1H NMR (400 MHz, CDCl3) δ 7.25–7.40 (5H,
a,b,b’,c,c’), 6.10 (1H, br s, NH), 5.78 (2H, s, n,n’), 4.43 (2H, d, J = 5.7 Hz, e), 3.77 (2H,
t, J = 7.6 Hz, l), 3.55–3.70 (1H, m, i), 2.30–2.45 (2H, m, g), 2.24 (6H, s, o,o’), 1.75–1.90

6

A pseudo-racemate was prepared for HPLC analysis by combining crude reactions mixtures obtained by
CAHB using (R)- and (S)-B1 then oxidizing and isolating the resulting alcohol
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(2H, m, h,k), 1.65–1.75 (2H, m, h,k), 1.45–1.55 (2H, m, j); 13C NMR (100 MHz, CDCl3)
δ 173.61 (f), 138.17 (d), 128.87 (b,b’), 127.92 (c,c’), 127.72 (a), 127.48 (m,m’), 105.19
(n,n’), 71.14 (i), 43.87 (e), 43.60 (l), 34.82 (j), 33.22 (g), 32.66 (h), 27.36 (k), 12.68
(o,o’); IR (neat) 3285 (N-H stretch, O-H stretch), 2923, 1643 (C=O stretch), 1541, 1453,
1407, 1298, 742, 697 cm-1; HRMS (ESI) calcd. for C20H28N2NaO2 (M+Na): 351.2048,
found 351.2059 m/z.

(S)-4-hydroxy-6-methylheptanecarboxylic acid benzyl amide (9h). Following
GP12 with 7h (122 mg, 0.528 mmol) affords, after flash chromatography on silica gel
(80:20-20:80 hexanes:ethyl acetate), the title compound (88 mg, 67%) as a white solid:
m.p. 50.5–51.5 ºC; TLC analysis Rf 0.4 (0:100 hexanes:ethyl acetate); [α]D20 = –18.4o (c
2.0, CHCl3); Chiral HPLC analysis (Chiralpak-IC, 90:10 hexanes:isopropanol, flowrate =
1.4 mL/min) showed peaks at 96 minutes (3.0% (R)) and 103 minutes (97.0% (S)); 1H
NMR (400 MHz, CDCl3) δ 7.30–7.40 (2H, b,b’), 7.25–7.30 (3H, a,c,c’), 6.21 (1H, br s,
NH), 4.43 (2H, d, J = 5.7 Hz, e), 3.65–3.75 (1H, m, i), 2.60–3.00 (1H, br s, OH), 2.40
(2H, td, J = 7.6 and 2.6 Hz, g), 1.80–1.90 (1H, m, h), 1.70–1.80 (1H, m, k), 1.60–1.70
(1H, m, h), 1.40–1.50 (1H, m, j), 1.20–1.25 (1H, m, j), 0.92 (6H, dd, J = 6.2 and 5.4 Hz,
l,l’); 13C NMR (100 MHz, CDCl3) δ 173.70 (f), 138.34 (d), 128.82 (b,b’), 127.89 (c,c’),
127.63 (a), 69.42 (i), 47.04 (j), 43.79 (e), 33.26 (h), 33.24 (g), 24.73 (k), 23.47 and 22.28
(l.l’); IR (neat) 3284 (N-H stretch, O-H stretch), 2952, 2916, 2868, 1643 (C=O stretch),
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1546, 1453, 696 cm-1; HRMS (ESI) calcd. for C15H23NNaO2 (M+Na): 272.1626, found
272.1638 m/z.

(S)-4-hydroxy-7-methyloctanecarboxylic acid benzyl amide (9i). Following
GP12 with 7i (130 mg, 0.528 mmol) affords, after flash chromatography on silica gel
(80:20-20:80 hexanes:ethyl acetate), the title compound (104 mg, 75%) as a white solid:
m.p. 61.0–62.0 ºC; TLC analysis Rf 0.4 (0:100 hexanes:ethyl acetate); [α]D20 = –5.9o (c
2.0, CHCl3); Chiral HPLC analysis (Chiralcel-OD, 60:40 hexanes:isopropanol, flowrate =
1.0 mL/min) showed peaks at 11 minutes (96.5% (S)) and 16 minutes (3.5% (R)); 1H
NMR (400 MHz, CDCl3) δ 7.30–7.35 (2H, b,b’), 7.20–7.30 (a,c,c’), 6.49 (1H, br s, NH),
4.39 (2H, d, J = 5.7 Hz, e), 3.50–3.60 (1H, m, i), 3.26 (1H, br s, OH), 2.30–2.45 (2H, m,
g), 1.80–1.90 (1H, m, h), 1.60–1.70 (1H, m, h), 1.50–1.60 (1H, m, l), 1.40–1.50 (2H, m,
j), 1.25–1.35 (1H, m, k), 1.15–1.25 (1H, m, k) 0.89 (6H, dd, J = 6.6 and 1.6 Hz, m,m’);
C NMR (100 MHz, CDCl3) δ 173.90 (f), 138.36 (d), 128.78 (b,b’), 127.84 (c,c’),

13

127.57 (a), 71.72 (i), 43.72 (e), 35.60 (j), 34.97 (k), 33.23 (g), 32.75 (h), 28.20 (l), 22.76
and 22.68 (m,m’); IR (neat) 3452 (N-H stretch), 3294 (O-H stretch), 2951. 2931, 2901,
2868, 1615 (C=O stretch), 1545, 1454, 1249, 1063, 1029, 723, 692 cm-1; HRMS (ESI)
calcd. for C16H25NNaO2 (M+Na): 286.1783, found 286.1785 m/z.
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(4S,7S)-4-hydroxy-7,11-dimethyl-10-dodecenecarboxylic acid benzyl amide
((4S,7S)-9j). Following GP12 with 1.0 mol% [Rh(nbd)2BF4/ 2(R)-B2] and 7j (167 mg,
0.528 mmol) affords, after flash chromatography on silica gel (80:20-20:80 hexanes:ethyl
acetate), the title compound (137 mg, 78%) as a white solid: m.p. 72.0–73.0 ºC; TLC
analysis Rf 0.5 (0:100 hexanes:ethyl acetate); [α]D20 = –2.5o (c 1.0, CHCl3); 1H NMR (400
MHz, CDCl3) δ 7.20–7.40 (5H, a,b,b’,c,c’), 6.30 (1H, br s, NH), 5.11 (1H, t, J = 5.8 Hz,
p), 4.42 (2H, d, J = 5.5 Hz, e), 3.45–3.65 (1H, m, i), 3.05 (1H. br s, OH), 2.30–2.45 (2H,
m, g), 1.80–2.05 (3H, m, o,h), 1.70 (3H, s, r), 1.62 (3H, s, s), 1.20–1.50 (6H, m, h,j,l,n),
1.15–1.20 (2H, m, k), 0.89 (3H, d, J = 5.5 Hz, m); 13C NMR (100 MHz, CDCl3) δ 173.77
(f), 138.33 (d), 131.19 (q), 128.80 (b,b’), 127.88 (c,c’), 127.61 (a), 125.01 (p), 71.92
(major diastereomer, 92%, i), 71.82 (minor diastereomer, 8%, i), 43.78 (e), 37.19 (minor
diastereomer, 7%, l), 37.12 (major diastereomer, 93%, l), 35.29 (n), 33.26 (g), 32.99 (h),
32.65 (j and k overlapping), 25.83 (r), 25.64 (o), 19.67 (m), 17.77 (s); IR (neat) 3300 (NH stretch, O-H stretch), 2962, 2911, 2849, 1642 (C=O stretch), 1552, 1452, 1344, 1256,
695 cm-1; HRMS (ESI) calcd. for C21H33NNaO2 (M+Na): 354.2409, found 354.2414 m/z.

(4R,7S)-4-hydroxy-7,11-dimethyl-10-dodecenecarboxylic acid benzyl amide
((4R,7S)-9j). Following GP12 with 1.0 mol% [Rh(nbd)2BF4/ 2(S)-B2] and 7j (167 mg,
0.528 mmol) affords, after flash chromatography on silica gel (80:20-20:80 hexanes:ethyl
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acetate), the title compound (133 mg, 76%) as a white semi-solid; TLC analysis Rf 0.5
(0:100 hexanes:ethyl acetate); [α]D20 = +6.5o (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3)
δ 7.30–7.35 (2H, m, b,b’), 7.25–7.30 (3H, m, a,c,c’), 6.30 (1H, br s, NH), 5.11 (1H, t, J =
6.2 Hz, p), 4.42 (2H, d, J = 5.7 Hz, e), 3.45–3.70 (1H, m, i), 3.04 (1H. br s, OH), 2.30–
2.45 (2H, m, g), 1.80–2.05 (3H, m, o,h), 1.70 (3H, s, r), 1.62 (3H, s, s), 1.20–1.50 (7H, m,
h,j,k,l,n), 1.10–1.20 (1H, m, k), 0.89 (3H, d, J = 6.4 Hz, m); 13C NMR (100 MHz, CDCl3)
δ 173.77 (f), 138.33 (d), 131.19 (q), 128.80 (b,b’), 127.88 (c,c’), 127.61 (a), 125.02 (p),
71.92 (minor diastereomer, 7%, i), 71.82 (major diastereomer, 93%, i), 43.78 (e), 37.19
(major diastereomer, 92%, l), 37.12 (minor diastereomer, 8%, l), 35.28 (n), 33.29 (g),
32.94 (h), 32.75 k), 32.58 (j), 25.83 (r), 25.65 (o), 19.61 (m), 17.77 (s); IR (neat) 3271
(N-H stretch, O-H stretch), 2912, 2851, 1651 (C=O stretch), 1616, 1538 1453, 727, 694
cm-1; HRMS (ESI) calcd. for C21H33NNaO2 (M+Na): 354.2409, found 354.2412 m/z.

(S)-4-hydroxy-7((triisopropylsilyl)oxy)heptanecarboxylic acid benzyl amide
(9k). Following GP12 with 7k (206 mg, 0.528 mmol) affords, after flash chromatography
on silica gel (80:20-20:80 hexanes:ethyl acetate), the title compound (168 mg, 78%) as a
colorless oil; TLC analysis Rf 0.4 (20:80 hexanes:ethyl acetate); [α]D20 = +7.1o (c 2.0,
CHCl3); Chiral HPLC analysis (Chiralpak-IC, 80:20 hexanes:isopropanol, flowrate = 1.4
mL/min) showed peaks at 29 minutes (3.0% (R)) and 35 minutes (97.0% (S)); 1H NMR
(400 MHz, CDCl3) δ 7.30–7.35 (2H, b,b’), 7.25–7.30 (3H, a,c,c’), 6.28 (1H, br s, NH),
4.44 (2H, dd, J = 5.6 and 3.2 Hz, e), 3.70–3.85 (3H, m, l, OH), 3.60–3.70 (1H, m, i),
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2.42 (2H, t, J = 7.0 Hz, g), 1.85–1.95 (1H, m, h), 1.60–1.80 (4H, m, h,j,k), 1.50–1.60
(1H, m, j), 1.00–1.15 (3H, m, m,m’,m’’, overlapping with n,n’,n’’), 1.08 (18H, s,
n,n’,n’’);

13

C NMR (100 MHz, CDCl3) δ 173.61 (f), 138.48 (d), 128.77 (b,b’), 127.88

(c,c’), 127.54 (a), 71.14 (i), 63.95 (l), 43.74 (e), 35.37 (j), 33.46 (g), 32.89 (h), 29.60 (k),
18.08 (n,n’,n’’), 12.02 (m,m’,m’’); IR (neat) 3289 (N-H stretch, O-H stretch), 2941,
2864, 1644 (C=O stretch), 1548, 1454, 1097, 881, 679 cm-1; HRMS (ESI) calcd. for
C23H41NNaO3Si (M+Na): 430.2753, found 430.2763 m/z.

(S,S)-4-hydroxy-6-(2,2-dimethyl-1,3-dioxolan-4-yl)hexanecarboxylic

acid

benzyl amide ((S,S)-9l). Following GP12 with 1.0 mol% [Rh(nbd)2BF4/ 2(R)-B1] and 7l
(160 mg, 0.528 mmol) affords, after flash chromatography on silica gel (70:30-0:100
hexanes:ethyl acetate), the title compound (122 mg, 72%) as a colorless oil; TLC analysis
Rf 0.25 (0:100 hexanes:ethyl acetate); [α]D20 = +10.1o (c 1.0, CHCl3); 1H NMR (400
MHz, CDCl3) δ 7.30–7.35 (2H, m, b,b’), 7.25–7.30 (3H, m, a,c,c’), 6.27 (1H, br s, NH),
4.42 (2H, d, J = 5.7 Hz, e), 4.05–4.15 (1H, m, l), 4.05 (1H, dd, J = 6.0 and 6.0 Hz, m),
3.60–3.70 (1H, m, i), 3.53 (1H, dd, J = 7.5 and 7.5 Hz, m), 3.08 (1H. br s, OH), 2.40 (2H,
t, J = 6.6 Hz, g), 1.80–1.90 (1H, m, h), 1.60–1.80 (3H, m, h,k), 1.50–1.60 (2H, m, j), 1.41
(3H, s, o,o’), 1.36 (3H, s, o,o’);

13

C NMR (100 MHz, CDCl3) δ 173.62 (f), 138.32 (d),

128.81 (b,b’), 127.87 (c,c’), 127.61 (a), 109.08 (n), 76.22 (l), 71.17 (major diastereomer,
96%, i), 71.02 (minor diastereomer, 4%, i), 69.56 (major diastereomer, 96%, m), 69.54
(minor diastereomer, 4%, m), 43.78 (e), 34.19 (major diastereomer, 95%, j), 34.01 (minor
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diastereomer, 5%, j), 33.28 (g), 32.86 (h), 30.23 (k), 27.01 (o,o’), 25.83 (o,o’); IR (neat)
3298 (N-H stretch, O-H stretch), 2984, 2932, 2868, 1644 (C=O stretch), 1543, 1454,
1369, 1214, 1155, 1053, 698 cm-1; HRMS (ESI) calcd. for C18H27NNaO4 (M+Na):
344.1838, found 344.1847 m/z.

(S,S)-4-hydroxy-6-(2,2-dimethyl-1,3-dioxolan-4-yl)hexanecarboxylic

acid

benzyl amide ((S,S)-9l). Following GP12 with 1.0 mol% [Rh(nbd)2BF4/ 2(S)-B1] and 7l
(160 mg, 0.528 mmol) affords, after flash chromatography on silica gel (70:30-0:100
hexanes:ethyl acetate), the title compound (122 mg, 72%) as a colorless oil; TLC analysis
Rf 0.25 (0:100 hexanes:ethyl acetate); [α]D20 = +22.3o (c 1.0, CHCl3); 1H NMR (400
MHz, CDCl3) δ 7.30–7.35 (2H, m, b,b’), 7.20–7.30 (3H, m, a,c,c’), 6.44 (1H, br s, NH),
4.39 (2H, d, J = 5.7 Hz, e), 4.05–4.15 (1H, m, l), 4.02 (1H, dd, J = 7.6 and 7.6 Hz, m),
3.55–3.75 (2H, m, i, OH), 3.50 (1H, dd, J = 7.2 and 7.2 Hz, m), 2.36 (1H, t, J = 6.0 Hz,
g), 1.80–1.90 (1H, m, h), 1.55–1.80 (4H, m, h,j,k), 1.45–1.50 (1H, m, j), 1.40 (3H, s,
o,o’), 1.35 (3H, s, o,o’);

13

C NMR (100 MHz, CDCl3) δ 173.68 (f), 138.28 (d), 128.75

(b,b’), 127.79 (c,c’), 127.55 (a), 108.93 (n), 76.21 (l), 71.06 (minor diastereomer, 5%, i),
70.95 (major diastereomer, 95%, i), 69.61 (minor diastereomer, 5%, m), 69.51 (major
diastereomer, 95%, m), 43.69 (e), 34.19 (minor diastereomer, 0%, j), 33.94 (major
diastereomer, 100%, j), 33.18 (g), 32.73 (h), 29.79 (k), 26.99 (o,o’), 25.79 (o,o’); IR
(neat) 3294 (N-H stretch, O-H stretch), 2984, 2931, 2869, 1644 (C=O stretch), 1542,
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1454, 1369, 1214, 1054, 698 cm-1; HRMS (ESI) calcd. for C18H27NNaO4 (M+Na):
344.1838, found 344.1851 m/z.

(R,S)-5-(2,2-dimethyl-1,3-dioxolan-4-yl)-4hydroxypentanecarboxylic

acid

benzyl amide ((R,S)-9m). Following GP12 with 1.0 mol% [Rh(nbd)2BF4/ 2(S)-B1] and
7m (153 mg, 0.528 mmol) affords, after flash chromatography on silica gel (70:30-0:100
hexanes:ethyl acetate), the title compound (114 mg, 70%) as a colorless oil; TLC analysis
Rf 0.25 (0:100 hexanes:ethyl acetate); [α]D20 = –3.5o (c 1.0, CHCl3); 1H NMR (400 MHz,
CDCl3) δ 7.30–7.35 (2H, m, b,b’), 7.20–7.30 (3H, m, a,c,c’), 6.37 (1H, br s, NH), 4.40
(2H, d, J = 5.7 Hz, e), 4.25–4.35 (1H, m, k), 4.07 (1H, dd, J = 8.0 and 6.1 Hz, l), 3.80–
3.90 (1H, m, i), 3.55 (1H, dd, J = 7.8 and 7.8 Hz, l), 2.39 (1H, t, J = 6.9 Hz, g), 1.80–1.90
(1H, m, h), 1.60–1.80 (3H, m, h,j), 1.40 (3H, s, n,n’), 1.35 (3H, s, n,n’);

13

C NMR (100

MHz, CDCl3) δ 173.60 (f), 138.27 (d), 128.81 (b,b’), 127.86 (c,c’), 127.62 (a), 108.81
(m), 73.79 (k), 69.66 (major diastereomer, 92%, i), 69.49 (minor diastereomer, 8%, i),
68.58 (l), 43.77 (e), 40.67 (minor diastereomer, 7%, j), 40.56 (major diastereomer, 93%,
j), 33.15 (g), 33.08 (h), 27.03 (n,n’), 25.78 (n,n’); IR (neat) 3304 (N-H stretch, O-H
stretch), 2984, 2935, 2873, 1644 (C=O stretch), 1542, 1454, 1369, 1214, 1155, 1052, 698
cm-1; HRMS (ESI) calcd. for C17H25NNaO4 (M+Na): 330.1681, found 330.1690 m/z.
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(S)-4-hydroxy-hexanecarboxylic acid benzyl amide (9n). Following GP12 with
7n (107 mg, 0.528 mmol) affords, after flash chromatography on silica gel (80:20-20:80
hexanes:ethyl acetate), the title compound (71 mg, 61%) as a white solid: m.p. 63.5–64.5
o

C; TLC analysis Rf 0.4 (0:100 hexanes:ethyl acetate); [α]D20 = +5.3o (c 1.44, CHCl3); 1H

NMR (300 MHz, CDCl3) δ 7.20–7.40 (5H, m, a,b,b’,c,c’), 6.48 (1H, br s, NH), 4.40 (2H,
d, J = 5.2 Hz, e), 3.40–3.60 (1H, m, i), 3.21 (1H, br s, OH), 2.37 (2H, t, J = 6.5 Hz, g)
1.75–1.95 (1H, m, h), 1.55–1.75 (1H, m, h), 1.40–1.55 (2H, m, j), 0.93 (3H, t, J = 7.2 Hz,
k);

13

C NMR (75 MHz, CDCl3) δ 173.80 (f), 138.24 (d), 128.67 (b,b’), 127.74 (c,c’),

127.46 (a), 72.67 (i), 43.62 (e), 33.12 (g), 32.16 (h), 30.40 (j), 10.02 (k); IR (neat) 3280
(N-H stretch, O-H stretch), 2964, 2920, 2877, 1631 (C=O stretch), 1549 (N-H bend),
1493, 1326, 1264, 936, 729, 693 cm-1; HRMS (ESI) calcd. for C13H19NNaO2 (M+Na):
244.1313, found 244.1316 m/z.
Er of 7n was determined by 19F NMR of the corresponding Mosher ester (S,S)-14:
19

F NMR (376 MHz, CDCl3) δ –71.01 (s, 5%, minor, CF3), –71.08 (s, 95%, major, CF3);

see GP13 vide infra.

(R)-5-hydroxy-5-phenyl-N-((R)-1-phenylethyl)pentanamide (21a). Following
GP12 with 20a (74 mg, 0.264 mmol) affords, after flash chromatography on silica gel
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(80:20-20:80 hexanes:ethyl acetate), the title compound (64 mg, 82%) as a white solid;
TLC analysis Rf 0.4 (0:100 hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.20–
7.40 (10H, m, aryl), 6.05 (1H, d, J = 7.6 Hz, NH), 5.05–5.15 (1H, m, e), 4.60–4.70 (1H,
m, j), 2.60–3.10 (1H, br s, OH), 2.10–2.30 (2H, m, g), 1.60–1.80 (4H, m, h,i), 1.47 (3H,
d, J = 6.9 Hz, q);

13

C NMR (100 MHz, CDCl3) δ 172.24 (f), 144.92 (m), 143.40 (d),

128.77, 128.53, 127.53, 127.43, 126.31, 125.92, 74. 02 (j), 48.78 (e), 38.52 (i), 36. 29 (g),
22.02 (minor q, 5.5%), 21.97 (major q, 94.5%), 21.86 (h).

(S)-5-hydroxy-5-phenyl-N-((R)-1-phenylethyl)pentanamide

(dia-21a).

Following GP12 with (S)-B1 and 20a (74 mg, 0.264 mmol) affords, after flash
chromatography on silica gel (80:20-20:80 hexanes:ethyl acetate), the title compound (62
mg, 80%) as a white solid; TLC analysis Rf 0.4 (0:100 hexanes:ethyl acetate); 1H NMR
(400 MHz, CDCl3) δ 7.20–7.40 (10H, m, aryl), 6.04 (1H, d, J = 7.6 Hz, NH), 5.05–5.15
(1H, m, e), 4.60–4.70 (1H, m, j), 2.60–3.10 (1H, br s, OH), 2.21 (2H, t, J = 6.6 Hz, g),
1.60–1.85 (4H, m, h,i), 1.47 (3H, d, J = 6.9 Hz, q);

13

C NMR (100 MHz, CDCl3) δ

172.23 (f), 144.90 (m), 143.39 (d), 128.76, 128.53, 127.53, 127.43, 126.32, 125.91, 74.
07 (j), 48.78 (e), 38.50 (i), 36. 33 (g), 22.02 (major q, 9.0%), 21.96 (major q, 91%), 21.86
(h).
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(2R,5R)-5-hydroxy-2-methyl-5-phenylpentanecarboxylic acid benzyl amide
(21b). Following GP12 with 20b (74 mg, 0.264 mmol) affords, after flash
chromatography on silica gel (80:20-20:80 hexanes:ethyl acetate), the title compound (62
mg, 79%) as a white solid; TLC analysis Rf 0.4 (0:100 hexanes:ethyl acetate); 1H NMR
(400 MHz, CDCl3) δ 7.20–7.35 (10H, m, aryl), 6.206.25 (br s, minor 8.0%, NH), 6.05–
6.20 (br s, major 92%, NH), 4.63 (1H, t, J = 6.2 Hz, j), 4.38 (2H, d, J = 5.7 Hz, e), 2.90
(1H, br s, OH), 2.20–2.30 (1H, m, g), 1.70–1.90 (3H, m, h,i), 1.55–1.65 (0.08H, m, minor
i), 1.35–1.45 (0.92H, m, major i), 1.13 (3H, d, J = 6.9 Hz, q);

13

C NMR (100 MHz,

CDCl3) δ 176.46 (f), 144.88 (m), 138.61 (d), 128.78, 128.52, 127.87, 127.54, 127.53,
125.97, 74.31 (j), 43.49 (e), 41.27 (g), 36.95 (i), 30.42 (h), 18.16 (q).

(2R,5S)-5-hydroxy-2-methyl-5-phenylpentanecarboxylic acid benzyl amide
(dia-21b). Following GP12 with (S)-B1 and 20b (74 mg, 0.264 mmol) affords, after flash
chromatography on silica gel (80:20-20:80 hexanes:ethyl acetate), the title compound (62
mg, 79%) as a white solid; TLC analysis Rf 0.4 (0:100 hexanes:ethyl acetate); 1H NMR
(400 MHz, CDCl3) δ 7.20–7.35 (10H, m, aryl), 6.10–6.20 (br s, major 91.0%, NH), 6.05–
6.10 (br s, minor 9.0%, NH), 4.60–4.65 (1H, m, j), 4.39 (2H, d, J = 5.6 Hz, e), 2.82 (1H,
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br s, OH), 2.20–2.35 (1H, m, g), 1.65–1.80 (3H, m, h,i), 1.50–1.65 (0.91H, m, major i),
1.35–1.45 (0.09H, m, minor i), 1.15 (3H, d, J = 6.8 Hz, q); 13C NMR (100 MHz, CDCl3)
δ 176.54 (f), 144.97 (m), 138.61 (d), 128.79, 128.53, 127.90, 127.53, 127.53, 125.87,
74.35 (j), 43.51 (e), 41.16 (g), 36.91 (i), 30.82 (h), 18.24 (q).

(1R,3S)-3-hydroxycyclopentanecarboxylic acid phenyl amide (26a). Following
GP12 with 1.0 mol% [Rh(nbd)2BF4/ 2(R)-B2], 2 equiv tmdBH, and 23a (99.1 mg, 0.528
mmol), affords, after flash chromatography on silica gel (80–40:20–60 hexanes:ethyl
acetate) affords the title compound (86.7 mg, 80%) as a white solid: mp 100.5–102.5 ºC;
TLC analysis Rf 0.4 (50:50 hexanes:ethyl acetate); [α]D20 = -14o (c 1.0, CHCl3); Chiral
HPLC analysis (Chiralpak-IC, 80:20 hexanes:isopropanol, flow rate = 1.0 mL/min)
showed peaks at 56 minutes (3.0% (1S,3R)) and 64 minutes (97.0% (1R,3S); 1H NMR
(400 MHz, CDCl3) δ 8.84 (1H, br s, NH), 7.54 (2H, d, J = 7.9 Hz, h,h’), 7.31 (2H, t, J =
7.8 Hz, i,i’), 7.11 (1H, t, J = 7.3 Hz, j), 4.56 (1H, d, J = 6.6 Hz, d), 4.40 (1H, br s, OH),
3.05–2.90 (1H, m, a), 2.20–1.90 (5H, m, b,c,e), 1.80–1.65 (1H, m, c);

13

C NMR (100

MHz, CDCl3) δ 177.41 (f), 138.18 (a), 128.93 (i,i’), 124.32 (j), 120.11 (h,h’), 73.89 (d),
45.28 (a), 38.94 (e), 36.50 (b), 29.20 (c); IR (neat) 3677 (N-H stretch, O-H stretch), 2907,
2803, 1728 (C=O stretch), 1663, 1597 (N-H bend), 1565, 1389 (C-N stretch), 1238 (COH bend), 1050 (C-OH stretch) cm-1; HRMS (ESI) calcd. for C12H15NNaO2 (M+Na):
228.1000, found 228.1002 m/z.
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(1R, 3S)-3-hydroxy-1-methylcyclopentanecarboxylic acid phenyl amide (26b).
Following GP12 with 1.0 mol% [Rh(nbd)2BF4/ 2(R)-B2], 2 equiv tmdBH, and 23b
(106.4 mg, 0.528 mmol) affords, after flash chromatography on silica gel (85:15
dichloromethane:ethyl acetate), the title compound (76.2 mg, 65 %) as a white solid: mp
91.0–93.5 ºC; TLC analysis Rf 0.5 (80:20 dichloromethane:ethyl acetate); [α]D20 = -13o (c
0.7, CHCl3); Chiral HPLC analysis (Chiralcel-OD, 90:10 hexanes:isopropanol, flow rate
= 1.3 mL/min) showed peaks at 87 minutes (96.0% (1R,3S)) and 105 minutes (4.0%
(1S,3R)); 1H NMR (400 MHz, CDCl3) δ 8.94 (1H, br s, NH), 7.54 (2H, d, J = 7.6 Hz,
h,h’), 7.31 (2H, t, J = 7.5 Hz, i,i’), 7.08 (1H, t, J = 7.4 Hz, j), 4.55 (1H, s, d), 3.44 (1H, br
s, OH), 2.40 (1H, ddd, J = 18.8 Hz, 10.9 Hz, 7.9 Hz, b), 2.31 (1H, dd, J = 14.9 Hz, 1.6
Hz, e), 2.00–1.85 (2H, m, c), 1.80–1.70 (2H, m, b,e), 1.37 (3H, s, k);

13

C NMR (100

MHz, CDCl3) δ 178.32 (f), 138.78 (g), 128.88 (i,i’), 123.78 (j), 119.64 (h,h’), 75.18 (d),
48.98 (a), 47.64 (e), 38.52 (b), 36.03 (c), 25.91 (k); IR (neat) 3318 (O-H stretch, N-H
stretch), 2962, 2901, 1663 (C=O stretch), 1536 (C-OH bend), 1495, 1434, 1311 (C-N
stretch), 657 cm-1; HRMS (CI) calcd. for C13H18NO2 (M+H): 220.1338, found 220.1346
m/z.
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(1R, 3S)-3-hydroxy-1-phenylcyclopentanecarboxylic acid phenyl amide (26c).
Following GP12 with 1.0 mol% [Rh(nbd)2BF4/ 2(R)-B2], 2 equiv tmdBH, and 23c (139.2
mg, 0.528 mmol) affords, after flash chromatography on silica gel (85:15
dichloromethane:ethyl acetate), the title compound (106.7 mg, 72 %) as a white solid: mp
113.5–114.5 ºC; TLC analysis Rf 0.5 (80:20 dichloromethane:ethyl acetate); [α]D20 = -43o
(c 0.8, CHCl3); Chiral HPLC analysis (Chiralcel-OD, 60:40 hexanes:isopropanol,
flowrate = 1.4 mL/min) showed peaks at 14 minutes (96.0% (1R,3S)) and 22 minutes
(4.0% (1S,3R)); 1H NMR (400 MHz, CDCl3) δ 7.50–7.40 (4H, m, h,h’,i,i’), 7.40–7.35
(1H, m, j), 7.40–7.35 (4H, m, l,l’,m,m’), 7.15–7.05 (2H, m, n,NH), 4.47 (2H, br s, d,OH),
2.80 (1H, d, J = 14.2 Hz, e), 2.75–2.60 (1H, m, b), 2.40–2.30 (1H, m, b), 2.30–2.20 (2H,
m, c,e), 2.00–1.90 (1H, m, c);

C NMR (100 MHz, CDCl3) δ 177.02 (f), 143.60 (k),

13

137.42 (g), 129.34 (i,i’), 128.96 (m,m’), 127.81 (j), 127.19 (l,l’), 124.74 (n), 120.15
(h,h’), 73.01 (d), 59.39 (a), 47.12 (e), 36.33 (b), 36.01 (c); IR (neat) 3492 (O-H stretch),
3400 (N-H stretch), 2896, 1668 (C=O stretch), 1596 (C-=C stretch), 1522 (C-OH bend),
1492, 1437, 1311 (C-N stretch), 1033, 751, 733, 691 cm-1; HRMS (ESI) calcd. for
C18H19NNaO2 (M+Na): 304.1313, found 304.1299 m/z.
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(1S, 3S)-3-hydroxy-1-(trifluoromethyl)cyclopentanecarboxylic acid phenyl
amide (26d). Following GP12 with 1.0 mol% [Rh(nbd)2BF4/ 2(R)-B2], 2 equiv tmdBH,
and 23d (135.2 mg, 0.528 mmol) affords, after flash chromatography on silica gel (90:10
dichloromethane:ethyl acetate), the title compound (111.9 mg, 78 %) as a white solid: mp
129.0–130.5 ºC; TLC analysis Rf 0.75 (80:20 dichloromethane:ethyl acetate); [α]D20 = 22o (c 1.3, CHCl3); Chiral HPLC analysis (Chiralpak-IC with OD guard column, 80:20
hexanes:isopropanol, flowrate = 1.0 mL/min) showed peaks at 14 minutes (97.0%
(1S,3S)) and 21 minutes (3.0% (1R,3R));

19

F NMR (282 MHz, CDCl3) δ -71.94; 1H NMR

(300 MHz, CDCl3) δ 9.53 (1H, br s, NH), 7.49 (2H, d, J = 7.6 Hz, h,h’), 7.30 (2H, t, J =
7.5 Hz, i,i’), 7.11 (1H, t, J = 7.4 Hz, j), 4.65 (1H, s, d), 3.88 (1H, br s, OH), 2.55–2.25
(4H, m, b,e), 2.10–1.95 (1H, m, c), 1.95–1.80 (1H, m, c); 13C NMR (75 MHz, CDCl3) δ
170.51 (f), 137.92 (g), 128.95 (i,i’), 127.3 (q, J = 279 Hz, k), 124.52 (j), 120.00 (h,h’),
74.16 (d), 58.58 (q, J = 24 Hz, a), 40.88 (e), 36.20 (c), 32.21 (b); IR (neat) 3416 (O-H
stretch), 3263 (N-H stretch), 3089, 2376, 1669 (C=O stretch), 1624, 1599 (C-=C stretch),
1567 (C-OH bend), 1450, 1157, 1131, 752, 692, 653 cm-1; HRMS (ESI) calcd. for
C13H14F3NNaO2 (M+Na): 296.0874, found 296.0870 m/z.
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(1R,3S)-3-hydroxycyclopentanecarboxylic acid benzyl amide (26e). Following
GP12 with 1.0 mol% [Rh(nbd)2BF4/ 2(R)-B2], 2 equiv tmdBH, and 23e (106.3 mg, 0.528
mmol) affords, after flash chromatography on silica gel (80–30:20–70 hexanes:ethyl
acetate), the title compound (80.0 mg, 69 %) as a white solid: mp 115.5–116.0 ºC; TLC
analysis Rf 0.3 (20:80 hexanes:ethyl acetate); [α]D20 = -12o (c 1.4, CHCl3); chiral HPLC
analysis determined by converting to the corresponding phenyl amide 26a using boric
acid-catalyzed transamidation;23 Chiralpak-IC, 80:20 hexanes:isopropanol, flow rate = 1.4
mL/min, showed peaks at 40 minutes (6.0% (1S,3R)) and 45 minutes (94.0% (1R,3S)). 1H
NMR (300 MHz, CDCl3) δ 7.40–7.20 (5H, m, h,h’,i,i’,j), 6.27 (1H, br s, NH), 4.45 (2H,
d, J = 5.7 Hz, k), 4.40–4.25 (2H, m, d,OH), 2.85–2.70 (1H, m, a), 2.20–1.80 (5H, m,
b,c,e), 1.80–1.60 (1H, m, c); 13C NMR (75 MHz, CDCl3) δ 178.42 (f), 138.02 (g), 128.78
(i,i’), 127.74 (h,h’), 127.61 (j), 73.65 (d), 44.09 (a), 43.87 (k), 38.99 (e), 36.56 (c), 28.93
(b); IR (neat) 3259 (O-H stretch), 3085 (N-H stretch), 2937, 1634 (C=O stretch), 1573,
1551 (C=C stretch), 1233, 1001, 752, 727, 700 cm-1; HRMS (ESI) calcd. for
C13H17NaNO2 (M+Na): 242.1157, found 242.1153 m/z.

(1R, 3S)-3-hydroxy-1-methylcyclopentanecarboxylic acid benzyl amide (26f).
Following GP12 with 1.0 mol% [Rh(nbd)2BF4/ 2(R)-B2], 2 equiv tmdBH, and 23f (114.0
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mg, 0.528 mmol) affords, after flash chromatography on silica gel (85:15
dichloromethane:ethyl acetate), the title compound (76.4 mg, 62 %) as a colorless oil:
TLC analysis Rf 0.4 (80:20 dichloromethane:ethyl acetate); [α]D20 = -12o (c 1.6, CHCl3);
chiral HPLC analysis determined by converting to the corresponding phenyl amide 26b
using boric acid-catalyzed transamidation;23 Chiral HPLC analysis (Chiralcel-OD, 90:10
hexanes:isopropanol, flow rate = 1.3 mL/min) showed peaks at 87 minutes (92.0%
(1R,3S)) and 105 minutes (8.0% (1S,3R)); 1H NMR (300 MHz, CDCl3) δ 7.40–7.20 (5H,
m, h,h’,i,i’,j), 6.60 (1H, br s, NH), 4.47 (2H, d, J = 5.6 Hz, k), 4.45–4.35 (1H, m, d), 4.00
(1H, d, J = 7.2 Hz, OH), 2.40–2.15 (2H, m, b,e), 1.95–1.80 (2H, m, c), 1.75–1.60 (2H, m,
b,e), 1.32 (3H, s, l);

13

C NMR (75 MHz, CDCl3) δ 180.08 (f), 138.35 (g), 128.74 (i,i’),

127.61 (j), 127.47 (h,h’), 74.59 (d), 48.18 (e), 47.81 (a), 43.89 (k), 38.29 (b), 36.21 (c),
25.66 (l); IR (neat) 3299 (O-H stretch, N-H stretch), 2958, 1636 (C=O stretch), 1535 (C=C stretch), 1453 (C-OH bend), 1227, 1190, 961, 721, 696 cm-1; HRMS (ESI) calcd. for
C14H19NaNO2 (M+Na): 256.1313, found 256.1325 m/z.

(1R, 3S)-3-hydroxy-1-phenylcyclopentanecarboxylic acid benzyl amide (26g).
Following GP12 with 1.0 mol% [Rh(nbd)2BF4/ 2(R)-B2], 2 equiv tmdBH, and 26g
(146.5 mg, 0.528 mmol) affords, after flash chromatography on silica gel (85:15
dichloromethane:ethyl acetate), the title compound (109.3 mg, 70 %) as a white solid: mp
91.0–93.5 ºC; TLC analysis Rf 0.4 (80:20 dichloromethane:ethyl acetate); [α]D20 = -45o (c
1.3, CHCl3); Chiral HPLC analysis (Chiralpak-AD, 70:30 hexanes:isopropanol, flowrate
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= 1.0 mL/min) showed peaks at 15 minutes (93.0% (1R,3S)) and 20 minutes (7.0%
(1S,3R)); 1H NMR (400 MHz, CDCl3) δ 7.45–7.30 (4H, m, i,i’,n,n’), 7.35–7.25 (4H, m,
h,h’,j,o), 7.08 (2H, d, J = 6.5 Hz, m,m’), 5.61 (2H, br s, NH), 4.70 (1H, d, J = 10.1 Hz,
OH), 4.45–4.35 (2H, m, d,k), 4.33 (1H, dd, J = 15.2 and 5.8 Hz, k), 2.75 (1H, dd, J =
14.1 and 1.3 Hz, e), 2.65–2.55 (1H, m, b), 2.35–2.25 (1H, m, b), 2.25–2.10 (1H, m, c,e),
2.00–1.90 (1H, m, c); 13C NMR (100 MHz, CDCl3) δ 178.88 (f), 143.95 (l), 137.96 (g),
129.11 (i,i’), 128.67 (n,n’), 127.52 (h,h’), 127.41 (j), 127.17 (o), 127.01 (m,m’), 73.02
(d), 58.46 (a), 47.14 (e), 43.81 (k), 36.35 (b), 36.11 (c); IR (neat) 3316 (O-H stretch, N-H
stretch), 1638 (C=O stretch), 1532 (C-OH bend), 1494, 1450, 1282, 1062, 1027, 992,
743, 719, 697, 662 cm-1; HRMS (ESI) calcd. for C19H21NaNO2 (M+Na): 318.1470, found
318.1456 m/z.

(1S, 3S)-3-hydroxy-1-(trifluoromethyl)cyclopentanecarboxylic acid benzyl
amide (26hh). Following GP12 with 1.0 mol% [Rh(nbd)2BF4/ 2(R)-B2], 2 equiv tmdBH,
and 23h (142.2 mg, 0.528 mmol) affords, after flash chromatography on silica gel (85:15
dichloromethane:ethyl acetate), the title compound (107.8 mg, 71 %) as a white solid: mp
100.5–102.0 ºC; TLC analysis Rf 0.5 (80:20 dichloromethane:ethyl acetate); [α]D20 = -16o
(c 1.3, CHCl3); Chiral HPLC analysis (Chiralcel-OD, 70:30 hexanes:isopropanol,
flowrate = 1.0 mL/min) showed peaks at 12 minutes (3.5% (1R,3R)) and 18 minutes
(96.5% (1S,3S));

19

F NMR (282 MHz, CDCl3) δ -71.04 (s, CF3); 1H NMR (300 MHz,

CDCl3) δ 7.45–7.20 (5H, m, h,h’,i,i’,j), 7.09 (1H, br s, NH), 4.60–4.40 (3H, m, d,k), 3.71
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(1H, br s, OH), 2.50–2.15 (4H, m, b,e), 2.20–1.80 (2H, m, c);

13

C NMR (75 MHz,

CDCl3) δ 171.70 (f), 137.58 (g), 129.29 (l), 128.80 (i,i’), 127.62 (j), 127.44 (h,h’), 73.57
(d), 57.96 (q, J = 24.5 Hz, a), 44.04 (k), 40.74 (e), 36.18 (c), 31.70 (b); IR (neat) 3421
(O-H stretch), 3311 (N-H stretch), 3269, 3084, 2944, 2360, 1657 (C=O stretch), 1526 (COH bend), 1455, 1362, 1301 (C-N stretch), 1169, 1123, 746, 696, 648 cm-1; HRMS (ESI)
calcd. for C14H16F3NaNO2 (M+Na): 310.1031, found 310.1026 m/z.

(1R,3S)-3-hydroxy-1-phenyl-N-((R)-1-phenylethyl)cyclopentane-1carboxamide (26k). Following GP12 with 2.0 mol% [Rh(nbd)2BF4/ 2(R)-B2], 2 equiv
tmdBH, and 23k (154.2 mg, 0.528 mmol) affords, after flash chromatography on silica
gel (85:15 dichloromethane:ethyl acetate), the title compound (124.3 mg, 76 %) as a
white solid: mp 98.5–99.5 ºC; TLC analysis Rf 0.5 (80:20 dichloromethane:ethyl acetate);
[α]D20 = -80o (c 1.3, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.45–7.35 (2H, m, i,i’), 7.35–
7.30 (3H, m, j,n,n’), 7.30–7.20 (3H, m, h,h’,o), 6.99 (2H, d, J = 7.3 Hz, m,m’), 5.47 (1H,
d, J = 6.9 Hz, NH), 5.05–4.95 (1H, m, k), 4.62 (1H, d, J = 10.0 Hz, OH), 4.45–4.35 (1H,
m, d), 2.67 (1H, d, J = 14.2 Hz, e), 2.60–2.50 (1H, m, b), 2.35–2.25 (1H, m, b), 2.25–2.15
(1H, m, c), 2.10 (1H, d, J = 14.1 Hz and 6.8 Hz, e), 2.20–1.85 (1H, m, c), 1.34 (2.63H, d,
J = 6.9 Hz, p major), 1.28 (0.33H, d, J = 6.7 Hz, p minor); the peaks at 1.34 and 1.28
ppm are used to determined the diastereoselectivity (88:12 major:minor); 13C NMR (100
MHz, CDCl3) δ 177.84 (f), 143.99 (l), 143.00 (g), 129.04 (i,i’), 128.56 (n,n’), 127.46
(h,h’), 127.17 (j), 127.06 (o), 125.53 (m,m’), 72.84 (d), 58.43 (a), 49.16 (k), 46.86 (e),

276

36.12 (b), 35.99 (c), 22.00 (p, major), 21.69 (p, minor); IR (neat) 3368 (O-H stretch, N-H
stretch), 1633 (C=O stretch), 1540 (C-=C stretch), 1493, 1445, 1096, 760, 736, 695 cm-1;
HRMS (ESI) calcd. for C20H23NaNO2 (M+Na): 332.1626, found 332.1619 m/z.

(1S,3S)-3-hydroxy-1-((E)-5-phenylpent-2-en-1-yl)cyclopentanecarboxylic acid
phenyl amide (26j). Following GP12 with 2.0 mol% [Rh(nbd)2BF4/ 2(R)-B2], 2 equiv
tmdBH, and 26j (175.0 mg, 0.528 mmol) affords, after flash chromatography on silica gel
(90:10 dichloromethane:ethyl acetate), the title compound (147.9 mg, 80%) as a light
yellow oil: TLC analysis Rf 0.75 (80:20 dichloromethane:ethyl acetate); [α]D20 = +17o (c
1.8, CHCl3); Chiral HPLC analysis (Chiralpak-ASH with OD guard column, 70:30
hexanes:isopropanol, flowrate = 1.0 mL/min) showed peaks at 15 minutes (99.0%
(1S,3S)) and 20 minutes (1.0% (1R,3R));

1

H NMR (400 MHz, CDCl3) δ 9.07 (1H, br s,

NH), 7.54 (2H, d, J = 7.6 Hz, h,h’), 7.35–7.25 (4H, m, i,i’,r,r’), 7.25–7.15 (3H, m, j,q,q’),
7.10 (1H, t, J = 7.4 Hz, s), 5.65–5.50 (2H, m, l,m), 4.55–4.45 (1H, m, d), 3.51 (1H, br s,
OH), 2.71 (2H, t, J = 7.3 Hz, o), 2.61 (1H, dd, J = 13.9 Hz and 6.1 Hz, k), 2.45–2.35 (2H,
m, b), 2.35–2.20 (2H, m, k,n), 2.12 (1H, d, J = 15.0 Hz, e), 1.90–1.70 (4H, m, c,e,n) ; 13C
NMR (100 MHz, CDCl3) δ 177.56 (f), 141.81 (p), 138.82 (g), 133.54 (m), 128.90 (i,i’),
128.49 (r,r’), 128.31 (j), 127.18 (l), 125.81 (q,q’), 123.81(s), 119.72 (h,h’), 74.81 (d),
52.75 (a), 44.15 (e), 41.86 (k), 36.56 (n), 36.06 (c), 35.86 (o), 34.36 (b); IR (neat) 3296
(O-H stretch), 2935 (N-H stretch), 1660 (C=O stretch), 1597 (C-=C stretch), 1555 (C-OH
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bend), 1497, 1442, 1333, 1308 (C-N stretch), 1254, 960, 907, 752, 692 cm-1; HRMS
(ESI) calcd. for C23H27NaNO2 (M+Na): 372.1939, found 372.1939 m/z.

(1S,3S)-3-hydroxy-1-(2-methylallyl)cyclopentanecarboxylic acid phenyl amide (26i).
Following GP12 with 2.0 mol% [Rh(nbd)2BF4/ 2(R)-B2], 2 equiv tmdBH, and 23i (127.5
mg, 0.528 mmol) affords, after flash chromatography on silica gel (90:10
dichloromethane:ethyl acetate), the title compound (102.5 mg, 75%) as a white solid: mp
76.5–78.5 ºC; TLC analysis Rf 0.6 (80:20 dichloromethane:ethyl acetate); [α]D20 = +10o (c
1.7, CHCl3); Chiral HPLC analysis (Chiralpak-AD, 80:20 hexanes:isopropanol, flowrate
= 1.0 mL/min) showed peaks at 16 minutes (97.0% (1S,3S)) and 21 minutes (3.0%
(1R,3R));

1

H NMR (300 MHz, CDCl3) δ 8.75 (1H, br s, NH), 7.52 (2H, d, J = 7.6 Hz,

h,h’), 7.31 (2H, t, J = 7.6 Hz, i,i’), 7.10 (1H, t, J = 7.4 Hz, j), 4.89 (1H, s, m), 4.72 (1H, s,
m), 4.55–4.45 (1H, m, d), 3.46 (1H, br s, OH), 2.93 (1H, d, J = 15.4 Hz, k), 2.40–2.30
(2H, m, b,e), 2.16 (1H, d, J = 15.4 Hz, k), 2.20–1.80 (4H, m, b,c,e), 1.76 (3H, s, n); 13C
NMR (75 MHz, CDCl3) δ 177.01 (f), 143.01 (l), 138.57 (g), 128.90 (i,i’), 124.01 (j),
119.98 (h,h’), 113.76 (m), 74.29 (d), 52.79 (a), 47.14 (k), 44.38 (e), 38.60 (b), 35.45 (c),
23.86 (n); IR (neat) 3348 (O-H stretch), 3081 (N-H stretch), 2954, 2916, 1653 (C=O
stretch), 1621, 1597 (C-=C stretch), 1556 (C-OH bend), 1499, 1442, 1352 1307 (C-N
stretch), 1259, 1072, 1027, 970, 959, 891, 750, 688 cm-1; HRMS (ESI) calcd. for
C16H21NaNO2 (M+Na): 282.1470, found 282.1459 m/z.
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General procedure for preparation of Mosher’s esters via CAHB/ oxidations and
DCC condensation with (S)-Mosher acid (GP13): checking ee or determine absolute
configuration purpose.

(S)-6-(benzylamino)-6-oxohexan-3-yl

(S)-3,3,3-trifluoro-2-methoxy-2-

phenylpropanoate ((S,S)-14). Following GP12 – CAHB/ oxidation of 7n described
above to afford (S)-9n; to a solution of 9n (0.06 mmol, 13.2 mg) and (S)-Mosher acid
(3.1 equiv, 0.186 mmol, 44 mg) in DCM (1 mL) was added DCC (3.1 equiv, 0.186 mmol,
38.6 mg) and DMAP (3.1 equiv, 0.186 mmol, 22.8 mg). The resultant mixture was stirred
at room temp for 5h then concentrated under vacuum. Flash column chromatography
(80:20-50:50 hexanes:ethyl acetate) affords the title compound (24 mg, 92%) as a white
semi-solid; TLC analysis Rf 0.5 (50:50 hexanes:ethyl acetate); [α]D20 = –34.5o (c 1.87,
CHCl3);

19

F NMR (376 MHz, CDCl3) δ –71.01 (s, 5%, minor, CF3), –71.08 (s, 95%,

major, CF3); 1H NMR (400 MHz, CDCl3) δ 7.50–7.60 (2H, m, r,r’), 7.25–7.45 (8H,
a,b,b’,c,c’,q,q’,s), 5.74 (0.94H, br s, major NH), 5.52 (0.05H, br s, minor NH), 5.00–5.15
(1H, m, i), 4.44 (2H, d, J = 5.7 Hz, e), 3.54 (3H, s, n), 2.05–2.30 (3H, m, g,h), 1.95–2.05
(1H, m, h), 1.60–1.70 (2H, m, j), 0.96 (0.12H, t, J = 7.4 Hz, minor k), 0.86 (2.89H, t, J =
7.4 Hz, major k);

C NMR (100 MHz, CDCl3) δ 171.60 (f), 166.59 (l), 138.26 (d),

13
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132.26 (p), 129.74 (r,r’), 128.85 (b,b’), 128.57 (q,q’), 127.98 (c,c’), 127.70 (s), 127.54
(a), 123.50 (q, J = 287 Hz, o), 84.79 and 84.52 (m), 78.16 (i), 55.47 (n), 43.82 (e), 32.21
(g), 29.38 (h), 26.82 (j), 9.37 (k); IR (neat) 3293 (N-H stretch), 2970, 2935, 1741 (C=O
stretch), 1644 (C=O stretch), 1545 (N-H bend), 1452, 1258, 1165, 1121, 1016, 992, 715,
696 cm-1; HRMS (ESI) calcd. for C23H26F3NNaO4 (M+Na): 460.1712, found 460.1729
m/z.

(R)-5-morpholino-5-oxo-1-phenylpentyl

(S)-3,3,3-trifluoro-2-methoxy-2-

phenylpropanoate (22e). CAHB without oxidation described in GP10 affords 19e.
Boronic ester 19e (0.06 mmol, 15.8 mg) was then oxidized with NaBO3 (GP11) to
generate the crude corresponding alcohol subjected to GP13, affords, after flash column
chromatography (80:20-50:50 hexanes:ethyl acetate) the title compound (26 mg, 90%) as
a white semi-solid; TLC analysis Rf 0.5 (50:50 hexanes:ethyl acetate);

19

F NMR (375

MHz, CDCl3) δ –71.22 (s, CF3, major 95.5%) and –71.61 (s, CF3, minor 4.5%); 1H NMR
(400 MHz, CDCl3) δ 7.20–7.45 (10H, m, aryl), 6.01 (0.955H, t, J = 6.4 Hz, g major),
5.93 (0.045H, t, J = 7.0 Hz, g minor), 3.50–3.70 (6H, m, a,a’,b,a’), 3.46 (3H, s, j), 3.35–
3.40 (2H, m, b,b’), 2.28 (2H, t, J =7.3 Hz, d), 2.00–2.10 (1H, m, f), 1.85–2.00 (1H, m, f),
1.55–1.75 (2H, m, e);

C NMR (100 MHz, CDCl3) δ 170.01, 166.11, 138.88, 132.38,

13

129.66, 128.73, 128.70, 128.45, 127.55, 127.08, 78.55, 67.01, 66.68, 55.49, 45.98, 41.98,
35.41, 32.45, 20.93.
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The two Mosher’s esters above (i.e., 14 and 22e) are isolated for proof of CAHB
absolute configuration purpose; other benzylic boronic esters 19 applied this method to
determine the ee were run at 0.02 mmol scale and the Mosher’s esters were not isolated;
the crude 19F NMR are essentially clean to obtain the ee.
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5.4 Procedures for preparation of trifluoroborate salts from boronic esters
General procedure for the preparation of potassium trifluoroborate salts (GP14).24

Preparation

of

(1R,3S)-1-phenyl-N-((R)-1-phenylethyl)-3-

(trifluoroborato)cyclopentane-1-carboxamide, potassium salt (31k). To a solution of
γ-dioxaborato amide 24k (839 mg, 2.0 mmol, 1.0 equiv) in acetonitrile (MeCN, 4.0 mL)
was slowly added a solution of KHF2 (467 mg, 6.0 mmol, 3.0 equiv) in H2O (1.2 mL).
After a 2 h stir, the reaction mixture was concentrated under reduced pressure and
allowed to dry under vacuum. The resultant crude solid was extracted with acetone (2 x 5
mL) and the combined organic extracts were concentrated under reduced pressure.
Diethyl ether (10.0 mL) was added to precipitate the product. Filtration affords the title
compound (575 mg, 72%) as a white solid: mp 214.0–216.0 ºC; [α]D20 = +17o (c 1.0,
MeOH); 19F NMR (282 MHz, MeOD) δ -147.27 (s, BF3K); 1H NMR (300 MHz, MeOD)
δ 7.40 (2H, d, J = 7.5 Hz, h,h’), 7.35–7.10 (8H, m, i,i’,j,m,m’,n,n’,o), 5.00–4.90 (1H, m,
k), 2.30–2.10 (2H, m, b,e), 1.65–1.55 (2H, m, c), 1.36 (3H, d, J = 7.0 Hz, p), 1.05–0.85
(1H, m, d); 13C NMR (75 MHz, MeOD) δ 178.16 (f), 145.39 (l), 144.11 (g), 127.86 (i,i’),
127.68 (n,n’), 126.58 (h,h’), 126.29 (m,m’), 125.69 (j), 125.61 (o), 60.20 (a), 48.86 (k),
38.82 (b), 37.25 (e), 26.24 (c), 20.78 (p); IR (neat) 3438 (N-H stretch), 2941, 2867, 1662
(C=O stretch), 1500 (N-H bend), 1461, 1446, 1320 (C-N stretch), 1172, 997, 958, 890,
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696 cm-1; HRMS (ESI) calcd. for C20H22BF3NO (M-K): 360.1747, found 360.1761 m/z.
The salt was recrystallized (3:1 Et2O/ MeOH) to give off-white single crystals, and an Xray crystal structure was obtained.
General procedure for the preparation of cesium trifluoroborate salts (GP15).25

Preparation

of

(1R,3S)-1-phenyl-N-((R)-1-phenylethyl)-3-

(trifluoroborato)cyclopentane-1-carboxamide, cesium salt (50k). To a solution of γdioxaborato amide 24k (839 mg, 2.0 mmol, 1.0 equiv) in acetonitrile (MeCN, 8.0 mL)
was added a solution of CsF (1.21 g, 8.0 mmol, 4.0 equiv) in H2O (0.8 mL). The resultant
mixture was stirred at room temp for 2 mins, and a solution of L-(+)-tartaric acid (614
mg, 4.1 mmol, 2.05 equiv) in THF (3.0 mL) was added dropwise. After a 5 h stir, the
mixture was filtered, washed through with more MeCN, and the filtrate was concentrated
under reduced pressure to afford the crude mixture of trifluorborate salt. Afterward,
diethyl ether was added to the crude mixture to dissolve undesired products. Following a
decantation to remove the solvent and undesired products, the precipitate was further
dried under vacuum to afford the title compound (947 mg, 96%) as an off-white solid: mp
246.0–247.5 ºC; [α]D20 = +16o (c 1.0, MeOH); 19F NMR (376 MHz, MeOD) δ -145.41 (s,
BF3Cs); 1H NMR (400 MHz, MeOD) δ 7.40 (2H, d, J = 7.3 Hz, h,h’), 7.35–7.15 (8H, m,
i,i’,j,m,m’,n,n’,o), 5.00–4.90 (1H, m, k), 2.35–2.20 (2H, m, b,e), 2.20–2.00 (2H, m, b,e),
1.70–1.55 (2H, m, c), 1.37 (3H, d, J = 7.0 Hz, p), 1.05–0.80 (1H, m, d); 13C NMR (100
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MHz, MeOD) δ 178.21 (f), 145.43 (l), 144.20 (g), 127.90 (i,i’), 127.69 (n,n’), 126.60
(h,h’), 126.32 (m,m’), 125.71 (j), 125.64 (o), 60.21 (a), 48.93 (k), 38.86 (b), 37.30 (e),
26.28 (c), 20.81 (p); IR (neat) 3441 (N-H stretch), 2941, 2851, 2830, 1659 (C=O stretch),
1497 (N-H bend), 1297 (C-N stretch), 929, 895, 696 cm-1; HRMS (ESI) calcd. for
C20H22BF3NO (M-Cs): 360.1747, found 360.1736 m/z.

(1R,3S)-1-phenyl-3-(trifluoroborato)1-1-cyclopentanecarboxylic acid benzyl
amide, cesium salt (50g). Following GP15 with 24g (203 mg, 0.50 mmol, 1.0 equiv)
affords the title compound (196 mg, 82 %) as the white solid: mp 167.5–169.0 ºC; [α]D20
= +3.2o (c 1.0, MeOH);

19

F NMR (376 MHz, MeOD) δ -144.61 (s, BF3Cs); 1H NMR

(400 MHz, MeOD) δ 7.44 (2H, d, J = 7.2 Hz, h,h’), 7.30 (2H, t, J = 7.4 Hz, n,n’), 7.25–
7.15 (4H, m, i,i’,j,o), 7.12 (2H, d, J = 6.8 Hz, m,m’), 4.40–4.25 (2H, m, k), 2.35–2.25
(2H, m, b,e), 2.20–2.05 (2H, m, b,e), 1.65–1.55 (2H, m, c), 1.05–0.85 (1H, m, d);

13

C

NMR (100 MHz, MeOD) δ 179.07 (f), 145.12 (l), 139.22 (g), 127.91 (i,i’), 127.79 (n,n’),
126.67 (h,h’), 126.59 (m,m’), 126.40 (j), 125.81 (o), 60.24 (a), 42.66 (k), 38.79 (b), 37.22
(e), 26.17 (c); IR (neat) 3354 (N-H stretch), 2936, 2872, 1656 (C=O stretch), 1628 (C=C
stretch), 1514 (N-H bend), 1443, 1287 (C-N stretch), 1091, 948, 919, 897, 728, 696 cm-1;
HRMS (ESI) calcd. for C19H20BF3NO (M-Cs): 346.1590, found 346.1573 m/z.
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(1R,3S)-1-trifluoromethyl-3-(trifluoroborato)-1-cyclopentanecarboxylic acid
benzyl amide, cesium salt (50h). Following GP10 with 23h (142.5 mg, 0.528 mmol)
affords, after passing through a short pad of silica gel and concentrating under reduced
pressure, the crude γ-dioxaborato amide 24h as the dark oil used in the next step without
further purification.
Following GP15 with 24h (200 mg, 0.50 mmol, 1.0 equiv) affords the title
compound (147 mg, 59%, 2 steps) as a white foamy solid: mp 73.0–75.5 ºC; [α]D20 = 26o (c 2.0, CHCl3);
1

19

F NMR (376 MHz, CDCl3) δ -69.90 (s, CF3), -133.70 (s, BF3Cs);

H NMR (400 MHz, CDCl3) δ 7.30–7.25 (2H, m, i,i’), 7.21 (1H, d, J = 7.1 Hz, j), 7.17

(1H, d, J = 7.0 Hz, h,h’), 6.51 (1H, br s, NH), 4.35 (2H, d, J = 5.2 Hz, k), 2.20–2.05 (2H,
m, b,e), 2.05–1.95 (2H, m, e), 1.90–1.85 (1H, m, b), 1.75–1.60 (1H, m, c), 1.45–1.30 (1H,
m, c), 1.05–0.85 (1H, m, d);

C NMR (100 MHz, CDCl3) δ 171.29 (f), 138.16 (g),

13

128.76 (i,i’), 127.46 (j), 127.11 (h,h’), 59.85 (q, J = 93.3 Hz, a), 43.95 (k), 34.84 (b),
33.71 (e), 29.37 (c); IR (neat) 3373 (N-H stretch), 2956, 2870, 1657 (C=O stretch), 1523
(N-H bend), 1497, 1454, 1293 (C-N stretch), 1273, 1146, 1090, 1001, 926, 895, 729, 697
cm-1; HRMS (ESI) calcd. for C14H15BF6NO (M-Cs): 338.1151, found 338.1179 m/z.
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(1R,3S)-1-phenyl-3-(trifluoroborato)-1-cyclopentanecarboxylic acid phenyl
amide, cesium salt (50c). Following GP15 with 24c (196 mg, 0.50 mmol, 1.0 equiv)
affords the title compound (186 mg, 80 %) as the white solid: mp 173.5–177.0 ºC; [α]D20
= +11o (c 1.0, MeOH); 19F NMR (376 MHz, MeOD) δ -144.25 (s, BF3Cs); 1H NMR (400
MHz, MeOD) δ 7.50–7.40 (4H, m, h,h’,l,l’), 7.33 (2H, t, J = 7.4 Hz, m,m’), 7.26 (2H, t, J
= 7.5 Hz, i,i’), 7.21 (1H, t, J = 7.3 Hz, j), 7.06 (1H, t, J = 7.4 Hz, n), 2.50–2.30 (2H, m,
b,e), 2.30–2.10 (2H, m, b,e), 1.75–1.60 (2H, m, c), 1.10–0.95 (1H, m, d); 13C NMR (100
MHz, MeOD) δ 177.61 (f), 145.34 (k), 138.55 (g), 128.18 (i,i’), 127.89 (m,m’), 126.51
(l,l’), 125.89 (j), 123.79 (n), 120.85 (h,h’), 61.13 (a), 38.97 (b), 37.77 (e), 26.60 (c); IR
(neat) 3402 (N-H stretch), 2947, 2842, 1663 (C=O stretch), 1596 (C=C stretch), 1516 (NH bend), 1493, 1436, 1311 (C-N stretch), 1241, 1080, 994, 901, 897, 745, 696 cm-1;
HRMS (ESI) calcd. for C18H18BF3NO (M-Cs): 332.1434, found 332.1426 m/z.

(S)-7-phenyl-4-(trifluoroborato)heptanecarboxylic acid morpholino amide,
cesium salt (67d). Following GP15 with 8d (803 mg, 2.0 mmol, 1.0 equiv) afford the
title compound (874 mg, 92%) as an off-white foamy solid: mp 61.5–62.5 ºC; [α]D20 =
+0.5o (c 1.0, CHCl3); 19F NMR (376 MHz, CDCl3) δ –133.36 (s, BF3Cs); 1H NMR (400
MHz, CDCl3) δ 7.25–7.30 (2H, m, b,b’), 7.15–7.20 (3H, m, a,c,c’), 3.55–3.60 (4H, m,

286

m,m’), 3.45–3.55 (2H, m, l,l’), 3.30–3.40 (2H, m, l,l’), 2.58 (2H, t, J = 6.9 Hz, e), 2.25–
2.35 (1H, m, j), 2.15–2.25 (1H, m, j), 1.50–1.70 (3H, m, f,i), 1.30–1.45 (2H, m, g,i),
1.10–1.25 (1H, m, g), 0.25–0.40 (1H, m, h); 13C NMR (100 MHz, CDCl3) δ 173.90 (k),
143.63 (d), 128.68 (b,b’), 128.39 (c,c’), 125.64 (a), 66.94 and 66.86 (m,m’), 46.28 and
41.86 (l,l’), 36.70 (e), 31.79 (j), 31.07 (f), 30.09 (g), 26.60 (i); IR (neat) 2908, 2854, 1609
(C=O stretch), 1461 (N-H bend), 1434, 1240 (C-N stretch), 1114, 1064, 957, 932, 742,
702 cm-1; HRMS (ESI) calcd. for C17H24BF3NO2 (M-Cs): 342.1852, found 342.1852 m/z.

(S)-7-phenyl-4-(trifluoroborato)heptanecarboxylic acid benzyl amide, cesium
salt (67b). Following GP15 with 8b (421 mg, 1.0 mmol, 1.0 equiv) affords the title
compound (396 mg, 80%) as a white foamy solid: mp 57.5–58.5 ºC; [α]D20 = -2.9o (c 1.0,
MeOH); 19F NMR (376 MHz, MeOD) δ -131.52 (s, BF3Cs); 1H NMR (400 MHz, MeOD)
δ 7.00–7.40 (10H, m, a,b,b’,c,c’,n,n’,o,o’,p), 4.36 (2H, s, l), 2.56 (2H, t, J = 7.7 Hz, e),
2.30 (2H, t, J = 8.1 Hz, j), 1.55–1.80 (4H, m, f,i), 1.40–1.55 (1H, m, g), 1.20–1.30 (1H,
m, g), 0.30–0.50 (1H, m, h);

13

C NMR (100 MHz, MeOD) δ 177.08 (k), 143.66 (d),

138.97 (m), 128.16 (b,b’), 128.14 (o,o’), 127.76 (n,n’), 127.16 (c,c’), 126.74 (p), 124.94
(a), 42.67 (l), 36.67 (e), 36.01 (j), 31.06 (f), 30.79 (g), 27.83 (i); IR (neat) 3408 (N-H
stretch), 3294 2919, 2852, 1640 (C=O stretch), 1521, 1495, 1452 (N-H bend), 1528, 912,
744, 697 cm-1; HRMS (ESI) calcd. for C20H24BF3NO (M-Cs): 362.1903, found 362.1897
m/z.
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5.5 Procedures for directed Suzuki–Miyaura reactions
General procedure for Suzuki-Miyaura cross-coupling reactions of secondary
acyclic -trifluoroborato amides (GP16).

(S)-4,7-diphenylheptanecarboxylic acid morpholino amide ((S)-69d). An 8mL vial was charged with Buchwald cataCXium® A Pd G3 precatalyst 52 (5.5 mg,
0.0075 mmol, 0.075 equiv), K2CO3 (42 mg, 0.3 mmol, 3.0 equiv), -trifluoroborato amide
67d (57 mg, 0.12 mmol, 1.2 equiv), chlorobenzene (11.3 mg, 0.1 mmol, 1.0 equiv),
toluene (0.5 mL), and water (0.05 mL). The resultant mixture was stirred at 100 oC for 24
h. After cooling to room temperature, the organic layer was separated, and water (1.0
mL) was added to the aqueous layer following by extraction with ethyl acetate (2 x 2
mL). The combined organic extracts were dried (anhyd. Na2SO4) and concentrated under
reduced pressure. Flash chromatography on silica gel (95:5–80:20 DCM:ethyl acetate)
affords the tile compound (22 mg, 63%) as a yellow oil; TLC analysis Rf = 0.4 (80:20
DCM:ethyl acetate); [α]D20 = –3.7o (c 1.0, CHCl3); Chiral HPLC analysis (Chiralpak-IC,
80:20 hexanes:isopropanol, flowrate = 1.5 mL/min) showed peaks at 75 minutes (6.5%
(R)) and 81 minutes (93.5% (S)); 1H NMR (400 MHz, CDCl3) δ 7.05–7.35 (10H, m,
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a,b,b’,c,c’,o,o’,p,p’,q), 3.50–3.65 (6H, m, l,l’,m,m’), 3.10–3.30 (2H, m, l,l’), 2.50–2.65
(3H, m, e,h), 2.05–2.15 (3H, m, i,j), 1.80–1.90 (1H, m, i), 1.60–1.75 (2H, m, g), 1.45–
1.60 (2H, m, f); 13C NMR (100 MHz, CDCl3) δ 171.72 (k), 144.84 (d), 142.55 (n), 128.60
(b,b’), 128.49 (p,p’), 128.33 (c,c’), 127.79 (o,o’), 126.42 (a), 125.74 (q), 67.01 and 66.67
(m,m’), 45.88 (l,l’), 45.61 (h), 41.95 (l,l’), 36.76 (g), 36.00 (e), 32.08 (i), 30.97 (j), 29.42
(f); IR (neat) 2919, 2851, 1644 (C=O stretch), 1452, 1426, 1230, 1114, 1029, 747, 699
cm-1; HRMS (ESI) calcd. for C23H29NNaO2 (M+Na): 374.2096, found 374.2106 m/z.

(S)-4-(4-methoxyphenyl)-7-phenylheptanecarboxylic acid morpholino amide
(22c). Following GP16 with 4-chloroanisole (14.3 mg, 0.1 mmol, 1.0 equiv) affords,
after flash chromatography on silica gel (95:5–80:20 DCM:ethyl acetate), the title
compound (19.8 mg, 52%) as a yellow oil; TLC analysis Rf 0.4 (80:20 DCM:ethyl
acetate); [α]D20 = –7.1o (c 2.0, CHCl3); Chiral HPLC analysis ((S,S)-WHELK-O 1, 50:50
hexanes:isopropanol, flow rate = 1.0 mL/min) showed peaks at 25 minutes (6.0% (R))
and 28 minutes (94.0% (S)); 1H NMR (400 MHz, CDCl3) δ 7.26 (2H, t, J = 7.2 Hz, o,o’),
7.17 (1H, t, J = 7.3 Hz, a), 7.11 (2H, d, J = 7.1 Hz, c,c’), 7.06 (2H, d, J = 8.6 Hz, b,b’),
6.85 (2H, d, J = 8.6 Hz, p,p’), 3.81 (3H, s, r), 3.60–3.65 (2H, m, m,m’), 3.55–3.60 (4H,
m, l,l’,m,m’), 3.15–3.30 (2H, m, l,l’), 2.45–2.65 (3H, m, e,h), 2.00–2.15 (3H, m, i,j),
1.75–1.85 (1H, m, i), 1.45–1.75 (4H, m, f,g); 13C NMR (100 MHz, CDCl3) δ 171.80 (k),
158.12 (q), 142.60 (d), 136.77 (n), 128.61 (b,b’), 128.49 (c,c’), 128.32 (o,o’), 125.72 (a),
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113.96 (p,p’), 67.02 and 66.69 (m,m’), 55.34 (r), 45.90 (l,l’), 44.76 (h), 41.95 (l,l’), 36.93
(g), 36.01 (e), 32.25 (i), 31.02 (j), 29.44 (f); IR (neat) 2920, 2852, 1643 (C=O stretch),
1510, 1426, 1244, 1113, 1030, 831, 700 cm-1; HRMS (ESI) calcd. for C24H31NNaO3
(M+Na): 404.2202, found 404.2213 m/z.
An allternative synthetic route for (R)-69d

To a cooled (-78 oC) solution of 20c (via GP6 vide upfra) (0.38 mmol, 156 mg) in
DCM (2 mL) was added dropwise a solution of DIBAL-H (2 equiv, 1M, 0.76 mmol, 0.76
mL) dropwise. The resultant mixture was stirred at -78 oC for 2h. After quenching with
satd. NH4Cl (1 mL), the Wittig reagent (Ph3P=CH(COOEt), 1.2 equiv, 0.456 mmol, 160
mg) in DCM (1 mL) was added dropwise. The resultant mixture was stirred OVN at
room temp and passed through a pad of celite and washed with DCM (3 x 3 mL). The
filtrate was concentrated under reduced pressure to give a crude 71 (61.7 mg, 53%) used
in the next step without further purification.
A solution of 71 (0.18 mmol, 55 mg) and Pd/C (10%, 0.1 equiv) in methanol (1
mL) was stirred under H2 (1 atm) for 5h. The resultant mixture was passed through a pad
of celite and concentrated under reduced pressure to give a crude reduced product (55
mg, 99%) used in the next step without further purification.

290

Following GP1 with the obtained reduced product (0.16 mmol, 50 mg) affords,
after column chromatography (95:5–80:20 DCM:ethyl acetate), the title compound (R)69d (40.2 mg, 71%) as a yellow oil; TLC analysis Rf = 0.4 (80:20 DCM:ethyl acetate);
[α]D20 = +3.2o (c 1.0, CHCl3); (Chiralpak-IC, 80:20 hexanes:isopropanol, flowrate = 1.5
mL/min) showed peaks at 74 minutes (82.0% (R)) and 80 minutes (18.0% (S));
spectroscopic data matched with (S)-69d obtained from Suzuki-Miyaura cross-coupling
of (S)-67d.
General procedure for Suzuki-Miyaura cross-coupling reactions of secondary cyclic
-trifluoroborato amides (GP16).

(1R,3S)-3-(naphthalen-1-yl)-1-phenylcyclopentanecarboxylic

acid

benzyl

amide

(51ga). An 8-mL vial was charged with Pd precatalyst 52 (5.5 mg, 0.0075 mmol, 0.075
equiv), Cs2CO3 (98 mg, 0.3 mmol, 3.0 equiv), γ-trifluoroborato amide 50g (R1 = CF3, R2
= CH2Ph, M = Cs) (57.5 mg, 0.12 mmol, 1.2 equiv), 1-bromonaphthalene 53 (20.7 mg,
0.1 mmol, 1.0 equiv), toluene (0.5 mL), and water (0.05 mL). The resultant mixture was
stirred at 100 oC for 24 h. After cooling to room temperature, the organic layer was
separated, and water (1.0 mL) was added to the aqueous layer following by extraction
with ethyl acetate (2 x 2 mL). The combined organic extracts were dried (anhyd. Na2SO4)
and concentrated under reduced pressure. Flash chromatography on silica gel (90:10–

291

85:15 hexanes:ethyl acetate) affords the tile compound (28.1 mg, 69%) as a yellow oil;
TLC analysis Rf = 0.55 (70:30 hexanes:ethyl acetate); [α]D20 = -3.2o (c 1.3, CHCl3); 1H
NMR (400 MHz, CDCl3) δ 8.10–8.00 (1H, m, v), 7.95–7.85 (1H, m, y), 7.76 (1H, d, J =
8.2 Hz, s), 7.69 (1H, d, J = 7.1 Hz, q), 7.60–7.45 (6H, m, a,n,n’,o,w,x), 7.40–7.35 (1H, m,
r), 7.35–7.25 (4H, m, b,b’,m,m’), 7.09 (2H, d, J = 6.4 Hz, c,c’), 5.49 (1H, br s, NH),
4.45–4.35 (2H, m, k), 4.00–3.90 (1H, m, h), 2.95–2.80 (3H, m, f,i), 2.50–2.40 (1H, m, f),
2.40–2.30 (1H, m, g), 2.20–2.10 (1H, m, g); 13C NMR (100 MHz, CDCl3) δ 176.52 (j),
143.90 (d), 140.67 (p), 138.47 (l), 133.90 (t), 132.12 (u), 129.12 (n,n’), 128.88 (y),
128.60 (b,b’), 127.30 (r), 127.27 (m,m’), 127.19 (c,c’), 126.97 (o,o’), 126.65 (s), 125.83
(w), 125.70 (a), 125.33 (x), 123.53 (v), 122.65 (q), 58.98 (e), 43.75 (k), 43.69 (i), 39.41
(h), 37.04 (f), 32.59 (g); IR (neat) 3325 (N-H stretch), 1646 (C=O stretch), 1598 (C=C
stretch), 1533 (N-H bend), 1449, 1418, 1285, 795, 775, 718, 695 cm-1; HRMS (ESI)
calcd. for C29H27NaNO (M+Na): 428.1990, found 428.1992 m/z.

(1S,3S)-3-(naphthalen-1-yl)-1-(trifluoromethyl)cyclopentanecarboxylic acid benzyl
amide (51ha). Following GP16 with 1-bromonaphthalene 53 (20.7 mg, 0.1 mmol, 1.0
equiv), cross-coupling of γ-trifluoroborato amide 50h (56.5 mg, 0.12 mmol, 1.2 equiv)
affords, after flash chromatography on silica gel (90:10 hexanes:ethyl acetate), the title
compound (25.0 mg, 63%) as a yellow oil; TLC analysis Rf = 0.75 (70:30 hexanes:ethyl
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acetate); [α]D20 = -16o (c 0.5, CHCl3);

19

F NMR (376 MHz, CDCl3) δ -70.47; 1H NMR

(400 MHz, CDCl3) δ 8.11 (1H, d, J = 8.4 Hz, v), 7.90 (1H, dd, J = 7.6 Hz, s), 7.77 (1H,
dd, J = 7.9 Hz, n), 7.60–7.40 (4H, m, l,p,t,u), 7.40–7.20 (5H, m, j,j’,k,k’,o), 6.12 (1H, br
s, NH), 4.60–4.45 (2H, m, h), 4.10–3.95 (1H, m, e), 2.80–2.65 (2H, m, c,f), 2.60–2.55
(1H, m, f), 2.40–2.20 (2H, m, c,d), 2.20–2.10 (1H, m, d); 13C NMR (100 MHz, CDCl3) δ
169.18 (g), 138.32 (m), 137.61 (i), 133.89 (q), 131.97 (r), 128.96 (v), 128.85 (k,k’),
127.70 (j,j’), 127.53 (o), 127.17 (l), 126.08 (p), 125.66 (t), 125.55 (u), 123.16 (s), 122.40
(n), 58.45 (d, J = 24 Hz, b), 44.41 (h), 41.13 (e), 39.01 (f), 32.70 (d), 31.73 (c); IR (neat)
3341 (N-H stretch), 3052, 2957, 1657 (C=O stretch), 1598 (C=C stretch), 1522 (N-H
bend), 1496, 1453, 1287,1147, 1111, 777, 726, 695 cm-1; HRMS (ESI) calcd. for
C24H22F3NaNO (M+Na): 420.1551, found 420.1534 m/z.

Preparation

of

(1R,3S)-3-(naphthalen-1-yl)-1-phenyl-N-((R)-1-

phenylethyl)cyclopentane-1-carboxamide

(51ka).

Following

GP16

with

1-

bromonaphthalene 53 (20.7 mg, 0.1 mmol, 1.0 equiv), cross-coupling of γ-trifluoroborato
amide 50k (59.2 mg, 0.12 mmol, 1.2 equiv) affords, after flash chromatography on silica
gel (90:10–85:15 hexanes:ethyl acetate), the title compound (36.0 mg, 86%) as a yellow
oil; TLC analysis Rf = 0.6 (70:30 hexanes:ethyl acetate); [α]D20 = -20o (c 1.0, CHCl3); 1H
NMR (400 MHz, CDCl3) δ 8.05–8.00 (1H, m, w), 7.90–7.85 (1H, m, z), 7.80–7.70 (1H,
m, t), 7.70–7.60 (1H, m, y), 7.55–7.45 (7H, m, a,c,c’,n,p,o,o’), 7.40–7.35 (1H, m, s),
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7.30–7.20 (3H, m, n’,r,x), 7.07 (2H, d, J = 6.9 Hz, b.b’), 5.34 (1H, br s, NH), 5.20–5.00
(1H, m, k), 4.00–3.85 (1H, m, h), 2.90–2.70 (3H, m, f,i), 2.50–2.40 (1H, m, f), 2.40–2.30
(1H, m, g), 2.20–2.10 (1H, m, g), 1.35 (3H, d, J = 6.9 Hz, l);

13

C NMR (100 MHz,

CDCl3) δ 175.63 (j), 144.10 (d), 143.33 (q), 140.65 (m), 133.87 (u), 132.10 (v), 129.07
(o,o’), 128.86 (z), 128.53 (b,b’), 127.25 (s), 127.08 (n,n’), 126.91 (c,c’), 126.60 (t),
125.83 (p), 125.72 (x), 125.67 (a), 125.29 (r), 123.50 (w), 122.69 (y), 58.94 (e), 48.88
(k), 43.57 (i), 37.47 (h), 37.01 (f), 32.71 (g), 21.82 (l); IR (neat) 3337 (N-H stretch),
3053, 2923, 1644 (C=O stretch), 1597 (C=C stretch), 1493 (N-H bend), 1445, 796, 777,
732, 696 cm-1; HRMS (ESI) calcd. for C30H29NaNO (M+Na): 442.2147, found 442.2151
m/z.

(1R,3S)-3-(naphthalen-2-yl)-1-phenyl-N-((R)-1-phenylethyl)cyclopentane-1carboxamide (51kb). Following GP16 with 2-bromonaphthalene 54 (20.7 mg, 0.1
mmol, 1.0 equiv), cross-coupling of γ-trifluoroborato amide 50k (59.2 mg, 0.12 mmol,
1.2 equiv) affords, after flash chromatography on silica gel (90:10–85:15 hexanes:ethyl
acetate), the title compound (28.0 mg, 66%) as a yellow oil; TLC analysis Rf = 0.6 (70:30
hexanes:ethyl acetate); [α]D20 = +48o (c 1.1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.90–
7.75 (3H, m, w,z,u), 7.75–7.70 (1H, m, r), 7.55–7.50 (1H, m, x), 7.50–7.40 (5H, m,
c,c’,o,o’,y), 7.40–7.30 (2H, m, n,n’), 7.30–7.20 (3H, m, a,p,v), 7.09 (2H, d, J = 6.8 Hz,
b.b’), 5.35 (1H, br s, NH), 5.15–5.05 (1H, m, k), 3.40–3.20 (1H, m, h), 2.90–2.75 (2H, m,
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f,i), 2.75–2.65 (1H, m, i), 2.45–2.35 (1H, m, f), 2.35–2.20 (1H, m, g), 2.15–2.05 (1H, m,
g), 1.37 (3H, d, J = 6.9 Hz, l); 13C NMR (100 MHz, CDCl3) δ 175.70 (j), 144.04 (d),
143.36 (q), 142.59 (m), 133.53 (s), 132.24 (t), 129.00 (o,o’), 128.71 (b,b’), 128.53 (z),
128.08 (w), 127.58 (u), 127.21 (n,n’), 127.09 (c,c’), 126.94 (p), 126.12 (x), 125.90 (a),
125.72 (v), 125.32 (y), 125.22 (r), 59.24 (e), 48.89 (k), 44.77 (i), 44.64 (h), 37.30 (f),
33.72 (g), 21.87 (l); IR (neat) 3325 (N-H stretch), 2920, 1708 (C=O stretch), 1644 (C=C
stretch), 1598 (N-H bend), 1493, 1446, 888, 857, 817, 745, 696 cm-1; HRMS (ESI) calcd.
for C30H29NaNO (M+Na): 442.2147, found 442.2151 m/z.

(1R,3S)-3-(3,5-dimethoxyphenyl)-1-phenyl-N-((R)-1-phenylethyl)cyclopentane-1carboxamide (51kc). Following GP16 with 1-bromo-3,5-dimethoxybenzene 55 (21.7
mg, 0.1 mmol, 1.0 equiv), cross-coupling of γ-trifluoroborato amide 50k (59.2 mg, 0.12
mmol, 1.2 equiv) affords, after flash chromatography on silica gel (90:10–85:15
hexanes:ethyl acetate), the title compound (28.5 mg, 66%) as a yellow oil; TLC analysis
Rf = 0.5 (70:30 hexanes:ethyl acetate); [α]D20 = +15o (c 0.8, CHCl3); 1H NMR (400 MHz,
CDCl3) δ 7.45–7.40 (4H, m, o,o’,c,c’), 7.35–7.30 (1H, m, p), 7.30–7.20 (3H, m, a,n,n’),
7.07 (2H, d, J = 6.8 Hz, b,b’), 6.49 (2H, d, J = 2.1 Hz, r,r’), 6.33 (1H, t, J = 2.2 Hz, t),
5.30 (1H, d, J = 7.5 Hz, NH), 5.20–5.00 (1H, m, k), 3.80 (6H, s, u,u’), 3.15–3.00 (1H, m,
h), 2.80–2.70 (1H, m, f), 2.70–2.55 (2H, m, i), 2.40–2.25 (1H, m, f), 2.25–2.10 (1H, m,
g), 2.05–1.90 (1H, m, g), 1.34 (3H, d, J = 6.9 Hz, l); 13C NMR (100 MHz, CDCl3) δ
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175.55 (j), 160.79 (s,s’), 147.65 (q), 143.94 (d), 143.33 (m), 128.95 (o,o’), 128.51 (n,n’),
127.16 (p), 127.07 (a), 126.85 (c,c’), 125.71 (b,b’), 105.25 (r,r’), 98.22 (t), 59.06 (e),
55.31 (u,u’), 48.83 (k), 44.70 (h), 44.54 (i), 36.98 (f), 33.41 (g), 21.81 (l); IR (neat) 3348
(N-H stretch), 2930, 1654 (C=O stretch), 1593 (C=C stretch), 1493 (N-H bend), 1451,
1427, 1203, 1149, 1059, 924. 831, 733, 697 cm-1; HRMS (ESI) calcd. for C28H31NaNO3
(M+Na): 452.2202, found 452.2195 m/z.

(1R,3S)-3-([1,1'-biphenyl]-4-yl)-1-phenyl-N-((R)-1-phenylethyl)cyclopentane-1carboxamide (51kd). Following GP16 with 4-bromo-1,1’-biphenyl 56 (23.3 mg, 0.1
mmol, 1.0 equiv), cross-coupling of γ-trifluoroborato amide 50k (59.2 mg, 0.12 mmol,
1.2 equiv) affords, after flash chromatography on silica gel (90:10–85:15 hexanes:ethyl
acetate), the title compound (31.8 mg, 71%) as a yellow oil; TLC analysis Rf = 0.6 (70:30
hexanes:ethyl acetate); [α]D20 = +49o (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.61
(2H, d, J = 8.1 Hz, v,v’), 7.56 (2H, d, J = 8.2 Hz, s,s’), 7.50–7.40 (8H, m,
b,b’c,c’,r,r’,w,w’), 7.40–7.30 (2H, m, n,n’), 7.30–7.20 (3H, m, o,o’,x), 7.10–7.00 (2H, m,
a,p), 5.34 (3H, d, J = 7.3 Hz, NH), 5.15–5.05 (1H, m, k), 3.25–3.10 (1H, m, h), 2.80–2.70
(2H, m, f,i), 2.70–2.60 (1H, m, i), 2.40–2.30 (1H, m, f), 2.30–2.15 (1H, m, g), 2.10–2.00
(1H, m, g), 1.36 (3H, d, J = 6.9 Hz, l); 13C NMR (100 MHz, CDCl3) δ 175.68 (j), 144.38
(q), 144.12 (d), 143.36 (u), 141.12 (t), 139.08 (m), 128.98 (w,w’), 128.72 (r,r’), 128.53
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(b,b’), 127.76 (v,v’), 127.19 (x), 127.15 (s,s’), 127.09 (n,n’), 127.04 (c,c’), 126.90 (p),
125.72 (p,a), 59.19 (e), 48.87 (k), 44.86 (i), 44.25 (h), 37.35 (f), 33.92 (g), 21.86 (l); IR
(neat) 3334 (N-H stretch), 3026, 1651 (C=O stretch), 1598 (C=C stretch), 1486 (N-H
bend), 1446, 1234, 1073, 837, 761, 732, 695 cm-1; HRMS (ESI) calcd. for C32H31NaNO
(M+Na): 468.2303, found 468.2293 m/z.

(1R,3S)-3-(6-methoxypyridin-3-yl)-1-phenyl-N-((R)-1-phenylethyl)cyclopentane-1carboxamide (51ke). Following GP16 with 5-chloro-2-methoxypyridine 57 (71.8 mg,
0.5 mmol, 1.0 equiv), cross-coupling of γ-trifluoroborato amide 50k (298 mg, 0.6 mmol,
1.2 equiv) affords, after flash chromatography on silica gel (85:15 hexanes:ethyl acetate),
the title compound (150.2 mg, 75%) as a yellow oil; TLC analysis Rf = 0.25 (80:20
hexanes:ethyl acetate); [α]D20 = +8.2o (c 0.8, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.00
(1H, d, J = 2.4 Hz, u), 7.68 (1H, dd, J = 8.6 Hz and 2.4 Hz, r), 7.45–7.40 (4H, m,
c,c’,o,o’), 7.40–7.30 (2H, m, n,n’), 7.30–7.20 (2H, m, b,b’), 7.10–7.00 (2H, m, a,p), 6.72
(1H, d, J = 8.6 Hz, s), 5.33 (1H, d, J = 7.8 Hz, NH), 5.15–5.00 (1H, m, k), 3.93 (3H, s, v),
3.15–3.05 (1H, m, h), 2.75–2.65 (2H, m, f,i), 2.60–2.50 (1H, m, i), 2.40–2.30 (1H, m, f),
2.20–2.10 (1H, m, g), 2.00–1.85 (1H, m, g), 1.34 (3H, d, J = 6.9 Hz, l); 13C NMR (100
MHz, CDCl3) δ 175.61 (j), 162.91 (t), 145.24 (u), 143.95 (d), 143.30 (m), 137.65 (r),
133.13 (q), 129.00 (o,o’), 128.51 (b,b’), 127.25 (n,n’), 127.09 (c,c’), 126.86 (p), 125.64
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(a), 110.82 (s), 59.10 (e), 53.32 (v), 48.89 (k), 44.59 (i), 41.03 (h), 37.29 (f), 33.88 (g),
21.89 (l); IR (neat) 3323 (N-H stretch), 2942, 1645 (C=O stretch), 1604 (C=C stretch),
1491 (N-H bend), 1446, 1282, 1252, 1128, 1026, 829, 760, 697 cm-1; HRMS (ESI) calcd.
for C26H28NaN2O2 (M+Na): 423.2048, found 423.2033 m/z.

(1R,3S)-3-(4-benzoylphenyl)-1-phenyl-N-((R)-1-phenylethyl)cyclopentane-1carboxamide (51kf). Using the general procedure with 4-chlorobenzophenone 58 (21.7
mg, 0.1 mmol, 1.0 equiv), cross-coupling of γ-trifluoroborato amide 50k (59.2 mg, 0.12
mmol, 1.2 equiv) affords, after flash chromatography on silica gel (90:10–85:15
hexanes:ethyl acetate), the title compound (33.1 mg, 70%) as a yellow oil; TLC analysis
Rf = 0.5 (70:30 hexanes:ethyl acetate); [α]D20 = +63o (c 1.5, CHCl3); 1H NMR (400 MHz,
CDCl3) δ 7.85–7.80 (2H, m, s,s’), 7.76 (2H, d, J = 8.2 Hz, w,w’), 7.60 (1H, t, J = 7.4 Hz,
y), 7.50 (2H, t, J = 7.7 Hz, b,b’), 7.45–7.40 (5H, m, c,c’,o,o’,p), 7.40–7.30 (2H, m, n,n’),
7.30–7.15 (4H, m, r,r’,x,x’), 7.05 (1H, d, J = 6.8 Hz, a), 5.36 (1H, br s, NH), 5.15–5.05
(1H, m, k), 3.30–3.15 (1H, m, h), 2.85–2.70 (2H, m, f,i), 2.65–2.55 (1H, m, i), 2.45–2.30
(1H, m, f), 2.30–2.20 (1H, m, g), 2.10–2.00 (1H, m, g), 1.35 (3H, d, J = 6.9 Hz, l); 13C
NMR (100 MHz, CDCl3) δ 196.47 (u), 175.53 (j), 150.51 (q), 143.83 (d), 143.30 (v),
137.93 (t), 135.48 (m), 132.21 (y), 130.45 (w,w’), 130.00 (s,s’), 129.04 (o,o’), 128.53
(x,x’), 128.23 (b,b’), 127.30 (n,n’), 127.11 (c,c’), 126.88 (p), 125.68 (a), 59.22 (e), 48.94

298

(k), 44.62 (i), 44.52 (h), 37.28 (f), 33.75 (g), 21.90 (l); IR (neat) 3346 (N-H stretch),
3054, 1651 (C=O stretch), 1598 (C=C stretch), 1493 (N-H bend), 1445, 1315, 1277, 923.
742, 696 cm-1; HRMS (ESI) calcd. for C33H31NaNO2 (M+Na): 496.2252, found 496.2245
m/z.

(1R,3S)-3-(naphthalen-1-yl)-1-phenylcyclopentanecarboxylic acid phenyl amide
(51ca). Using the general procedure with 1-bromonaphthalene 53 (20.7 mg, 0.1 mmol,
1.0 equiv), cross-coupling of γ-trifluoroborato amide 50c (55.8 mg, 0.12 mmol, 1.2
equiv) affords, after flash chromatography on silica gel (90:10 hexanes:ethyl acetate), the
title compound (7.9 mg, 20%) as a yellow oil; TLC analysis Rf = 0.70 (70:30
hexanes:ethyl acetate); [α]D20 = -23o (c 1.0, CHCl3); 1H NMR (300 MHz, CDCl3) δ 8.10–
8.00 (1H, m, u), 7.95–7.85 (1H, m, x), 7.76 (1H, d, J = 8.2 Hz, r), 7.70 (1H, d, J = 7.1
Hz, w), 7.65–7.55 (2H, m, b,b’), 7.55–7.25 (10H, m, a,c,c’,l,l’,m,m’,n,q,v), 7.09 (1H, tt, J
= 7.3 and 1.2 Hz, p), 6.83 (1H, br s, NH), 4.05–3.90 (1H, m, h), 3.00–2.80 (3H, m, i,f),
2.55–2.45 (1H, m, f), 2.45–2.35 (1H, m, g), 2.25–2.15 (1H, m, g); 13C NMR (75 MHz,
CDCl3) δ 174.70 (j), 143.52 (d), 140.42 (o), 137.98 (k), 133.91 (s), 132.09 (t), 129.40
(m,m’), 128.91 (x), 127.63 (n), 127.00 (b,b’), 126.72 (q), 125.83 (c,c’), 125.74 (r), 125.35
(a), 124.22 (v), 123.47 (w), 122.63 (u), 119.70 (p), 110.61 (l,l’), 59.84 (e), 43.70 (i),
39.59 (h), 37.16 (f), 32.70 (g); IR (neat) 3332 (N-H stretch), 3055, 2948, 1661 (C=O
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stretch), 1596 (C=C stretch), 1515 (N-H bend), 1498, 1435, 1308, 1240, 905, 777, 751,
691 cm-1; HRMS (ESI) calcd. for C28H25NaNO (M+Na): 414.1834, found 414.1846 m/z.
Direct competition experiment of Suzuki-Miyaura cross-coupling.

An 8-mL vial was charged with Pd precatalyst 52 (5.5 mg, 0.0075 mmol, 0.075
equiv), Cs2CO3 (98 mg, 0.3 mmol, 3.0 equiv), γ-trifluoroborato amide 50k (59.2 mg, 0.12
mmol, 1.2 equiv), γ-trifluoroborato amide 50c (55.8 mg, 0.12 mmol, 1.2 equiv), 1bromonaphthalene 53 (20.7 mg, 0.1 mmol, 1.0 equiv), toluene (0.5 mL), and water (0.05
mL). The resultant mixture was stirred at 100 oC for 24 h. After cooling to room
temperature, the organic layer was separated, and water (1.0 mL) was added to the
aqueous layer following by extraction with ethyl acetate (2 x 2 mL). The combined
organic extracts were dried (anhyd. Na2SO4) and concentrated under reduced pressure.
The resulting mixture was diluted with 1.2 mL acetone and Oxone (0.6 mL of a 0.2 M
solution in H2O, 1.2 mmol, 1.2 equiv) was added in one portion. After a 0.5 h-stir, to the
crude mixture was added water (1 mL) and HCl (1 mL of the 1M solution). The resultant
mixture was extracted with DCM (3 x 2 mL). The combined organic extracts were dried
(Na2SO4), and concentrated under reduced pressure. Flash chromatography on silica gel
(90:10 hexanes:ethyl acetate) affords 50c (18.8 mg, 48%, TLC analysis Rf = 0.70 (70:30
hexanes:ethyl acetate) as a yellow oil and 50k (17.6 mg, 42%, TLC analysis Rf = 0.60
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(70:30 hexanes:ethyl acetate) as a yellow oil. The eluent was then switched to 85:15
DCM:EtOAc to afford a mixture of alcohols 26c (61%) and 26k (60%) (mass was
calculated using 1H NMR ratio (1:0.98 26c:26k); total mass of 26c and 26k was 43.1
mg).
Preparation of tetrafluoroborate salt 59 for x-ray crystallography

2-methoxy-5-((1S,3R)-3-phenyl-3-(((R)-1phenylethyl)carbamoyl)cyclopentyl)pyridin-1-ium tetrafluoroborate (59). A solution
of (1R,3S)-pyridinyl amide 51ke (64.9 mg, 0.162 mmol) in Et2O (4.0 mL) was treated
with HBF4 (54% in Et2O, 15 μL, 1.2 equiv), which immediately produced a light yellow
precipitate. The liquid was pipetted out and washed with Et2O (2 x 2 mL) and then dried
under vacuum to give a white solid (69.6 mg, 88%). The salt was recrystallized (5:1
TBME/ MeOH) to give off-white single crystals (59.2 mg, 85%), and an X-ray crystal
structure was obtained; [α]D20 = +25 (c 1.2, MeOH); 1H NMR (400 MHz, CDCl3) δ 8.46
(1H, dd, J = 9.1 and 2.4 Hz, r), 8.24 (1H, d, J = 2.1 Hz, u), 7.48 (1H, d, J = 9.2 Hz, s),
7.45–7.35 (4H, m, b,b’,o,o’), 7.30 (1H, tt, J = 7.0 and 1.4 Hz, p), 7.20–7.10 (3H, m,
a,b,b’), 7.01 (2H, dd, J = 7.8 and 2.1 Hz, n,n’), 5.05–4.95 (1H, m, k), 4.21 (3H, s, v),
3.40–3.30 (1H, m, h), 2.80–2.65 (2H, m, f,i), 2.60–2.40 (2H, m, f,i), 2.40–2.25 (1H, m,
g), 1.85–1.75 (1H, m, g), 1.37 (3H, d, J = 7.0 Hz, l); 13C NMR (100 MHz, CDCl3) δ
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175.96 (j), 159.80 (t), 147.81 (r), 143.77 (d), 143.42 (m), 136.91 (u), 136.89 (q), 128.35
(o,o’), 127.89 (b,b’), 126.70 (p), 126.41 (a), 126.29 (c,c’), 125.44 (n,n’), 110.24 (s), 59.40
(e), 57.26 (v), 49.07 (k), 43.40 (i), 39.73 (h), 35.70 (f), 32.89 (g), 20.64 (l); IR (neat)
3378 (N-H stretch), 1646 (C=O stretch), 1597 (C=C stretch), 1555, 1529 (N-H bend),
1495, 1444, 1330, 1303, 1060, 1014, 836, 766, 703, 643 cm-1; HRMS (ESI) calcd. for
C26H28NaN2O2 (M-HBF4+Na): 423.2048, found 423.2044 m/z.
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5.5 Other stereospecific transformations of organoboranes
Formation of -lactone via harsh oxidation of -borylated Weinreb amide

(S)-5-(3-phenylpropyl)--lactone (13). To a solution of-borylated Weinreb
amide 8c (0.264 mmol, 99 mg) in THF (5 mL) was added aq NaOH (3M, 4 mL) and
H2O2 (0.5 mL of a 30% soln.). The resultant mixture was stirred for 2h at room temp.
Sodium metabisulfite (Na2S2O5, 3 mL of a 10% aq soln.) was added and the resultant
mixture was stirred for another 15 mins before acidifying with HCl (6M). The resulting
mixture was extracted with DCM (3 x 10 mL). The combined organic extracts were dried
(anhyd. Na2SO4) and concentrated under reduced pressure. Flash chromatography on
silica gel (75:25 hexanes:ethyl acetate) affords the title compound (51 mg, 95%) as a
yellow oil; TLC analysis Rf 0.5 (75:25 hexanes:ethyl acetate); [α]D20 = -22.1o (c 1.04,
CHCl3); literature value +21.7o (c 1.04, CHCl3) for the (R)-enantiomer;13 spectroscopic
data matched with literature:14 1H NMR (400 MHz, CDCl3) δ 7.25–7.35 (2H, b,b’), 7.15–
7.25 (2H, a,c,c’), 4.45–4.60 (1H, m, h), 2.69 (2H, t, J = 6.9 Hz, e), 2.54 (2H, dd, J = 9.4
and 7.0 Hz, j), 2.25–2.40 (1H, m, i), 1.65–1.90 (5H, m, f,g,i);

13

C NMR (100 MHz,

CDCl3) δ 177.33 (k), 141.78 (d), 128.52 (b,b’,c,c’), 126.08 (a), 80.95 (h), 35.59 (e), 35.20
(g), 28.94 (j), 28.10 (i), 27.14 (f). -lactone 23 was converting to 4-hydroxy benzyl amide
9b following GP1 to confirm the er.
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C(sp3)–C(sp2) coupling of boronic ester with thiophene using NBS26

(S)-7-phenyl-4-(thiophen-2-yl)heptanecarboxylic acid morpholino amide
(45d). To a cooled (-78 oC) of thiophene (1.2 equiv, 0.3 mmol, 24 L) in THF (1 mL)
was added n-BuLi (1.2 equiv, 1.6M, 0.3 mmol, 0.19 mL) dropwise. The resultant mixture
was allowed to warm to room temp and stirred for 1h. The reaction mixture was cooled to
–78 oC again, and a solution of -borylated morpholino amide 8d (0.25 mmol, 100 mg) in
THF (0.5 ml) was added dropwise. The resulting mixture was stirred at the same
temperature for 1h and a solution of NBS (1.2 equiv, 0.3 mmol, 54 mg) in THF (1 mL)
was added dropwise. After 1h at –78 oC, satd. Na2S2O3 (1 mL) was added and the
reaction mixture was allowed to warm to room temp. The reaction mixture was diluted
with EtOAc (10 mL) and water (5 mL). The layers were separated and the aqueous layer
was extracted with EtOAc (2 x 10 mL). The combined organic extracts were dried
(anhyd. Na2SO4) and concentrated under reduced pressure. Flash chromatography on
silica gel (95:5–80:20 DCM:ethyl acetate) affords the title compound (75 mg, 84%) as a
yellow oil; TLC analysis Rf = 0.4 (80:20 DCM:ethyl acetate); [α]D20 = –9.1o (c 2.0,
CHCl3); Chiral HPLC analysis (Chiralcel-OJ-H, 100% isopropanol, flow rate = 1.0
mL/min) showed peaks at 12 minutes (5.5% (R)) and 18 minutes (94.5% (S)); 1H NMR
(400 MHz, CDCl3) δ 7.25–7.30 (2H, m, c,c’), 7.10–7.20 (4H, m, a,b,b’,r), 6.94 (1H, dd, J
= 4.9 and 3.5 Hz, q), 6.79 (1H, d, J = 3.0, p), 3.55–3.70 (6H, m, l,l’,m,m’), 3.25–3.35
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(2H, m, l,l’), 2.90–3.00 (1H, m, h), 2.55–2.65 (2H, m, e), 2.10–2.25 (3H, m, i,j), 1.55–
1.85 (5H, m, f,g,i);

13

C NMR (100 MHz, CDCl3) δ 171.51 (k), 149.02 (o), 142.43 (d),

128.50 (b,b’), 128.37 ( c,c’), 126.65 (q), 125.79 (a), 124.28 (p), 123.18 (r), 67.02 and
66.71 (m,m’), 45.92 and 41.99 (l,l’), 40.93 (h), 37.89 (g), 35.86 (e), 33.24 (i), 30.78 (j),
29.28 (f); IR (neat) 2920, 2853, 1642 (C=O stretch), 1452, 1429, 1229, 1113, 697 cm-1;
HRMS (ESI) calcd. for C21H27NNaO2S (M+Na): 380.1660, found 380.1678 m/z.
General procedure for BCl3-assisted C–B to C–N bond formation (GP17)27

(S)-4-(benzylamino)-7-phenylheptanecarboxylic

acid

morpholino

amide

(43d). To a solution of BCl3 (5 equiv, 1M, 0.5 mmol) in DCM was added dropwise at
room temp a solution of -borylated morpholino amide 8d (0.1 mmol, 40 mg) in DCM.
After a 4h stir, the reaction mixture was carefully reduced under vacuum at room temp. It
was then taken up in DCM (0.5 mL) and a solution of benzyl azide (3 equiv, 0.3 mmol,
40 mg) in DCM (0.2 mL) was added. The resultant mixture was stirred at room temp
overnight and quenched with NaOH (2M). After extractions with DCM (3 x 5 mL), the
combined organic extracts were dried (anhyd. Na2SO4) and concentrated under reduced
pressure. Flash chromatography on silica gel (20:80-0:100 hexanes:acetone) affords the
title compound (24.7 mg, 65%) as a yellow oil; TLC analysis Rf 0.2 (5:95 methanol:ethyl
acetate); [α]D20 = +7.5o (c 1.5, CHCl3); Chiral HPLC analysis (Chiralcel-OJ-H, 90:10
hexanes:isopropanol, flow rate = 1.5 mL/min) showed peaks at 18 minutes (94.0% (S))
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and 20 minutes (6.0% (R)); 1H NMR (400 MHz, CDCl3) δ 7.25–7.35 (7H, m,
c,c’,p,p’,q,q’,r), 7.15–7.25 (3H, a,b,b’), 3.70–3.80 (2H, m, n), 3.55–3.70 (6H, m,
l,l’,m,m’), 3.35–3.50 (2H, m, l,l’), 2.60–2.70 (3H, m, e,h), 2.36 (2H, t, J = 7.5 Hz, j),
1.80–1.90 (1H, m, i), 1.60–1.80 (1H, m, f,i), 1.45–1.60 (2H, m, g); 13C NMR (100 MHz,
CDCl3) δ 172.10 (k), 142.40 (d), 140.76 (o), 128.55 (b,b’), 128.51 (q,q’), 128.43 (c,c’),
128.28 (p,p’), 127.06 (r), 125.89 (a), 67.04 and 66.76 (m,m’), 56.17 (h), 50.99 (n), 46.03
and 42.03 (l,l’), 36.07 (e), 33.47 (g), 29.02 (j), 28.99 (i), 27.64 (f); IR (neat) 2934, 2854,
1640 (C=O stretch), 1452, 1430, 1114, 746, 698 cm-1; HRMS (ESI) calcd. for
C24H32N2NaO2 (M+Na): 403.2361, found 403.2363 m/z.
Formation of -lactam via C–B to C–N formation followed by acidic removal of
morpholino amide

(S)-N-phenyl-3-(phenylpropyl)--lactam (44). Following GP17 with phenyl
azide (3 equiv, 0.3 mmol, 36 mg) affords the corresponding amine, which was then taken
up in HCl (6M, 1 mL). After 6h reflux, the reaction mixture was cooled to room temp and
extracted with DCM (3 x 2 mL). The combined organic extracts were dried (anhyd.
Na2SO4) and concentrated under reduced pressure. Flash chromatography on silica gel
(80:20-40:60 hexanes:ethyl acetate) affords the title compound (19 mg, 68%) as a yellow
liquid; TLC analysis Rf 0.4 (40:60 hexanes:ethyl acetate); [α]D20 = +30.5o (c 0.74,
CHCl3); Chiral HPLC analysis ((S,S)-WHELK-O 1, 100% isopropanol, flow rate = 1.0
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mL/min) showed peaks at 9 minutes (5.5% (R)) and 17 minutes (94.5% (S)); 1H NMR
(400 MHz, CDCl3) δ 7.35–7.45 (4H, m, m,m’,n,n’), 7.20–7.30 (4H, m, a,b,b’,o), 7.12
(2H, d, J = 7.2 Hz, c.c’), 4.30–4.30 (1H, m, h), 2.50–2.70 (4H, m, e,j), 2.30–2.40 (1H, m,
i), 1.80–1.90 (1H, m, i), 1.55–1.80 (3H, m, f,g), 1.40–1.50 (1H, m, g);

13

C NMR (100

MHz, CDCl3) δ 174.46 (k), 141.83 (d), 137.71 (l), 129.15 (n,n’), 128.50 (b,b’), 128.36
(c,c’), 126.06 (o), 126.00 (a), 124.32 (m,m’), 59.78 (h), 35.71 (e), 33.08 (g), 31.41 (j),
26.50 (f), 24.07 (i); IR (neat) 2933, 1690 (C=O stretch), 1596, 1496, 1388, 1292, 1220,
752, 693 cm-1; HRMS (ESI) calcd. for C19H21NNaO (M+Na): 302.1521, found 302.1534
m/z.
Formation of 1,4-aminoalcohol via oxidation of C–B bond followed by amide
reduction with LiAlH4

(S)-1-(benzylamino)-7-phenyl-4-heptanol (47). To a solution of-borylated
benzyl amide 8b (0.3 mmol, 127 mg) in THF (5 mL) was added aq NaOH (3M, 6 mL)
and H2O2 (0.8 mL of a 30% soln.). The resultant mixture was stirred for 1h at room temp.
After extraction with DCM and concentration under reduced pressure, without further
purification, the obtained residue (crude alcohol 9b) was taken up with THF (1.5 mL). To
the cooled (0 oC) resultant mixture was added LiAlH4 (2 equiv, 0.6 mmol, 23 mg). The
reaction mixture was refluxed overnight. After cooling to room temp, the resulting
mixture was quenched with KOH (5M, 0.05 mL) and water (0.05 mL) followed by 30min stir. The reaction mixture was then filtered through a pad of celite and washed with
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EtOAc (3 x 2 mL). The filtrate was concentrated under reduced pressure. Flash
chromatography on silica gel (50:50-0:100 hexanes:acetone) affords the title compound
(84 mg, 94%) as a light yellow solid: m.p. 48.5–49.0 ºC; TLC analysis Rf 0.2 (5:95
methanol:ethyl acetate); [α]D20 = +20.4o (c 2.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ
7.20–7.40 (10H, a,b,b’,c,c’,n,n’,o,o’,p), 3.80 (2H, d, J = 1.9 Hz, e), 3.40–3.70 (2H, m,
i,OH), 2.75–2.85 (1H, m, f), 2.67 (2H, t, J = 7.7 Hz, l), 2.55–2.65 (1H, m, f), 1.65–1.90
(4H, m, h,k), 1.40–1.60 (4H, m, g,j); 13C NMR (100 MHz, CDCl3) δ 142.85 (m), 139.41
(d), 128.69 (b,b’), 128.58 (o,o’), 128.45 (n,n’), 127.35 (c,c’), 127.37 (a), 125.72 (p),
71.33 (i), 53.98 (e), 49.57 (f), 37.51 (j), 37.19 (h), 36.20 (l), 27.97 (k), 27.41 (g); IR
(neat) 3267 (N-H stretch, O-H stretch), 3084, 3026, 2868, 2827, 2813, 1495, 1451, 1363
(C-N stretch), 1346, 1118, 858, 734, 691 cm-1; HRMS (ESI) calcd. for C20H27NNaO
(M+Na): 320.1990, found 320.1990 m/z.
Vinylation of boronic ester using vinylmagnesium bromide28

(S)-7-phenyl-4-vinylheptanecarboxylic acid benzyl amide (46b). To ad
solution of -borylated benzyl amide 8b (0.15 mmol, 63 mg) in THF (1.5 mL) was added
vinylmagnesium bromide (4 equiv, 1M, 0.6 mmol, 0.6 mL) dropwise. The resultant
mixture was stirred as room temp for 30 mins. To the above solution at-78 oC was added
iodine (4 equiv, 0.6 mmol, 152 mg) in methanol (2.0 mL) dropwise. The reaction mixture
was allowed to stir 30 mins at the same temp followed by dropwise addition of a solution
of NaOMe (8 equiv, 1.2 mmol, 65 mg) in methanol (2.5 mL). After warming to room
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temp, the resultant mixture was stirred for another 1.5h. It was then diluted with pentane
(20 mL) and wash sequentially with 10% aqueous soln. of Na2S2O3 (5 mL) and water (5
mL). The organic layer was separated and the aqueous layer was washed with pentane (2
x 10 mL). The combined organic layers were dried (anhyd. Na2SO4) and concentrated
under reduced pressure. Flash chromatography on silica gel (80:20-60:40 hexanes:ethyl
acetate) affords the title compound (45 mg, 93%) as a colorless oil; TLC analysis Rf 0.5
(50:50 hexanes:ethyl acetate); [α]D20 = –4.1o (c 2.0, CHCl3); Chiral HPLC analysis
(Chiralcel-OJ-H, 90:10 hexanes:isopropanol, flow rate = 1.0 mL/min) showed peaks at 18
minutes (4.0% (R)) and 22 minutes (96.0% (S)); 1H NMR (400 MHz, CDCl3) δ 7.35–7.40
(2H, m, b,b’), 7.25–7.35 (5H, a, n,n’,o,o’), 7.15–7.25 (3H. c,c’,p), 5.76 (1H, br s, NH),
5.50 (1H, dt, J = 17.0 and 9.6 Hz, q), 5.02 (1H, dd, J = 10.1 and 1.6 Hz, r), 4.96 (1H, dd,
J = 17.1 and 1.5 Hz, r), 4.45 (2H, dd, J = 5.1 and 4.0 Hz, e), 2.50–2.70 (2H, m, l), 2.20–
2.30 (1H, m, g), 2.10–2.20 (1H, m, g), 1.95–2.10 (1H, m, i), 1.80–1.90 (1H, m, k), 1.50–
1.75 (3H, m, h,k), 1.40–1.50 (1H, m, j), 1.30–1.40 (1H, m, j);

13

C NMR (100 MHz,

CDCl3) δ 172.96 (f), 142.72 (q), 142.36 (m), 138.54 (d), 128.83 (o,o’), 128.53 (b,b’),
128.38 (n,n’), 127.98 (c,c’) 127.63 (a), 125.76 (p), 115.58 (r), 43.96 (i), 43.71 (e), 36.03
(l), 34.77 (j), 34.59 (g), 30.69 (k), 29.13 (h); IR (neat) 3275 (N-H stretch), 3063, 3027,
2925, 2856, 1641 (C=O stretch), 1541, 1495, 1453, 911, 745, 696 cm-1; HRMS (ESI)
calcd. for C22H27NNaO (M+Na): 344.1990, found 344.1996 m/z.
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5.6 Preparation of chiral ligands and palladium pre-catalyst
General precedures for preparation of effective BINOL-derived phospharamidite
ligands (GP18).

Preparation of (BINOL)PN(Bn)Ph (B2). To a cooled (0 oC) of N-benzylaniline (1.41 g,
1.1 equiv, 7.7 mmol) and TEA (1.8 mL, 1.84 equiv, 12.9 mmol) in THF (50 mL) was
added PCl3 (0.67 mL, 1.1 equiv, 7.7 mmol) dropwise. The resultant mixture was refluxed
for 6 h and slowly cooled to -78 oC. A solution of (R)-BINOL (2.0 g, 7.0 mmol) and TEA
(3.5 mL, 3.6 equiv, 25.2 mmol) in THF (35 mL) was then added slowly to the above
mixture at -78 oC. The resulting mixture was stirred at rt overnight, then filtered through
a pad of celite, and washed with THF. The organic phase was concentrated under reduced
pressure. Flash chromatography on silica gel (80:20–70:30 hexanes:DCM) affords the tile
compound (3.01 g, 86%) as a white foamy solid: mp 99.5–100.0 oC; TLC analysis Rf =
0.6 (50:50 hexanes:DCM); [α]D20 = –165o (c 1.0, CHCl3); 31P NMR (121 MHz, CDCl3) δ
140.95; 1H NMR (300 MHz, CDCl3) δ 8.05 (1H, d, J = 8.8 Hz), 8.00–7.90 (3H, m), 7.67
(1H, dd J = 8.8 and 0.5 Hz), 7.50–7.40 (5H, m), 7.35–7.25 (6H, m), 7.25–7.05 (6H, m),
4.56 (1H, dd, J = 15.7 and 2.1 Hz), 4.06 (1H, dd, J = 15.7 and 1.6 Hz); 13C NMR (75
MHz, CDCl3) δ 149.56 (JCP = 4.9 Hz), 149.15, 143.78, 143.47, 138.45, 132.87, 132.64,
131.58, 130.89, 130.48, 130.27, 129.09, 128.41, 128.34, 128.10, 127.84, 127.08, 126.99,
126.73, 126.24, 125.02, 124.82, 124.71, 124.55, 124.32, 124.18, 124.11, 122.69, 122.08,
121.71, 50.37; IR (neat) 3052, 1618, 1589, 1489, 1462, 1359, 1324, 1223, 1096, 1063,
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947, 819, 747, 692 cm-1; HRMS (EI) calcd. for C33H24NO2P (M): 497.1545, found
497.1545 m/z.

(BINOL)PN(Bn)Ph (B1). Following GP18 with aniline (0.7 mL, 1.1 equiv, 7.7
mmol) affords, after flash chromatography on silica gel (75:25 hexanes:DCM), the title
compound (2.42 g, 82%) as a white foamy solid; TLC analysis Rf 0.6 (75:25 hexanes:
DCM); 31P NMR (162 MHz, CDCl3) δ 139.14; 1H NMR (400 MHz, CDCl3) δ 8.03 (1H,
d, J = 8.8 Hz), 7.90–8.00 (3H, m), 7.55–7.60 (1H, m), 7.40–7.50 (4H, m), 7.41–7.25 (7H,
m), 7.10–7.15 (1H, m), 2.67 (3H, d, J = 2.5 Hz); 13C NMR (100 MHz, CDCl3) δ 149.89,
149.18, 146.39, 146.13 132.86, 132.64, 131.53, 130.90, 130.49, 130.24, 129.17, 128.39,
128.33, 127.02, 126.93, 126.22, 124.98, 124.79, 124.07, 123.23, 122.72, 121.83, 121.28,
121.12, 33.53 (JCP = 4.02 Hz).

(BINOL)PN(Ph)Ph (B7). Following GP18 with diphenyl amine (170 mg, 1.1 equiv, 1.1
mmol) affords, after flash chromatography on silica gel (75:25 hexanes:DCM), the title
compound (343 mg, 71%) as a white foamy solid; TLC analysis Rf 0.6 (75:25 hexanes:
DCM); 31P NMR (162 MHz, CDCl3) δ 143.76; 1H NMR (400 MHz, CDCl3) δ 8.01 (1H,
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d, J = 8.8 Hz), 7.95 (1H, d, J = 8.2 Hz), 7.81 (1H, d, J = 8.1 Hz), 7.59 (1H, d, J = 8.8 Hz),
7.54 (1H, d, J = 8.8 Hz), 7.43 (2H, dt, J = 18.6 and 7.6 Hz), 7.20–7.40 (6H, m), 7.05–
7.20 (9H, m), 6.95–7.05 (3H, m) ;

C NMR (100 MHz, CDCl3) δ 149.97, 149.90,

13

148.84, 145.02, 144.92, 143.27, 133.00, 132.41, 131.65, 130.55, 129.49, 129.37, 128.87,
128.48, 128.09, 127.23, 126.86, 126.61, 126.54, 126.29, 125.91, 125.10, 124.73, 124.57,
124.50, 124.45, 122.03, 121.85, 121.14, 117.96.
Preparation sequence of Palladium-precatalyst 52.29

2-Ammoniumbiphenyl mesylate.29 To a solution of 2-aminobiphenyl (2.54 g, 15.0
mmol, 1.0 equiv) in diethyl ether (50 mL) was added a solution of methanesulfonic acid
(0.97 mL, 15.0 mmol, 1.0 equiv) in diethyl ether (8 mL). After 30 min of stir, the
resultant mixture was filtered and washed with diethyl ether (2 x 10 mL). The precipitate
was dried under vacuum to provide the title compound (3.97 g, 99%) as a white solid: mp
152.5–153.0 ºC; 1H NMR (400 MHz, CDCl3) δ 9.17 (3H, br s, NH3), 7.50 (1H, dd, J =
7.9 and 0.8 Hz), 7.45–7.35 (6H, m), 7.35–7.25 (2H, m), 2.38 (3H, s);

13

C NMR (100

MHz, CDCl3) δ 136.76, 136.18, 131.16, 129.42, 128.97, 128.65, 128.24, 128.19, 124.42,
38.85.
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μ-OMs dimer.29 The solution of 2-ammoniumbiphenyl mesylate (789 mg, 3.0 mmol, 1.0
equiv) and Pd(OAc)2 (672 mg, 3.0 mmol, 1.0 equiv) in 12 mL anhydrous toluene was
stirred at 50 oC for 1 h. After cooling to room temp, the suspension was filtered, washed
with toluene (5 mL) and diethyl ether (3 x 5 mL) and dried under vacuum for 24 h to
afford the title compound (1.01 g, 91%) as an off-white solid: mp 200.5–202.0 ºC; 1H
NMR (400 MHz, CD3CN) δ 7.65–7.55 (1H, m), 7.48 (1H, dd, J = 7.5 and 1.2 Hz), 7.45–
7.35 (1H, m), 7.35–7.25 (2H, m), 7.22 (1H, d, J = 7.6 Hz), 7.18 (1H, t, J = 7.4 Hz), 7.08
(1H, td, J = 7.6 and 1.4 Hz), 6.38 (2H, br s), 2.58 (3H, s); 13C NMR (100 MHz, CD3CN)
δ 139.19, 138.83, 136.81, 136.39, 135.55, 127.89, 127.86, 127.18, 126.28, 126.14,
125.22, 120.49, 39.10.

Preparation of Pd-precatalyst (52). The solution of μ-OMs dimer (370 mg, 0.5 mmol,
0.5 equiv) and nBuPAd2 (359 mg, 1.0 mmol, 1.0 equiv) in anhydrous THF (5 mL) was
stirred at room temp for 1 h. The solvent was then concentrated under reduced pressure at
room temp until ~ 0.5 mL remained. The residue was then added pentane (5 mL) to
crystalize out the product. The solvent was removed by pipet and the solid was dried
under vacuum to afford the title compound (671 mg, 92%) as an off-white solid: mp
219.0–220.5 ºC;

31

P NMR (283 MHz, CDCl3) δ 47.97; 1H NMR (700 MHz, CDCl3) δ
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7.45–7.35 (3H, m), 7.30–7.20 (3H, m), 7.16 (1H, t, J = 7.4 Hz), 7.08 (1H, t, J = 7.2 Hz),
7.01 (1H, t, J = 7.3 Hz), 4.18 (1H, br s), 2.83 (3H, s), 2.30–2.15 (6H, m), 2.10–2.00 (9H,
m), 2.85–2.75 (9H, m), 1.65–1.55 (7H, m), 1.45–1.35 (1H, m), 1.10–1.00 (1H, m), 0.95–
0.90 (1H, m), 0.60 (3H, t, J = 7.2 Hz), 0.60–0.50 (1H, m), 0.40–0.20 (1H, m); 13C NMR
(176 MHz, CDCl3) δ 140.16, 137.58 and 137.55, 136.63 and 136.61, 128.12, 127.63,
126.91, 125.33, 125.26, 124.65, 119.83, 41.34 and 41.26, 40.55 and 40.45, 40.08, 39.87,
36.65 and 36.46, 28.84 and 28.79, 28.65 and 28.61, 27.73, 25.41 and 25.34, 17.63 and
17.51, 13.80 (observed complexity due to P-C splitting). IR (neat) 2898, 2841, 1611,
1492, 1419, 1341, 1300, 1249, 1239, 1166, 1141, 1034, 1021, 771, 754, 735, 709 cm-1;
HRMS (ESI) calcd. for C36H49NPPd (M-OMs): 632.2637, found 632.2637 m/z.
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